Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.9132002186477342,1.875462849779282,0.0,0.10454602536732387,0.13,4/11,5.82%,PRIMPOL;ATR;THOC1;FAM111A
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.8242408911883521,-1.777316311253841,0.0,0.0,0.0,24/73,5.71%,MAFF;SERPINE1;DDIT4;ANGPTL4;BHLHE40;ADM;NDRG1;LDHA;PCK1;PGK1;ATF3;DTNA;KLF6;ERO1A;BNIP3L;SLC6A6;AKAP12;JUN;SLC2A3;FOS;HSPA5;GAPDH;CDKN1B;DUSP1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.8106527181408894,1.7493740099830961,0.0,0.41121436644480724,0.62,6/13,14.21%,PRIMPOL;ATR;THOC1;FAM111A;MSH3;MCM9
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),0.7349841395128827,1.6977456139495937,0.0,0.6365691322365942,0.92,3/20,5.82%,RSAD2;EIF2AK2;FAM111A
prerank,MSigDB_Hallmark_2020__Coagulation,-0.813202695378664,-1.6973254042124344,0.0,0.10675142256625827,0.17,10/30,10.94%,MAFF;SERPINE1;CD9;TIMP3;LAMP2;RAPGEF3;PECAM1;ANXA1;VWF;CFH
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.8540615448352499,1.6553638619633955,0.0,0.8590198417681778,0.99,3/10,3.72%,RSAD2;HOMER1;IL15
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.8679518637832909,1.6387592256872967,0.0625,0.8781866130855205,0.99,2/7,5.26%,ARID5B;TGFBR3
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.7681889291153027,1.6315641370701712,0.0,0.7991962828079869,0.99,4/22,5.82%,UBP1;RSAD2;EIF2AK2;FAM111A
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.7470112976837406,-1.623163877691493,0.0,0.5431212727055245,0.67,20/67,9.14%,PIK3R3;DDIT4;PSMC6;BHLHE40;BTG2;LDHA;PGK1;ERO1A;SLC6A6;PPA1;SLC2A3;CD9;HSPA5;GAPDH;CANX;GMPS;SLC2A1;PNP;PLOD2;STARD4
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.8588646814246437,-1.615658435226496,0.0136986301369863,0.5253293689444815,0.75,1/13,0.37%,DDIT4
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.7404733148378146,-1.6105170087919822,0.0,0.4921802429896961,0.78,26/67,15.14%,RPS18;RPS12;RPL23;PPA1;RPL34;RPS9;RPS27A;RPL37;EEF1A1;RRBP1;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;PPA2;RPL37A;LARS1;RPL24;RPL7A;RPLP1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.8328989648577227,1.6034857028461371,0.03225806451612903,0.9598320805152402,1.0,1/7,4.52%,OTUD4
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.7669401407353786,-1.6022696662337153,0.0,0.5131559611079782,0.84,34/70,17.32%,MAFF;SERPINE1;BHLHE40;BTG2;NR4A1;ATF3;KLF6;HES1;JUN;SLC2A3;JUNB;FOS;ATP2B1;NFE2L2;DUSP1;KLF2;IFNGR2;REL;BCL6;FOSL2;KLF4;SOD2;ZFP36;DUSP5;NFKBIA;CDKN1A;CCNL1;SMAD3;BTG1;MCL1;SLC16A6;PNRC1;B4GALT1;TSC22D1
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.8591636038609861,1.591241199384083,0.02857142857142857,0.9687931684038679,1.0,1/8,1.99%,UIMC1
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7541382899630102,-1.5848565840144666,0.0,0.6196398362492586,0.92,25/60,15.14%,RPS18;RPS12;RPL23;RPL34;RPS9;DMD;RPS27A;RPL37;EEF1A1;RRBP1;GGT5;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL24;RPL7A;RPLP1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.5995482440095337,1.5790991891824753,0.0,1.0,1.0,9/47,9.83%,RSAD2;SAMD9L;GBP2;GBP4;IL15;EIF2AK2;NCOA7;IFI44;DDX60
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),-0.7682891041429183,-1.5743466103529549,0.0,0.6700056390013841,0.94,4/49,2.47%,PIK3R3;PKM;PCK1;PPARG
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.8533272085670718,-1.5718608050768785,0.015625,0.6242773249488788,0.94,7/15,8.13%,SERPINE1;VSIR;SPOCK1;PSMB9;GAPDH;TIMP3;SERPINB6
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.7345284962261852,-1.5713590528324317,0.0,0.5719628851181627,0.95,15/81,7.01%,PIK3R3;SERPINE1;LAMC1;BHLHE40;MGLL;YTHDC1;PPARG;GRK5;MAP1B;ATP2B1;SMAD7;CDKN1B;DUSP1;MAGI2;PRKCE
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.8519440613979103,-1.567506716137745,0.0,0.5598065030268854,0.95,9/16,9.19%,MAFF;SERPINE1;BHLHE40;NFKBIZ;LGALS3;TINAGL1;FOSL2;CD55;KLF4
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.8652667883470138,-1.5660248516680355,0.012658227848101266,0.530011448881598,0.96,2/17,1.86%,DIXDC1;WNT2B
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.8245665817702518,-1.5616136868691486,0.0,0.5255454649415792,0.98,3/18,3.56%,MAP3K5;BCAP31;GRIN2B
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.7241698037314047,-1.5575375505083524,0.011363636363636364,0.5265333323568829,0.98,16/71,8.47%,TBX3;DDIT4;NRCAM;GRIK1;PBX3;SPOCK1;GRIN2B;NES;BTD;SEMA6B;ELP3;SMARCA1;MBP;SLC2A1;PRKN;NPAS2
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.7121028819747712,1.5565274513452132,0.041666666666666664,1.0,1.0,4/19,3.35%,PLA2G4A;IL1R1;OCLN;NKD1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),-0.9102144345545422,-1.5563633886171002,0.014285714285714285,0.5011698364689599,0.98,1/9,0.16%,TBX3
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.7469682180336821,-1.5498578222533634,0.0,0.5337571128312913,0.98,23/51,19.10%,RPS18;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPL13A;RPL15;RPL37A;RPL24;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.9002989165670864,-1.5477891307786296,0.0,0.5221896212219445,0.98,3/13,2.31%,MAP2;NRCAM;RTN4
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.9178156336990406,-1.547098427370069,0.0,0.5000461372840519,0.98,2/11,2.82%,TBX3;HES1
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.9578478415957563,-1.543258813046441,0.0,0.4876854462500641,0.98,1/8,0.16%,TBX3
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.9578478415957563,-1.543258813046441,0.0,0.4876854462500641,0.98,1/8,0.16%,TBX3
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.8369668178738696,1.5415958211490768,0.034482758620689655,1.0,1.0,1/7,6.08%,SMYD3
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.6738845317389391,1.5413113408317307,0.029411764705882353,1.0,1.0,6/17,14.21%,PSMD14;INO80;RAD51B;SEM1;SPIDR;MCM9
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.7352478381754087,1.5407284774278565,0.06451612903225806,1.0,1.0,4/12,14.56%,PRIMPOL;ERCC6;CIRBP;CLOCK
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),-0.7816566011191581,-1.537696987556096,0.0,0.5169016250576716,0.98,1/33,0.05%,PIK3R3
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.8513610669769436,1.53763224490901,0.02631578947368421,1.0,1.0,2/6,3.27%,PACS2;ATP2A2
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.7936016486463868,1.5330216416170523,0.043478260869565216,1.0,1.0,3/13,3.24%,BMP6;PRKD1;IL6R
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.7779682438263396,-1.526742467616673,0.025,0.6144591452019554,0.98,6/27,12.22%,CEP57;NR4A1;HYAL2;KIF16B;FGFR1;ZFP36
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.8305426882549302,1.5251511155145079,0.0,1.0,1.0,2/10,2.79%,GULP1;ARHGAP12
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.837360614027884,-1.5239511573742066,0.012658227848101266,0.6131489030693552,0.99,3/17,4.70%,MAP2;KDM1A;GPC5
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.7542955438500405,-1.5218204477232802,0.013157894736842105,0.6156935117308316,0.99,10/28,12.75%,ENPP2;GLUL;GRIA2;GAS7;TMEM132C;SLC8A1;TNS1;VWF;PLXDC2;PLP1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.9247896147483392,1.5202599013534879,0.05555555555555555,1.0,1.0,2/6,0.98%,GBP2;GBP4
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.7076574316353842,-1.5132420165955685,0.0,0.6944460962731327,0.99,18/63,12.46%,MAFF;BHLHE40;NDRG1;KLF6;NFKBIZ;SLC2A3;IFNGR1;EMP1;AHNAK;SERPINB6;PNP;PHTF2;CD81;TGM2;PRNP;PLIN2;GABARAPL1;PLEC
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.9729269842240502,-1.5118766645151618,0.030303030303030304,0.6897784227358227,0.99,1/5,0.19%,CCDC3
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.7749988342783746,1.5107679287342006,0.0625,1.0,1.0,2/8,13.84%,YEATS2;KAT6B
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.8071747484328591,-1.507306538689344,0.013333333333333334,0.7249940667072978,0.99,1/22,0.11%,CEP57
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.8519483570953704,-1.507185688980956,0.014285714285714285,0.7007067060176201,0.99,2/14,3.88%,SERPINE1;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.7040036750435396,-1.5069777689453783,0.0,0.6788693006754428,0.99,9/65,7.92%,PIK3R3;SUN2;NEDD9;VSIR;HSPA5;SEMA6B;ELP3;FLT1;PECAM1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.8373742710164711,-1.5059794327453424,0.0410958904109589,0.6667281830454025,0.99,4/12,7.60%,CLIC2;CX3CL1;DMD;ANK2
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.8169849328473278,-1.5047254259095015,0.025974025974025976,0.6586327157992913,1.0,1/17,0.05%,PIK3R3
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7369042005445825,-1.5035218054236188,0.0,0.6556082431947506,1.0,24/51,19.10%,RPS18;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL24;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),-0.8217647486454157,-1.5028053596503756,0.013888888888888888,0.6432326546336902,1.0,2/18,5.37%,TBX3;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.6691351700227726,-1.502660778120435,0.010638297872340425,0.6259665459457993,1.0,15/90,9.83%,PIK3R3;SUN2;NEDD9;VSIR;RTN4;ENPP2;HSPA5;SEMA6B;ELP3;PRKCE;FLT1;HIF1A;PECAM1;RREB1;SOD2
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.8957190598149103,-1.5016822238921037,0.01639344262295082,0.6002426479383469,1.0,1/9,0.29%,LAMC1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.8957190598149103,-1.5016822238921037,0.01639344262295082,0.6002426479383469,1.0,1/9,0.29%,LAMC1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.7317926232875996,-1.4986170383026973,0.0,0.6137827169456841,1.0,22/54,15.14%,RPS18;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPL10;TRAM1;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL24;RPL7A;RPLP1
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.9458750932265803,-1.496578860049779,0.0,0.6186259723230257,1.0,1/6,1.62%,PRKAG2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.9405697841168081,-1.495876865734784,0.015873015873015872,0.6102550958038733,1.0,2/6,3.61%,GRIN2B;PSMB9
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),0.8444168426260446,1.4936013838186062,0.05263157894736842,1.0,1.0,5/6,14.56%,ATR;ERCC6;ATM;STK33;CLOCK
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.9083552496433587,-1.489200891408578,0.0,0.6610160455221203,1.0,4/10,6.53%,ADAMTS9;HES1;SMAD7;FOXF1
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.9851079770626494,-1.4885123367014033,0.0,0.6561306947974899,1.0,1/5,0.11%,CEP57
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.9839929597221411,-1.4880729476671264,0.0,0.6453243890471552,1.0,1/5,0.05%,PIK3R3
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.8631204883421055,-1.4872392036346274,0.0273972602739726,0.6394632338301933,1.0,2/15,2.47%,CCDC3;PPARG
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),-0.8622386735272395,-1.4872232827879504,0.03125,0.6249299785158707,1.0,5/11,8.13%,SERPINE1;SPOCK1;GAPDH;TIMP3;SERPINB6
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.9531264966332116,-1.4869980073163152,0.0,0.6137894658897376,1.0,3/6,4.01%,PCK1;PGK1;GAPDH
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.8016901401377844,-1.4849754831992934,0.014084507042253521,0.6195002462884004,1.0,6/22,6.24%,MTHFD1L;LDHA;PPARG;SCP2;BTD;GGT5
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.8841207622861706,-1.4846197628342572,0.028985507246376812,0.609905663978779,1.0,1/7,0.16%,TBX3
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.8126162103408838,-1.483642433656619,0.0136986301369863,0.607031663847166,1.0,3/14,4.59%,ST18;SLC4A10;GRIA2
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.9276987558795273,-1.4832556383800677,0.016129032258064516,0.5976245052796327,1.0,1/6,2.34%,SLC6A6
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.6253492812658159,1.4808897334511804,0.04,1.0,1.0,3/25,5.82%,RSAD2;EIF2AK2;FAM111A
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.7109249174987042,-1.480823376325549,0.012345679012345678,0.6110676167529605,1.0,6/47,10.12%,PIK3R3;CDKN1B;ARF1;VAV3;SLC2A1;CFL1
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.724269110524769,-1.480548036358027,0.011494252873563218,0.6015095636860373,1.0,26/55,19.84%,RPS18;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL24;RPL7A;RPLP1;RPS28;RPL31;RPS19;CHMP4B;SPCS3
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.8739241714949736,1.4805122194771256,0.07317073170731707,1.0,1.0,1/6,1.54%,ATG10
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.938602382705573,-1.4787423788476852,0.0,0.6076619438387009,1.0,3/7,4.01%,PCK1;PGK1;GAPDH
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.7752299502906513,-1.4770077325252002,0.05263157894736842,0.6131581212743176,1.0,4/17,9.61%,ADAMTS9;DENND3;PRKN;NGLY1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.9560542205860282,-1.4739140704636795,0.014925373134328358,0.6307281906400171,1.0,1/6,0.37%,DDIT4
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),-0.8173340840110426,-1.4729417886802578,0.012658227848101266,0.6290672346057592,1.0,8/22,11.00%,DDIT4;MAP3K5;SLC6A6;GRIN2B;FOS;CDKN1B;PRNP;EFNB2
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),0.8430582200391239,1.4727797658314945,0.02631578947368421,1.0,1.0,4/5,14.56%,ATR;ERCC6;ATM;CLOCK
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.7774093232883538,1.4722351577885096,0.027777777777777776,1.0,1.0,2/11,1.81%,CREB5;UBE3D
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.6797185281742838,-1.4720466282245204,0.0,0.6282682407048019,1.0,18/76,15.59%,TBX3;NR4A1;RPL23;JUN;GRK5;JUNB;CDKN1B;JUND;DUSP1;MAGI2;RASSF1;CRLF3;CDKN1A;SDCBP;CYLD;SMAD3;CDK6;RACK1
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.7191292315339913,-1.471881570369806,0.0,0.6190202527387829,1.0,14/40,12.56%,CCDC3;MAP2;DOK5;ADM;MAP1B;NES;NFASC;PTPRD;ANK2;SHC2;STOX2;GJA1;DCLK1;ADGRL3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.8931721876757887,-1.4717094220826794,0.03225806451612903,0.6093161959544142,1.0,5/9,7.49%,ATF3;HSPA5;NFE2L2;KLF2;HIF1A
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.8655805151480557,1.4661866081845123,0.02564102564102564,1.0,1.0,3/7,6.85%,STX8;GBP1;ZDHHC2
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.7257025881824171,-1.4651603791805008,0.024390243902439025,0.6639348065405466,1.0,14/32,18.83%,MAP2;RTN4;ESR2;CDKN1B;BCL6;HYAL2;CRLF3;GJA1;CDKN1A;SMAD3;BTG1;RACK1;ADAM15;ACVRL1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.763322180792041,-1.4647683495506223,0.02564102564102564,0.6575513063686539,1.0,5/18,7.81%,MTHFD1L;SLC2A3;BTD;SLC52A3;SLC2A1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.9016750721633178,-1.46453088169068,0.0,0.6489823325296425,1.0,3/8,4.01%,PCK1;PGK1;GAPDH
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.948054050120574,-1.4634314039325116,0.015151515151515152,0.6484831747743159,1.0,1/5,1.62%,PRKAG2
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),-0.917783112235113,-1.4633503220901634,0.017543859649122806,0.6394383456976372,1.0,2/7,2.47%,PRKAG2;PPARG
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.937132558757795,-1.4629532978142945,0.0,0.6336609934895167,1.0,3/6,3.19%,RIMKLB;GLUD1;GLUL
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.7187201017771864,-1.462047282169508,0.03571428571428571,0.6332477098950673,1.0,7/30,9.54%,SERPINE1;ADAMTS9;PGK1;PPARG;KLF2;KLF4;ADAMTS1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.9056483266915627,-1.4614998851571885,0.014285714285714285,0.6277392264781406,1.0,2/8,3.88%,SERPINE1;LGALS3
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,-0.8048622323879794,-1.461331682571627,0.041666666666666664,0.6203825798469589,1.0,4/16,4.59%,MAP2;RTN4;GRIN2B;GRIA2
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.8686109777721179,-1.460048815939083,0.02857142857142857,0.6248097967848645,1.0,1/11,0.32%,MAP2
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.9092450215434277,-1.4598203738967759,0.0,0.6172202769277174,1.0,1/7,0.24%,SERPINE1
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.6855482626218988,-1.459491787855981,0.012658227848101266,0.6112923565899421,1.0,12/56,10.49%,SERPINE1;LAMC1;ADAMTS9;GPM6B;LAMA5;COL18A1;PECAM1;PLOD2;ITGA10;VWF;ADAMTS1;ITGB5
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6978748407221268,-1.459340250715242,0.0,0.6039487450153321,1.0,21/60,15.14%,RPS18;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL24;RPL7A;RPLP1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.9644221658146839,-1.4586337435129793,0.015873015873015872,0.6011790639257703,1.0,3/6,3.19%,RIMKLB;GLUD1;GLUL
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.6482117282588195,-1.4584769018694477,0.0,0.5941751854444944,1.0,21/140,9.99%,PIK3R3;SERPINE1;SUN2;NEDD9;VSIR;CX3CL1;ENPP2;HSPA5;SMAD7;SEMA6B;ELP3;ERBB4;MAGI2;FLT1;PECAM1;TPM1;ANXA1;DLC1;TMSB4X;SOD2;AFDN
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.6392175428938874,-1.4569837499324882,0.0,0.5998124027549362,1.0,23/142,14.50%,PIK3R3;CEP57;DDIT4;NEDD9;GRIN2B;FES;ERBB4;PIK3R1;FLT1;VAV3;SULF2;ANKS1B;KIF16B;SHC2;EFNB2;FGFR1;ARPC2;PAK2;CASS4;BCAR1;SDCBP;VEGFC;NCK1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.7509194523773062,-1.4549320843879179,0.012048192771084338,0.6111425300319544,1.0,6/28,8.29%,CCDC3;PCK1;PRKAG2;PPARG;LSS;SIN3B
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),-0.9367930839103579,-1.4544813297396442,0.04838709677419355,0.6069454150062191,1.0,2/5,2.31%,NRCAM;RTN4
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.7108029493929529,-1.4539140766970429,0.03614457831325301,0.604170730586889,1.0,7/27,9.40%,RFC3;RPS27A;POLA1;HMGN1;COMMD1;UBC;CCNH
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.6997190063951673,-1.4538746289814501,0.03529411764705882,0.5967130799857513,1.0,15/50,20.48%,TBX3;PPARG;HES1;ABCA5;SMAD7;ZFPM2;NFKBIA;TRIB2;SMAD3;WWTR1;CDK6;NOTCH4;GATA2;EGFR;SPRED1
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.7554988135481487,-1.4538650179486954,0.0,0.5891597498593494,1.0,7/34,3.85%,DDIT4;ANGPTL4;PKM;LDHA;PGK1;ERO1A;HSPA5
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),-0.6393535425045912,-1.452124107918379,0.0,0.5983698159635003,1.0,22/106,9.03%,TBX3;RAPGEF5;NRCAM;GRIK1;ZEB2;HES1;SPOCK1;NES;NFASC;BTD;SEMA6B;SPG7;ELP3;GPM6B;FEZ2;ERBB4;PRX;MBP;SLC2A1;PRKN;NPAS2;LSAMP
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.8458283465019534,-1.4500571737360137,0.043478260869565216,0.6109594086833027,1.0,3/10,7.30%,PIK3R3;PIK3R1;FLT1
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),-0.9541547506446242,-1.4462657831016144,0.031746031746031744,0.6384529881080838,1.0,1/5,0.50%,B3GNT2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.874168929356177,1.4459239028322493,0.02702702702702703,1.0,1.0,1/5,0.16%,BMP6
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.9020258577080977,-1.4457621974734705,0.0,0.6363115866346402,1.0,2/6,1.91%,PGK1;VSIR
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.8367278755460116,1.4451330393029114,0.11428571428571428,1.0,1.0,1/5,2.28%,RC3H1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.8661965946836426,-1.4448120040015966,0.015384615384615385,0.6368966451603453,1.0,1/11,0.24%,SERPINE1
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.7703289514730852,-1.4443682040889738,0.05128205128205128,0.6335019404798881,1.0,5/16,9.40%,RFC3;RPS27A;HMGN1;UBC;CCNH
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.6882758355838287,1.4403699698672394,0.03125,1.0,1.0,2/14,3.19%,FAXDC2;TNRC6C
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.5892139802129663,1.4400879524143497,0.05263157894736842,1.0,1.0,3/16,3.24%,SAMD9L;GBP2;IL6R
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),0.73091900192334,1.4390545117116478,0.037037037037037035,1.0,1.0,4/12,4.52%,PSMD14;UIMC1;USP25;OTUD4
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.7341574520693251,-1.4386015979235252,0.04819277108433735,0.6768327648631797,1.0,11/36,15.43%,LBR;RFC3;PPM1D;RAD21;CDKN1B;SPC25;IPO7;CBX5;CDKN1A;SMC6;SMC3
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),-0.9181508438839998,-1.4383245386722427,0.0,0.6706030078209473,1.0,3/6,7.60%,SMAD7;DMD;ANK2
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.8704789654114604,-1.4383020710099577,0.03389830508474576,0.6632379052740974,1.0,3/7,10.84%,HES1;ERBB4;CRLF3
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.7409937006394922,-1.4381538563517335,0.023529411764705882,0.657174635668095,1.0,19/48,15.46%,DDIT4;BHLHE40;NRCAM;WNT2B;CX3CL1;HES1;SPOCK1;MAP1B;ELP3;PTPRD;SMARCA1;IL1RAPL1;GPM6A;FGFR1;ADGRL3;NAV1;MYEF2;PAFAH1B1;CDK6
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.640762506138191,-1.4368825958895095,0.0,0.6592368551460159,1.0,35/125,15.14%,LAMC1;RPS18;DENND3;ERO1A;RPS12;RPL23;RPL34;RPS9;SPG7;RPS27A;RPL37;EEF1A1;RRBP1;MGAT4A;RPS11;SHISA5;PRKN;MSRB3;PLOD2;RPL10;RPS27;RPS6;MSRA;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;CST3;RPL37A;STK38;RPL24;RPL7A;RPLP1
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.8404607683219519,1.4362490449846046,0.08823529411764706,1.0,1.0,1/5,1.65%,PLA2G4A
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.8404607683219519,1.4362490449846046,0.08823529411764706,1.0,1.0,1/5,1.65%,PLA2G4A
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.8834830842196976,-1.4352460024628657,0.0136986301369863,0.6660696047685334,1.0,2/10,1.75%,PIK3R3;NR4A1
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.9408026572577564,-1.4338747045319857,0.014084507042253521,0.6688452974517509,1.0,1/6,0.85%,BHLHE40
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.9577972199811304,-1.433329614658287,0.01639344262295082,0.6660032158293329,1.0,1/6,0.53%,PSMC6
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.8256196220744374,-1.433235714603143,0.09210526315789473,0.6595157875678016,1.0,4/9,8.50%,PCK1;VSIR;BCL6;PNP
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.8338442974965707,1.4328847356457306,0.0625,1.0,1.0,3/6,12.93%,ABL1;MTERF1;TOP2B
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.7008874914674299,-1.4318472539150935,0.025974025974025976,0.6573640231711694,1.0,10/43,10.49%,SERPINE1;LAMC1;ADAMTS9;LAMA5;COL18A1;PECAM1;ITGA10;VWF;ADAMTS1;ITGB5
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.7008874914674299,-1.4318472539150935,0.025974025974025976,0.6573640231711694,1.0,10/43,10.49%,SERPINE1;LAMC1;ADAMTS9;LAMA5;COL18A1;PECAM1;ITGA10;VWF;ADAMTS1;ITGB5
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.8252303430840138,-1.4305517071080482,0.0684931506849315,0.6606656135598165,1.0,2/14,1.75%,PIK3R3;NR4A1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),-0.9495711529413178,-1.4305314861056764,0.01639344262295082,0.6540387908892987,1.0,2/6,2.31%,MAP2;RTN4
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.9572159289043713,-1.4285801491640477,0.0,0.6655931333636773,1.0,4/5,4.01%,PKM;LDHA;PGK1;GAPDH
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.8728159818958445,-1.4284818156539822,0.0,0.6594990516224946,1.0,1/11,0.16%,TBX3
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.7050261409555479,-1.427652592437434,0.033707865168539325,0.6608686295399417,1.0,18/51,17.32%,DDIT4;BTG2;NDRG1;ATF3;RPS12;JUN;FOS;PPM1D;JAG2;CD81;KLF4;CDKN1A;BTG1;UPP1;RACK1;STOM;BLCAP;TSC22D1
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.9476351135502636,-1.4273593902584227,0.0,0.6564826904771239,1.0,4/6,4.01%,PKM;LDHA;PGK1;GAPDH
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6970376283496406,-1.4263209876831566,0.022988505747126436,0.6589459297907,1.0,22/53,19.10%,RPL23;RPL34;GLUL;RPS9;RPL37;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;NPM1;RPL37A;RPL24;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.8645342205748143,-1.425388709863698,0.06349206349206349,0.6595249831421462,1.0,3/9,2.82%,BHLHE40;CX3CL1;HES1
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.8488316235979978,-1.4253124811584437,0.043478260869565216,0.6542069635564279,1.0,3/9,9.06%,RTN4;SCARB2;CD81
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.8289802958993184,-1.424657239831411,0.04,0.6553498453869002,1.0,1/14,0.16%,TBX3
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.7081289168369554,-1.424289198427593,0.04938271604938271,0.6513254527849816,1.0,6/42,8.90%,TBX3;LAMC1;PLS3;NES;SMARCA1;PLOD2
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.8464092338237097,-1.4241859929273761,0.10294117647058823,0.6459189388804399,1.0,3/12,2.82%,BHLHE40;CX3CL1;HES1
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.6594471547624973,-1.4223616886424306,0.0,0.6527764439300312,1.0,29/89,16.18%,RPS18;RFC3;RPS12;RPL23;RPL34;RPS9;RPS27A;POLA1;RPL37;EEF1A1;RRBP1;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;GOLPH3;RPS7;RPLP2;RPL13A;MEF2A;RPL15;RPL37A;RPL24;RPL7A;RPLP1;PTMA;THRB
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.6927590050562715,-1.421897882130808,0.05747126436781609,0.6513369093612084,1.0,12/42,11.13%,SERPINE1;UFL1;MGLL;NFKBIZ;PPARG;CX3CL1;BCL6;ANXA1;KLF4;TMSB4X;HYAL2;SNX6
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.8813295890730132,-1.4216026649958777,0.0,0.6468862875281085,1.0,5/10,4.01%,PKM;LDHA;PCK1;PGK1;GAPDH
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.8766398232877255,-1.4213417839932803,0.0,0.6426154713692521,1.0,4/8,8.84%,RFC3;NPLOC4;RPS27A;UBC
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.8997250287011347,-1.4211290868626916,0.04285714285714286,0.6389174569056445,1.0,1/7,0.85%,BHLHE40
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.890459533009375,-1.420793446539238,0.029411764705882353,0.6310303770552823,1.0,2/8,2.52%,VSIR;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.890459533009375,-1.420793446539238,0.029411764705882353,0.6310303770552823,1.0,2/8,2.52%,VSIR;CX3CL1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.8264563168286323,-1.4204709026539257,0.06329113924050633,0.6276247430188633,1.0,4/11,11.93%,PLS3;SULF2;TGM2;GJA1
prerank,PanglaoDB_Augmented_2021__T Cells,-0.7872850829653204,-1.4204416467785457,0.0410958904109589,0.6227406423028508,1.0,4/16,10.17%,MAFF;JUNB;CD81;CREM
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.7661432768872847,-1.4177532108621025,0.039473684210526314,0.6391753329747775,1.0,4/17,11.16%,TBX3;HIF1A;FGFR1;LIMS1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.6227734463230157,-1.417571950096453,0.0,0.6353149677362102,1.0,28/101,15.46%,TBX3;LAMC1;UFL1;RPL23;CX3CL1;HES1;GRK5;NES;RPS9;KDM1A;S100A6;ERBB4;FLT1;CD81;CNOT6L;ZFPM2;RPS6;EFNB2;FGFR1;GJA1;CLDN5;NPM1;CDKN1A;CNBP;SDCBP;VEGFC;WWTR1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.8803800419245155,-1.4164280440894217,0.0821917808219178,0.6396657610088686,1.0,3/8,4.46%,CX3CL1;NES;KDM1A
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.8354704848408472,1.4148418096673094,0.1111111111111111,1.0,1.0,2/5,13.94%,DDX60;ANKRD17
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.8354704848408472,1.4148418096673094,0.1111111111111111,1.0,1.0,2/5,13.94%,DDX60;ANKRD17
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.8281452241563798,-1.4132513024699642,0.09836065573770492,0.659825017253819,1.0,5/10,8.13%,SERPINE1;SPOCK1;GAPDH;TIMP3;SERPINB6
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),-0.8958148201123664,-1.4123534427030027,0.04225352112676056,0.6612324957749509,1.0,2/8,3.80%,MAP2;MAP1B
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.86736403759563,-1.4121210913882856,0.06451612903225806,0.6580492056009912,1.0,1/8,0.24%,SERPINE1
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6842596652094705,-1.4118132054238437,0.011494252873563218,0.655279742424969,1.0,20/49,19.10%,RPL23;RPL34;RPS9;RPL37;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;RPL24;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),-0.7484006976764569,-1.4115797279891982,0.06756756756756757,0.6525545906597632,1.0,6/18,13.23%,SERPINE1;ANXA1;KLF4;TMSB4X;HYAL2;RAB1A
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.8153110477999025,1.409197210793923,0.18518518518518517,1.0,1.0,5/9,10.84%,PLA2G4A;PLAAT3;MBOAT2;OSBPL8;PLA1A
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.6850413992642164,-1.4087530226313991,0.011363636363636364,0.6706522119450812,1.0,21/52,19.10%,RPL23;RPL34;RPS9;RPL37;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RIOK3;RPL37A;RPL24;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.8818687212642571,-1.4078618460725185,0.03076923076923077,0.6733347084369875,1.0,2/8,3.19%,SLC6A6;GLUL
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.8014948484732756,-1.4071949447019096,0.07142857142857142,0.6731660429589378,1.0,2/14,2.47%,ADAMTS9;PPARG
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.9069270170278455,-1.4055655306531512,0.08620689655172414,0.6816237303802293,1.0,1/7,0.13%,MAFF
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),-0.7952344682380966,-1.4051579115780712,0.07894736842105263,0.6798380068693289,1.0,5/14,12.30%,ITPR1;ERO1A;GRIN2B;SLC8A1;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.7402601245975502,-1.40361473966651,0.025,0.6868289598136037,1.0,7/22,18.33%,UFL1;COMMD1;KLF4;TMSB4X;NFKBIA;CYLD;ERBIN
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,-0.7698098195495159,-1.4028351188135881,0.06666666666666667,0.6879252358516212,1.0,6/20,9.14%,ATF3;PPARG;CD9;LGALS3;LSS;STARD4
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.7785835599352836,1.4025345591644705,0.14285714285714285,1.0,1.0,1/6,3.61%,TTN
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.6891491950372136,-1.4024927252606014,0.036585365853658534,0.6856254801149076,1.0,13/38,13.78%,TBX3;ANGPTL4;EPS8;TIMP3;LAMA5;COL18A1;TNS1;CD55;ITGB5;SHC2;EPAS1;CST3;PLSCR4
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.9060212463879859,-1.4012041040732583,0.08571428571428572,0.6910749987184088,1.0,2/8,2.47%,PRKAG2;PPARG
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),-0.7396809671769308,-1.4003049607035956,0.05128205128205128,0.6938634374365138,1.0,5/30,6.27%,PKM;PCK1;NR4A1;PPARG;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.902911350749552,-1.4000483155413106,0.04411764705882353,0.691322873538609,1.0,1/7,0.80%,MAP3K5
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.7681757525028359,-1.399293437537404,0.02666666666666667,0.692920490080484,1.0,6/23,9.11%,MAP3K5;JUN;FOS;NFE2L2;TPM1;ANXA1
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),-0.8579298795083625,-1.3987000271165728,0.0,0.6925406933074191,1.0,3/10,3.13%,MAP2;MDGA2;SPOCK1
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,-0.7427908327866829,-1.3982614475346369,0.05405405405405406,0.6908728945484613,1.0,5/29,6.06%,TBX3;LAMC1;PLS3;PPARG;TIMP3
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.7284648565197529,-1.398104755402926,0.0641025641025641,0.6868209946612571,1.0,3/19,8.34%,DENND3;BNIP3L;PRKN
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),-0.8877492438771231,-1.3967386965418147,0.08450704225352113,0.692389965849684,1.0,2/8,1.62%,PCK1;PRKAG2
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.811840728429313,-1.3959663247509155,0.04,0.6940029472988027,1.0,4/11,13.89%,DDIT4;MAGI2;RAP1A;BCAR1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),-0.8971944964733839,-1.3951910843404836,0.01694915254237288,0.6970863964558537,1.0,2/6,6.88%,ATG12;RB1CC1
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.9266478176455608,-1.3938781146975299,0.016129032258064516,0.7030923372236747,1.0,1/6,0.40%,DOK5
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.8082931440854701,-1.3936780677099885,0.02857142857142857,0.6997158579678737,1.0,2/11,5.29%,SERPINE1;NFE2L2
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.7560823384652098,-1.3930240999288699,0.02531645569620253,0.6995412254540168,1.0,5/20,9.61%,ADAMTS9;DENND3;LAMP2;PRKN;NGLY1
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.7115513413929602,-1.3924143771070696,0.07228915662650602,0.6991396425284627,1.0,7/28,9.11%,ADM;MGLL;CX3CL1;FOS;GGT5;REL;ANXA1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.6596912632696275,1.392378389346413,0.10714285714285714,1.0,1.0,6/17,12.96%,EFNA5;CLASP1;BICD1;PHLDB2;ROCK1;MARK2
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.8479136450197546,-1.3914046754203446,0.07462686567164178,0.7037545773589244,1.0,3/6,14.26%,TSG101;PRKN;SDCBP
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.6131556578579965,-1.3913306059648607,0.010526315789473684,0.6995593046447275,1.0,34/123,18.22%,RPS18;YTHDC1;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;EEF1A1;RRBP1;RPS11;RPL10;RPS27;RPS6;RPL8;RPS15;TPR;GOLPH3;RPS7;RPLP2;RPL13A;MEF2A;HNRNPH3;RPL15;RPL37A;RPL24;RPL7A;RPLP1;PTMA;THRB;SRRM1;RPS28;NUP54;RPL31
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.886133206784306,1.391239749953892,0.0,1.0,1.0,3/5,9.69%,GBP1;EFNA5;KANK1
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.886133206784306,1.391239749953892,0.0,1.0,1.0,3/5,9.69%,GBP1;EFNA5;KANK1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.770065705112241,-1.3911693771889937,0.09876543209876543,0.6967684079219426,1.0,1/18,0.19%,CCDC3
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.8127824640787278,-1.3902061050332923,0.0958904109589041,0.6997445983900498,1.0,1/12,0.32%,MAP2
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.8855478904824651,1.3877383673194368,0.14285714285714285,1.0,1.0,4/5,11.05%,ACAT1;HIBCH;HIBADH;AUH
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.8855478904824651,1.3877383673194368,0.14285714285714285,1.0,1.0,4/5,11.05%,ACAT1;HIBCH;HIBADH;AUH
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.7530191174612726,-1.3876446305724843,0.06666666666666667,0.7153232442874758,1.0,6/19,13.89%,HES1;KIAA1217;SHC2;EPAS1;EFNB2;BCAR1
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.8596670684983638,-1.3872598977843391,0.046153846153846156,0.7140263709591763,1.0,2/7,4.86%,CLIC2;DMD
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.6978558497802012,1.3863392715019176,0.0967741935483871,1.0,1.0,1/8,2.84%,RHBDD1
prerank,PanglaoDB_Augmented_2021__Satellite Cells,-0.6844145994960457,-1.3848752499833699,0.08641975308641975,0.7287262181607802,1.0,6/41,6.06%,LAMC1;PLS3;KIAA1217;NES;DMD;TIMP3
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.5932598029734457,1.384821383172937,0.1111111111111111,1.0,1.0,4/13,10.81%,ALS2;EEA1;TMCC1;RAB27A
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.9211194208604797,-1.3835940908571949,0.04411764705882353,0.7348267702082131,1.0,2/5,1.75%,PIK3R3;NR4A1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.8199782657146883,-1.3822890554607865,0.02666666666666667,0.7405609820537796,1.0,6/15,11.00%,DDIT4;MAP3K5;GRIN2B;FOS;PRNP;EFNB2
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.8139757323176825,-1.3792173051454095,0.046875,0.7601789199304251,1.0,5/10,14.61%,CLIC2;DMD;SLC8A1;ANK2;CACNA1C
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.8891737991379589,-1.3784448055144538,0.028985507246376812,0.762764161907475,1.0,3/8,2.02%,MAP3K5;ITPR1;ERO1A
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.7286802951004792,-1.3779905296955697,0.0625,0.7607231463112902,1.0,7/26,15.70%,PKM;PCK1;PPARG;PIK3R1;OGT;LPIN2;RAB8B
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.7911035219853941,-1.3779705828943538,0.06329113924050633,0.7559686266468447,1.0,10/21,15.38%,DDIT4;NRCAM;SPOCK1;MAP1B;ELP3;GPM6A;FGFR1;ADGRL3;NAV1;PAFAH1B1
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),0.8009033169500496,1.37791591218671,0.0975609756097561,1.0,1.0,4/7,19.52%,INO80;TOP2B;SMC1A;LATS1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.75079475329563,1.3774189437309476,0.12121212121212122,1.0,1.0,2/5,18.86%,HDAC9;HDAC4
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),-0.688524843907591,-1.3761414551362896,0.05,0.7659999102090124,1.0,6/27,13.33%,PCK1;PPARG;PIK3R1;HIF1A;RPS6;FOXK1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.8838396947744231,1.3750766212831071,0.058823529411764705,1.0,1.0,2/5,10.41%,PARD3;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.9163419727193751,-1.3750075037928788,0.0,0.7692483926314516,1.0,2/5,5.71%,SERPINE1;DUSP1
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.7830757286827134,-1.3748281243443456,0.1,0.7662525423467618,1.0,4/17,9.93%,BHLHE40;CX3CL1;HES1;TGM2
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.8563751112868601,1.3739890602284957,0.1875,1.0,1.0,5/6,10.84%,PLA2G4A;PLAAT3;MBOAT2;OSBPL8;PLA1A
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),-0.9028815581215092,-1.3723465124557108,0.05714285714285714,0.7837801814733173,1.0,1/6,0.16%,TBX3
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.7156560533762681,-1.3723458754443143,0.10843373493975904,0.7790299985552972,1.0,4/20,11.71%,UFL1;RPL23;COMMD1;RPS7
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.8335649569524276,-1.3720796218089468,0.06944444444444445,0.7769770629140852,1.0,2/8,8.34%,PSMC6;PRKN
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.614157121477709,-1.371553622188655,0.043010752688172046,0.7769673346187105,1.0,18/88,15.27%,LAMC1;ADM;PLS3;EHD4;KIAA1217;MAGI2;SMARCA1;TPM1;PLOD2;ITGB5;GJA1;MYO1B;NEBL;TRIB2;PLSCR4;BCAR1;NAV2;WWTR1
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.7364779061996722,-1.371484503433565,0.06944444444444445,0.7726769633367264,1.0,6/21,8.84%,UFL1;RPS27A;RB1CC1;CALCOCO2;PRKN;UBC
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.7133543461664525,-1.3703064019941367,0.08333333333333333,0.7774801520194693,1.0,12/24,12.75%,CCDC3;CX3CL1;NFASC;GPM6B;CNTN1;PTPRD;TMEM132C;ANK2;SHC2;DCLK1;ADGRL3;PLP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.8202521079896179,-1.3701928985200211,0.08823529411764706,0.7739643385933858,1.0,5/8,14.61%,CLIC2;DMD;SLC8A1;ANK2;CACNA1C
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.8493442579406592,-1.3690776389212167,0.08695652173913043,0.7781781138994339,1.0,3/8,11.02%,PPARG;FLT1;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.8940248898436827,-1.3679555922423634,0.07692307692307693,0.7829962052978,1.0,1/6,0.24%,SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.7911259523468868,-1.3673533166493141,0.07894736842105263,0.784056234741286,1.0,6/13,14.95%,BTG2;CDKN1B;BCL6;CHFR;SMAD3;BTG1
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.7180508921166375,-1.3669191794434332,0.15384615384615385,0.7825208634212651,1.0,1/14,1.12%,NDRG1
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.8606840702261841,-1.3654890368411527,0.15942028985507245,0.7901852668272927,1.0,2/6,11.08%,FGFR1;STOX2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.7395970361886299,-1.3652423545157903,0.08333333333333333,0.7878025137829311,1.0,1/14,0.32%,MAP2
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.7374872419020205,-1.3645700791221256,0.05333333333333334,0.789827206748034,1.0,6/23,10.92%,CD9;LGALS3;TINAGL1;MT1L;EMP1;EPAS1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.8228856209451334,-1.3638463876918823,0.04477611940298507,0.7918922795216699,1.0,2/9,5.29%,SERPINE1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.7550925127157304,1.3633035523378658,0.18421052631578946,1.0,1.0,1/6,1.17%,MLLT3
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.5666614299966348,1.3632591086610926,0.125,1.0,1.0,2/23,0.72%,RSAD2;GBP2
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.5666614299966348,1.3632591086610926,0.125,1.0,1.0,2/23,0.72%,RSAD2;GBP2
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.6145942567948096,-1.3629429990306183,0.042105263157894736,0.7951270321812568,1.0,15/89,9.83%,TBX3;ST18;BTG2;PPARG;HES1;PPM1D;CDKN1B;ERBB4;PBRM1;MAGI2;COL18A1;KLF4;ADAMTS1;DLC1;SOD2
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.8210671381282992,-1.3616711687909775,0.07462686567164178,0.8019466516293297,1.0,2/6,11.93%,SLC6A6;GJA1
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.7882024613663031,1.3616116202963189,0.10810810810810811,1.0,1.0,1/7,0.05%,DSE
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.7911729580332014,-1.3615028274941157,0.07042253521126761,0.7985714152194127,1.0,3/13,4.57%,DDIT4;PRKAG2;SMAD7
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.6534502297856968,-1.3611271283579993,0.05952380952380952,0.7965915870155375,1.0,13/47,14.42%,SERPINE1;LAMC1;JUN;SPOCK1;TIMP3;TPM1;PLOD2;TGM2;ITGB5;WIPF1;GJA1;VEGFC;COPA
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.7471124346226403,-1.3609653810635676,0.0379746835443038,0.7935895227186205,1.0,12/23,19.76%,DDIT4;MAP3K5;GRIN2B;FOS;PRKN;PRNP;EFNB2;PICALM;TBK1;CD34;CHMP4B;CLU
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),-0.6724981644133449,-1.3607729131551383,0.08433734939759036,0.7909865132026185,1.0,19/43,21.25%,PIK3R3;PIK3R1;MTMR12;ARF1;SYNJ2;PLCG2;TTC7A;INPP5D;PIGN;EFR3B;PIK3C3;RAB14;PIP5K1C;MTMR2;PIKFYVE;PIGC;PIK3CB;SOCS3;MTMR6
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.7202624549447082,1.3599702878269,0.16666666666666666,1.0,1.0,1/8,0.16%,BMP6
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.8197676305550334,-1.3590755507664767,0.05084745762711865,0.7987982692283713,1.0,7/15,11.98%,PCK1;PGK1;PPARG;LGALS3;ERBB4;ANXA1;HNRNPH3
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.7115601399338045,-1.359031241412819,0.125,0.794624482747026,1.0,2/19,5.10%,CCDC3;PLCL1
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.8489722240019721,1.3583499129533765,0.1282051282051282,1.0,1.0,2/5,5.58%,OFD1;RFX3
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),-0.7969736327978314,-1.3574317391131159,0.0273972602739726,0.8030543265834369,1.0,3/12,4.17%,PLS3;NEDD9;EPS8
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),-0.9118643914931825,-1.357320540678552,0.03508771929824561,0.799500015815381,1.0,3/6,5.02%,MAP2;RTN4;SEMA6B
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.8450865748542995,-1.3572647857173232,0.05405405405405406,0.7955671319181854,1.0,1/9,0.16%,TBX3
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),-0.8197673400972865,-1.3565687883570545,0.0821917808219178,0.7968801482868497,1.0,4/8,12.59%,TSG101;PPARG;SNX6;ZFYVE28
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),-0.6525061143366211,-1.3565432733792757,0.06172839506172839,0.7928844981677943,1.0,25/50,24.67%,ADM;CD9;SCARB2;CANX;HIP1R;SCARF1;AP1G1;CD81;LRP1B;SGIP1;PICALM;HSPH1;PIP5K1C;PIKFYVE;SCARB1;ITGB1;GRB2;CAV2;SPARC;CLTA;DNM2;CALR;SNX9;NEDD4;HSP90AA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.8590651150402562,-1.35626246574603,0.07142857142857142,0.7872881025039238,1.0,3/7,8.84%,RFC3;RPS27A;UBC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.8590651150402562,-1.35626246574603,0.07142857142857142,0.7872881025039238,1.0,3/7,8.84%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.6617324067232971,1.3553184329067745,0.1388888888888889,1.0,1.0,4/10,17.53%,IL15;PIAS1;STAT2;PKD2
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),-0.7922535478253954,-1.3546219918871296,0.04,0.7960887421327475,1.0,3/13,4.17%,PLS3;NEDD9;EPS8
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),-0.8961859469518314,-1.3540142587117432,0.06153846153846154,0.796673909300146,1.0,3/5,7.01%,ADM;PPARG;PRKCE
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.9324623344841946,-1.353472065360783,0.03076923076923077,0.7977690896936003,1.0,2/5,4.44%,KCNMB4;RIMS1
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.8765685083117696,-1.352630987173482,0.04285714285714286,0.800849571376044,1.0,4/7,9.19%,ANGPTL4;TMEM45B;LGALS3;KLF4
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.7363774151998168,-1.3517346343540508,0.0641025641025641,0.8031044023046893,1.0,2/17,2.55%,ZEB2;PKN3
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.8787209054870895,-1.3515121986821685,0.057971014492753624,0.8011015244366603,1.0,3/6,4.33%,ADM;ATP2B1;KCNMB4
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.7145419620761331,-1.3509918679170203,0.11842105263157894,0.8021526631465627,1.0,4/21,12.30%,ADM;GGT5;CD81;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.667107054087374,-1.35039355228969,0.04878048780487805,0.8017957069627002,1.0,14/35,18.94%,RTN4;ESR2;CDKN1B;BCL6;HYAL2;CRLF3;GJA1;CDKN1A;SMAD3;BTG1;RACK1;ADAM15;ACVRL1;MT1M
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.7483807513914036,-1.3497923249138308,0.06756756756756757,0.8029998878290454,1.0,4/18,4.04%,HES1;TMEM45B;LGALS3;KIAA1217
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),-0.7905100105431189,-1.3491431139433576,0.10526315789473684,0.8044689780427438,1.0,2/12,7.65%,SLC4A10;COL18A1
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.7801461499786171,-1.3491063613522842,0.029850746268656716,0.8008009191270705,1.0,4/17,3.88%,PPP2R3A;PGK1;PPARG;LGALS3
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.7328773776406886,-1.3480216413611539,0.0684931506849315,0.8058841666593731,1.0,6/20,10.04%,JUN;FOS;HIF1A;TPM1;SOD2;HYAL2
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.6138701562155868,-1.3479715011026216,0.030612244897959183,0.8024630441350156,1.0,21/105,15.96%,TBX3;ANGPTL4;BNIP3L;CX3CL1;GRK5;HSPA5;RPS27A;PIK3R1;UBC;RPL10;ANXA1;CFL1;GOLPH3;TMBIM6;PAK2;NPM1;NFKBIA;NAA16;PTMA;MALT1;MCL1
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.8928127455636672,-1.3475008529005277,0.0410958904109589,0.8018977951430293,1.0,2/6,1.54%,MTHFD1L;PCK1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.8698044967258887,-1.346861625506994,0.10294117647058823,0.8037150372055791,1.0,3/6,4.09%,PPARG;SCP2;ABCA5
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.865767449426178,1.34526641129816,0.08571428571428572,1.0,1.0,2/5,7.65%,PLA2G4A;HADHB
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.8356958182584948,-1.343840132762904,0.13114754098360656,0.8255156595730695,1.0,2/8,2.82%,BHLHE40;HES1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.8590978286649653,-1.342953095651153,0.109375,0.8290759605221082,1.0,3/6,8.84%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.8832436066584728,-1.342610020570811,0.05454545454545454,0.8277029730729787,1.0,3/6,10.84%,HES1;ERBB4;CRLF3
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.7403597695366958,-1.3425233652282342,0.15942028985507245,0.8247527979796319,1.0,2/12,3.85%,ERO1A;HSPA5
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.7004685607432909,-1.3422853437259525,0.10526315789473684,0.8226744173453083,1.0,2/26,4.94%,CEP57;CEP70
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.6179955114313922,-1.341549220950867,0.06451612903225806,0.8250787519840709,1.0,27/85,19.10%,RPS18;RPS12;RPL23;RPL34;RPS9;RPS27A;RPL37;RPS11;RPL10;CNOT6L;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;ZFP36;RPL15;RPL37A;RPL24;RPL7A;RPLP1;DCP2;RPS28;RPL31;RPS19
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.8922415270674409,-1.3413150654194423,0.07017543859649122,0.8231227192146886,1.0,2/5,6.19%,TBX3;ERBB4
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),-0.6361683578037584,-1.3403688898842285,0.09411764705882353,0.8260749702386038,1.0,13/40,20.35%,NEDD9;FES;ERBB4;PTPRD;FLT1;SHC2;FGFR1;CASS4;BCAR1;TIE1;LCP2;EGFR;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.7610576755932025,-1.338909640107822,0.1,0.8326248476560111,1.0,5/13,19.76%,HSPA5;RPL13A;RIOK3;PPM1A;CLU
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.7061406336615418,-1.3388835473712914,0.056338028169014086,0.8289085592892318,1.0,6/23,13.41%,LAMC1;PIK3R1;LAMA5;TMEFF2;ATRNL1;PARVB
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),-0.8205348831148517,-1.3387000327762135,0.07042253521126761,0.826508971255606,1.0,1/10,0.80%,MAP3K5
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.7311029498615415,-1.3384028447544583,0.1038961038961039,0.8244887383083928,1.0,3/15,8.84%,MAP3K5;RPS27A;UBC
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.7487488368163073,-1.337538534885266,0.11940298507462686,0.8270120924220961,1.0,2/16,2.82%,TBX3;HES1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),-0.7045485432467096,-1.3366737051266875,0.10666666666666667,0.8307781406258875,1.0,6/20,12.88%,LAMC1;DMD;MBP;PECAM1;GJA1;CLDN5
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.8520244945135202,-1.3365827697515127,0.04838709677419355,0.8277581394835613,1.0,3/6,11.87%,FLT1;FGFR1;GNA13
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.9174124413879119,-1.3365744759786902,0.028985507246376812,0.8242132860731313,1.0,1/5,0.61%,ANGPTL4
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.6737826391008197,-1.3359354352296224,0.11392405063291139,0.8257441032563808,1.0,7/30,8.26%,CX3CL1;SCARB2;FES;LRRC7;MAGI2;SCARF1;RAP1A
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.8857038543012055,-1.3357138670859596,0.078125,0.8235322831695089,1.0,2/5,8.26%,MAGI2;RAP1A
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.7199109115409366,-1.335473196302122,0.05194805194805195,0.8215379591512275,1.0,2/24,3.88%,SERPINE1;LGALS3
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.8234465729944811,-1.335334732153452,0.09090909090909091,0.8191175637355551,1.0,2/8,6.88%,UFL1;RB1CC1
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.6263097513693222,-1.3353234403158798,0.047619047619047616,0.8155406311428234,1.0,15/58,13.86%,ANGPTL4;MGLL;PPARG;ENPP2;SCP2;CAVIN2;DHRS7B;IFNGR1;BCL6;UBC;RREB1;PLIN2;ATP1B3;RIOK3;ACOX1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.912483164291558,-1.335094458768771,0.07142857142857142,0.8101822478200188,1.0,2/5,6.37%,LBR;LSS
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.912483164291558,-1.335094458768771,0.07142857142857142,0.8101822478200188,1.0,2/5,6.37%,LBR;LSS
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.689793970874586,1.33480537367943,0.23529411764705882,1.0,1.0,3/7,19.07%,CPEB3;NLGN1;CAPRIN1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.6693751463443179,-1.334107345053563,0.10588235294117647,0.8139069441031779,1.0,10/36,15.83%,ST18;MAP3K5;PPARG;BCAP31;HIP1R;DLC1;TNFRSF10B;SMAD3;RACK1;MALT1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.7554803267084915,-1.3340945052553423,0.15942028985507245,0.8106066909842643,1.0,2/10,3.85%,ERO1A;HSPA5
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),0.7886019303095544,1.3335214193723852,0.2857142857142857,1.0,1.0,4/7,18.51%,MFF;PLAAT3;PEX14;TMEM135
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),-0.8033562475973314,-1.3329260635051623,0.0945945945945946,0.8112629945169709,1.0,2/9,2.02%,ITPR1;ERO1A
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),-0.8033562475973314,-1.3329260635051623,0.0945945945945946,0.8112629945169709,1.0,2/9,2.02%,ITPR1;ERO1A
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.8379932821856014,-1.3324697961274448,0.06349206349206349,0.811491746118082,1.0,1/10,0.32%,MAP2
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.8819629241956641,-1.3316624590712276,0.10714285714285714,0.8154168178079102,1.0,1/5,0.29%,LAMC1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.8815300554358897,-1.3312126126103796,0.06060606060606061,0.8122605488899705,1.0,2/6,7.84%,HIF1A;SULF2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.8815300554358897,-1.3312126126103796,0.06060606060606061,0.8122605488899705,1.0,2/6,7.84%,HIF1A;SULF2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),-0.8331876653543977,-1.3309060512588278,0.1111111111111111,0.8114044531023051,1.0,2/7,3.80%,MAP2;MAP1B
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.727947849076031,-1.3306208245846136,0.06666666666666667,0.8101824496664353,1.0,8/21,15.46%,BTG2;NR4A1;CDKN1B;DUSP1;IPO7;SMAD3;BTG1;CDK6
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.7208097467753444,-1.3305546656988847,0.05063291139240506,0.8073917945115697,1.0,5/23,13.17%,BTG2;NDRG1;CDKN1B;CNOT6L;CDKN1A
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),-0.6377070663792854,-1.3302976780204092,0.07142857142857142,0.805872662361786,1.0,16/53,18.54%,PIK3R3;CHPT1;PIK3R1;MTMR12;ARF1;DGKG;SYNJ2;PLCG2;INPP5D;LPIN2;PIK3C3;AGPAT4;RAB14;PIP5K1C;MTMR2;PIKFYVE
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.773910679248124,-1.3295950809475916,0.07142857142857142,0.8073594430582716,1.0,1/11,0.24%,SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.840095552828656,-1.3279276157117215,0.1864406779661017,0.816539452608849,1.0,1/6,2.82%,HES1
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.688359472455059,-1.3277782136445184,0.14814814814814814,0.8143164784290484,1.0,7/23,14.26%,TSG101;RFC3;BCAP31;POLA1;PNP;CSTF3;SDCBP
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.7516254945814052,-1.3270210956927466,0.125,0.8171158323940187,1.0,5/15,11.50%,PRKAG2;SCARB2;HIF1A;TPR;OGT
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.6719518430850911,-1.3261583791695195,0.12941176470588237,0.820345715433831,1.0,11/35,9.80%,MAP3K5;UFL1;ITPR1;ATF3;ERO1A;BCAP31;JUN;HSPA5;PIK3R1;PRKN;HERPUD1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.7085431188742816,-1.3256215254216384,0.13157894736842105,0.8205260473894347,1.0,3/17,12.22%,SERPINE1;PRKCE;ZFP36
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.8011472132526525,-1.32561278768322,0.09230769230769231,0.8172888911672732,1.0,2/8,15.59%,DYSF;RACK1
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),-0.6850296185194925,-1.3253548328847837,0.075,0.8154205957734653,1.0,4/27,8.34%,SEC22B;VSIR;CDKN1B;PRKN
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.8483537362340874,-1.324822891563275,0.13513513513513514,0.8159750549456809,1.0,3/8,12.67%,POLA1;PURA;NOC3L
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),-0.7582362060116528,-1.3244095955882829,0.07142857142857142,0.8155480013154293,1.0,6/15,14.00%,RAPGEF3;PECAM1;RAP1A;AFDN;RAB1A;MSN
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.7438875782071683,-1.3243153459830632,0.07692307692307693,0.813089264544244,1.0,8/13,13.17%,PPARG;JUN;CDKN1B;TPM1;ADAMTS1;SOD2;GJA1;CDKN1A
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.8437618992668883,-1.3236548497604272,0.07462686567164178,0.814880208914447,1.0,2/7,4.46%,CX3CL1;KDM1A
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.864443686846896,-1.323567257562436,0.0625,0.8123116060901215,1.0,2/6,5.87%,CANX;JAK1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.7646230240013144,-1.3234633942059726,0.10526315789473684,0.8097192686891406,1.0,4/15,13.71%,NEDD9;DOCK3;PRNP;CASS4
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),-0.7435764065118796,-1.3233565677382049,0.08450704225352113,0.807364798086793,1.0,6/19,13.07%,SERPINE1;NFKBIZ;CX3CL1;CD81;HYAL2;NFKBIA
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.5703642113767373,-1.3216986531121553,0.02040816326530612,0.8161353423669516,1.0,42/180,15.46%,TBX3;ST18;UFL1;BTG2;RPL23;CX3CL1;HES1;JUN;GRK5;JUNB;RPS9;PPM1D;CDKN1B;FES;JUND;ERBB4;PBRM1;MAGI2;FLT1;COL18A1;BCL6;JAG2;CD81;KLF4;CNOT6L;ADAMTS1;DLC1;SOD2;RPS6;EFNB2;FGFR1;LIMS1;CLDN5;NPM1;CDKN1A;CNBP;PLPP1;SDCBP;VEGFC;BTG1;WWTR1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.909898554977705,-1.3216608322175887,0.08064516129032258,0.8133421138762811,1.0,1/5,4.46%,KDM1A
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.8085111756358072,-1.3210670083783485,0.13636363636363635,0.814617328645361,1.0,1/7,2.34%,SLC6A6
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.7641199929335482,-1.3210175152536052,0.12,0.8118083271732167,1.0,6/12,11.10%,JUNB;FES;MBP;SOD2;PRNP;MSRA
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.6158494299642626,-1.3208536492062797,0.04395604395604396,0.8105588302999742,1.0,27/61,23.53%,SERPINE1;ANGPTL4;PGK1;PPARG;GLUL;RAPGEF3;FLT1;HIF1A;KLF4;ADAMTS1;CLDN5;VEGFC;BTG1;TIE1;ATF2;GATA2;ITGB1;MECP2;CD34;EMP2;SPRED1;SASH1;PPP1R16B;SPARC;CDH5;AGO2;ANXA3
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),-0.7065884798256326,-1.319983965116214,0.09210526315789473,0.8141711367015104,1.0,6/25,12.56%,ADM;AKAP12;GRK5;S1PR1;GNA13;ADGRL3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.6456497706864954,-1.3194826236934774,0.10227272727272728,0.8150847446151406,1.0,3/34,2.02%,MAP3K5;ITPR1;ERO1A
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.7875272145868049,-1.3184029299392461,0.14084507042253522,0.8205116266341251,1.0,3/11,9.11%,MAP3K5;NFE2L2;ANXA1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.6706271119749947,-1.3176630364358717,0.05952380952380952,0.8226993133551022,1.0,9/38,11.00%,UFL1;MGLL;CX3CL1;BCL6;CAMKMT;CD55;ANXA1;TMSB4X;EFNB2
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),-0.6560580657788799,-1.3174254872589526,0.08974358974358974,0.8219356388713122,1.0,13/39,18.54%,PIK3R3;PIK3R1;MTMR12;ARF1;LPGAT1;SYNJ2;PLCG2;INPP5D;PIK3C3;RAB14;PIP5K1C;MTMR2;PIKFYVE
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),-0.7308135036372354,-1.3172720321590274,0.10810810810810811,0.8197573533321277,1.0,7/13,20.42%,SUN2;SUN1;TPR;NUP54;RPS19;CHMP4B;REEP3
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.8417992338880318,-1.3171177544541304,0.12903225806451613,0.817928151148021,1.0,1/5,5.05%,SPG7
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.6936992041518673,-1.316834878296531,0.18181818181818182,0.8170661416461912,1.0,3/20,12.30%,ADM;GGT5;PLCG2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.8442413693352255,-1.3164828969721105,0.015151515151515152,0.816003908099355,1.0,3/7,8.02%,DMD;ANK2;AHNAK
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.7917599162093737,-1.3162615196806349,0.07547169811320754,0.8146613284871346,1.0,3/9,7.36%,VSIR;GRIN2B;MBP
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.6391436669879695,-1.316124731500856,0.11363636363636363,0.8126313631004255,1.0,12/49,9.19%,LAMC1;NR4A1;KLF6;ZEB2;TIMP3;FOXF1;KLF2;HIF1A;FOSL2;TNS1;CD55;KLF4
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),-0.923049749122248,-1.314986955299447,0.01694915254237288,0.8176035269390476,1.0,1/7,0.32%,MAP2
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.7422957523691274,-1.3149287654344237,0.12857142857142856,0.814966905228372,1.0,6/14,14.56%,CDC37;YBX3;OGT;PELI1;SDCBP;CYLD
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.7608625219222196,-1.3147578284923125,0.10126582278481013,0.8132417891642711,1.0,7/16,19.10%,GLUL;RPS6;RPS15;RPS7;NPM1;RPS28;RPS19
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,-0.7587800145082412,-1.3145258883443989,0.12121212121212122,0.8119332923470011,1.0,10/16,15.86%,HES1;MAP1B;GRIA2;ANK2;STOX2;CTNND2;ADGRL3;LRRC4C;EFR3B;CADM2
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.7567346838176513,1.3140359647933173,0.09302325581395349,1.0,1.0,3/6,14.21%,ABL1;MSH3;MCM9
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.8628290697108452,-1.3137622722226534,0.09230769230769231,0.814057631733338,1.0,1/6,0.37%,DDIT4
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),0.8422691118063041,1.313652064192445,0.22857142857142856,1.0,1.0,2/5,1.54%,UGCG;ATG10
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.7232368786720372,1.31322461296661,0.19444444444444445,1.0,1.0,2/7,8.07%,MOB3B;WWC3
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.6764109761400812,-1.312619986395201,0.125,0.8197385553903727,1.0,6/34,9.54%,LAMC1;PLS3;GAPDH;NES;SMARCA1;ADAMTS1
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.6797285176478297,-1.3124839310776137,0.12658227848101267,0.8175411436391024,1.0,4/30,5.26%,NPLOC4;GAPDH;LRRFIP1;POLA1
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.7828592729837375,-1.311838045773235,0.1232876712328767,0.8196229976727758,1.0,7/11,16.65%,CX3CL1;HIF1A;PRKN;SOD2;SNX6;CPEB4;PINK1
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.755581146782418,-1.3116673921155186,0.057971014492753624,0.8180768306239983,1.0,7/20,13.68%,SERPINE1;NFKBIZ;CX3CL1;NPAS2;HYAL2;NFKBIA;RIOK3
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.7623482059493494,-1.311432721768363,0.1746031746031746,0.8169372208026443,1.0,2/12,4.46%,UFL1;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.8142310810565871,-1.311340533817148,0.14925373134328357,0.8147410511206503,1.0,2/6,4.57%,DDIT4;SMAD7
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.6616933933285385,1.3111215755020198,0.1724137931034483,1.0,1.0,6/15,12.96%,EFNA5;CLASP1;BICD1;PHLDB2;ROCK1;MARK2
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.8247303657151077,-1.3106326451233654,0.0967741935483871,0.8170786101170067,1.0,3/6,7.60%,LGALS3;ATP2B1;ANK2
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,-0.6643675327729002,-1.310383110217636,0.15384615384615385,0.815876084150262,1.0,10/37,9.03%,SERPINE1;MAP2;AKAP12;MAP1B;NFASC;GRIA2;CNTN1;PTPRD;ANK2;LSAMP
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.925338387258942,-1.3097470099895487,0.04477611940298507,0.8176862436846032,1.0,2/5,6.27%,PIK3R3;PIK3R1
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.7043333404392983,-1.309505772604772,0.10666666666666667,0.8166454664575205,1.0,2/22,4.94%,CEP57;CEP70
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.8844622997475196,-1.3094590668588675,0.15492957746478872,0.8142556783329769,1.0,2/5,10.15%,BCAP31;PRNP
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,-0.6749430870344709,-1.3091911731905614,0.0945945945945946,0.8130021525447645,1.0,14/29,17.29%,MAP1B;NFASC;GRIA2;GPM6B;CNTN1;MAGI2;PTPRD;ANK2;LSAMP;DCLK1;ADGRL3;PLP1;EFR3B;ROBO2
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.6331348993542637,-1.3089370754522265,0.04938271604938271,0.8121420410376043,1.0,20/57,19.42%,RTN4;SPOCK1;NRG3;CHPT1;ESR2;CDKN1B;BCL6;HYAL2;CRLF3;GJA1;CDKN1A;BCAR1;SDCBP;SMAD3;BTG1;RACK1;MTOR;ADAM15;ACVRL1;EGFR
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.7752644637746677,-1.308878269798349,0.10144927536231885,0.8098304432940936,1.0,5/14,7.46%,PPARG;CDC37;JAK1;IFNGR1;IFNGR2
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.6258732443987619,1.3080083689224404,0.13793103448275862,1.0,1.0,5/22,5.87%,BMP6;HIVEP1;SMAD1;TGFBR3;SMAD9
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.6258732443987619,1.3080083689224404,0.13793103448275862,1.0,1.0,5/22,5.87%,BMP6;HIVEP1;SMAD1;TGFBR3;SMAD9
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.7401734761923466,-1.3072314146187514,0.16666666666666666,0.8185040151294024,1.0,2/12,12.30%,PPP1R9A;PLCG2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.6855032031387374,-1.3069902757651752,0.0759493670886076,0.8172911766571408,1.0,3/24,9.19%,MAP3K5;BCAP31;KLF4
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,-0.5963056606310903,-1.3068280510380017,0.020618556701030927,0.8157069049364123,1.0,5/102,3.96%,CEP57;RAPGEF5;SUN2;NEDD9;MYO9B
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.6359300227344982,-1.3064009286288798,0.09195402298850575,0.815684536277144,1.0,7/51,8.84%,CEP57;PSMC6;PSMB9;CEP70;RPS27A;PSMA1;UBC
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.7138362350069192,1.3063209284989947,0.11627906976744186,1.0,1.0,2/6,9.64%,ATR;ATM
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),-0.7381737231818465,-1.3062689782778827,0.0759493670886076,0.8138146244524853,1.0,5/16,15.59%,PCK1;PIK3R1;HIF1A;FOXK1;RACK1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.8721040339952211,-1.3060087744062718,0.13793103448275862,0.8130095139503133,1.0,2/6,12.03%,SYTL4;DYSF
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),-0.8010360352369994,-1.3055655621138498,0.1111111111111111,0.8134832965943849,1.0,2/8,6.19%,SEMA6B;ERBB4
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.8577622034659189,-1.3055513655517932,0.13846153846153847,0.8108180264789521,1.0,2/5,7.84%,KIAA1217;SULF2
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.8845763791581367,-1.3055030895063007,0.109375,0.8086169101463662,1.0,1/6,1.62%,PRKAG2
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.855073238358214,-1.304825812650057,0.08695652173913043,0.8099163861123898,1.0,1/7,2.05%,RFTN1
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.7471339590575359,-1.304685391941589,0.18840579710144928,0.8079544994644298,1.0,3/9,11.39%,RTN4;AFDN;TPR
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.7326588838055362,-1.3045963279888233,0.14864864864864866,0.8060791628394011,1.0,5/15,9.19%,PPARG;JUN;FOS;HIF1A;KLF4
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.8455268098976358,-1.3042818280989048,0.047619047619047616,0.805868582117832,1.0,2/7,5.87%,CANX;JAK1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.8777508492427115,-1.3041617199207245,0.12280701754385964,0.8039024494506191,1.0,2/5,10.39%,PRKAG2;LPGAT1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.8456275055377285,-1.3041401503945371,0.1267605633802817,0.8014747952616411,1.0,5/8,13.89%,RFTN1;VAV3;PLCG2;TEC;BCAR1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.6088366393909836,-1.303404204921233,0.1111111111111111,0.8043358761098621,1.0,19/63,20.48%,DDIT4;ITPR1;DUSP1;PEBP1;MAGI2;TMSB4X;HERPUD1;HYAL2;DGKG;RIOK3;CYLD;RACK1;MCL1;PINK1;DAG1;PDE10A;PPM1A;PIK3CB;SPRED1
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.7530678050372971,-1.3034032523993069,0.12,0.8017412442514431,1.0,5/12,14.56%,CDC37;OGT;PELI1;SDCBP;CYLD
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.7903480012477825,-1.3032814414813485,0.14285714285714285,0.7999943296799878,1.0,2/10,2.52%,NR4A1;CX3CL1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.8541846792404043,-1.3032333501122757,0.045454545454545456,0.7926731511373183,1.0,2/6,9.69%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.8541846792404043,-1.3032333501122757,0.045454545454545456,0.7926731511373183,1.0,2/6,9.69%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.8541846792404043,-1.3032333501122757,0.045454545454545456,0.7926731511373183,1.0,2/6,9.69%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.7948908099662901,-1.3028767162523605,0.13333333333333333,0.7926895107250878,1.0,5/8,18.73%,PPARG;CD9;CD81;SREBF2;ITGB1
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.7278482403542196,-1.3027710002289976,0.18309859154929578,0.7908210814293863,1.0,5/15,12.75%,GLUD1;HSPA5;CCDC14;MBP;PLP1
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.7535601085847418,-1.302008587603052,0.14516129032258066,0.7937144621222277,1.0,3/13,12.22%,JUNB;CD55;ZFP36
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),-0.9016938801649033,-1.3016021543485874,0.031746031746031744,0.7938687386208402,1.0,1/5,0.32%,MAP2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.736373074948569,-1.3009611368954102,0.060240963855421686,0.7957833318575617,1.0,1/13,0.37%,DDIT4
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.7568940323907615,-1.3001525625260515,0.08695652173913043,0.7988447736709899,1.0,5/13,14.00%,RAPGEF3;COL18A1;PECAM1;RAP1A;MSN
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.7002563540901301,-1.2999045910181666,0.12162162162162163,0.7981414771309029,1.0,2/22,4.20%,YTHDC1;KHDRBS3
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.8619826572724565,-1.2997712954614051,0.078125,0.7964305216760856,1.0,1/6,4.06%,NES
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.6551168773754249,-1.2991243585869972,0.0963855421686747,0.7987309469443453,1.0,9/38,11.93%,TBX3;PLS3;KIAA1217;ALPL;SULF2;TGM2;HYAL2;FGFR1;GJA1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.762917259353289,1.298836588962664,0.08108108108108109,1.0,1.0,1/5,5.79%,MFHAS1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.651569211894112,-1.2986692867122305,0.07228915662650602,0.7990056117873482,1.0,5/39,6.48%,CEP57;PSMC6;PSMB9;CEP70;PSMA1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.846152997990478,-1.2981681428271283,0.1076923076923077,0.800073819654483,1.0,2/6,5.29%,SERPINE1;NFE2L2
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.8864402698903526,-1.2975087379338466,0.10294117647058823,0.7973810527052827,1.0,3/6,4.01%,PKM;PGK1;GAPDH
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.8864402698903526,-1.2975087379338466,0.10294117647058823,0.7973810527052827,1.0,3/6,4.01%,PKM;PGK1;GAPDH
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.8864402698903526,-1.2975087379338466,0.10294117647058823,0.7973810527052827,1.0,3/6,4.01%,PKM;PGK1;GAPDH
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.7202497037890556,-1.2971626954848687,0.09722222222222222,0.7976556463325534,1.0,9/22,19.23%,ADM;CD9;CD81;KIF16B;PICALM;SNX25;ITGB1;GRB2;ARFGEF2
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.7485214448217281,-1.2968039090904215,0.11764705882352941,0.797554009361053,1.0,1/16,0.24%,SERPINE1
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.8490615466486799,-1.2963406461629194,0.109375,0.7982677532908242,1.0,3/6,12.64%,MAGI2;RAP1A;ACAP2
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.7406667238357335,1.2961758571922575,0.25,1.0,1.0,1/9,0.19%,UBP1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.8485825000465965,-1.2961397589755594,0.125,0.7970479549818693,1.0,2/5,9.93%,BCAP31;TGM2
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.8299993132726836,-1.2959104886371322,0.14925373134328357,0.7954642908659416,1.0,3/7,14.56%,HYAL2;PAK2;CYLD
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.8634095235740806,-1.295740015364741,0.0958904109589041,0.7943611214030646,1.0,3/5,12.46%,LAMA5;REL;PLEC
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.864735052106522,-1.2953238422219309,0.11475409836065574,0.7942372925448118,1.0,3/7,8.34%,PPARG;HES1;PRKN
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.7342783399377343,-1.2951412630840389,0.16455696202531644,0.7930105676350614,1.0,5/14,16.65%,SSH1;ARF1;PRKN;KIF16B;PINK1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.8326067323008126,-1.2948478434461386,0.1076923076923077,0.7928914812441216,1.0,2/6,7.33%,CDKN1B;IPO7
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.7236633553868204,-1.2938169815606928,0.16455696202531644,0.7979926489747422,1.0,4/14,13.07%,SSH1;RPL10;KLF4;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.7148601670860483,-1.293467796731318,0.07407407407407407,0.7976938314103416,1.0,3/14,11.00%,RTN4;SPOCK1;EFNB2
prerank,MSigDB_Hallmark_2020__Apical Junction,-0.6252799843466347,-1.2934097970089429,0.08888888888888889,0.7954468230107442,1.0,22/64,19.42%,PIK3R3;CX3CL1;NFASC;ACTN1;CNTN1;PECAM1;ITGA10;VWF;ARPC2;CLDN5;RSU1;MSN;CADM2;CTNNA1;B4GALT1;MYH10;DLG1;ITGB1;ADAM15;MYL12B;CD34;EGFR
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.645076820843318,-1.2933417913514496,0.13253012048192772,0.7937072893751803,1.0,8/27,19.76%,VSIR;CX3CL1;IFNGR1;ZFP36;PLCG2;CD34;ARFGEF2;CLU
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.8036897277070929,-1.2927560209003897,0.14705882352941177,0.7950007449717407,1.0,1/6,2.52%,CX3CL1
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.6978225217475272,-1.2912436327820425,0.0945945945945946,0.8023146658424628,1.0,1/20,0.37%,DDIT4
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.6904493937562366,-1.2911717928342255,0.1,0.8003090125071383,1.0,9/30,13.07%,BHLHE40;EHD4;JUNB;LGALS3;NFE2L2;FOSL2;KLF4;ZFP36;NFKBIA
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.8175015271947819,-1.290572005092088,0.15625,0.8013440882982921,1.0,3/8,9.40%,RPS27A;UBC;CCNH
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.8490175692005123,-1.2903398084998878,0.208955223880597,0.8000023705733618,1.0,2/6,7.81%,PRKAG2;SLC2A1
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.8129572141804688,-1.2903343333879642,0.15,0.7954369460064143,1.0,1/6,0.50%,B3GNT2
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.8129572141804688,-1.2903343333879642,0.15,0.7954369460064143,1.0,1/6,0.50%,B3GNT2
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.7287621826331832,-1.2897105939606026,0.15492957746478872,0.7966673046469397,1.0,1/9,1.62%,PRKAG2
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),-0.6761294167941073,-1.2882026941532478,0.14864864864864866,0.8045365107031176,1.0,3/19,10.52%,PCK1;PPARG;RPS6
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),-0.8164140523593004,-1.2875036002947995,0.11475409836065574,0.8071425598262119,1.0,5/8,15.56%,SMAD7;NFE2L2;KLF2;KLF4;SREBF2
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.9026701753795873,-1.2858836042167294,0.05,0.8146819090582867,1.0,1/5,2.76%,ATG12
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.8008941985405991,-1.285328485673563,0.1,0.8157164762965166,1.0,1/7,2.58%,SYTL4
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.7731046986910796,-1.285042065442478,0.15873015873015872,0.8147453948879425,1.0,7/10,12.70%,HES1;KDM1A;DMD;SLC8A1;ANK2;DYSF;NEBL
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.8747032142368565,-1.2847410653123599,0.12903225806451613,0.8144445078220386,1.0,1/5,3.56%,GRIN2B
prerank,PanglaoDB_Augmented_2021__Luteal Cells,-0.6654910699839581,-1.2843892009187354,0.14285714285714285,0.8145556507229039,1.0,12/34,19.42%,PLS3;GAPDH;KIAA1217;PEBP1;SMARCA1;ADAMTS1;ITGB5;MYO1B;BCAR1;FKBP5;DAG1;EGFR
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.7892006167473596,-1.2841753326240406,0.0945945945945946,0.8114175315378837,1.0,3/8,14.48%,PPA1;PPA2;LARS1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.7892006167473596,-1.2841753326240406,0.0945945945945946,0.8114175315378837,1.0,3/8,14.48%,PPA1;PPA2;LARS1
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.8135831862117322,-1.283715737406859,0.1875,0.8122873968676053,1.0,1/5,1.27%,ADAMTS9
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.7488721125019502,-1.2834741225143371,0.1625,0.8112795976373154,1.0,4/15,11.66%,TSG101;RPL23;LAMP2;GABARAPL1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.8187616836802128,-1.2824179392527328,0.15,0.8147597275613968,1.0,1/7,2.39%,AKAP12
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.6658990261997871,-1.2820139453573143,0.11538461538461539,0.8154269029930323,1.0,5/32,12.30%,DIXDC1;WNT2B;RPS27A;UBC;PLCG2
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.7641400346686801,-1.2819892598409637,0.15714285714285714,0.8133353273904218,1.0,3/9,12.22%,PCK1;ANXA1;ZFP36
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.73570662610457,-1.2819574176255257,0.16216216216216217,0.8113169856749085,1.0,5/10,20.19%,PIK3R1;HYAL2;TPR;SMAD3;ECT2
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),-0.7014357185645423,-1.281908196541284,0.18309859154929578,0.8092789170870168,1.0,2/14,6.08%,SEC22B;FEZ2
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.7506539262186016,1.2818956706348283,0.13513513513513514,1.0,1.0,2/5,11.50%,MDM4;ACVR1
prerank,MSigDB_Hallmark_2020__Complement,-0.59236100860205,-1.2815195585888433,0.0975609756097561,0.8096467542406662,1.0,10/60,10.94%,MAFF;SERPINE1;PSMB9;HSPA5;LGALS3;LAMP2;CD55;ZFPM2;DGKG;CFH
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.8302100146696779,-1.2804946224308216,0.11475409836065574,0.8138092816258651,1.0,3/6,16.33%,UFL1;CHD1;MBD2
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.7777083684241805,-1.2799863022056086,0.15625,0.8150483327055394,1.0,4/11,12.22%,PPARG;RREB1;AAMDC;ZFP36
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.7717292390526358,-1.27963651635887,0.11842105263157894,0.8144839674674492,1.0,3/11,7.73%,MAP2;SSH1;HIP1R
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.6801162402926414,-1.2795971732706657,0.14457831325301204,0.8123433999437486,1.0,9/25,18.41%,MAP2;UFL1;KDM1A;AFDN;TPR;RACK1;PICALM;RAB14;DLG1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.8326479408576324,-1.2794099616843757,0.14864864864864866,0.8111533118873494,1.0,1/7,1.51%,MTFR1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.6763662545119699,1.2790830400736655,0.21621621621621623,1.0,1.0,5/8,29.93%,STAT2;OAS3;ISG15;PTPN2;YTHDF2
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.604467552930875,-1.2786391259616263,0.11956521739130435,0.8141381836462347,1.0,17/61,21.67%,LBR;YTHDC1;RAD21;DMD;CDKN1B;HIF1A;PURA;SMAD3;PAFAH1B1;EWSR1;SMARCC1;NSD2;KPNB1;AMD1;TRA2B;MTF2;CUL1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.7562657814434023,-1.2785171195244738,0.12,0.8125580272208601,1.0,1/16,1.89%,YTHDC1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.679676482902402,-1.2781089366980447,0.2028985507246377,0.8131195465552062,1.0,5/17,8.34%,PPARG;HES1;JUN;KDM1A;PRKN
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),-0.7458225707801226,-1.2780141460285919,0.15942028985507245,0.8113108115035629,1.0,3/12,13.23%,SERPINE1;HYAL2;RAB1A
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.6628580899146485,-1.2779489730444196,0.18666666666666668,0.8095714686162849,1.0,8/25,18.27%,PPARG;AAMDC;ZFPM2;ZFP36;TRIB2;SMAD3;WWTR1;GATA2
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.5980301557576654,-1.2777387014754928,0.10843373493975904,0.8089441877560378,1.0,10/52,8.92%,SERPINE1;ADM;BTG2;KLF6;CX3CL1;ATP2B1;IFNGR2;HIF1A;SCARF1;CD55
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.6456316822881296,-1.2774020085906326,0.10588235294117647,0.8087066832337761,1.0,11/39,14.56%,BHLHE40;UFL1;HES1;KDM1A;SMAD7;COMMD1;KLF4;TMSB4X;PRNP;NFKBIA;CYLD
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.7878403310267968,1.277197132944789,0.18604651162790697,1.0,1.0,3/5,17.53%,TTN;CDH2;PKD2
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.7381293917780077,-1.2770438488256963,0.10526315789473684,0.8088855188036824,1.0,4/14,11.00%,SPOCK1;GRIN2B;PRNP;EFNB2
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.7631475542197084,-1.2770412233834347,0.1267605633802817,0.806786443732749,1.0,6/9,21.38%,PPM1D;DUSP1;DUSP16;DUSP5;PPM1A;DUSP6
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.6876418618291804,-1.276847523674927,0.1375,0.8060255911902948,1.0,9/21,20.35%,SERPINE1;ARF1;HIP1R;RAB21;SGIP1;PICALM;LRPAP1;CLU;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.6771505993228949,-1.2765803723826201,0.1566265060240964,0.8054158032141503,1.0,7/26,15.59%,TSG101;CX3CL1;LGALS3;TPR;SDCBP;SMAD3;RACK1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),-0.6103536788616916,-1.27615627203515,0.1125,0.8060121150859549,1.0,9/46,12.88%,SERPINE1;CX3CL1;SMAD7;MAGI2;TPM1;DLC1;AFDN;TMEFF2;CLDN5
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.584576455690101,-1.2760618236749801,0.020833333333333332,0.8045276481946652,1.0,27/129,16.65%,TBX3;ANGPTL4;BNIP3L;CX3CL1;GRK5;HSPA5;RPS27A;PIK3R1;PRKN;UBC;RPL10;ANXA1;KLF4;SOD2;CFL1;SNX6;GOLPH3;TMBIM6;PAK2;NPM1;NFKBIA;CPEB4;NAA16;PTMA;MALT1;MCL1;PINK1
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.9049435743703154,-1.2759067198144185,0.06557377049180328,0.8031092668033254,1.0,1/5,1.94%,ATF3
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.604331097907512,-1.2754022641119114,0.1111111111111111,0.80385247649907,1.0,21/63,19.10%,RPL23;RPL34;RPS9;RPL37;RPL10;RPS27;RPS6;RPL8;RPS15;RPS7;RPLP2;RPL13A;RPL15;RPL37A;SMAD3;RPL24;RPL7A;RPLP1;RPS28;RPL31;RPS19
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.7929726760291977,-1.2743682999627683,0.16176470588235295,0.8077858223292003,1.0,2/7,6.67%,KCNMB4;KLF2
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.6424213165288378,-1.2743266019095483,0.12658227848101267,0.805819745383497,1.0,4/28,8.34%,MAP2;SSH1;HIP1R;PRKN
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.8017710831847966,-1.2741540155206443,0.125,0.8048459303317785,1.0,1/8,2.82%,HES1
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),-0.7778505959254014,-1.2739204410374418,0.19480519480519481,0.8043093011975977,1.0,3/10,17.66%,SUN2;MYO1B;MYO1E
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.7467240537077506,-1.2734598279694918,0.14705882352941177,0.8047812858050694,1.0,3/12,9.11%,ALPL;GGT5;ANXA1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.8150468919774736,-1.2733682815423786,0.14084507042253522,0.8034162514136737,1.0,3/8,12.59%,TSG101;SNX6;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.8428466046819387,-1.2729615854222986,0.12307692307692308,0.8037165493276962,1.0,4/6,15.56%,PPARG;ABCA5;NFKBIA;SREBF2
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.6819258736329505,1.2727119029391971,0.125,1.0,1.0,2/10,2.79%,GULP1;ARHGAP12
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.7539786833272607,-1.2724241617409553,0.19047619047619047,0.8052702153775855,1.0,4/6,22.66%,FES;RASSF1;GATA2;GUK1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),-0.7929623936984009,-1.2723480067779287,0.17142857142857143,0.8036867258945669,1.0,1/6,2.31%,RTN4
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.72889587185418,-1.272303257044857,0.15492957746478872,0.8018558476547917,1.0,3/15,9.11%,MAP3K5;NFE2L2;ANXA1
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),-0.8007978516226748,-1.2715735143854636,0.10144927536231885,0.8040817744298726,1.0,3/9,12.70%,KDM1A;DMD;NEBL
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.6686779058322601,-1.2707736847984594,0.09876543209876543,0.8063812165868561,1.0,10/39,10.92%,PSMC6;NDRG1;PGK1;BNIP3L;PSMB9;RPS27A;PSMA1;HIF1A;UBC;EPAS1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.7927978757832777,-1.2706891628901955,0.14754098360655737,0.804838980107777,1.0,1/8,3.05%,JUN
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.6058072043114537,-1.2706193614226888,0.12643678160919541,0.801301201806577,1.0,17/45,22.60%,PSMC6;JUN;PSMB9;FOS;PIK3R1;PSMA1;VAV3;PLCG2;PAK2;TEC;MALT1;LCP2;GRB2;PSMA7;PIK3CB;CUL1;MAPK8
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.6058072043114537,-1.2706193614226888,0.12643678160919541,0.801301201806577,1.0,17/45,22.60%,PSMC6;JUN;PSMB9;FOS;PIK3R1;PSMA1;VAV3;PLCG2;PAK2;TEC;MALT1;LCP2;GRB2;PSMA7;PIK3CB;CUL1;MAPK8
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.8833768339453696,-1.270040674778766,0.11594202898550725,0.8027740520241873,1.0,1/5,0.32%,MAP2
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.7723962801367827,-1.2695656621754294,0.10144927536231885,0.8037376924310813,1.0,5/11,18.41%,DUSP1;PRKN;CYLD;PINK1;DLG1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.6470481820244273,-1.2694314039545753,0.13513513513513514,0.8025270441126238,1.0,15/34,13.31%,MAP2;DOK5;MAP1B;NFASC;GRIA2;GPM6B;NPAS3;PTPRD;ANK2;PPFIA2;GJA1;DCLK1;ADGRL3;PLP1;LRRC4C
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.6328005418673976,-1.2691454822224741,0.08536585365853659,0.802321218024299,1.0,8/35,9.19%,SERPINE1;ANGPTL4;PKM;JAK1;RAPGEF3;FLT1;HIF1A;KLF4
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.6546218610553647,1.2683227110542572,0.25,1.0,1.0,2/7,11.50%,MDM4;ACVR1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.610166972859949,1.2680034162388578,0.16216216216216217,1.0,1.0,3/12,9.91%,ATR;ATM;NEK7
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.5807376828997135,-1.26725807608665,0.1368421052631579,0.8113606306792484,1.0,34/90,27.38%,SUN2;SCARB2;RIMS1;RPS27A;ANK2;HIP1R;SUN1;UBC;ARPC2;SYNJ2;DYSF;SH3KBP1;SYT1;SGIP1;PICALM;PIP5K1C;TOR1AIP2;ANK3;GRB2;USO1;CHMP4B;EGFR;REEP3;VAPB;CLTA;DNM2;CCDC88A;SNX9;TF;SERP1;SYNJ1;SPTBN1;FZD4;FCHO2
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.7351693932503037,1.267049403250697,0.2647058823529412,1.0,1.0,1/6,0.58%,PGM5
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.6524322449233076,-1.266701917054357,0.1282051282051282,0.8130667640382102,1.0,8/32,16.23%,LAMC1;ACTN1;PIK3R1;LAMA5;TMEFF2;ATRNL1;PARVB;TBCD
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.8112686887704339,-1.2661087635064114,0.078125,0.8143789509447087,1.0,1/5,11.53%,GOLPH3
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),-0.7582207118333717,-1.2657294364002918,0.125,0.8146406975967377,1.0,1/11,0.37%,DDIT4
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.8033043926163216,-1.2656280454241609,0.234375,0.8132293223070642,1.0,2/6,9.00%,WNT2B;ARIH2
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.616538232731616,-1.2654122344607686,0.18055555555555555,0.8126176927940397,1.0,9/41,9.16%,CX3CL1;SCARB2;FES;LRRC7;MAGI2;PTPRD;SCARF1;RAP1A;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.7321870880311734,-1.2651290301048137,0.16216216216216217,0.8121726778686864,1.0,6/12,18.43%,EPS8;VAV3;MSN;LARS1;PICALM;MTOR
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.7983178981978349,-1.2640026512748945,0.13846153846153847,0.8167905455432836,1.0,2/7,7.60%,CX3CL1;ANK2
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.7833999278227994,-1.2632493024252691,0.1694915254237288,0.820083265043714,1.0,1/6,4.91%,ESR2
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.6263807134400202,-1.2631169929037704,0.12222222222222222,0.8188382421880066,1.0,12/40,14.95%,BTG2;NR4A1;ATF3;JUNB;FOS;PLCL1;PTPRD;SOD2;HYAL2;TMBIM6;NFKBIA;BTG1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.6688397287217903,-1.2630166915978622,0.09876543209876543,0.817383109022008,1.0,7/26,13.07%,PSMC6;ST18;PSMB9;PSMA1;TMSB4X;LIMS1;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.6831879494032116,-1.2629909144084412,0.14814814814814814,0.8155307465720661,1.0,2/25,2.47%,SERPINE1;PPARG
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.738792960062497,-1.2627465485166975,0.17567567567567569,0.8154615089712611,1.0,6/15,9.19%,PKM;ADAMTS9;GLUL;JAK1;KLF2;KLF4
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.8438187153636901,-1.262309399610278,0.22388059701492538,0.8157412436120782,1.0,1/5,9.43%,CNOT6L
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.5449622360949247,-1.2621225252672683,0.08247422680412371,0.8147889280282781,1.0,25/135,14.37%,TBX3;UFL1;RPL23;SLC6A6;CX3CL1;HES1;GRK5;RPS9;CDKN1B;ERBB4;FLT1;TPM1;CD81;CNOT6L;TGM2;RPS6;EFNB2;FGFR1;ZFP36;CLDN5;NPM1;SMC6;CNBP;SDCBP;VEGFC
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.7475748929395463,-1.2615986119949711,0.14285714285714285,0.8144156296305836,1.0,5/9,20.19%,PIK3R1;HYAL2;TPR;SMAD3;ECT2
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.7475748929395463,-1.2615986119949711,0.14285714285714285,0.8144156296305836,1.0,5/9,20.19%,PIK3R1;HYAL2;TPR;SMAD3;ECT2
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.7140220135778552,-1.2615479250483377,0.1780821917808219,0.812702817113236,1.0,4/12,8.10%,LBR;ABCA5;LSS;SCARF1
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.5826879290556207,-1.2612726001875612,0.13333333333333333,0.8123232008635506,1.0,18/91,12.93%,PSMC6;MAP3K5;GRIN2B;PSMB9;RPS27A;LRRC7;JAK1;PEBP1;ERBB4;PIK3R1;PSMA1;MBP;UBC;SHC2;FGFR1;MEF2A;ZFP36;DUSP5
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.6819659892037967,-1.2608728808600445,0.17647058823529413,0.8122890907939533,1.0,5/20,9.19%,PPARG;JUN;FOS;HIF1A;KLF4
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.4127579393351367,1.2588295078752818,0.0,1.0,1.0,9/81,5.66%,RSAD2;SAMD9L;ARID5B;GBP4;PLA2G4A;GCH1;RNF213;IL15;EIF2AK2
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.7494426208279197,-1.258643525731889,0.22727272727272727,0.8220941032122573,1.0,5/14,19.65%,SCP2;LSS;ACSL5;AGPAT4;CBR4
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.650261688916338,-1.258545555562935,0.15476190476190477,0.8208004116459005,1.0,4/22,9.80%,PSMC6;NPLOC4;HSPA5;HERPUD1
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),-0.7532502256469654,-1.2585327954733163,0.1724137931034483,0.8189089083286182,1.0,1/10,4.17%,EPS8
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.6734962785690177,-1.2583861686762234,0.16216216216216217,0.8177858333802354,1.0,4/19,11.50%,VSIR;SRGN;SPG7;OGT
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.5494079473005578,1.2577218631402738,0.21428571428571427,1.0,1.0,2/18,2.74%,RC3H1;CPEB3
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.7678979855429872,1.2575469220301443,0.2571428571428571,1.0,1.0,1/5,2.79%,ARHGAP12
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.6207618273424967,-1.2572912659381974,0.1625,0.8225739358918265,1.0,5/29,7.49%,SERPINE1;ANGPTL4;RAPGEF3;FLT1;HIF1A
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.8001954626629816,-1.2570152440143918,0.2153846153846154,0.8222297260891652,1.0,1/7,3.43%,PKIG
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.6995086165490803,-1.256615747313554,0.18421052631578946,0.818539770315229,1.0,4/12,20.42%,LBR;KPNB1;CHMP4B;REEP3
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.6995086165490803,-1.256615747313554,0.18421052631578946,0.818539770315229,1.0,4/12,20.42%,LBR;KPNB1;CHMP4B;REEP3
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.6995086165490803,-1.256615747313554,0.18421052631578946,0.818539770315229,1.0,4/12,20.42%,LBR;KPNB1;CHMP4B;REEP3
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),-0.7080349859713235,-1.2565931240971766,0.1891891891891892,0.8167872305196662,1.0,3/15,11.95%,MAP2;CTNND2;MEF2A
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.684183550693834,-1.2559422494062975,0.16883116883116883,0.8181870257818529,1.0,8/24,10.92%,PSMC6;PSMB9;RPS27A;NFE2L2;PSMA1;HIF1A;UBC;EPAS1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.8272272440940406,-1.255522418372369,0.16901408450704225,0.8185518570520774,1.0,2/7,8.26%,RAPGEF3;RAP1A
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.7532530835320412,1.2552978877515824,0.17073170731707318,1.0,1.0,1/5,9.64%,ATM
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),-0.6075433323506707,-1.254826159367127,0.18421052631578946,0.8208904753310661,1.0,7/30,16.65%,ZEB2;SCARB2;PRKN;GOLPH3;PAK2;MSN;PINK1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.6913365718385016,-1.2545323496374854,0.24242424242424243,0.8187680879124977,1.0,5/13,16.65%,ATG12;RB1CC1;PRKN;GABARAPL1;PINK1
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.6913365718385016,-1.2545323496374854,0.24242424242424243,0.8187680879124977,1.0,5/13,16.65%,ATG12;RB1CC1;PRKN;GABARAPL1;PINK1
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.7424307699481215,1.254397567415151,0.3,1.0,1.0,2/5,22.15%,ROCK1;GAS6
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),-0.7501663000900477,-1.2540153476870923,0.24615384615384617,0.8203004049828267,1.0,1/8,4.73%,RAD21
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.6713665538515904,-1.2534961327574066,0.16455696202531644,0.8215461348484486,1.0,7/27,9.16%,DDIT4;WNT2B;PBX3;SPOCK1;PTPRD;SMARCA1;IL1RAPL1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.8075836811239858,-1.2524118283548584,0.1935483870967742,0.8251452479696759,1.0,3/9,4.86%,DDIT4;SMAD7;DMD
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.7365449350117839,-1.2517546702529112,0.14516129032258066,0.8264250717113792,1.0,4/13,11.63%,ENPP2;NFASC;GRIA2;CTNND2
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.6162247253554182,-1.2509273483017849,0.1875,0.8303253168122304,1.0,11/39,11.24%,MAP2;PPP1R9A;NFASC;GRIA2;ERBB4;CNTN1;PTPRD;ANK2;SHC2;STOX2;PPFIA2
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),-0.700051024117671,-1.2509215710429549,0.15714285714285714,0.8284887959042414,1.0,4/18,12.56%,ADM;S1PR1;GNA13;ADGRL3
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.7266254465661935,-1.2507271203035701,0.19696969696969696,0.8278671489348916,1.0,3/13,6.19%,CCDC60;CX3CL1;ERBB4
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.8091210065087518,-1.2501885789577347,0.1891891891891892,0.8291294700071037,1.0,4/7,18.09%,RIMS1;RIMS2;SYT1;ARHGAP17
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.7119994730015322,-1.2499350176227368,0.23880597014925373,0.828634298714995,1.0,4/14,8.66%,PKN3;SEMA6B;ERBB4;PDXDC1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),-0.5948719603535665,-1.2499091671583311,0.1111111111111111,0.8270176289992766,1.0,10/58,12.75%,MAP2;BTG2;PPP1R9A;GRM7;GPM6B;GAS7;GPM6A;CTNND2;DCLK1;PLP1
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.7257123788044283,-1.249355916397707,0.21428571428571427,0.8280491953709948,1.0,4/12,9.11%,SERPINE1;PRKCE;RREB1;ANXA1
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.6926287991185103,-1.249040071681844,0.19736842105263158,0.8277834460150678,1.0,4/17,12.56%,MAP1B;NES;ERBB4;ADGRL3
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.7046981342044366,-1.2488722710270688,0.24242424242424243,0.8268491154644096,1.0,4/16,6.48%,PSMC6;PRKAG2;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.7807167259235196,1.248861927956188,0.18421052631578946,1.0,1.0,1/5,3.61%,TTN
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.6450008190330889,-1.248179071653103,0.11494252873563218,0.8292107949953128,1.0,7/35,14.53%,CLIC2;PPARG;HES1;HIP1R;PRKN;CLDN5;AMFR
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.6726506424119791,-1.2476665001191283,0.1728395061728395,0.8297592354843598,1.0,8/19,22.97%,LGALS3;PIK3R1;PRKCE;DPP10;DLG1;ITGB1;EGFR;PRKCH
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.7672876326257737,-1.246959358660005,0.2,0.8318577496697093,1.0,2/8,7.73%,RTN4;HIP1R
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.7380925456595638,-1.2465506850032066,0.2028985507246377,0.8324225865618121,1.0,2/9,7.07%,SCARB2;LAMP2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.8216645250464805,-1.2465325904044446,0.22388059701492538,0.830801349330875,1.0,2/5,9.80%,NPLOC4;HERPUD1
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.6290782928931515,-1.2462791551288428,0.19480519480519481,0.8304602124280731,1.0,13/30,18.83%,LRRC32;HIF1A;SLC2A1;TNS1;VWF;ITGB5;EFNB2;DYSF;CST3;EGFL7;PSAP;ITGB1;ACVRL1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.5965252753475819,-1.2460518096830833,0.14634146341463414,0.8297541350819438,1.0,7/42,12.75%,MAP2;BTG2;PPP1R9A;GPM6B;TPM1;GPM6A;PLP1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),-0.5484880687875359,-1.2459877442780576,0.0625,0.8282467376136293,1.0,35/147,15.59%,ST18;BTG2;NR4A1;BNIP3L;RTN4;CD9;PPM1D;ESR2;CDKN1B;DUSP1;ACTN1;ERBB4;PBRM1;MAGI2;COL18A1;BCL6;PRKN;NPAS2;KLF4;ADAMTS1;DLC1;SOD2;HYAL2;CRLF3;GJA1;DYSF;TMBIM6;NPM1;CDKN1A;PLPP1;NCK1;SMAD3;BTG1;CDK6;RACK1
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.556679255733722,-1.2455908578250507,0.02,0.8284241177048887,1.0,38/209,15.96%,TBX3;ANGPTL4;MAP3K5;NDRG1;BNIP3L;RTN4;CX3CL1;JUN;GRK5;HSPA5;RPS27A;ACTN1;PIK3R1;BCL2L14;HIP1R;VAV3;BCL6;PRKN;UBC;RPL10;ANXA1;TGM2;CFL1;RPS6;GOLPH3;GNA13;TMBIM6;FGD4;PAK2;NPM1;NFKBIA;BCAR1;TNFRSF10B;NAA16;RACK1;PTMA;MALT1;MCL1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),-0.7230441435214454,-1.2453911022450617,0.1232876712328767,0.8277998228691456,1.0,2/13,5.74%,SLC4A10;ANO2
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.7116942186426134,-1.244586390274699,0.20833333333333334,0.8303265140895488,1.0,6/15,18.01%,PRKAG2;HIF1A;TPR;OGT;PINK1;NUP54
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.5258749610862621,1.2444708871206507,0.09523809523809523,1.0,1.0,6/29,7.84%,PRIMPOL;ATR;RHBDD1;INO80;ERCC6;TAF1
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.817662228638177,-1.2443401410312003,0.18518518518518517,0.8299424689565532,1.0,2/5,11.39%,RTN4;TPR
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.7046832431989742,-1.2442396218507663,0.19736842105263158,0.8286919782950151,1.0,4/16,13.17%,BTG2;CDKN1B;CNOT6L;CDKN1A
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.5943421807375466,-1.2440157082930332,0.1744186046511628,0.8280965192421454,1.0,14/57,9.83%,BTG2;NEDD9;ATF3;BNIP3L;BCAP31;JUN;LGALS3;SMAD7;CDKN1B;TIMP3;IFNGR1;EMP1;ANXA1;SOD2
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.7903801938533456,-1.2429682200987537,0.20588235294117646,0.8319935994924461,1.0,1/5,8.34%,PRKN
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.8154374041168438,-1.2422703124755385,0.17857142857142858,0.8342687765137723,1.0,3/6,13.07%,PPARG;ABCA5;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.7846221038312606,-1.241983505266204,0.17391304347826086,0.8337369782151306,1.0,3/6,9.16%,PRKN;ANXA1;IL1RAPL1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.844368649271953,-1.2419707497071404,0.109375,0.8319668360108523,1.0,1/5,0.24%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.6868586630474922,-1.2419478378697733,0.22666666666666666,0.8303232303397391,1.0,5/12,19.07%,PRKN;CDKN1A;PINK1;PIKFYVE;GRB2
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.6682765979388834,1.2416022275977303,0.2558139534883721,1.0,1.0,1/5,1.65%,PLA2G4A
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.6745845976410458,-1.2413657672517684,0.1891891891891892,0.8319650202003704,1.0,10/27,10.92%,PSMC6;ATF3;PSMB9;RPS27A;NFE2L2;PSMA1;KLF2;HIF1A;UBC;EPAS1
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.8136532514201341,-1.2413331432375327,0.2727272727272727,0.8304468870744008,1.0,3/5,13.89%,NEDD9;CASS4;BCAR1
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.6538863465738227,-1.2412660682637704,0.1917808219178082,0.8290770870375818,1.0,8/24,15.51%,PPP1R9A;BCAP31;SLC8A1;ANK2;PRNP;PLCG2;CACNA1C;PPP3CC
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.8289865008306996,-1.2412531036315584,0.1896551724137931,0.8274769712057684,1.0,2/6,6.53%,HES1;FOXF1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.7814224565047498,-1.2412049763348263,0.19402985074626866,0.8258364491852035,1.0,3/8,13.23%,RPL23;RPS7;RAB1A
prerank,PanglaoDB_Augmented_2021__Platelets,-0.6166415478168814,-1.2409364661761895,0.11842105263157894,0.8252136503729055,1.0,10/35,10.57%,SERPINE1;ERO1A;SRGN;SLC2A3;CD9;LRRC32;CAVIN2;PECAM1;VWF;WIPF1
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.6893760626813742,-1.2408165364878667,0.2,0.8240538886902439,1.0,6/20,16.57%,SYN3;GLUL;RIMS1;PPFIA2;SYT1;SLC38A2
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.6175108653617007,-1.2406507007262706,0.14772727272727273,0.8232267049435245,1.0,14/50,18.35%,DIXDC1;ADAMTS9;AKAP12;MAP1B;NES;NFASC;ANK2;TPM1;GJA1;NAV1;WWTR1;MYH10;CALD1;PDE10A
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),-0.6542457017960146,-1.2405549725990137,0.16883116883116883,0.8220525346890241,1.0,7/25,11.85%,ITPR1;ATP2B1;SMAD7;SLC8A1;ANK2;TPM1;ATP1B3
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),-0.6994378507867547,-1.2405443510848173,0.17105263157894737,0.8204869110716081,1.0,5/19,17.66%,PPFIA2;MYO1B;RAB1A;PAFAH1B1;MYO1E
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.7144151508084423,-1.2401768122247743,0.14705882352941177,0.8208587648262593,1.0,2/12,13.86%,PPARG;ACOX1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.6844166541582022,1.240126656417044,0.27906976744186046,1.0,1.0,2/7,9.22%,ZNRF3;CHD7
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.6699094610954905,1.2399116767294913,0.3055555555555556,1.0,1.0,3/11,15.94%,TLE4;TCF7L1;TCF7L2
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.6770355355150905,-1.2396325253685168,0.21794871794871795,0.8216702035759996,1.0,6/15,14.61%,ITPR1;RAPGEF3;SLC2A1;RAP1A;ENSA;CACNA1C
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.6333305840188782,1.2395155569395548,0.16666666666666666,1.0,1.0,4/9,23.13%,PDGFC;PPP2R5A;PPP2R5E;PDGFB
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.5655329698611664,-1.239052692755724,0.17777777777777778,0.822733155795514,1.0,14/86,12.06%,LAMC1;PLS3;NEDD9;RTN4;HES1;EPS8;RIMS1;RAD21;SPG7;GPM6B;SLC2A1;WIPF1;LIMS1;MYO1B
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.7428381370015069,-1.2386731176592742,0.17647058823529413,0.8231212136362994,1.0,7/10,24.75%,COMMD1;PRKN;PICALM;XIAP;FTL;B2M;TF
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.7599596670105129,-1.238560382837895,0.23076923076923078,0.82189250444399,1.0,1/8,2.52%,CX3CL1
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.8363340121045346,-1.238293714074072,0.2153846153846154,0.8197948552472852,1.0,2/6,9.91%,GRIN2B;INSYN2A
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.8363340121045346,-1.238293714074072,0.2153846153846154,0.8197948552472852,1.0,2/6,9.91%,GRIN2B;INSYN2A
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7406084060955188,-1.2379917185018352,0.1643835616438356,0.8197958869814395,1.0,8/12,19.10%,RPS27;RPS6;RPS15;RPS7;NPM1;RIOK3;RPS28;RPS19
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.7036237200066078,1.237804115408418,0.3055555555555556,1.0,1.0,1/7,1.12%,HABP4
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.714189130474534,-1.2377474721410324,0.14084507042253522,0.8193163099736404,1.0,5/9,23.05%,DMD;ANK2;ATP1B3;ANK3;STK39
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.832120481534639,-1.2374789415265512,0.12121212121212122,0.8192497919237663,1.0,2/5,13.17%,LBR;CDKN1A
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.64550356678263,-1.2374078429922841,0.17073170731707318,0.8179071308567549,1.0,7/30,13.47%,TSG101;CDKN1B;CDC37;SLC8A1;CCNH;CDKN1A;TRIB2
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.5811621316905451,-1.2371796270302942,0.18181818181818182,0.8176845060705915,1.0,17/65,19.39%,CCDC3;NDFIP1;HIF1A;REL;PRKN;KLF4;CLDN5;SDCBP;RACK1;PICALM;PINK1;MTMR2;GATA2;ACVRL1;MECP2;CD34;LRPAP1
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),-0.7341308385999532,-1.2367885079262448,0.15942028985507245,0.8180530066130106,1.0,2/12,5.87%,ST18;JAK1
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,-0.7667813096304483,-1.2364672851679563,0.18333333333333332,0.8179216063050981,1.0,1/8,1.25%,NEDD9
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.6872474986397105,-1.2363815583760682,0.1643835616438356,0.8166828623352357,1.0,8/18,24.14%,ADM;CD9;CD81;PICALM;ITGB1;GRB2;DNM2;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),-0.7984817105779501,-1.2363119950464692,0.18840579710144928,0.8154490932407542,1.0,4/8,12.59%,TSG101;HYAL2;SNX6;ZFYVE28
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.8508336044696445,-1.235936748074855,0.1875,0.8156164484605649,1.0,3/5,12.59%,TSG101;SNX6;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.7128533901560947,-1.235851267685324,0.21621621621621623,0.8145021171887016,1.0,6/14,16.65%,PRKN;SOD2;PRNP;SNX6;CPEB4;PINK1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.8348292208679631,-1.2358241441328872,0.11475409836065574,0.8129885100870183,1.0,2/5,5.26%,RFC3;POLA1
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.7897215966943139,-1.2355545727017414,0.23809523809523808,0.8129583067228701,1.0,2/6,9.80%,NPLOC4;HERPUD1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.4704142645449956,1.234625720500204,0.10526315789473684,1.0,1.0,3/25,3.59%,HOMER1;ALS2;RNF213
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.7832430755062677,-1.234140722937494,0.18032786885245902,0.8183344899078385,1.0,3/7,6.48%,PSMB9;NFE2L2;PSMA1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.6754173065984496,-1.2337985664581836,0.14666666666666667,0.8188288941454471,1.0,10/22,12.75%,MAP2;GRIA2;S100A6;GPM6B;NPAS3;STOX2;CTNND2;DCLK1;ADGRL3;PLP1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.698950365363149,-1.233717039269385,0.1875,0.8175412228258249,1.0,5/16,16.49%,RPS27A;REL;UBC;NFKBIA;TBK1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.5814067849153681,1.2333288487897802,0.17142857142857143,1.0,1.0,3/14,9.91%,ATR;ATM;NEK7
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.6974230015658035,-1.2328770233210595,0.14102564102564102,0.8199450850824606,1.0,4/18,13.17%,BTG2;CDKN1B;CNOT6L;CDKN1A
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.6849705509149238,1.2326983023552602,0.18518518518518517,1.0,1.0,2/7,12.59%,HERC5;RNF216
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),-0.797139312828492,-1.2325419409972656,0.27419354838709675,0.8202117502147867,1.0,1/5,8.31%,CALCOCO2
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.7768115943075449,-1.2321530021108635,0.2923076923076923,0.8205658457351671,1.0,1/8,0.96%,SUN2
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.6934516032213428,-1.2315764218125054,0.2537313432835821,0.8215587714570852,1.0,4/13,19.63%,SPOPL;OGT;CST3;PLAT
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.6618523487736457,-1.23131209052846,0.21794871794871795,0.8216224040238949,1.0,8/27,15.46%,POLA1;CDKN1B;CCNH;CDK14;CRLF3;CDKN1A;MAX;CDK6
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.6379736686901789,-1.2308883860871174,0.23376623376623376,0.8222575327217075,1.0,7/27,12.30%,RTN4;ENPP2;GLUL;PRKCE;HIF1A;RREB1;PLCG2
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.7943192725654644,-1.2308719431880053,0.2835820895522388,0.8208490862254575,1.0,2/6,7.94%,VSIR;BCL6
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.686152351696108,-1.2306672239832726,0.19736842105263158,0.8202565960477425,1.0,5/15,15.72%,PRKAG2;HSPA5;SIK2;CPEB4;PIK3C3
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),0.5926510875731659,1.2299250866121025,0.2222222222222222,1.0,1.0,2/9,4.52%,USP25;OTUD4
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.8327636876680956,-1.2294494686031974,0.11940298507462686,0.825131874240894,1.0,4/5,15.59%,UFL1;HSPA5;NCK1;RACK1
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.6731107039125299,-1.2292699229952417,0.22857142857142856,0.8243806330911333,1.0,9/16,12.38%,PCK1;PPARG;TMEM45B;COL18A1;CD55;SLC26A2;PLIN2;ACSL5;TTC7A
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.616502487011676,-1.2292426255182292,0.12195121951219512,0.8230007673651637,1.0,5/40,5.63%,MAP2;BTG2;PPP1R9A;PBX3;GPM6B
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.721323219057248,-1.2290235144803676,0.23943661971830985,0.8224956393672697,1.0,4/11,13.17%,CDKN1B;CDC37;CCNH;CDKN1A
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.6993402067129506,-1.229021153715387,0.25,0.8209078099476418,1.0,3/12,9.11%,SERPINE1;PRKCE;ANXA1
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.8598700926482996,-1.228382095168725,0.13846153846153847,0.8224655286531697,1.0,1/5,7.49%,HIF1A
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.712978294084124,-1.2283290382620755,0.21212121212121213,0.8210567409726686,1.0,6/12,18.27%,PPARG;CD9;PECAM1;VWF;LCP2;GATA2
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.7988967316773692,-1.2280828059261715,0.16129032258064516,0.8207964718015001,1.0,1/6,2.05%,RFTN1
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.758390589984498,-1.2270503297611919,0.22580645161290322,0.8246703462574688,1.0,4/9,14.53%,RPS27A;UBC;UGGT2;AMFR
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.724701622115276,-1.2268506588929045,0.208955223880597,0.8239099931867376,1.0,2/10,8.34%,CX3CL1;PRKN
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),-0.7417663233096837,-1.226560501722463,0.19718309859154928,0.8236886582502974,1.0,1/12,0.24%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.6485780218140864,-1.2265193677327173,0.1794871794871795,0.8223551692066584,1.0,5/21,9.93%,CX3CL1;KDM1A;PTPRD;IL1RAPL1;TGM2
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),-0.7826274838421998,-1.2260940943477174,0.2835820895522388,0.8233980548271548,1.0,1/6,1.62%,PRKAG2
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.7108207841537307,-1.2259307552641943,0.2638888888888889,0.8225179517613928,1.0,4/14,11.50%,PRKAG2;HIF1A;TPR;OGT
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),-0.6832020695840837,-1.2257327793691617,0.20833333333333334,0.8221093904130763,1.0,4/17,8.34%,MAP2;KDM1A;FES;PRKN
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.7135245077807872,-1.2252846911225745,0.22580645161290322,0.8227007453967132,1.0,4/11,14.87%,RPL10;NPM1;RPL24;RPL7A
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),-0.6722842074108517,-1.225261622462907,0.25396825396825395,0.8212332873250144,1.0,4/22,5.71%,SERPINE1;CX3CL1;SPOCK1;DUSP1
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),-0.6782892511269565,-1.2252587513164184,0.1,0.8196867086294871,1.0,8/21,18.43%,NDRG1;PGK1;BNIP3L;HIF1A;EPAS1;CPEB4;PINK1;MTOR
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.6047638603239192,-1.2250832114506474,0.18292682926829268,0.8190541972401656,1.0,12/36,24.14%,PRKAG2;BNIP3L;GAPDH;RB1CC1;SNX6;TBK1;PINK1;MTOR;GNAI3;MAPK8;ATP6V1E1;NEDD4
prerank,PanglaoDB_Augmented_2021__Schwann Cells,-0.6211016877560049,-1.2247951574056515,0.17567567567567569,0.8187192147601606,1.0,10/27,12.75%,LAMC1;NDRG1;NFASC;GRIA2;PRX;TMEM132C;ANK2;SHC2;DCLK1;PLP1
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.7130564431051998,-1.2245600927525981,0.23376623376623376,0.8182381855049057,1.0,7/15,18.27%,RFC3;KDM1A;ALPL;GMPS;NPM1;SMARCC1;GATA2
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.8087661744096972,-1.224347903035489,0.23943661971830985,0.8177379507667749,1.0,1/6,1.46%,TSG101
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.6316609396592625,-1.2241684369703414,0.22077922077922077,0.8170928308169513,1.0,4/26,6.96%,PSMC6;PSMB9;PSMA1;MAGI2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.7856437874757065,-1.2238088170500403,0.265625,0.8174336119040112,1.0,3/6,11.71%,RPL23;SMAD7;RPS7
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.668232858333489,-1.2229729613292417,0.22388059701492538,0.8200915389633271,1.0,3/12,12.01%,TAF1D;CCNH;CSTF3
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.6012148569588975,-1.2226451578022308,0.19767441860465115,0.8201961657263417,1.0,12/42,13.07%,PSMC6;ST18;CX3CL1;PSMB9;NFE2L2;YBX3;PSMA1;TMSB4X;HYAL2;LIMS1;ZFP36;NFKBIA
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.7896404210055429,-1.2219343385483181,0.203125,0.8222772831784981,1.0,3/6,9.77%,ANXA1;KLF4;TMSB4X
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.7840017309338432,-1.2204024537613936,0.20967741935483872,0.828297155189658,1.0,1/5,0.45%,MTHFD1L
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.699329527301715,-1.2201354425238875,0.18055555555555555,0.8276604273194011,1.0,1/15,0.93%,NRCAM
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.8225666157918621,-1.219825556305851,0.2033898305084746,0.8274606244667707,1.0,2/5,9.06%,CD55;CD81
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.6390687873733548,-1.2193241511399595,0.21428571428571427,0.8286868363996032,1.0,9/22,19.42%,LGALS3;PIK3R1;PRKCE;DPP10;CNST;RACK1;DLG1;ITGB1;EGFR
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.5972160153672145,-1.2193232482133385,0.1686746987951807,0.8271663100942828,1.0,15/48,15.83%,PSMC6;RFTN1;NFKBIZ;PSMB9;PIK3R1;PSMA1;VAV3;PLCG2;BTNL9;PAK2;INPP5D;TEC;BCAR1;NCK1;MALT1
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.7760926425487957,-1.2190692060173478,0.2222222222222222,0.8270302517495832,1.0,2/6,15.88%,JUN;CHD1
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.7014527898147176,-1.218764303775892,0.21428571428571427,0.8270590344496407,1.0,2/14,5.87%,ST18;JAK1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.7190740798376701,-1.2176899822129539,0.18181818181818182,0.8312913313169631,1.0,4/10,14.56%,RPS27A;UBC;ALPK1;CYLD
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.7262667794555349,1.2175776889646763,0.2826086956521739,1.0,1.0,3/5,5.31%,RSAD2;IL15;MIA3
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.7109769668955755,-1.2173684218786731,0.25675675675675674,0.8311485027606268,1.0,4/12,12.30%,RPS27A;UBC;ALPK1;PLCG2
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),-0.7295125386376834,-1.2169686371700676,0.189873417721519,0.8318642911402434,1.0,2/10,5.71%,CX3CL1;DUSP1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.6890905905019634,-1.2167420868430678,0.28378378378378377,0.8315781844611227,1.0,4/15,11.50%,PRKAG2;HIF1A;TPR;OGT
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.7349708013551153,-1.2166116275844214,0.1111111111111111,0.8307841926681094,1.0,5/10,21.62%,PCK1;GOLPH3;MSN;ADAM15;ADCY2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.7907684715540733,-1.2162641858824461,0.18032786885245902,0.8307652346433622,1.0,3/7,13.17%,CDKN1B;IPO7;CDKN1A
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),-0.7995855712940342,-1.2160430199874148,0.15942028985507245,0.8301986938318356,1.0,3/8,13.33%,SCARB2;PRKN;FOXK1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),-0.6160857457597414,-1.2159321095190396,0.19230769230769232,0.8292090111334486,1.0,3/29,6.24%,ADM;LGALS3;GGT5
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.696267671453086,-1.2151431768557583,0.23529411764705882,0.8310523468240325,1.0,3/16,8.84%,MAP3K5;RPS27A;UBC
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.7300510121482007,-1.2150801329029197,0.323943661971831,0.8298629438274655,1.0,3/9,5.82%,GRIN2B;GRIA2;LRRC7
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.803233498537675,-1.2148579180413233,0.16129032258064516,0.82942290911837,1.0,4/7,18.41%,KCNMB4;ANK2;NOS1AP;DLG1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.7753245817462597,-1.2145641976348682,0.29508196721311475,0.8296277112761594,1.0,3/7,15.17%,CX3CL1;SCARF1;ANKS1A
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.566600909299554,-1.214470393746616,0.2,0.8286679506990164,1.0,6/69,7.92%,PIK3R3;ERBB4;RB1CC1;FLT1;HIF1A;PECAM1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.5650247201273886,-1.2140958407311209,0.18181818181818182,0.8289735199037742,1.0,14/63,13.31%,CX3CL1;SPOCK1;SCARB2;FES;LRRC7;MAGI2;SCARF1;RAP1A;IL1RAPL1;CFL1;EFNB2;PPFIA2;PAK2;LRRC4C
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.7112699983012593,-1.214022642366037,0.22058823529411764,0.8279783495914506,1.0,3/11,18.73%,PRKCE;HYAL2;ITGB1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.6384460166024583,-1.213199780069421,0.21686746987951808,0.8305194810516168,1.0,9/33,8.84%,PSMC6;RFC3;PSMB9;RPS27A;POLA1;PSMA1;BAZ1A;PURA;UBC
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),-0.7551633664514106,-1.2131190471457984,0.2,0.8294454036685139,1.0,1/6,6.53%,FOXF1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),-0.7962750067763433,-1.212858080305603,0.17333333333333334,0.8291905560563464,1.0,1/6,2.52%,CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.8002759811346107,-1.2123661656819789,0.2153846153846154,0.830485169679961,1.0,1/7,3.88%,LGALS3
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.8030990437499121,-1.2116520147869965,0.23728813559322035,0.8328454064651327,1.0,2/5,11.93%,KDM1A;GJA1
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.7365828086597321,-1.2116468364292923,0.208955223880597,0.8313791293410743,1.0,4/10,15.03%,WNT2B;SULF2;HYAL2;CREB3L2
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.7899248375592475,1.211609459566731,0.2564102564102564,1.0,1.0,3/5,15.59%,SLC44A1;SLC25A29;SLC25A26
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),-0.8123865326995754,-1.2112132119534291,0.2153846153846154,0.8317743808427835,1.0,1/5,8.55%,AP1G1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.734091457131322,-1.2110030169283434,0.25,0.8315965388942701,1.0,1/7,3.03%,SRGN
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.5568550797655895,-1.2108021473665909,0.19047619047619047,0.8312028454108304,1.0,6/65,9.69%,PIK3R3;ERBB4;RB1CC1;RAPGEF3;PECAM1;DLC1
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.7926236635990598,-1.210466420267037,0.18571428571428572,0.8312820106535184,1.0,1/6,1.89%,YTHDC1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.6291499214282987,-1.2099086931729268,0.19736842105263158,0.8324002722967573,1.0,4/32,3.85%,DDIT4;ATF3;ERO1A;HSPA5
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.7688477243653075,-1.2090767248443612,0.24324324324324326,0.8350416155444242,1.0,3/8,10.73%,RPS27A;UBC;CHFR
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.589949030782763,-1.2087307302110297,0.1566265060240964,0.8354068305468939,1.0,14/44,15.83%,PSMC6;RFTN1;NFKBIZ;PSMB9;PIK3R1;PSMA1;PLCG2;BTNL9;PAK2;INPP5D;TEC;BCAR1;NCK1;MALT1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.6226836068509527,-1.2083686123031376,0.20512820512820512,0.8359463554393579,1.0,5/25,20.27%,BNIP3L;CALCOCO2;TBK1;PINK1;GNAI3
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.7653768849690986,-1.2083518607799404,0.2361111111111111,0.8345559994950043,1.0,6/8,19.76%,CX3CL1;IFNGR1;DYSF;PLCG2;CRTC3;CLU
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),-0.6858849240639138,-1.2078650447981731,0.2625,0.8355811586045857,1.0,4/12,17.56%,ARF1;PRNP;CTNND2;MTMR2
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.7144809740915381,1.2078254199702738,0.30303030303030304,1.0,1.0,1/6,6.29%,EZH1
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.5877640839119469,-1.2076020000534944,0.13636363636363635,0.835496544219147,1.0,17/57,21.67%,PSMC6;LDHA;PGK1;RPL34;CANX;PSMA1;RPS6;DDX18;NPM1;CNBP;RACK1;SMARCC1;KPNB1;SERBP1;PSMA7;TRA2B;CUL1
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.7667714829274808,-1.2072706295235143,0.18461538461538463,0.8355284663507176,1.0,3/9,5.37%,MAP2;RTN4;CDKN1B
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.6996077810270089,1.2071538611243826,0.15151515151515152,1.0,1.0,1/9,0.16%,BMP6
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.6648254478027615,-1.2068686322660305,0.23684210526315788,0.8359664349273269,1.0,6/21,9.03%,ADM;PCK1;ENPP2;NFASC;PTPRD;LSAMP
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.6795075337291565,1.2067206821061949,0.2564102564102564,1.0,1.0,2/8,9.69%,EVL;KANK1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.7830082574737299,-1.2064667897946262,0.234375,0.8369048946567246,1.0,2/6,9.61%,ADAMTS9;NGLY1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.7235086859778133,-1.205920535406649,0.2361111111111111,0.8381292513986052,1.0,4/10,17.10%,KCNMB4;ANK2;ATP1B3;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.5643355724307683,-1.2058793498612073,0.2159090909090909,0.8368480299660607,1.0,16/70,17.26%,SERPINE1;RFTN1;GAPDH;LRRFIP1;MBP;HIF1A;SULF2;PNP;ANXA1;HYAL2;PLCG2;TMED10;RAB1A;MALT1;TBK1;IL18R1
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.6926427354547933,1.2057220489033076,0.2857142857142857,1.0,1.0,2/7,8.26%,SLCO1A2;NCOA2
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.7707654533617302,-1.2055197837130551,0.25,0.8373383738206623,1.0,3/7,14.61%,GRIN2B;SLC8A1;CACNA1C
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.8049203056177989,-1.2046580155309805,0.234375,0.8391180591355446,1.0,2/6,8.84%,RPS27A;UBC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.8049203056177989,-1.2046580155309805,0.234375,0.8391180591355446,1.0,2/6,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.7641528448052235,-1.2044910699993399,0.27419354838709675,0.8385891825331148,1.0,1/8,1.62%,PRKAG2
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.7405942890800618,-1.2041043108084488,0.23076923076923078,0.8391304745160046,1.0,1/11,1.89%,YTHDC1
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.6833616465623594,-1.2036270157257885,0.24285714285714285,0.8398413433508874,1.0,6/15,15.86%,DTNA;PIAS2;BTNL9;CTNNA3;LRP1B;CADM2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.5253224659450616,-1.2034476897961537,0.12,0.8395230763185623,1.0,51/264,15.56%,MAFF;TBX3;SERPINE1;ST18;NR4A1;ATF3;KLF6;ZEB2;PPARG;CX3CL1;PHF10;HES1;JUN;JUNB;FOS;KDM1A;SMAD7;RPS27A;NFE2L2;JUND;PIK3R1;FOXF1;KLF2;SMARCA1;HIF1A;REL;FOSL2;PRKN;NPAS2;UBC;RREB1;CD81;KLF4;CEBPZ;HYAL2;ZFPM2;CRLF3;EPAS1;OGT;MEF2A;NPM1;NFKBIA;CNBP;NCK1;SMAD3;MAX;TMF1;LPIN2;WWTR1;CRTC3;SREBF2
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.5808797252341286,-1.203225404689075,0.19230769230769232,0.8393387543487507,1.0,16/51,21.83%,LAMC1;PPARG;EPS8;ZC3H7A;TIMP3;EMP1;PRKN;EPAS1;NAV2;WWTR1;CALD1;EGFR;PLAT;HMCN1;SASH1;GLI3
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.6786310763020921,-1.203074478119395,0.19480519480519481,0.8387760661174857,1.0,1/18,0.24%,SERPINE1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,-0.6021645921748588,-1.2026335738542993,0.24705882352941178,0.8391989821835519,1.0,15/37,17.29%,NES;GRIA2;GPM6B;NPAS3;ANK2;LSAMP;PPFIA2;CTNND2;DCLK1;ATRNL1;ADGRL3;LRRC4C;EFR3B;CADM2;ROBO2
prerank,GO_Biological_Process_2021__gland development (GO:0048732),-0.699122922844444,-1.2022675873893158,0.30303030303030304,0.8394882767789025,1.0,2/13,2.82%,TBX3;HES1
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.5983383054432465,-1.201828807073106,0.2413793103448276,0.8400405567713949,1.0,7/32,15.27%,SERPINE1;JUNB;SMAD7;IFNGR2;SLC20A1;SMAD3;WWTR1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.8077729611575504,-1.201468874526926,0.2,0.8404404071243936,1.0,4/5,17.56%,PRKN;RAB21;MSN;MTMR2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.8051018099171239,-1.2009462779242093,0.21621621621621623,0.8415341855672083,1.0,2/5,13.97%,SULF2;HS6ST3
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8043660618003665,-1.2006620235160492,0.25806451612903225,0.8414049389230852,1.0,2/5,6.67%,ADAMTS9;KLF2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.6687012936701984,-1.200096979396049,0.2602739726027397,0.8426807470822439,1.0,6/17,20.19%,PIK3R1;HYAL2;TPR;SMAD3;WWTR1;ECT2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.7037230693422698,-1.199169097847061,0.22857142857142856,0.8453545964599762,1.0,5/12,21.70%,PPARG;FLT1;CAV2;ATOH8;SPARC
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),-0.6225015318333044,-1.1991023695298086,0.21794871794871795,0.8440810156401818,1.0,5/20,17.37%,MYO9B;EPS8;CFL1;GNA13;ARHGAP29
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.6755390140324836,1.1986885696447915,0.26666666666666666,1.0,1.0,2/5,16.68%,MCM9;PARN
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),-0.7673920184050121,-1.1981890702479292,0.27586206896551724,0.8474331746880674,1.0,4/7,17.48%,SMAD7;PAK2;TBCD;PIP5K1C
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.7155457081116672,1.1981761008578593,0.2647058823529412,1.0,1.0,2/6,11.18%,HSPD1;NFAT5
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.6996149335819349,-1.197485503139722,0.2028985507246377,0.8491370562511605,1.0,2/12,2.58%,TSG101;SYTL4
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.7819160309425528,-1.19738031237814,0.21875,0.8481978624329389,1.0,6/8,21.78%,KCNIP4;ANK2;DPP10;ANK3;DLG1;CD63
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),-0.65661837521458,-1.196824722368742,0.2125,0.8496538011826507,1.0,4/14,18.19%,AFDN;GOLPH3;PREPL;ANK3
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.5651984482602036,-1.1965455091273831,0.19767441860465115,0.8497720541158335,1.0,4/78,4.94%,CEP57;EHD4;RAB11FIP3;CEP70
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.7448591117979314,-1.1964808862270269,0.22580645161290322,0.8486885949173442,1.0,5/7,16.65%,NFE2L2;HIF1A;PRKN;SOD2;PINK1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.8067932736504395,-1.1963555537988138,0.1875,0.8479223701684957,1.0,4/6,18.19%,KCNMB4;ANK2;NOS1AP;ANK3
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7467374945230058,1.1946993758479012,0.27906976744186046,1.0,1.0,5/6,25.26%,MBOAT2;TAPT1;SOX5;TRPS1;BMPR2
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.5339824949790526,1.1938296872965763,0.22727272727272727,1.0,1.0,3/23,3.24%,BMP6;PRKD1;IL6R
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.7287320219549108,-1.1932493058833336,0.25806451612903225,0.8605509413602684,1.0,4/7,19.18%,LRRC32;HIF1A;SMAD3;CD34
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.8023250999939991,-1.1932484183233003,0.234375,0.8591792933117215,1.0,2/5,6.69%,CX3CL1;IFNGR1
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.650203541316221,-1.1931567889951282,0.22666666666666666,0.85825279412016,1.0,3/23,5.74%,MAP2;SPOCK1;ANO2
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.6950611829021636,1.1929351660648073,0.25806451612903225,1.0,1.0,2/6,8.26%,SLCO1A2;NCOA2
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7131377060216142,-1.1929066995355155,0.2898550724637681,0.8580259012722333,1.0,3/11,17.45%,NR4A1;S1PR1;LCP2
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),-0.6531713283847224,-1.1922568977024903,0.20270270270270271,0.8597762867718579,1.0,5/17,19.31%,SEC22B;FEZ2;PINK1;PIKFYVE;CHMP4B
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.6095785046433776,-1.192229743471631,0.24358974358974358,0.858506177269698,1.0,8/38,13.31%,NRCAM;CX3CL1;PTPRD;GPM6A;PPFIA2;CTNND2;ADGRL3;LRRC4C
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.7892383023300714,-1.1917051448754155,0.1746031746031746,0.8594474577557574,1.0,2/6,17.34%,BLCAP;KPNB1
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.5794999044071816,-1.191549422136147,0.2222222222222222,0.8586555181662336,1.0,14/72,15.46%,CEP57;NES;EPS8;CEP70;CDKN1B;CCNH;ENSA;CDK14;CRLF3;ARPP19;CDKN1A;MAX;PAFAH1B1;CDK6
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.7622926784383217,-1.1914602674589354,0.15384615384615385,0.8576115818021015,1.0,2/7,6.08%,SEC22B;FEZ2
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.7139047009499473,1.191159048973997,0.2972972972972973,1.0,1.0,1/6,2.28%,RC3H1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.6992684315254043,-1.1907670320654276,0.25,0.8591488097599362,1.0,3/14,5.82%,GRIN2B;GRIA2;LRRC7
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.7307057397974037,-1.1902838543675252,0.31746031746031744,0.8604998371138897,1.0,3/8,13.92%,KDM1A;PRKN;PTTG1IP
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.5380339937453282,1.1898649157532923,0.14814814814814814,1.0,1.0,5/22,9.91%,INO80;OFD1;STARD9;CLASP1;NEK7
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.7341256583756686,-1.1896620523070542,0.2191780821917808,0.8617017533736393,1.0,4/9,14.61%,DMD;SLC8A1;ANK2;CACNA1C
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.7961898732322698,-1.1895101673494155,0.25,0.8610028851049759,1.0,1/5,3.85%,HSPA5
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.6258295030407293,-1.1894096846572024,0.2112676056338028,0.8600537437233915,1.0,4/22,8.82%,MGLL;GRK5;GIT2;CAMKMT
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),-0.7542336576780302,-1.189379681461621,0.25862068965517243,0.8589275644640386,1.0,3/8,13.07%,PPARG;ABCA5;NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.634616697158096,-1.1893593279913137,0.2564102564102564,0.8576251971087302,1.0,7/22,16.65%,KDM1A;SMAD7;NDFIP1;COMMD1;PTTG1IP;MALT1;PINK1
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.563530685073405,-1.189205731983643,0.23076923076923078,0.8567398513943794,1.0,16/65,14.90%,RPL23;RTN4;GAPDH;SMAD7;CDC37;PIK3R1;LAMP2;ANK2;HIP1R;PRKN;CCNH;RAB21;RPS7;ATP1B3;CDKN1A;NAA16
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.5738875020206946,-1.188909705535101,0.2235294117647059,0.8567354997662067,1.0,17/62,22.18%,MAP2;ATG12;GRIA2;OXR1;ARHGAP21;NCALD;LPGAT1;PPFIA2;CTNND2;SYT1;CADM2;TRIM9;GATA2;PSD3;HIVEP2;SCAMP1;NOL4
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.7772333106783083,-1.1888799570097783,0.3064516129032258,0.8555502042546216,1.0,3/5,15.33%,PPA1;PPA2;SULT1C4
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.7531918110184118,-1.1886476431065394,0.203125,0.8552083256077901,1.0,4/10,18.83%,HES1;SMAD7;ROBO2;ACVRL1
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.6622341210446283,-1.1882922591541638,0.22972972972972974,0.8551350797149742,1.0,3/13,14.10%,RIMS1;RIMS2;SYT1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.6192181335871473,-1.1881823923505628,0.2876712328767123,0.8543853533174364,1.0,10/25,20.48%,SMAD7;RPS27A;UBC;SNX6;SMAD3;STRAP;SNX25;PPM1A;CD109;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.8064581214943343,-1.1880127339448276,0.23636363636363636,0.853531319169425,1.0,1/5,2.20%,GLUD1
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.7070214439952877,1.1877906134541167,0.2692307692307692,1.0,1.0,1/11,0.16%,BMP6
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.7600711082894873,-1.1869778488598812,0.34375,0.8574020052428217,1.0,1/7,2.90%,PBX3
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.6592486330637509,-1.18674008812042,0.23076923076923078,0.857219417635245,1.0,3/18,5.66%,BCAP31;SEC24D;CANX
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.7625745799640724,-1.186359769851774,0.17647058823529413,0.8573382379594,1.0,2/5,14.63%,ARPC2;SPIRE1
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.5777243207515715,-1.186212115508158,0.22727272727272727,0.8565026004211357,1.0,9/54,7.36%,GRIK1;DTNA;SYN3;GRIN2B;GRM7;KCNMB4;RIMS1;GRIA2;MBP
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),-0.799048503144258,-1.1853873426237485,0.23214285714285715,0.8588801556483486,1.0,1/6,2.20%,GLUD1
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.7402740985169318,-1.1853535577995513,0.36363636363636365,0.8577100769067225,1.0,1/8,1.54%,PCK1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.7713804810766862,-1.185172301806664,0.2786885245901639,0.8571063892396718,1.0,3/5,15.19%,ENPP2;ACOX1;LPIN2
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.5905070982033047,-1.184945397018225,0.2125,0.8569610908904497,1.0,11/38,22.60%,SERPINE1;FES;ZFP36;MSN;TFPI;ADAM15;EGFR;ADCY2;ADAM9;ATP1A1;MAPK8
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.6863570341194987,1.184860905526927,0.21875,1.0,1.0,1/6,6.96%,TRIM22
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.696327512611085,-1.184803092510688,0.2923076923076923,0.8563078640436845,1.0,5/12,19.39%,PRKN;SDCBP;PINK1;MTMR2;LRPAP1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.6755791455454767,-1.1846894572275932,0.27631578947368424,0.8553766225304215,1.0,4/15,22.50%,RIMS1;DYSF;USO1;DNM2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.7588361070645839,-1.184197159686788,0.288135593220339,0.8562832451340792,1.0,3/7,13.92%,KDM1A;PRKN;PTTG1IP
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8364169577654323,-1.1838024418774327,0.3220338983050847,0.8567508335119071,1.0,3/5,8.84%,PGK1;RPS27A;UBC
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.38869503347128953,1.1829619528853468,0.14285714285714285,1.0,1.0,18/101,10.92%,SCFD2;PACS2;STX8;PIGU;EVI5;HERC2;TBC1D5;OCLN;WLS;ITSN1;VPS45;COG3;BICD1;CEP68;ID1;RAB28;TBC1D4;SYNRG
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.7723254111987461,1.1829418027442165,0.35294117647058826,1.0,1.0,2/5,5.68%,DISP1;CLYBL
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.7723254111987461,1.1829418027442165,0.35294117647058826,1.0,1.0,2/5,5.68%,DISP1;CLYBL
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.597690101520345,-1.1828181398706854,0.24691358024691357,0.8599695994639969,1.0,7/27,14.53%,PSMC6;NPLOC4;HSPA5;PRKN;HERPUD1;UGGT2;AMFR
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.6422769371538707,-1.1825432080990703,0.225,0.8599255867664239,1.0,5/25,9.77%,UFL1;MGLL;BCL6;ANXA1;TMSB4X
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.598706973895436,-1.182493358285496,0.20512820512820512,0.8587875362619006,1.0,9/35,16.65%,DDIT4;SMAD7;DMD;RAPGEF3;NCK1;RACK1;SH2D3C;TBK1;PINK1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.7143998466720816,-1.1822623791049292,0.15714285714285714,0.8583119576574917,1.0,4/14,13.71%,NEDD9;HYAL2;PRNP;CASS4
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.5474297386372622,-1.1822057459622326,0.24444444444444444,0.8571625862566186,1.0,18/65,19.60%,RFTN1;EHD4;KCNIP4;LRRC7;MAGI2;ANK2;RAP1A;PACS1;CD81;DPP10;ATP1B3;TTC7A;EFR3B;RAB8B;NUP54;ANK3;DLG1;EMP2
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7247092353575961,1.1822037680977209,0.25,1.0,1.0,2/5,18.70%,NLGN1;BTRC
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),-0.7871798071632299,-1.182112576241285,0.2542372881355932,0.8562242035403465,1.0,4/5,21.09%,APOLD1;BTG1;NOTCH4;ATOH8
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.605103261062015,1.1819321301726158,0.20689655172413793,1.0,1.0,1/11,0.13%,THSD1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),-0.8183158726158826,-1.181472350185786,0.2545454545454545,0.8576016943620303,1.0,1/5,5.58%,ARHGAP21
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.791367410973981,-1.1814369947940733,0.23529411764705882,0.8565104047909812,1.0,2/6,10.15%,ARF1;PRNP
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.7029287138745178,1.181214467670009,0.3125,1.0,1.0,1/5,0.16%,BMP6
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.7241066635767831,-1.1807923362410018,0.25,0.8582101952485583,1.0,3/8,10.15%,ARF1;COMMD1;PRNP
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),-0.708461374306109,-1.180729466674409,0.3,0.8572072222486119,1.0,6/9,27.04%,PNP;ANXA1;PLCG2;MALT1;PDE4B;SPTBN1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.6123553702455046,-1.180474388638186,0.28,0.857185187388203,1.0,3/24,6.48%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7225987526285549,-1.1803940703997464,0.3,0.8561697051840053,1.0,4/11,7.46%,CDC37;JAK1;IFNGR1;IFNGR2
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),-0.7281156121170145,-1.1800083796212413,0.2222222222222222,0.8565426968065712,1.0,5/11,19.31%,SEC22B;FEZ2;PINK1;MTOR;CHMP4B
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.6707120173039869,-1.179981523166198,0.2318840579710145,0.855445890127821,1.0,5/19,11.53%,ADAMTS9;MGAT4A;HIF1A;NGLY1;GOLPH3
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.7099562259542883,-1.17971997956418,0.2714285714285714,0.8552390943587972,1.0,1/9,1.54%,PCK1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.7643225984918074,-1.179486382456583,0.24242424242424243,0.8538243806657093,1.0,3/6,14.10%,RIMS1;RIMS2;SYT1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.7643225984918074,-1.179486382456583,0.24242424242424243,0.8538243806657093,1.0,3/6,14.10%,RIMS1;RIMS2;SYT1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.7741265111656147,-1.1793319059142144,0.21311475409836064,0.8530777935939643,1.0,2/7,15.46%,PPARG;CDK6
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),-0.6958265550891231,-1.1791753842811552,0.3380281690140845,0.8524012534928677,1.0,1/15,0.24%,SERPINE1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.7280057734030319,-1.1788399504628215,0.19444444444444445,0.8526744492709135,1.0,3/8,18.91%,BCAP31;TGM2;MICU2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.7224913104496512,-1.1785609080739936,0.26865671641791045,0.8512949305485318,1.0,3/8,21.75%,ZEB2;SDCBP;RNF111
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.7224913104496512,-1.1785609080739936,0.26865671641791045,0.8512949305485318,1.0,3/8,21.75%,ZEB2;SDCBP;RNF111
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.7193511997809692,-1.1784405881226028,0.30434782608695654,0.8505745794248003,1.0,4/9,11.93%,CX3CL1;JUN;ADAMTS1;GJA1
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.6871395065873237,1.1779845457741376,0.2903225806451613,1.0,1.0,4/7,13.17%,CLASP1;BICD1;PCM1;PEX14
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.7293648347685996,-1.1775038536758382,0.2153846153846154,0.8533048630784773,1.0,6/10,23.11%,MAGI2;HYAL2;RACK1;DAG1;PIK3CB;PHLPP1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.5868092917736865,1.1773980389071494,0.2413793103448276,1.0,1.0,6/15,22.92%,THOC1;WRNIP1;PARG;WDR70;SUB1;MPHOSPH8
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.7970407694777182,-1.1772704226329858,0.2638888888888889,0.8530539686684853,1.0,2/6,10.54%,POLA1;CDK14
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.7485210178803905,-1.1769396365401164,0.3387096774193548,0.851934797833664,1.0,2/5,9.40%,TAF1D;CCNH
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.7485210178803905,-1.1769396365401164,0.3387096774193548,0.851934797833664,1.0,2/5,9.40%,TAF1D;CCNH
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.6562603345373496,-1.1763111697574289,0.22077922077922077,0.8535097291082322,1.0,7/26,14.71%,PKIG;CDKN1B;DUSP1;IPO7;SLC8A1;HYAL2;STK38
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),-0.7229814895397908,-1.1757985614331672,0.3188405797101449,0.8542785304105792,1.0,3/10,13.33%,PRKN;OGT;FOXK1
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),-0.6217106833343465,-1.1746702274177034,0.275,0.8581293879287645,1.0,5/18,11.85%,ITPR1;ATP2B1;SLC8A1;ANK2;ATP1B3
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),-0.6793983566849178,-1.1745244578685767,0.2571428571428571,0.8575572757357757,1.0,3/11,8.15%,SMAD7;FOXF1;TPM1
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.7867896705879791,-1.1741888928736621,0.25,0.8579177312468321,1.0,1/5,5.63%,GPM6B
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.7605590470628385,-1.1741418079652757,0.2698412698412698,0.8568662735847805,1.0,1/10,0.90%,UFL1
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.5892131261449753,-1.1739680223371718,0.20454545454545456,0.8564145720022144,1.0,8/35,13.78%,ADM;PDE5A;ALPL;TIMP3;PECAM1;TNS1;MYO1B;PLSCR4
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.7119511849712766,-1.1739075460160757,0.25396825396825395,0.855368425201089,1.0,1/8,5.05%,SPG7
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.5944084457178705,-1.1737037554708276,0.25609756097560976,0.8549533048468273,1.0,10/26,22.50%,SEC24D;CANX;ARF1;AP1G1;PIKFYVE;DYNC1I2;CAPZA2;KLC1;CLTA;DNM2
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.7799460592528106,-1.1734896380576594,0.19642857142857142,0.8549354209758054,1.0,2/5,16.65%,PRKN;PINK1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.8063965744284284,-1.173163835402942,0.2631578947368421,0.8552306435752741,1.0,4/5,15.56%,NFE2L2;KLF2;KLF4;SREBF2
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.6989938283202279,-1.1730430603450066,0.2923076923076923,0.8546530242813313,1.0,5/11,17.48%,SYN3;RIMS1;RIMS2;SYT1;PIP5K1C
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.7343171195113478,-1.1729248616122248,0.3076923076923077,0.8538306686728442,1.0,2/7,15.88%,JUN;CHD1
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.7804068042933583,-1.1727709704660403,0.3076923076923077,0.8532567796175732,1.0,1/6,0.96%,SUN2
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.5892568572104139,-1.172611931814748,0.2625,0.8525043787077405,1.0,4/33,8.15%,TBX3;NES;TIMP3;TPM1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.8428544253400978,-1.172068528306147,0.1774193548387097,0.8537987445853238,1.0,1/5,0.93%,NRCAM
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.6189450040774129,-1.1718871850827908,0.2125,0.8532764028655188,1.0,7/31,12.99%,PSMC6;PSMB9;RPS27A;PSMA1;UBC;CCNH;NPM1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.6418584097778002,-1.1717728031285228,0.26865671641791045,0.8524457038718489,1.0,5/20,11.00%,ADM;HES1;SMAD7;FLT1;EFNB2
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.6470217596543416,-1.1717343367273807,0.2972972972972973,0.8514219867561477,1.0,7/22,14.56%,LGALS3;BCL2L14;HYAL2;FGFR1;PAK2;TNFRSF10B;CYLD
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.6511695022091104,-1.1716438439045125,0.22535211267605634,0.850645161553569,1.0,7/16,24.67%,KLF2;KLF4;SMAD3;NOS1AP;CD34;CLU;HSP90AA1
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.6711905403946368,-1.1716310379262327,0.2948717948717949,0.8494970976774011,1.0,1/12,2.31%,RTN4
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.8002558094670618,-1.1715367259031748,0.24193548387096775,0.848709077016864,1.0,1/5,2.05%,RFTN1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),-0.7536028876562306,-1.1707367861678837,0.23809523809523808,0.8504492217306461,1.0,1/5,3.56%,GRIN2B
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.7317062238731389,-1.1690189397607198,0.2753623188405797,0.8571803739148427,1.0,2/6,14.16%,ESR2;PLPP1
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),-0.7659761674304608,-1.1688259507190182,0.23809523809523808,0.856739902976179,1.0,2/5,9.16%,PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),-0.5959444755924735,-1.168801490310198,0.27906976744186046,0.8555752086640126,1.0,5/32,12.30%,ADM;PPARG;GGT5;KLF4;PLCG2
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.6721606837098747,-1.1687002345110453,0.30985915492957744,0.8547680261130272,1.0,5/17,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.7609871416962005,-1.1686552262960461,0.32786885245901637,0.8537702433659228,1.0,1/7,5.42%,FES
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.5937470123452562,-1.1686218321176316,0.23255813953488372,0.8514465892378368,1.0,2/37,2.23%,DDIT4;BNIP3L
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.5937470123452562,-1.1686218321176316,0.23255813953488372,0.8514465892378368,1.0,2/37,2.23%,DDIT4;BNIP3L
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.6267323474914483,-1.1686133786911062,0.2077922077922078,0.8502337023585805,1.0,6/20,14.61%,BCAP31;ATP2B1;SLC8A1;CD55;SMAD3;CACNA1C
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.5188917648733165,1.1684806948533135,0.24,1.0,1.0,6/22,15.43%,ATG10;HSPB1;NDUFS4;STAT2;FNIP2;PARG
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6115714716836971,1.1683859452710743,0.2558139534883721,1.0,1.0,2/9,3.19%,CPEB3;TNRC6C
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6115714716836971,1.1683859452710743,0.2558139534883721,1.0,1.0,2/9,3.19%,CPEB3;TNRC6C
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.750410122283109,-1.1673694573600641,0.18055555555555555,0.8531015672695583,1.0,2/8,3.67%,JUN;FOS
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.750410122283109,-1.1673694573600641,0.18055555555555555,0.8531015672695583,1.0,2/8,3.67%,JUN;FOS
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.7212070230273268,-1.16728801314923,0.30303030303030304,0.8522262130306377,1.0,2/7,13.04%,OGT;ARPP19
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.8019156941031296,-1.1664284867867374,0.2903225806451613,0.8541546283015135,1.0,2/5,8.98%,ENPP2;RREB1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.6054923121085395,-1.1659406601335467,0.30952380952380953,0.8552352113255105,1.0,8/33,13.76%,PSMC6;ST18;PSMB9;RPS27A;PSMA1;UBC;NFKBIA;PELI1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.7055669355017599,-1.1652479638449973,0.3,0.8572332863850989,1.0,5/15,19.42%,TSG101;ZFYVE28;SH3KBP1;GRB2;EGFR
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.7474851713285494,1.1650725041671506,0.3829787234042553,1.0,1.0,1/5,1.06%,CWC27
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.7474851713285494,1.1650725041671506,0.3829787234042553,1.0,1.0,1/5,1.06%,CWC27
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.616724305274903,-1.1645490026061418,0.3076923076923077,0.8589245927630912,1.0,7/24,10.44%,ITPR1;GLUD1;RAPGEF3;SLC2A1;RAP1A;PRKN;ENSA
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),-0.7968549662049444,-1.1644143406678926,0.3387096774193548,0.8581738155389507,1.0,3/5,15.17%,CX3CL1;SCARF1;ANKS1A
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.7061013479645157,-1.1640629753688254,0.2857142857142857,0.858262788135414,1.0,6/11,24.41%,DUSP1;DUSP16;DUSP5;DUSP22;DUSP6;TNS2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.7385565102436329,1.1639957978496418,0.36363636363636365,1.0,1.0,2/5,13.49%,RNF213;SERPINB9
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.6968908611190946,-1.1639070404516934,0.3194444444444444,0.8574677024611735,1.0,4/12,15.59%,BCAP31;RPS7;NCK1;RACK1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.606013238736644,-1.1638985894970457,0.24390243902439024,0.8562808431195016,1.0,4/27,4.78%,MAP2;NRCAM;MAP1B;S100A6
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.6842195081379137,-1.1637931806010504,0.28125,0.8555222365770013,1.0,4/9,22.36%,CD55;PLCG2;MALT1;B2M
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.7242043129910771,1.1636834210873637,0.35,1.0,1.0,2/5,2.74%,RC3H1;CPEB3
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.5896260474106028,-1.163644751754873,0.2345679012345679,0.8548757645184569,1.0,9/24,21.70%,PGK1;PPARG;KLF4;ADAMTS1;CLDN5;ATF2;MECP2;SPRED1;SPARC
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.7192505676340915,-1.1629782460585882,0.2535211267605634,0.8564125813022856,1.0,7/9,24.99%,CX3CL1;LGALS3;PECAM1;PIP5K1C;PIKFYVE;BSG;PDE4B
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.7854961139640191,-1.1629253301025952,0.3384615384615385,0.8554688983012858,1.0,1/6,7.49%,HIF1A
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.5744745909637441,1.1629166186628834,0.3055555555555556,1.0,1.0,2/11,9.64%,ATR;ATM
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.7412317225425852,1.1627243150685935,0.35294117647058826,1.0,1.0,2/5,14.56%,RFX3;CLOCK
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.7030025907376649,-1.1625723159726251,0.30985915492957744,0.8560459333718216,1.0,6/17,19.42%,TSG101;SNX6;ZFYVE28;SH3KBP1;GRB2;EGFR
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),-0.693891587152967,-1.16107692906979,0.3548387096774194,0.8613255838476869,1.0,3/8,12.22%,SMAD7;CDKN1B;ZFP36
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.7414037390197883,-1.1606126452256194,0.30357142857142855,0.8622050204200202,1.0,1/6,2.47%,PPARG
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.7586158825376064,-1.1606007911910066,0.3103448275862069,0.8611026860658932,1.0,3/6,18.01%,RTN4;TPR;NUP54
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.5715420327767495,-1.1603851430470342,0.2777777777777778,0.8605636984919257,1.0,11/42,15.59%,UFL1;SMAD7;RNF19A;COMMD1;PRKN;ARIH2;HERPUD1;OGT;TRIB2;SDCBP;RACK1
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.7509619029324457,-1.1603308459434423,0.3076923076923077,0.8584347820176182,1.0,2/5,13.76%,YBX3;PELI1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.7509619029324457,-1.1603308459434423,0.3076923076923077,0.8584347820176182,1.0,2/5,13.76%,YBX3;PELI1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),-0.5650057500798639,-1.1597599019103888,0.24719101123595505,0.8595601296086463,1.0,11/43,15.38%,GRIK1;DTNA;GRIN2B;GRM7;KCNMB4;GRIA2;MBP;PLP1;SYT1;SDCBP;PAFAH1B1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.7444931075117188,-1.1594656564884522,0.32857142857142857,0.8597072662056328,1.0,4/8,15.56%,NFE2L2;KLF2;KLF4;SREBF2
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.5145707715772619,-1.1590969149948882,0.22105263157894736,0.8586265736109383,1.0,49/118,30.89%,PKM;SLC2A3;LGALS3;NFASC;EEF1A1;LRRC7;LAMP2;PECAM1;SERPINB6;RAP1A;PNP;CD55;BRI3;CST3;SDCBP;STOM;TMEM30A;RAB14;B4GALT1;KPNB1;PSAP;CD63;SCAMP1;FTL;CYSTM1;B2M;DNAJC5;ANXA3;HLA-B;DNAJC3;PDXK;HSP90AA1;DSP;STK10;TUBB4B;ANO6;DYNC1H1;ANXA2;SNAP25;VCL;PSMD12;RAC1;RHOA;CAB39;KCMF1;STXBP3;RAP1B;FGR;CAP1
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.5145707715772619,-1.1590969149948882,0.22105263157894736,0.8586265736109383,1.0,49/118,30.89%,PKM;SLC2A3;LGALS3;NFASC;EEF1A1;LRRC7;LAMP2;PECAM1;SERPINB6;RAP1A;PNP;CD55;BRI3;CST3;SDCBP;STOM;TMEM30A;RAB14;B4GALT1;KPNB1;PSAP;CD63;SCAMP1;FTL;CYSTM1;B2M;DNAJC5;ANXA3;HLA-B;DNAJC3;PDXK;HSP90AA1;DSP;STK10;TUBB4B;ANO6;DYNC1H1;ANXA2;SNAP25;VCL;PSMD12;RAC1;RHOA;CAB39;KCMF1;STXBP3;RAP1B;FGR;CAP1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.6927947733396354,-1.1590453451308527,0.21739130434782608,0.8576491446952004,1.0,4/13,14.95%,CD9;HIF1A;ANXA1;BTG1
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.7186262145765638,-1.158893541037491,0.2898550724637681,0.8572285466895972,1.0,7/9,24.99%,CX3CL1;LGALS3;ANXA1;PIP5K1C;PIKFYVE;BSG;PDE4B
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.6546760808585024,1.1588516821017785,0.2647058823529412,1.0,1.0,2/5,8.98%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.6546760808585024,1.1588516821017785,0.2647058823529412,1.0,1.0,2/5,8.98%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.6938490914518975,-1.1583338241485481,0.32432432432432434,0.8581925867994913,1.0,1/9,1.46%,TSG101
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.5773402594796536,-1.1582186828680185,0.2857142857142857,0.8576342358256711,1.0,8/47,13.17%,CEP57;NES;CEP70;CCNH;ENSA;CDK14;ARPP19;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.6449564398732542,-1.1581410221956765,0.2911392405063291,0.8566788247070647,1.0,10/21,22.60%,MAP2;NES;KDM1A;TMBIM6;CDKN1A;RACK1;ADAM15;LRPAP1;B2M;MAPK8
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.7410066329352043,-1.158057947569144,0.3064516129032258,0.8558178724077111,1.0,2/7,21.43%,KMT2A;SETD3
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.7002740103426436,-1.1578196586398954,0.30985915492957744,0.8554943576856588,1.0,3/10,22.68%,SPG7;HSPA9;MFN1
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.7461126133341878,-1.1576195025934137,0.2923076923076923,0.8548663690403223,1.0,3/5,20.16%,RAP1A;PRKN;SLC30A1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.8398883275387159,-1.1574325805917374,0.23636363636363636,0.8543163192505296,1.0,3/5,14.05%,PKM;YBX3;CNBP
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.6663405378637847,-1.157155552937143,0.28169014084507044,0.8542702272257766,1.0,4/11,22.36%,SOD2;CBR4;RYR3;B2M
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.688238776281179,-1.1570914006137225,0.27692307692307694,0.8534183593093434,1.0,3/10,12.40%,RAPGEF3;PDE7A;RIMS2
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),-0.7022210719713031,-1.156839617764072,0.3333333333333333,0.85296360696576,1.0,4/8,23.27%,FOXF1;NOTCH4;ACVRL1;CDH5
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.5734476601870095,-1.1567825810201642,0.275,0.8520399784512801,1.0,9/42,14.95%,PSMC6;BTG2;PSMB9;CDKN1B;PSMA1;SDCBP;CYLD;SMAD3;BTG1
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.5410907604725581,-1.156725324268636,0.26373626373626374,0.8510582627260628,1.0,16/60,18.67%,BHLHE40;HES1;KAZN;CHPT1;FOS;SLC2A1;KLF4;DLC1;TGM2;SLC26A2;GJA1;NAV2;AMFR;B4GALT1;FKBP5;SCARB1
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),-0.6062853872655374,-1.1564232752818775,0.32894736842105265,0.8511378563694669,1.0,5/27,9.11%,PCK1;PPARG;ALPL;GGT5;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.5987082418792342,-1.15642174363909,0.34210526315789475,0.8499938538743468,1.0,6/24,13.71%,NEDD9;PTPRD;RREB1;IL1RAPL1;LIMS1;CASS4
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),-0.6643537241738388,-1.155950169258008,0.3055555555555556,0.8508439063175739,1.0,4/13,13.39%,ANO2;SLC20A2;SLC26A2;SLC20A1
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.5151848622495162,-1.1559024608374082,0.20212765957446807,0.8498841207892514,1.0,50/120,30.89%,PKM;SLC2A3;LGALS3;NFASC;EEF1A1;LRRC7;LAMP2;PECAM1;SERPINB6;RAP1A;PNP;CD55;BRI3;CST3;SDCBP;STOM;TMEM30A;RAB14;B4GALT1;KPNB1;PSAP;CD63;SCAMP1;FTL;CYSTM1;B2M;DNAJC5;ANXA3;HLA-B;DNAJC3;PDXK;HSP90AA1;DSP;STK10;TUBB4B;ANO6;DYNC1H1;ANXA2;SNAP25;VCL;PSMD12;RAC1;RHOA;CAB39;KCMF1;KMT2E;STXBP3;RAP1B;FGR;CAP1
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.7430320171204504,-1.155685570142497,0.29508196721311475,0.849679046323192,1.0,1/5,8.82%,CAMKMT
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.6293343548983258,-1.15538746305207,0.33766233766233766,0.8498500880939763,1.0,5/22,15.72%,RFTN1;RPS27A;UBC;PLCG2;PIK3C3
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.6358136186510515,-1.1550153664494385,0.28169014084507044,0.8503357289906475,1.0,5/20,11.24%,GRIN2B;GRIA2;MAGI2;LSAMP;PPFIA2
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.6114954959674482,-1.1548458941871331,0.3333333333333333,0.8497712889390133,1.0,4/19,14.16%,MTHFD1L;BTD;MTHFD2L;PLPP1
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.772415266840004,-1.1538872401117146,0.3333333333333333,0.8520063779897509,1.0,1/5,2.26%,RPL23
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.6558403952050996,-1.1538212688808844,0.32857142857142857,0.8510825901013166,1.0,4/18,8.34%,PSMC6;UFL1;COMMD1;PRKN
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.7072340928112016,-1.153820716363957,0.2857142857142857,0.8499523343375699,1.0,5/12,20.16%,KCNMB4;RIMS1;RIMS2;PREPL;SLC30A1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.682871737150493,-1.153404487490609,0.30303030303030304,0.8502557811322303,1.0,4/10,7.60%,CLIC2;DMD;SLC8A1;ANK2
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.6840038484806552,-1.1528060453435973,0.2537313432835821,0.8506819014636722,1.0,3/11,16.49%,RPS27A;UBC;TBK1
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.6840038484806552,-1.1528060453435973,0.2537313432835821,0.8506819014636722,1.0,3/11,16.49%,RPS27A;UBC;TBK1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.5532571105152301,1.1527664942582845,0.3125,1.0,1.0,2/15,10.97%,BICD1;CIRBP
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.7497298550584799,-1.152414967914459,0.3548387096774194,0.8508792731586582,1.0,5/7,21.62%,AKAP12;GRM7;PSAP;GNAI3;ADCY2
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.7726207566751077,-1.1523659056039703,0.2753623188405797,0.8498753373560645,1.0,2/5,8.15%,KCNMB4;TPM1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.5798360977440049,-1.152252875222634,0.2891566265060241,0.8491109269041828,1.0,11/37,16.95%,ERO1A;JUN;FOS;NFE2L2;HIF1A;TPM1;SOD2;MSRA;PINK1;VRK2;TXNRD1
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.7430442887836797,-1.151684614723534,0.29411764705882354,0.8502706450855698,1.0,1/7,1.78%,RFC3
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.6861156797063634,-1.1516146591817746,0.3181818181818182,0.8493157650136307,1.0,3/13,8.84%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.6832208243529839,-1.151356669126219,0.3384615384615385,0.8491744601540843,1.0,3/6,22.44%,ZFP36;CDK6;HSPA9
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.5876614022017784,-1.1512623725965279,0.3125,0.8485180673456535,1.0,10/27,19.04%,DTNA;DMD;SLC8A1;TPM1;ITGB5;MYL12A;DYSF;MYL6;CALD1;MYL12B
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.5769823978119198,-1.1511628857764533,0.27380952380952384,0.8477604361114026,1.0,8/48,13.17%,CEP57;NES;CEP70;CCNH;ENSA;CDK14;ARPP19;CDKN1A
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,-0.605571954420962,-1.151155467459618,0.2898550724637681,0.8466669414130206,1.0,6/26,16.18%,PCK1;SLC8A1;FGD4;NEBL;CPEB4;THRB
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),-0.7616552958386431,-1.151082098973202,0.32786885245901637,0.8459430443460011,1.0,1/5,9.54%,ADAMTS1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.7345813888446139,-1.1508624683146869,0.3684210526315789,0.8456898533197958,1.0,4/6,21.83%,PNP;CD55;HSPH1;GLI3
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),-0.6276261305638144,-1.1506916411977186,0.3484848484848485,0.845276375147383,1.0,5/18,14.66%,SSH1;SPOPL;KLF2;KLF4;CENATAC
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.7358972260329409,-1.1505380456792587,0.27692307692307694,0.8448347473945368,1.0,4/8,24.14%,KIF16B;SNX25;MTOR;NEDD4
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.6362266142433483,-1.1505071693438662,0.2777777777777778,0.8438397138822628,1.0,2/20,3.19%,PCK1;GLUL
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.6819108224728239,-1.150500521122361,0.2459016393442623,0.8427743886809862,1.0,4/10,18.57%,ITGB5;LCP2;ARHGAP15;KPNA4
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.6771916527979689,-1.1502616021979442,0.3026315789473684,0.8426433874806731,1.0,9/15,24.44%,KCNIP4;KCNMB4;DPP10;NOS1AP;DLG1;CD63;STK39;NEDD4;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.6055249541670017,-1.1496428570780524,0.34177215189873417,0.844068169113804,1.0,10/23,19.76%,NFE2L2;YBX3;PRKN;HERPUD1;SOD2;TMBIM6;PTTG1IP;MCL1;PINK1;CLU
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.7634375956141937,-1.1492291829810384,0.3076923076923077,0.8444294494959671,1.0,2/6,13.68%,NPM1;RIOK3
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.6438398633207045,-1.1491386243820942,0.32432432432432434,0.8435718526186629,1.0,5/21,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),-0.5268214466032464,-1.1490154174362512,0.2823529411764706,0.8430060792345755,1.0,14/57,19.07%,JUN;MYO9B;EPS8;RAPGEF3;RASSF1;RAP1A;RREB1;CFL1;SHC2;GNA13;CDKN1A;KPNB1;ARHGAP29;GRB2
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.6975903545086832,1.1490031540510939,0.35294117647058826,1.0,1.0,2/6,9.08%,DISP1;ABCG2
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.806516427418585,-1.1488822455402472,0.3220338983050847,0.8425285342904659,1.0,3/5,13.23%,ANXA1;RIMS2;RAB1A
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.5235210681464568,-1.1487506776180383,0.25,0.841893339191534,1.0,15/60,21.38%,PPP2R3A;SSH1;PPM1D;DUSP1;PTPRD;PPP2R2B;DUSP16;DUSP5;NCK1;PPP3CC;MTMR2;PPM1A;DUSP22;MTMR6;DUSP6
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.6120111660168858,1.1487469883849075,0.3,1.0,1.0,1/8,0.93%,HOMER1
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.7914251385666473,-1.148746137703297,0.3382352941176471,0.8408414529842254,1.0,2/5,13.68%,RFTN1;RIOK3
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.6013696175270488,-1.148668835254158,0.3055555555555556,0.8402100495154271,1.0,9/18,13.31%,MAP2;NFASC;GRIA2;ANK2;CTNND2;DCLK1;ADGRL3;PLP1;LRRC4C
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),-0.7542803406098402,-1.1479894359757121,0.3064516129032258,0.8418103957822816,1.0,3/5,10.15%,VSIR;RFTN1;PRNP
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.6485909883572837,-1.1475734216552824,0.3026315789473684,0.8421564978248348,1.0,5/14,9.11%,MGLL;GRK5;SLC8A1;ANK2;ANXA1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.5411362038341273,-1.1475549393226196,0.25287356321839083,0.8411383515535341,1.0,12/73,14.48%,SERPINE1;JUN;SSH1;FOS;FES;RAPGEF3;TPM1;RAP1A;TGM2;ZFP36;CPEB4;LARS1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.6022857572307784,-1.1473627465206804,0.2875,0.840925444869084,1.0,5/27,10.49%,PSMC6;SEC22B;PSMB9;PSMA1;ITGB5
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.6017677010520974,-1.1466639869853918,0.30985915492957744,0.8422304323876549,1.0,6/24,13.55%,SMAD7;TPM1;TGM2;AFDN;LIMS1;RSU1
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.7029024035821215,-1.1465415122074891,0.27941176470588236,0.8417307494888961,1.0,1/7,2.82%,HES1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.6910105970766905,-1.1461721267731617,0.2714285714285714,0.8422318147416407,1.0,5/9,13.17%,PPARG;CDKN1B;TPM1;SOD2;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.6427141420918673,-1.145927461402604,0.3,0.8421326822936658,1.0,4/16,18.99%,PPARG;KLF4;ACVRL1;MECP2
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.6757803264255585,-1.1458737094526878,0.34328358208955223,0.8412504873782594,1.0,3/9,19.39%,JAG2;FGFR1;LRPAP1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.602544533593063,-1.1456599461745822,0.3333333333333333,0.8409963836415749,1.0,5/26,10.49%,PSMC6;SEC22B;PSMB9;PSMA1;ITGB5
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),-0.684342929791464,-1.145313740686312,0.35526315789473684,0.841240134420935,1.0,2/10,4.46%,NES;KDM1A
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.5773305993414812,-1.145260902792198,0.2564102564102564,0.8403765962283417,1.0,4/27,6.48%,PSMC6;HES1;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),-0.7170042461602619,-1.145191661996748,0.36764705882352944,0.8395152359378735,1.0,1/8,6.03%,ZC3H7A
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.595405478146301,-1.1446880827702266,0.32926829268292684,0.8403118740944122,1.0,4/20,7.01%,CX3CL1;NES;FES;PRKCE
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.7964855731215204,-1.144681357649206,0.23809523809523808,0.8392831471882533,1.0,2/5,10.92%,HIF1A;EPAS1
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.651120475105614,-1.144207640571278,0.30985915492957744,0.8401345426058885,1.0,7/15,19.10%,RPL10;RPS27;RPS15;NPM1;RPL24;RPS28;RPS19
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),-0.7779635323691572,-1.1440191968623397,0.38095238095238093,0.8397994761588335,1.0,2/5,14.10%,KCNMB4;SYT1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.7480667189295496,-1.1436843177180631,0.43283582089552236,0.8399299371101666,1.0,3/7,18.73%,GJA1;PAFAH1B1;ITGB1
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.5593615359774957,-1.1436342416306469,0.24096385542168675,0.8390896679494984,1.0,14/46,14.13%,DOK5;HES1;GLUL;NES;NFASC;TIMP3;SPC25;PTPRD;ANK2;GJA1;DCLK1;PLP1;PLSCR4;NAV2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.5816004629157081,-1.14345843371844,0.2962962962962963,0.838700979135695,1.0,10/29,22.50%,SEC24D;CANX;ARF1;AP1G1;PIKFYVE;DYNC1I2;CAPZA2;KLC1;CLTA;DNM2
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.6527666129015108,-1.1434560375248395,0.29411764705882354,0.8376679404499437,1.0,3/9,18.67%,ANXA1;TGM2;SCARB1
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.6812981224621407,1.142977051870724,0.41379310344827586,1.0,1.0,3/7,20.50%,NKD1;SKI;SHROOM2
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),-0.7770195786856485,-1.1429295705659235,0.2153846153846154,0.8386410812053273,1.0,2/5,11.85%,KCNMB4;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.5593624946293273,-1.1425005930070538,0.2682926829268293,0.839066041433158,1.0,12/46,14.56%,VSIR;CX3CL1;SRGN;NPLOC4;ATP2B1;ANXA1;KLF4;TMSB4X;PRNP;ZFP36;TRIB2;CYLD
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.6536689659943165,-1.1423627133525665,0.3026315789473684,0.8384836467684645,1.0,4/15,8.84%,RFC3;NPLOC4;RPS27A;UBC
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.6399998927383623,-1.1422133679906497,0.22784810126582278,0.8380422890078956,1.0,9/25,28.18%,RAB11FIP3;PIK3C3;ECT2;CAV2;PRPF40A;RAB11A;CSNK2A1;RPRD1B;DYNC1H1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.7975459022040056,1.1420814953970813,0.2857142857142857,1.0,1.0,2/5,3.59%,ZNRF3;RNF213
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.5724861636561523,1.141535046239275,0.2857142857142857,1.0,1.0,1/15,0.16%,BMP6
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.5906853541174365,-1.14153215658852,0.3048780487804878,0.8395259778859049,1.0,9/30,15.27%,PRKAG2;CDKN1B;SLC8A1;HYAL2;PAK2;NPM1;CDKN1A;TRIB2;WWTR1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),-0.7015465602157318,-1.141234208577901,0.3225806451612903,0.8398084912040917,1.0,3/6,16.41%,PRNP;TMED10;PICALM
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.7531039615661114,-1.1412165485335168,0.35384615384615387,0.8388247529320523,1.0,1/5,8.50%,PNP
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.6959682952293902,-1.1410591393934482,0.2777777777777778,0.8384129357259664,1.0,3/10,9.77%,SSH1;HIP1R;TMSB4X
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.7676320256270444,-1.1408647545733073,0.3076923076923077,0.8382379734530244,1.0,3/5,9.80%,BCAP31;NFE2L2;HERPUD1
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.7377755597725435,-1.1406863794157351,0.3333333333333333,0.8380218754821769,1.0,1/5,6.27%,PIK3R1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.7485662197391607,-1.14066142284461,0.2711864406779661,0.8371420540965337,1.0,2/5,11.37%,SULF2;CHST11
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.7219671292067525,-1.1401300272689485,0.2878787878787879,0.8379644585906053,1.0,3/7,14.00%,CD81;PTTG1IP;MSN
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.6253904560637666,-1.139991915096403,0.32,0.8374319859222715,1.0,6/22,15.46%,CDKN1B;CCNH;CRLF3;CDKN1A;MAX;CDK6
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.7537605995231202,-1.1397962027216708,0.38333333333333336,0.8372593006568979,1.0,1/5,17.34%,KPNB1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.738448395337189,-1.1390995713298513,0.3148148148148148,0.8390562663779819,1.0,4/5,25.05%,CTNNA3;CACNA1C;DLG1;DSP
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.4090751551000511,1.138188598019487,0.125,1.0,1.0,11/54,18.62%,FASTKD1;THOC1;NOVA1;BICD1;TENT2;RBMX;DDX17;PNPT1;PARN;HNRNPR;ADARB1
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.7510440279844552,-1.138138769767378,0.29508196721311475,0.8416190553696978,1.0,2/5,14.00%,LGALS3;MSN
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.6722215815486,-1.137353505272767,0.323943661971831,0.8434062977580741,1.0,3/10,7.60%,BCAP31;HSPA5;ANK2
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.736850143934846,-1.1371126913323577,0.3492063492063492,0.8432134408655657,1.0,4/5,26.37%,ABCA5;SCARB1;CLU;ABCG1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.4898657376495213,1.1367635351075613,0.23333333333333334,1.0,1.0,5/20,12.88%,UIMC1;ATR;ERCC6;ATM;BABAM2
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.75477480641136,-1.1366752402473164,0.31343283582089554,0.843856976920105,1.0,2/6,10.15%,ARF1;PRNP
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),-0.6391629004960308,-1.1363454888959408,0.4025974025974026,0.8441157104851396,1.0,7/20,17.48%,SMAD7;AFDN;PAK2;CADM2;TBCD;CTNNA1;PIP5K1C
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.5798581960363317,-1.1362467310054716,0.3058823529411765,0.8435262555322022,1.0,12/45,26.22%,YTHDC1;RPL10;RPS27;RPS15;RPL24;STRAP;RPS28;RPS19;USP39;HSP90AA1;RPS14;EIF3A
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.7556100445238081,-1.1357512162233832,0.3484848484848485,0.844563022863525,1.0,2/7,18.49%,RAPGEF3;KMT2A
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),-0.6955837267791591,-1.1355280158132735,0.296875,0.8444244809306692,1.0,3/9,9.93%,PTPRD;IL1RAPL1;TGM2
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7151138789661893,-1.135465523356664,0.3787878787878788,0.8435643832594671,1.0,4/6,22.12%,SLC8A1;GJA1;CACNA1C;ATP1A1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),-0.5515170634047085,-1.1351675245362023,0.24691358024691357,0.8436858638067591,1.0,16/51,19.60%,PLS3;NEDD9;PPP1R9A;EPS8;ACTN1;HIP1R;TPM1;MYO1B;NEBL;CASS4;BCAR1;SPIRE1;MYO1E;ARHGAP17;DLG1;EMP2
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.6912325648913114,1.1350925496196287,0.4358974358974359,1.0,1.0,3/5,23.13%,STX3;PPM1F;PDGFB
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.7407355731040585,-1.1349694799175916,0.38095238095238093,0.8434130085321432,1.0,1/5,21.43%,SETD3
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.5660672909528819,-1.134853606249121,0.35,0.8427743886809863,1.0,14/34,25.10%,SCARB2;KIAA1217;LAMA5;COL18A1;SUN1;EPAS1;BCAR1;CTNNA1;DAG1;CADPS2;ATP1A1;TMEM50B;DSP;APLP2
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.6983367903042732,-1.13483073008432,0.36486486486486486,0.8418119925153836,1.0,1/9,5.71%,DUSP1
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.6720442311018355,-1.1344698120475312,0.265625,0.842205769816334,1.0,4/8,22.36%,SMAD7;CD55;MALT1;B2M
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.6265706080123793,-1.1342079500479816,0.36363636363636365,0.842044187044584,1.0,1/14,0.93%,NRCAM
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.5056359220157682,-1.134029118180816,0.21505376344086022,0.8417884506942281,1.0,28/112,18.43%,PIK3R3;VSIR;RPL23;RIMS1;NFE2L2;KLF2;IFNGR1;MAGI2;HIF1A;ANK2;PRKN;KLF4;AFDN;LIMS1;RPS7;GJA1;PLCG2;RIMS2;CLDN5;MSN;SMAD3;PPHLN1;SLC38A2;NOS1AP;ATF2;ANK3;GATA2;MTOR
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.7550366307845315,-1.1340066323128863,0.30303030303030304,0.8408453492639174,1.0,3/5,18.19%,DMD;ATP1B3;ANK3
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),-0.6730547573471444,-1.1335694088377781,0.3283582089552239,0.8411979761553959,1.0,2/8,6.19%,SEMA6B;ERBB4
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.7440199084841748,-1.133566853763077,0.25,0.8401905534294614,1.0,2/5,13.07%,TMSB4X;NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.7290294538423648,-1.1332765541923484,0.28125,0.8399382579630965,1.0,2/7,9.16%,PTPRD;IL1RAPL1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.652784778454737,-1.1330631451160758,0.2898550724637681,0.8397805425849948,1.0,7/14,19.76%,RTN4;IFNGR1;PRNP;TMED10;PICALM;SLC2A13;CLU
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.7001967181727851,-1.1329762111476251,0.35294117647058826,0.8391404688825369,1.0,4/8,21.75%,RPS27A;UBC;USP45;RNF111
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.6508757455524875,1.1328438080914287,0.37142857142857144,1.0,1.0,1/6,11.00%,BCOR
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.5434757467486002,-1.1328244993833674,0.26744186046511625,0.8387697872949613,1.0,13/55,18.43%,MAP3K5;PRKAG2;HSPA5;LAMP2;SIK2;GABARAPL1;CDKN1A;CPEB4;LARS1;SREBF2;PIK3C3;ATF2;MTOR
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.6845833300760082,-1.1324352562554005,0.36363636363636365,0.8395370648387515,1.0,4/10,17.48%,SYN3;RIMS1;SYT1;PIP5K1C
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.6803151787100679,-1.132220280718719,0.35384615384615387,0.839340492241969,1.0,5/8,25.07%,ANK2;CTNNA3;CACNA1C;DSP;CAMK2D
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.6328882752642024,-1.1314596406423345,0.36486486486486486,0.840839277258045,1.0,1/18,0.90%,UFL1
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),0.41687222885913033,1.1309601609380506,0.16666666666666666,1.0,1.0,7/60,8.42%,IVNS1ABP;THOC1;NOVA1;BICD1;TENT2;CDK12;WBP4
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.6971954457509262,-1.130701588492908,0.2948717948717949,0.8425744422068033,1.0,3/8,13.68%,ARF1;HIF1A;RIOK3
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),-0.6978057687429138,-1.1306227174104262,0.32857142857142857,0.8419622364264912,1.0,4/10,8.15%,DTNA;DMD;SLC8A1;TPM1
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.7133001245452011,-1.130284872392307,0.2857142857142857,0.8421759689967158,1.0,6/8,24.99%,CX3CL1;LGALS3;PIP5K1C;PIKFYVE;BSG;PDE4B
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.6996818110655478,-1.1301204555465496,0.3283582089552239,0.8418446139417008,1.0,3/8,14.56%,RPS27A;UBC;CYLD
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.7797502778626737,-1.1299354058112927,0.2833333333333333,0.8414477072348139,1.0,2/5,14.87%,DDX18;RPL7A
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.6604575740130959,-1.129907653745751,0.28125,0.8405879456914837,1.0,3/11,12.40%,RAPGEF3;PDE7A;RIMS2
prerank,GO_Biological_Process_2021__action potential (GO:0001508),-0.7220881367329759,-1.1295422784788063,0.3466666666666667,0.8410008234185874,1.0,2/8,4.86%,KCNMB4;DMD
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.7445711092572113,-1.1292115106214882,0.34375,0.8392133701372638,1.0,5/6,25.55%,CD55;CD81;CFH;CLU;CD46
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.7445711092572113,-1.1292115106214882,0.34375,0.8392133701372638,1.0,5/6,25.55%,CD55;CD81;CFH;CLU;CD46
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.7445711092572113,-1.1292115106214882,0.34375,0.8392133701372638,1.0,5/6,25.55%,CD55;CD81;CFH;CLU;CD46
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.6402060411218559,1.1291986995157017,0.2571428571428571,1.0,1.0,2/7,5.10%,PRKD1;STXBP4
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),-0.7184087667761552,-1.1291800956358027,0.30434782608695654,0.8382822266404983,1.0,4/7,9.11%,CX3CL1;LGALS3;FLT1;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),-0.7236185815579854,-1.1291788866327492,0.3230769230769231,0.8373006315273362,1.0,6/7,25.07%,PRKCE;COMMD1;STK39;NEDD4;NEDD4L;CAMK2D
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.6805515285791427,-1.1282491063563265,0.373134328358209,0.8394624331886259,1.0,3/11,17.45%,PPARG;IL18R1;LCP2
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.6580380889220642,-1.1276808094526984,0.32857142857142857,0.8403064512188052,1.0,4/12,16.65%,PRKN;ARIH2;SREBF2;PINK1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.5561323618006353,-1.1271864368866733,0.25882352941176473,0.8412402836094083,1.0,6/38,7.60%,ADAMTS9;MAP1B;NES;TIMP3;SMARCA1;ANK2
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.5733017726777758,-1.1269770180025631,0.2926829268292683,0.8410194272500112,1.0,7/29,12.32%,SRGN;GAPDH;ATP2B1;POLA1;BCL6;ANXA1;BTNL9
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.6111780363216177,-1.1269194444575172,0.36,0.8401842555190332,1.0,5/24,14.42%,SEC22B;GOLPH3;TMED10;RAB1A;COPA
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.7173376919167909,-1.1266552111100796,0.4,0.8403701950760669,1.0,3/6,26.37%,ABCA5;SCARB1;ABCG1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),-0.7357622347968988,-1.1266131659032341,0.3333333333333333,0.8395768706751505,1.0,2/6,8.15%,ADM;TPM1
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.7384124183775208,-1.126092599487625,0.29577464788732394,0.8403236294377996,1.0,1/5,5.05%,SPG7
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.5918787685456826,-1.1259903285490775,0.2876712328767123,0.8396233434579535,1.0,7/29,15.46%,NEDD9;CX3CL1;RREB1;LIMS1;RSU1;CASS4;CDK6
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.39694600217234843,1.125256927534064,0.25,1.0,1.0,9/53,10.39%,IVNS1ABP;MLLT3;TAF3;ERCC6;BAZ2A;TAF1;FUBP3;RTF1;MTERF1
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.7257992653848385,-1.1251346139247385,0.38461538461538464,0.8417599380279444,1.0,3/8,14.50%,DUSP1;PPP2R2B;NCK1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.7052033461124203,-1.1249516518318234,0.3582089552238806,0.84134540705856,1.0,2/6,9.19%,MBP;KLF4
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.5511330390645229,-1.1249365987743114,0.32558139534883723,0.8404517310124121,1.0,6/36,8.29%,PSMC6;PPARG;PSMB9;LSS;PSMA1;SIN3B
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.5624757377156925,1.124898856101182,0.3076923076923077,1.0,1.0,4/18,17.88%,TNRC6C;TCF7L2;PPP3CA;TNRC6A
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.6241581618840306,-1.1246169118595974,0.3382352941176471,0.8407654685695591,1.0,4/19,11.93%,RPL23;PRNP;SNX6;GJA1
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.5149878081991089,-1.1245644029457713,0.30526315789473685,0.8400557616207251,1.0,24/90,23.16%,MAP3K5;BNIP3L;JUN;RPS27A;HIP1R;VAV3;BCL6;UBC;TGM2;RPS6;GNA13;FGD4;TNFRSF10B;RACK1;RASGRF2;ITGB1;CLU;GADD45B;ECT2;DUSP6;DNM2;MAPK8;BCLAF1;KALRN
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.70867870318422,-1.1242192854237336,0.34782608695652173,0.8403563018273867,1.0,4/5,26.43%,GATA2;PPP1R16B;JCAD;DLL4
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.6736212509894135,-1.1241632319928776,0.2972972972972973,0.8395582841172842,1.0,2/11,8.84%,RPS27A;UBC
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),-0.6641128140817822,-1.1241418173138833,0.3181818181818182,0.8386975925566359,1.0,5/9,27.38%,HIP1R;SGIP1;PICALM;CLTA;FCHO2
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.7395285461782111,-1.1234592902100864,0.359375,0.840106891762684,1.0,1/7,5.58%,ARHGAP21
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.7058907208776928,-1.1234405914496077,0.3142857142857143,0.8382744491533227,1.0,6/10,24.67%,KLF2;KLF4;SMAD3;NOS1AP;CLU;HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.7058907208776928,-1.1234405914496077,0.3142857142857143,0.8382744491533227,1.0,6/10,24.67%,KLF2;KLF4;SMAD3;NOS1AP;CLU;HSP90AA1
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),-0.6964411702980084,-1.1232599236345522,0.2876712328767123,0.8379970618605774,1.0,2/8,4.70%,B3GNT2;GPC5
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.5807175372131242,1.1232389174814401,0.2926829268292683,1.0,1.0,1/10,1.12%,HABP4
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),-0.6123687636420081,-1.1230626951237062,0.36363636363636365,0.8376689974070893,1.0,2/16,5.42%,MAP2;FES
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.5663640792968134,-1.1227743689449687,0.3068181818181818,0.8377901357399463,1.0,10/32,16.65%,UFL1;SPOPL;SMAD7;NDFIP1;COMMD1;PRKN;OGT;PTTG1IP;MALT1;PINK1
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.6948585688826456,-1.1225149414303133,0.36363636363636365,0.8377702157732525,1.0,6/10,24.67%,NOSTRIN;NOS1AP;ZDHHC21;EGFR;DNM2;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.7406027566667659,-1.1221437642280174,0.359375,0.8380699370308596,1.0,3/5,19.60%,RAP1A;CD34;EMP2
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),-0.5284069825546214,-1.1219494267775412,0.32941176470588235,0.8376794344221421,1.0,15/52,19.60%,EHD4;KCNIP4;ANK2;RAP1A;PACS1;CD81;AFDN;DPP10;ATP1B3;TTC7A;EFR3B;RAB8B;ANK3;DLG1;EMP2
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.6192280330384771,-1.1219039749562687,0.35714285714285715,0.8369071738676189,1.0,6/25,20.53%,RAB11FIP3;PRKCE;PIK3C3;CSPP1;ECT2;PRPF40A
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),-0.7362576728062253,-1.1217741322981754,0.3225806451612903,0.8365570961386383,1.0,3/6,19.42%,FLT1;FGFR1;EGFR
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.7298340963123748,1.1210775022854436,0.3548387096774194,1.0,1.0,1/5,1.12%,HABP4
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.5849300840282693,-1.1209366756833405,0.33783783783783783,0.8382821371263711,1.0,4/24,6.48%,PSMC6;PSMB9;CDKN1B;PSMA1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.5950713359353297,-1.1209173756201298,0.3150684931506849,0.8374482579289905,1.0,11/20,26.77%,TIMP3;FOXF1;TPM1;MSRB3;ADAMTS1;VEGFC;CALD1;PLAT;NID1;SERPINH1;LAMA4
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.5257371365381436,-1.1207556838196262,0.2727272727272727,0.8369209951867198,1.0,5/49,6.24%,ADAMTS9;SRGN;TINAGL1;SPG7;GGT5
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.5764771252011182,-1.119719214062699,0.30120481927710846,0.8395402657447387,1.0,9/36,11.93%,SLC6A6;CX3CL1;ALPL;TIMP3;EMP1;HIF1A;EFNB2;FGFR1;GJA1
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),-0.5213360669645266,-1.1196782238473255,0.29411764705882354,0.8387584626199285,1.0,14/49,19.60%,EHD4;KCNIP4;ANK2;RAP1A;PACS1;CD81;DPP10;ATP1B3;TTC7A;EFR3B;RAB8B;ANK3;DLG1;EMP2
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.6926503107867433,1.1194196577932538,0.3783783783783784,1.0,1.0,1/5,10.04%,TMTC4
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.5776905176622633,-1.1193852735711216,0.32432432432432434,0.8386997137086848,1.0,7/21,20.29%,SMIM3;TINAGL1;EMP1;WWTR1;EGFR;CD109;CAV2
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),-0.602120568464697,-1.119265369626297,0.37142857142857144,0.8382998159986755,1.0,3/21,8.34%,ITPR1;SCARB2;PRKN
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.615359685301906,-1.119177325424934,0.35526315789473684,0.837698803598593,1.0,5/21,13.17%,CDKN1B;CDC37;IPO7;CCNH;CDKN1A
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.5984607781516529,-1.1190303913538437,0.38961038961038963,0.8372252569036629,1.0,9/26,17.48%,CD9;SMAD7;CTNND2;GJA1;PAK2;CLDN5;TBCD;CTNNA1;PIP5K1C
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.7400504846298909,-1.1189699765694643,0.38095238095238093,0.8366016016786891,1.0,3/5,25.07%,SLC8A1;ANK3;CAMK2D
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.6858044722499972,-1.1188280469423397,0.3194444444444444,0.8361806778983235,1.0,4/10,14.50%,PRKN;HERPUD1;TMBIM6;NCK1
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.6554115959361716,-1.1186463334657346,0.3380281690140845,0.835722987755557,1.0,6/16,15.19%,PPARG;GGT5;ACSL5;PON2;ACOX1;LPIN2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.5339489686995903,-1.118297500078001,0.2891566265060241,0.8359443064844506,1.0,14/36,22.97%,LGALS3;PIK3R1;PRKCE;PRKN;CD81;PRNP;DPP10;PPP3CC;ANK3;DLG1;ITGB1;EGFR;MAPK8;PRKCH
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.6249473088156818,-1.1182869956358599,0.38666666666666666,0.835036415499198,1.0,4/16,16.73%,EHD4;RAB11FIP3;ACAP2;RAB14
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.6950586756117553,-1.1181347136633701,0.3188405797101449,0.8346316409642618,1.0,3/9,14.56%,RPS27A;UBC;CYLD
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),-0.5540816473412249,-1.117464836907398,0.29333333333333333,0.835967124130987,1.0,10/33,18.75%,NEDD9;LAMA5;ITGA10;ADAMTS1;ITGB5;TEC;BCAR1;ERBIN;ITGB1;ADAM15
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.7411619786047999,-1.1171581122509746,0.32786885245901637,0.836062192214962,1.0,2/5,18.83%,TIE1;ACVRL1
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.6794007338667004,1.1171115283443571,0.3333333333333333,1.0,1.0,2/6,15.64%,MFF;PNPT1
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.6006548666879344,-1.1170924512868636,0.3108108108108108,0.8353205174210967,1.0,5/27,16.12%,MAP3K5;RPS27A;UBC;ZFP36;SH2D3C
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),-0.5393240899806006,-1.1166725170602263,0.31521739130434784,0.8360521482740452,1.0,20/50,24.67%,NDRG1;BNIP3L;RTN4;ACTN1;BCL2L14;BCL6;PRKN;TGM2;BCAR1;TNFRSF10B;MALT1;PINK1;CLU;ACER2;ZNF420;PHLPP1;CALR;CHM;ACER3;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),-0.52030800102189,-1.1165116979533787,0.26373626373626374,0.8355114549248738,1.0,18/73,20.35%,UFL1;ITPR1;PRKAG2;GAPDH;EEF1A1;RB1CC1;PRKN;SNX6;FOXK1;DHRSX;TMEM59;SREBF2;MCL1;PINK1;PSAP;MTOR;ACER2;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.7095097351637216,-1.1163578953934672,0.41935483870967744,0.8351337319862632,1.0,1/6,2.42%,CLIC2
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.564504884599333,-1.1160221733187536,0.36470588235294116,0.835291347648745,1.0,7/48,12.56%,DDIT4;PBX3;GRIN2B;NES;SMARCA1;SYNJ2;ADGRL3
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.7158504380212394,-1.1155275261782935,0.3333333333333333,0.8358956113501684,1.0,3/9,15.03%,WNT2B;SULF2;CREB3L2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.6774826462821261,1.1151381763674515,0.3783783783783784,1.0,1.0,4/5,32.30%,PDCD4;PDGFB;NFATC3;NFATC2
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.7331253096510367,-1.1149052179189545,0.30985915492957744,0.8371931013387282,1.0,4/7,25.37%,NPM1;CENATAC;CHMP4B;ALMS1
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.5270588592543564,-1.1148465469723818,0.3372093023255814,0.8364930712967709,1.0,11/58,12.88%,SERPINE1;CX3CL1;SMAD7;MAGI2;TPM1;DLC1;AFDN;HYAL2;TMEFF2;GJA1;CLDN5
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.5630196068393745,-1.1145680453811249,0.36585365853658536,0.8368465042143461,1.0,7/39,13.23%,SEC22B;CDKN1B;KLF2;PRKN;KLF4;NFKBIA;RAB1A
prerank,PanglaoDB_Augmented_2021__Parietal Cells,-0.5602121233784924,-1.113945343390141,0.29069767441860467,0.8380768563348363,1.0,5/34,12.70%,RAPGEF5;PPP1R9A;HIP1R;SHC2;NEBL
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7552829467566771,-1.1133159961141381,0.3770491803278688,0.8396502579800883,1.0,2/5,19.81%,PIK3R1;GIGYF2
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.6469131734042906,-1.113144686104004,0.358974358974359,0.8393329828347806,1.0,1/10,1.46%,TSG101
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,-0.5401552652500514,-1.1126639571056431,0.2948717948717949,0.8399774619817088,1.0,13/45,13.31%,UFL1;ZEB2;GRIN2B;NFASC;GRIA2;GPM6B;NPAS3;MAGI2;LSAMP;PPFIA2;GJA1;PLP1;LRRC4C
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.7125417898240278,-1.1125112421322483,0.34782608695652173,0.8395128302581975,1.0,3/8,18.19%,ANK2;TMSB4X;ANK3
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,0.5932140029728865,1.112464543507587,0.2894736842105263,1.0,1.0,3/10,8.87%,RSAD2;FBXO7;SLC25A37
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.49446376068047837,-1.1122160823795115,0.27472527472527475,0.8394918100992529,1.0,29/104,14.37%,SPNS2;MGLL;SRGN;CD9;APOLD1;LRRC32;CAVIN2;TIMP3;GGT5;FOXF1;EMP1;FLT1;SLC2A1;PECAM1;SCARF1;TNS1;CD55;VWF;ADAMTS1;HYAL2;GPM6A;EPAS1;CFH;BTNL9;PLEC;CLDN5;NOSTRIN;PLSCR4;VEGFC
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.6594097029753474,-1.1118958260021263,0.4090909090909091,0.8387997321754165,1.0,3/11,6.48%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.6594097029753474,-1.1118958260021263,0.4090909090909091,0.8387997321754165,1.0,3/11,6.48%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.5959281777824266,1.1109361175907835,0.3,1.0,1.0,3/12,8.13%,PRKD1;IL6R;HSPB1
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.6004605735701618,-1.1097128313301818,0.345679012345679,0.8460462281833901,1.0,4/17,8.84%,RFC3;RPS27A;POLA1;UBC
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.4932138809327727,-1.1096737037344717,0.2736842105263158,0.8452959794445053,1.0,21/106,16.65%,PIK3R3;PRKAG2;CX3CL1;ENPP2;ERBB4;RB1CC1;RAPGEF3;PECAM1;RAP1A;CD81;PRNP;PLCG2;PAK2;TEC;CDKN1A;SDCBP;VEGFC;RACK1;SH2D3C;TBK1;PINK1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5846245735911154,1.1093330057414714,0.36,1.0,1.0,3/12,8.37%,HOMER1;CTNNA2;FBXO7
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.629487702030954,-1.1088744676076554,0.32432432432432434,0.8472863037977549,1.0,3/15,4.57%,UFL1;SPOPL;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.6108582957763511,-1.1084995515728238,0.3448275862068966,0.8476966796757462,1.0,8/25,19.76%,CX3CL1;LGALS3;PRKN;HERPUD1;TMBIM6;MCL1;PINK1;CLU
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.5094148997668874,1.108146866371642,0.3225806451612903,1.0,1.0,7/16,15.09%,UIMC1;MGMT;ERCC6;SLF2;BABAM2;SPIDR;FAM168A
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.5360589268707754,-1.1079964799341353,0.325,0.8486918056699153,1.0,2/25,4.20%,YTHDC1;KHDRBS3
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.566501804928868,-1.1079243686545195,0.32,0.8479541300430892,1.0,13/30,30.20%,GRIA2;MAGI2;LSAMP;PPFIA2;RNPC3;SGIP1;CADM2;SCN2A;KIF1B;CNTNAP2;SLC1A2;SNAP25;GRIA4
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.5232705697788124,-1.1076962050103651,0.32978723404255317,0.8479241693442158,1.0,17/74,16.65%,UFL1;CX3CL1;GAPDH;NDFIP1;REL;SHISA5;PRKN;ALPK1;GJA1;PLCG2;SLC20A1;RIOK3;PELI1;TNFRSF10B;MALT1;TBK1;PINK1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.6650609762131474,-1.1073414180882815,0.3787878787878788,0.8483077558793968,1.0,2/9,8.34%,MTFR1;PRKN
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.7290236431304572,-1.1071463298076056,0.36666666666666664,0.8480831080734705,1.0,2/5,26.37%,STARD4;ABCG1
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.6311462055694013,1.1070493711047429,0.4411764705882353,1.0,1.0,1/6,1.65%,PLA2G4A
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.6991006421181993,-1.1059569398874178,0.37142857142857144,0.8510747152736111,1.0,2/8,12.70%,CCDC60;NEBL
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.7514772359940756,-1.1059399212202774,0.41379310344827586,0.8502414728007631,1.0,1/5,11.02%,FGFR1
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.6807355290513293,1.1057307824968332,0.375,1.0,1.0,2/5,15.64%,MFF;PNPT1
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.5693128293251543,-1.105433930327452,0.36363636363636365,0.8510326089838661,1.0,6/29,18.67%,SERPINE1;GGT5;ZFP36;PELI1;ERBIN;SCARB1
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.43759376615065604,1.1053234906600427,0.2777777777777778,1.0,1.0,2/29,2.31%,EVI5;TBC1D5
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5617838651360293,1.1051581968383604,0.3548387096774194,1.0,1.0,3/9,12.88%,UIMC1;ATM;BABAM2
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7102494281823922,-1.1049322337332417,0.41935483870967744,0.8515922218973256,1.0,5/7,25.66%,RPS27;RPS15;RPS28;RPS19;RPS14
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.7461683304604378,-1.1046386852908197,0.4482758620689655,0.8517518993733156,1.0,3/5,24.89%,CFL1;RACK1;NR2C2
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.6548239662868509,-1.1045386333422085,0.3898305084745763,0.851126696263761,1.0,2/9,10.81%,MGLL;DGKG
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.5839161628405822,-1.104374662002841,0.3448275862068966,0.8507439719559238,1.0,9/29,21.49%,CDC37;JAK1;IFNGR1;IFNGR2;CYLD;RACK1;VRK2;SOCS3;CBFB
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),-0.7353211226745769,-1.1039515334839118,0.42424242424242425,0.851000396647676,1.0,4/5,25.07%,COMMD1;NEDD4;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.6739135860040624,-1.1038955340887557,0.3582089552238806,0.8502937890082614,1.0,5/10,22.79%,RIMS1;RIMS2;SYT1;PIP5K1C;DNAJC5
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.6996503648396023,-1.1037929457056126,0.3787878787878788,0.8497809835986477,1.0,2/6,12.40%,RIMS1;RIMS2
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.46400620442625495,1.1037590508608388,0.30434782608695654,1.0,1.0,8/25,14.56%,UIMC1;INO80;ATM;XRRA1;COP1;BABAM2;SPIDR;CLOCK
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.7337433293217099,-1.1034873713867084,0.35384615384615387,0.8499175619183822,1.0,3/5,13.92%,PRKN;RPS7;PTTG1IP
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.5133574874451492,-1.1031418840136644,0.29473684210526313,0.8501497888807559,1.0,26/113,19.81%,CCDC3;BTG2;SRGN;GAPDH;ATP2B1;PPM1D;NDFIP1;HIF1A;REL;PRKN;KLF4;RPL13A;ZFP36;TMBIM6;CLDN5;PPHLN1;RACK1;PICALM;PINK1;PTBP2;DCP2;GATA2;ACVRL1;MECP2;CD34;GIGYF2
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.6593580570400802,-1.1031132684165765,0.4090909090909091,0.8493153242349283,1.0,5/10,19.63%,TIMP3;PRNP;CST3;TMEM59;PLAT
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.5909842771964787,-1.1030831070573919,0.35064935064935066,0.8485903397338648,1.0,6/22,8.02%,GRIN2B;GRIA2;DMD;LRRC7;ANK2;AHNAK
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.6913432914553039,-1.102149906795923,0.30357142857142855,0.8510945443479645,1.0,3/6,18.67%,PPARG;SREBF2;SCARB1
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.7056420317738515,1.1015355590176614,0.4411764705882353,1.0,1.0,3/5,21.86%,PIAS1;HDAC4;UBA2
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.7183443764031334,-1.100832840264977,0.3880597014925373,0.8544651591594656,1.0,3/7,6.37%,LBR;PRKAG2;LSS
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.5589453420585726,-1.1008020098760196,0.36363636363636365,0.853689301145857,1.0,8/29,19.42%,CDC37;ERBB4;PIK3R1;KIF16B;BCAR1;ERBIN;GRB2;EGFR
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.5582233788879291,-1.1006062199716353,0.3493975903614458,0.8534513183700378,1.0,12/37,26.72%,RFC3;ERBB4;FLT1;KLF4;FGFR1;PINK1;TIE1;EGFR;HSP90AA1;ARRDC3;TNKS;CD74
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.5918116519038827,-1.1004447931878378,0.3888888888888889,0.8531543218297126,1.0,4/21,7.68%,PSMC6;PSMB9;PSMA1;REL
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.564372017639698,-1.0996961276490358,0.42105263157894735,0.8549745512599872,1.0,7/25,16.65%,SMAD7;NDFIP1;WDR48;COMMD1;PTTG1IP;MALT1;PINK1
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.7322561635620917,-1.0993963297043918,0.3620689655172414,0.8548072351324851,1.0,1/5,13.86%,ACOX1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.6509210417669226,1.099338194349062,0.3953488372093023,1.0,1.0,2/8,6.19%,PLPPR4;MBOAT2
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.5299981802611701,-1.0991862090529534,0.2823529411764706,0.8547114676674429,1.0,9/51,12.14%,MAP2;NRCAM;MAP1B;S100A6;GAS7;GPM6A;CTNND2;MEF2A;DCLK1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.7327745156068503,-1.0984897056257263,0.3898305084745763,0.8561568399442891,1.0,1/7,1.54%,PCK1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.6489163131270863,-1.0979167683695206,0.3974358974358974,0.8570308040511571,1.0,4/11,18.14%,RIMS1;RAP1A;RIMS2;PREPL
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.6908746160214765,-1.097715893316212,0.3188405797101449,0.8569093415858815,1.0,2/7,13.17%,CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.6758021918752795,-1.097489503453048,0.43478260869565216,0.8566108949431024,1.0,2/7,8.23%,SUN2;SUN1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.5689198463743813,1.09716125693491,0.3888888888888889,1.0,1.0,3/11,16.18%,SOBP;CHD7;APP
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.6139500997283697,-1.096872966996898,0.3108108108108108,0.8577295028330705,1.0,3/18,9.64%,SERPINE1;MAGI2;RAB21
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),-0.6446052230819275,-1.0965778535666104,0.37142857142857144,0.8577963484036807,1.0,5/13,12.72%,PIK3R1;PRKN;DLC1;TMEFF2;PAK2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.5409228142048038,1.0960249248516944,0.34375,1.0,1.0,2/13,5.31%,BMP6;MIA3
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.7150446935493618,1.0953941488948242,0.5,1.0,1.0,2/5,13.49%,RNF213;SERPINB9
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.6188492710177707,-1.0953923318671985,0.36363636363636365,0.8604661724936885,1.0,6/18,18.67%,SYTL4;TPM1;DYSF;PLEC;SMAD3;SCARB1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.6791178812919919,-1.09487856891403,0.4166666666666667,0.8612948338856478,1.0,2/8,10.15%,LGALS3;PRNP
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.71362534742141,-1.0948618336745213,0.4393939393939394,0.8604761770959594,1.0,1/6,2.47%,PPARG
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.4802016253512437,-1.0937289802647518,0.22,0.8643677303847039,1.0,59/279,19.18%,PIK3R3;CCDC3;BHLHE40;YTHDC1;VSIR;NFKBIZ;RPL23;RIMS1;ESR2;NFE2L2;NDFIP1;ZC3H7A;YBX3;IFNGR1;PRX;HIF1A;SLC8A1;ANK2;REL;BCL6;AHNAK;PRKN;RREB1;KLF4;AFF4;AFDN;CREM;SBNO1;LIMS1;RPS7;GJA1;HNRNPH3;ZNF280D;PLCG2;BTNL9;RIMS2;CLDN5;MSN;CNBP;SMAD3;BTG1;WWTR1;CDK6;RACK1;PICALM;NSD2;SLC38A2;PINK1;ZBTB38;NOS1AP;PTBP2;ATF2;ANK3;GATA2;ZNF326;MTOR;ACVRL1;MECP2;CD34
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),-0.7325923528541072,-1.0937046591924424,0.39705882352941174,0.8635944936205654,1.0,2/5,18.19%,SLC8A1;ANK3
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.4807606300553599,-1.0929826569492318,0.28,0.8648968502149411,1.0,65/334,16.92%,MAFF;TBX3;SERPINE1;ST18;MAP3K5;NR4A1;ATF3;KLF6;ZEB2;PPARG;CX3CL1;PHF10;HES1;JUN;JUNB;FOS;KDM1A;SMAD7;ESR2;RPS27A;NFE2L2;JUND;NPAS3;ERBB4;PIK3R1;FOXF1;HMGN1;KLF2;SMARCA1;HIF1A;REL;FOSL2;PRKN;NPAS2;UBC;RREB1;CD81;KLF4;CEBPZ;HYAL2;ZFPM2;CRLF3;EPAS1;OGT;MEF2A;NPM1;NFKBIA;FOXK1;CNBP;NCK1;SMAD3;MAX;NAA16;TMF1;CREB3L2;LPIN2;WWTR1;CRTC3;SREBF2;THRB;SMARCC1;PICALM;TBK1;NOTCH4;ZBTB38
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.620135561041125,-1.0928944824957352,0.37142857142857144,0.8643470719912509,1.0,1/12,1.27%,ADAMTS9
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.6486968500984324,-1.0927911194363957,0.4,0.8638685960646908,1.0,3/15,12.56%,NRCAM;GPM6A;ADGRL3
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.6286033639986427,-1.0918998327296254,0.41025641025641024,0.8661244372322446,1.0,2/15,8.92%,CX3CL1;CD55
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.5337459138212635,-1.091896358745224,0.34146341463414637,0.8652250349090543,1.0,11/46,15.59%,DDIT4;PRKAG2;SMAD7;DMD;PRKN;PRNP;PAK2;TRIB2;NCK1;WWTR1;RACK1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.48271346843182167,1.0915511849134738,0.3333333333333333,1.0,1.0,3/17,9.91%,ATR;ATM;NEK7
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.6605320117257426,-1.0914264225046098,0.41935483870967744,0.8659594268426252,1.0,3/7,26.80%,GOLPH3;ALG11;GCNT1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.583477020912625,-1.0910763054342483,0.35064935064935066,0.8662847374305118,1.0,7/24,19.18%,WNT2B;FLT1;ARIH2;ZNF160;NOTCH4;KMT2A;CD34
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),-0.683769390836888,-1.0908197814629523,0.38333333333333336,0.8660975446410331,1.0,2/5,27.73%,GJA1;SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.7219822401731106,-1.0902990633808674,0.38333333333333336,0.8668055149931859,1.0,2/6,18.43%,MAGI2;MTOR
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),0.7266085731512483,1.090224277927445,0.5,1.0,1.0,2/6,12.72%,NKD1;PROM1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.5805554693369269,-1.0898950758223216,0.37333333333333335,0.8670244671652091,1.0,6/20,14.00%,JAK1;ARF1;SOD2;CFL1;PAK2;MSN
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.46996202867991055,1.0893635305083185,0.27586206896551724,1.0,1.0,6/19,14.21%,PSMD14;INO80;RAD51B;SEM1;SPIDR;MCM9
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.49871194152695897,-1.0891116086979422,0.3563218390804598,0.8684953875677346,1.0,6/86,8.34%,PIK3R3;ATF3;ERBB4;RB1CC1;PECAM1;PRKN
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.6857438086753246,-1.0890705015387947,0.4492753623188406,0.8677506303579101,1.0,2/7,9.06%,PCK1;CD81
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.6141176240245845,-1.0889413931367249,0.3380281690140845,0.8672851494805239,1.0,3/16,6.48%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.5870909100046984,-1.0889249442578117,0.3333333333333333,0.8664506842642327,1.0,1/18,1.75%,NR4A1
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.6618382458635327,-1.0886066296593708,0.35714285714285715,0.8665995831153662,1.0,1/7,3.03%,SRGN
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.5272697209143701,1.0886015099949538,0.3,1.0,1.0,1/9,4.91%,CLASP1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.6152835808622656,-1.0885121854128323,0.4142857142857143,0.8660328851571104,1.0,3/13,9.19%,NR4A1;PPARG;KLF4
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.7000904173710405,-1.088466970703911,0.3770491803278688,0.8652253221394556,1.0,3/6,19.12%,TMSB4X;CYLD;PPM1A
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.5453940276899604,-1.0883466180987058,0.39473684210526316,0.8646842201244278,1.0,8/27,21.30%,GRIN2B;ATP2B1;SPG7;SLC8A1;CACNA1C;MICU2;TMEM165;RYR3
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.4733641120292087,1.0883139534219912,0.3333333333333333,1.0,1.0,3/26,3.61%,PGM5;EPB41L5;TTN
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.6752996878390449,-1.088250954423129,0.390625,0.864144225790086,1.0,6/10,30.36%,ARIH2;SREBF2;PINK1;UBE2D3;NPEPPS;MICALL2
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.648394493477275,1.0878528452550724,0.4444444444444444,1.0,1.0,2/9,4.99%,IL1R1;HSPD1
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.6508350779142668,-1.0876291943650893,0.36764705882352944,0.865167944012128,1.0,5/9,26.37%,IFNGR1;PICALM;SLC2A13;CLU;ABCG1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.5312024412886442,-1.0870847683173117,0.32954545454545453,0.8660747905743795,1.0,5/39,6.48%,PSMC6;ZEB2;PSMB9;GPC5;PSMA1
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.5810041768976042,-1.0861920902289515,0.4025974025974026,0.8679314908410691,1.0,6/19,14.00%,JAK1;ARF1;SOD2;CFL1;PAK2;MSN
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.6528201187284073,-1.0861690769554724,0.36764705882352944,0.8671269316689003,1.0,5/8,26.37%,IFNGR1;PICALM;SLC2A13;CLU;ABCG1
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.7044639176361183,-1.0852968767573998,0.40298507462686567,0.869093208694106,1.0,1/8,3.82%,NPLOC4
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.6590243503284257,-1.0852523037457131,0.4025974025974026,0.8683005359841351,1.0,4/10,6.37%,LBR;PRKAG2;SCP2;LSS
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.6825530800760007,-1.0844349655877428,0.40298507462686567,0.8701360070452091,1.0,4/7,25.07%,ANK2;PRNP;NOS1AP;CAMK2D
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.5805892913085425,-1.084204976852975,0.32051282051282054,0.8699599232762727,1.0,3/21,7.57%,ITPR1;NDFIP1;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),-0.6740421707483816,-1.0837970666580041,0.4262295081967213,0.8705933512607062,1.0,2/7,5.95%,CD9;ACTN1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.6788935474090732,-1.083488918461887,0.39344262295081966,0.8698660026329177,1.0,2/5,30.65%,TERF2IP;POLR2B
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.6788935474090732,-1.083488918461887,0.39344262295081966,0.8698660026329177,1.0,2/5,30.65%,TERF2IP;POLR2B
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.604957921212828,-1.0831360858132697,0.39436619718309857,0.8701908308769718,1.0,3/15,11.50%,PCK1;ANXA1;OGT
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.6094733126642091,-1.0828894257592176,0.3855421686746988,0.8701290860105644,1.0,3/16,13.76%,PRKN;ARIH2;PELI1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.710962500139782,-1.082807948234126,0.37681159420289856,0.8694324793340505,1.0,5/6,25.07%,PRKCE;STK39;NEDD4;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.6754018742845945,-1.0823355969614987,0.45714285714285713,0.8701305734748651,1.0,4/9,25.05%,JAK1;PAK2;CDH5;DSP
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.6685223030978971,1.081443050596866,0.39473684210526316,1.0,1.0,3/6,18.99%,SLC23A2;ABCG2;SLC12A2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.7248233257023121,-1.0812130294031823,0.37681159420289856,0.872807597510249,1.0,2/5,8.15%,SERPINE1;TPM1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.5670391961754468,1.080907993785449,0.40540540540540543,1.0,1.0,1/7,1.25%,SLC4A4
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.5146954744327157,1.080857455199977,0.3125,1.0,1.0,1/12,0.16%,BMP6
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.5679472566729563,1.0806084128901114,0.3225806451612903,1.0,1.0,1/7,4.91%,CLASP1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.5548606128697655,-1.0800492874839334,0.36585365853658536,0.8753774917924011,1.0,9/29,19.42%,PRKAG2;ERBB4;FLT1;RAP1A;FGFR1;CDKN1A;TIE1;LCP2;EGFR
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.6225168072217224,-1.0800437827155274,0.4647887323943662,0.8745315957961747,1.0,3/14,11.93%,PRNP;SNX6;GJA1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.3986581883713617,1.0798923173213244,0.4,1.0,1.0,7/50,3.59%,ANKRD6;ZNRF3;PSMD14;MLLT3;TLE4;NKD1;RNF213
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),-0.6567804644312153,-1.0792177012747295,0.44285714285714284,0.8764289536265738,1.0,3/9,10.09%,HES1;SMAD7;ZFPM2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.6850351033101054,-1.0790529035550371,0.4,0.8761472401003698,1.0,2/7,26.75%,SMC6;CSNK2A1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.5544845090992396,-1.079033595416585,0.3950617283950617,0.8753368941194019,1.0,3/27,4.09%,SPNS2;SCP2;ABCA5
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),-0.7273535890046657,-1.0780037510247853,0.38095238095238093,0.8778688977591936,1.0,3/5,18.19%,SLC8A1;PRKN;ANK3
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.5562208560970102,-1.0779796198566092,0.38666666666666666,0.8752966205795207,1.0,6/29,15.83%,PSMC6;PSMB9;PSMA1;PLCG2;PAK2;MALT1
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.5562208560970102,-1.0779796198566092,0.38666666666666666,0.8752966205795207,1.0,6/29,15.83%,PSMC6;PSMB9;PSMA1;PLCG2;PAK2;MALT1
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.5562208560970102,-1.0779796198566092,0.38666666666666666,0.8752966205795207,1.0,6/29,15.83%,PSMC6;PSMB9;PSMA1;PLCG2;PAK2;MALT1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.6366375643713981,-1.0778304685738647,0.4142857142857143,0.8750513313701178,1.0,3/10,4.09%,LBR;PRKAG2;ABCA5
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.6825884697096012,-1.077823508654789,0.45901639344262296,0.874179766299032,1.0,2/7,13.92%,KDM1A;PTTG1IP
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.609269998753622,-1.0775792174483327,0.3424657534246575,0.873980800870819,1.0,3/17,14.93%,ESR2;PLPP1;TMF1
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.5717832356494208,-1.0774230103327709,0.4166666666666667,0.8735588315597775,1.0,2/12,12.16%,KDM1A;PIAS2
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.6144928439526423,-1.0772654361343674,0.3972602739726027,0.8731934947193097,1.0,4/13,4.59%,GRIK1;GRIN2B;GRM7;GRIA2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.5153529608766331,-1.0772352044460514,0.37777777777777777,0.8723606747598136,1.0,13/48,19.65%,ANGPTL4;ERO1A;AKAP12;EMP1;PECAM1;KLF4;CFH;TRIB2;PTBP2;TOR1AIP2;TFPI;PLAT;CBR4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.7201620872076253,-1.077007890478882,0.3484848484848485,0.8721754377211951,1.0,2/5,20.35%,ANXA1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.6621756756969489,-1.076895406897896,0.3880597014925373,0.8715121609049202,1.0,4/8,23.72%,TGM2;ERBIN;GRB2;SHOC2
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.4827490247493083,-1.076803956467691,0.35789473684210527,0.8709391140475227,1.0,27/128,13.17%,CX3CL1;JUNB;FOS;GAPDH;RPS27A;NFE2L2;CDKN1B;DUSP1;JAK1;PIK3R1;YBX3;LAMA5;IFNGR1;IFNGR2;HIF1A;BCL6;UBC;ANXA1;IL1RAPL1;HYAL2;S1PR1;TPR;RPL13A;ZFP36;INPP5D;TEC;CDKN1A
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.555267447920068,1.0764524093093946,0.41025641025641024,1.0,1.0,3/8,17.53%,PIAS1;STAT2;PKD2
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.5626811865436214,-1.0761678569184094,0.4027777777777778,0.8718551017765792,1.0,7/30,13.68%,SERPINE1;NFKBIZ;CX3CL1;SCARF1;HYAL2;NFKBIA;RIOK3
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.674189726940738,-1.0761471780562692,0.373134328358209,0.8710609920523126,1.0,3/8,20.37%,CCDC14;NUDCD3;CSNK1D
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6292329268142871,-1.0759329980705281,0.4166666666666667,0.8709333593797158,1.0,2/13,2.52%,PPARG;CX3CL1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.6463489711727626,-1.0757472505081904,0.4117647058823529,0.8705734887135375,1.0,4/8,28.82%,TMBIM6;PTBP2;PTBP1;NCOR2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.49181418216655753,-1.0755840438692716,0.3473684210526316,0.8702585665795723,1.0,27/95,23.16%,MAP3K5;BNIP3L;JUN;RPS27A;HIP1R;VAV3;BCL6;UBC;DLC1;TGM2;PRNP;RPS6;GNA13;FGD4;TNFRSF10B;BTG1;RACK1;RASGRF2;ITGB1;CLU;GADD45B;ECT2;DUSP6;DNM2;MAPK8;BCLAF1;KALRN
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.5880384613490374,1.0742942460706804,0.38235294117647056,1.0,1.0,2/7,9.64%,LDB2;ATM
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.5143237276798078,-1.0741484205725895,0.38823529411764707,0.8741208448027556,1.0,9/56,14.08%,DDIT4;RTN4;GAPDH;PRKCE;BCL2L14;DLC1;OGT;NFKBIA;TNFRSF10B
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.6960190515405511,-1.0740427021780363,0.4305555555555556,0.8735381374858837,1.0,4/8,14.21%,PKM;YBX3;CNBP;CPEB4
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5985523752737971,-1.073932465803128,0.36764705882352944,0.8731219859024463,1.0,4/12,11.71%,RPL23;RPL37;RPS15;RPS7
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.6236703436412854,-1.0736895258412953,0.410958904109589,0.8730481667214484,1.0,4/15,16.49%,NPLOC4;REL;CYLD;TBK1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.5168197232242745,-1.0734506680510554,0.31868131868131866,0.8728974510619183,1.0,6/48,7.84%,PSMC6;ZEB2;PSMB9;GPC5;PSMA1;SULF2
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),-0.5403749659225952,-1.072988186612249,0.4074074074074074,0.8731868343312356,1.0,9/37,20.35%,UFL1;BNIP3L;PRKN;DHRSX;TMEM59;TBK1;PINK1;GNAI3;PIK3CB
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.5077575016498316,1.072762750932911,0.43902439024390244,1.0,1.0,3/12,9.27%,SLC23A2;SLC38A3;SLC38A6
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.7032574704744092,-1.0727033368824337,0.4857142857142857,0.8733987613840503,1.0,1/6,11.00%,EFNB2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.6345672869132459,-1.0726257916115276,0.46774193548387094,0.8728091999025991,1.0,2/10,7.22%,FES;RAPGEF3
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.6125242699950142,-1.0722696340633224,0.423728813559322,0.8731964885650804,1.0,3/9,7.81%,GLUD1;SLC2A3;SLC2A1
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.6013469313811353,-1.0720808064786802,0.4307692307692308,0.8730135061228083,1.0,1/11,1.01%,ADM
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),-0.6401390819214928,-1.0720361581337887,0.42424242424242425,0.8722509768420584,1.0,2/12,9.11%,CALCOCO2;ANXA1
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.5677646400529023,-1.0710607043940794,0.38961038961038963,0.8744850047842747,1.0,7/22,16.39%,SCP2;ESR2;SOD2;ACSL5;ACOX1;CNBP;SMARCC1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.6098903966349459,1.070850833037651,0.391304347826087,1.0,1.0,2/7,3.27%,UGCG;ATP2A2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),-0.643309746802339,-1.0701079735997407,0.40298507462686567,0.8763434002884415,1.0,3/10,7.60%,SMAD7;SLC8A1;ANK2
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.6947334694240086,1.0699811284255853,0.4864864864864865,1.0,1.0,2/5,12.54%,BICD1;PCM1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.5386653895989534,1.0698940885869113,0.28,1.0,1.0,8/16,14.02%,HABP4;RBM20;HSPA1A;HNRNPLL;CIRBP;TRA2A;RBMX;NCL
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.6813222971724638,-1.0695882278010513,0.4794520547945205,0.8772272238842815,1.0,2/8,21.43%,CAMKMT;SETD3
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.6178973820052173,-1.068500428402271,0.3888888888888889,0.8795698149491662,1.0,5/15,18.27%,ZFPM2;TRIB2;SMAD3;WWTR1;GATA2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.5618005773310233,-1.0683844373220552,0.3563218390804598,0.8789897325666836,1.0,2/29,3.88%,PSMC6;LGALS3
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.7487783584691017,-1.0681696856273757,0.46774193548387094,0.8787153577703956,1.0,1/5,2.82%,HES1
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.6220835465112651,-1.0679172524375635,0.4142857142857143,0.8785501886492365,1.0,5/13,30.23%,ZFP36;EGFR;AGO2;MAP2K1;STAT3
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),-0.5920891282058871,-1.0675151624935788,0.4473684210526316,0.879080186500622,1.0,4/13,13.86%,PPARG;SLC4A10;SLC4A7;ACOX1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.6644991433811361,1.0674990153263815,0.48717948717948717,1.0,1.0,1/5,11.26%,MSH3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.6189320083555305,-1.0667506944036205,0.42857142857142855,0.8805419616718124,1.0,3/10,10.09%,SMAD7;TPM1;ZFPM2
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),-0.6985054758271299,-1.0664228668971356,0.47761194029850745,0.8797871778254988,1.0,1/6,8.26%,RAP1A
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),-0.6985054758271299,-1.0664228668971356,0.47761194029850745,0.8797871778254988,1.0,1/6,8.26%,RAP1A
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.6297019455541177,-1.0663799685119775,0.43478260869565216,0.8790377512122323,1.0,3/13,11.93%,PRNP;SNX6;GJA1
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.42814377706111684,1.066349601188538,0.375,1.0,1.0,3/24,4.91%,BMP6;TTN;CLASP1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),-0.5290381785464485,-1.0660813073107012,0.38372093023255816,0.879089320993253,1.0,11/37,24.67%,SEC22B;CDKN1B;PRKN;PTTG1IP;MSN;ADAM9;GPC3;SNX9;NEDD4;NEDD4L;HSP90AA1
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.7142284824938626,-1.0660588479554756,0.45454545454545453,0.8783096213103531,1.0,1/5,4.01%,GAPDH
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),0.6879235085081098,1.0659527409601537,0.5333333333333333,1.0,1.0,1/7,7.92%,SLTM
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.6769504281462428,-1.0657938766606496,0.4225352112676056,0.8782970865225112,1.0,1/6,11.29%,ACSL5
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),0.5247281406043081,1.0650525278901688,0.42857142857142855,1.0,1.0,5/19,9.64%,PSMD14;UIMC1;HERC2;ERCC6;ATM
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.7213982920253915,-1.0647101545606847,0.421875,0.8808164003963275,1.0,2/5,20.66%,PRKN;XIAP
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.6676098956784658,-1.063950818330803,0.36065573770491804,0.8824913426303201,1.0,4/7,32.67%,STARD4;ABCG1;LDLR;LRP6
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.5907928377516458,-1.0636042371239502,0.4084507042253521,0.8826361387140378,1.0,4/17,10.73%,PSMC6;PSMB9;PSMA1;CHFR
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.67603556325358,-1.0631473625648844,0.42857142857142855,0.8831566567122398,1.0,3/6,28.82%,EGFR;MAP2K1;NCOR2
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.652171770172974,1.0629931766093048,0.4722222222222222,1.0,1.0,3/5,9.08%,SLCO1A2;SLC26A3;ABCG2
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.6107388819534281,-1.0628987664152805,0.463768115942029,0.8831502848951585,1.0,3/12,13.04%,PRKAG2;PIK3R1;ARPP19
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.6765059596018423,-1.0623758750588386,0.515625,0.8840017108753678,1.0,2/7,9.06%,VAV3;CD81
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.6545240027870844,-1.0621569452229762,0.4246575342465753,0.8839302730319536,1.0,3/8,3.93%,LBR;PRKAG2;SCP2
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.7046110154668664,-1.062039129088442,0.40384615384615385,0.8833987896896596,1.0,3/5,22.60%,CD55;CFH;MAPK8
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.698409828844877,-1.0620051110576656,0.463768115942029,0.8826865585883269,1.0,2/7,15.96%,PRNP;MCL1
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.5055526893199157,-1.0614117623951094,0.4125,0.8818586506532128,1.0,11/35,24.67%,PIK3R1;PRKCE;VAV3;WIPF1;ARPC2;PLCG2;NCK1;GRB2;PIK3CB;ABI1;HSP90AA1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.5055526893199157,-1.0614117623951094,0.4125,0.8818586506532128,1.0,11/35,24.67%,PIK3R1;PRKCE;VAV3;WIPF1;ARPC2;PLCG2;NCK1;GRB2;PIK3CB;ABI1;HSP90AA1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),-0.5055526893199157,-1.0614117623951094,0.4125,0.8818586506532128,1.0,11/35,24.67%,PIK3R1;PRKCE;VAV3;WIPF1;ARPC2;PLCG2;NCK1;GRB2;PIK3CB;ABI1;HSP90AA1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.609401561641661,-1.0610797034068218,0.4827586206896552,0.8820133251473465,1.0,2/13,7.65%,SLC4A10;COL18A1
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6134580236272613,1.0609746766276456,0.4375,1.0,1.0,2/6,21.41%,CDC16;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.6134580236272613,1.0609746766276456,0.4375,1.0,1.0,2/6,21.41%,CDC16;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6134580236272613,1.0609746766276456,0.4375,1.0,1.0,2/6,21.41%,CDC16;NSMCE2
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.6233647065766906,-1.0608229609079374,0.3880597014925373,0.8821357834250642,1.0,1/9,2.52%,CX3CL1
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.6220367017029509,1.060606266341184,0.34285714285714286,1.0,1.0,1/8,2.18%,GCH1
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.6070447999233093,-1.060560832239311,0.44285714285714284,0.8818859241708299,1.0,3/12,8.84%,RPS27A;WDR48;UBC
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.5159874748828324,-1.0604406418473518,0.37037037037037035,0.8813816338335432,1.0,3/30,7.60%,ITPR1;SLC8A1;ANK2
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.5697223197085358,-1.060174443607266,0.44,0.8812921227812316,1.0,4/17,13.73%,RPS27A;PRKN;UBC;CST3
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),-0.5349118395763081,-1.0597663010779992,0.32941176470588235,0.8817328274030319,1.0,4/35,8.34%,SEC22B;CDKN1B;EEF1A1;PRKN
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.6279136941617931,-1.0595767341295645,0.44,0.8813360166946522,1.0,8/11,22.18%,GRIA2;CTNND2;ATRNL1;HS6ST3;SMAD3;CADPS2;SCN2A;NOL4
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.7226413934827008,-1.059560686411705,0.48214285714285715,0.8805061334397609,1.0,3/5,21.43%,ATP2B1;ZDHHC21;SETD3
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.51602162780534,1.0590964450142775,0.34375,1.0,1.0,1/17,0.16%,BMP6
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.5894048005220549,-1.0590605178774746,0.4,0.8812211801721465,1.0,8/19,15.70%,KCNMB4;RIMS1;ANXA1;RAB21;STXBP5L;RIMS2;SYT1;RAB8B
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),-0.6656573633765379,-1.059052298165996,0.45454545454545453,0.8787728194170159,1.0,5/6,28.61%,SLC8A1;ATP1B3;ATP1A1;NEDD4L;ATP1B1
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),-0.6656573633765379,-1.059052298165996,0.45454545454545453,0.8787728194170159,1.0,5/6,28.61%,SLC8A1;ATP1B3;ATP1A1;NEDD4L;ATP1B1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),-0.6656573633765379,-1.059052298165996,0.45454545454545453,0.8787728194170159,1.0,5/6,28.61%,SLC8A1;ATP1B3;ATP1A1;NEDD4L;ATP1B1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.6495363972719868,-1.0590275093204289,0.4393939393939394,0.878012415604155,1.0,5/10,25.29%,RPS6;PINK1;MTOR;CCDC88A;MAPKAP1
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.6932443614881622,-1.0589706857708239,0.42857142857142855,0.8765589460270503,1.0,1/7,9.40%,CCNH
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.6932443614881622,-1.0589706857708239,0.42857142857142855,0.8765589460270503,1.0,1/7,9.40%,CCNH
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.5907975643002954,-1.0586810587388689,0.4189189189189189,0.8765798809820966,1.0,7/15,15.86%,MAP2;GRIA2;ANK2;PPFIA2;CTNND2;HS6ST3;CADM2
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.523478074634613,-1.058547165356874,0.3764705882352941,0.8760342058253215,1.0,6/42,11.95%,MTFR1;BNIP3L;BCAP31;SPG7;PRKN;MEF2A
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,-0.5324765601608609,-1.0581872610889944,0.41025641025641024,0.8761708961727478,1.0,11/36,12.75%,MAP2;MAP1B;NFASC;GRIA2;MAGI2;PTPRD;ANK2;LSAMP;PPFIA2;DCLK1;PLP1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.6568074715676692,-1.0581243059283512,0.4246575342465753,0.8755637842816097,1.0,1/8,4.46%,KDM1A
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),-0.4942828248085879,-1.0580353748277318,0.391304347826087,0.8749578029526526,1.0,7/62,6.69%,ADM;SRGN;RAB11FIP3;ATP2B1;SMAD7;PLCL1;IFNGR1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),-0.5503487437591856,-1.057965924485516,0.352112676056338,0.8743424960151455,1.0,5/23,13.09%,FES;ERBB4;FLT1;FGFR1;TEC
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.6699582356096772,1.0579524549978114,0.55,1.0,1.0,2/5,15.43%,GMDS;PARG
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.5731336233327229,1.057727444812908,0.36,1.0,1.0,4/11,23.51%,CDC16;NSMCE2;PDGFB;PHIP
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),-0.5231525227719495,-1.0575427503501984,0.38823529411764707,0.8748039927712538,1.0,10/29,19.95%,BNIP3L;CDKN1B;PRKN;NPAS2;NCK1;TBK1;CHMP4B;LRPAP1;CLU;ACER2
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.6164997361495732,1.0570814530802877,0.38235294117647056,1.0,1.0,1/6,2.60%,PRKD1
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),-0.7091069146070408,-1.056979831503156,0.4444444444444444,0.8757445783217405,1.0,1/6,1.38%,SLCO4A1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.6393639365587618,-1.0568622861828725,0.4153846153846154,0.8752240692247575,1.0,3/8,10.04%,FOXF1;SULF2;HYAL2
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.5402496244228068,-1.0565140013170515,0.4146341463414634,0.8755272518555517,1.0,10/26,21.70%,NR4A1;HIF1A;VEGFC;EGFL7;TIE1;ACVRL1;CAV2;ATOH8;PPP1R16B;SPARC
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.6170286454892,-1.0564392688715785,0.4444444444444444,0.8748414339391937,1.0,7/13,27.36%,MAGI2;DLC1;MTOR;PPP1R16B;CDH5;PTBP1;SPPL3
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),-0.5226752973068857,-1.0562962724611513,0.4177215189873418,0.8743751798199342,1.0,6/40,13.17%,RAPGEF5;JUN;RASSF1;RREB1;SHC2;CDKN1A
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.6250109257152294,-1.0559850867216833,0.40789473684210525,0.8742940469637563,1.0,9/14,35.06%,EEF1A1;ZFP36;EGFR;DUSP22;STAT5B;FOXC1;DAB2IP;ZFP36L1;IQGAP1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.7512726451955014,-1.054656140499585,0.40625,0.8774814410680333,1.0,3/5,9.80%,BCAP31;NFE2L2;HERPUD1
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.6582404146283374,-1.0546377070148971,0.4032258064516129,0.8766926888010871,1.0,1/9,2.82%,HES1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.6565930302092066,-1.0541869055390305,0.5,0.8770549813265662,1.0,1/7,3.35%,SLC4A10
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.613231130230985,1.053957171034077,0.4642857142857143,1.0,1.0,4/8,18.49%,ZDHHC2;ABL1;APP;EPHA4
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.6969695746260112,-1.0539142643460702,0.421875,0.8771579281970934,1.0,2/5,8.66%,ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.49579062116964634,-1.0537946191101741,0.43529411764705883,0.8768265056551068,1.0,13/85,13.73%,LAMC1;PSMC6;PSMB9;MGAT4A;PSMA1;FEM1C;HIF1A;SHISA5;COMMD1;EPAS1;RAB2A;RAB1A;CST3
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),-0.47594087530972357,-1.053115156023973,0.37755102040816324,0.8779416287969024,1.0,39/149,20.35%,RPL23;RTN4;CX3CL1;BCAP31;GAPDH;NDFIP1;RPL37;ERBB4;PIK3R1;FLT1;REL;SHISA5;PRKN;VWF;TGM2;ALPK1;FGFR1;LIMS1;RPS15;GOLPH3;GJA1;PLCG2;SLC20A1;CASS4;PELI1;TNFRSF10B;LARS1;RACK1;MALT1;TBK1;PINK1;NOS1AP;ITGB1;GRB2;PPM1A;EGFR;ECT2;CAV2;PIK3CB
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),-0.6528091212310441,-1.0528731668615585,0.42028985507246375,0.8776823257107723,1.0,3/8,29.75%,ACSL5;CBR4;ACSL4
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.603375734130742,-1.0525551264120343,0.46153846153846156,0.8779080292513204,1.0,4/17,14.26%,RPL23;OGT;RPS7;SDCBP
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),-0.7165817462597673,-1.0524533420592614,0.5161290322580645,0.8774329382429968,1.0,2/5,15.46%,FES;CDK6
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.646039698851347,-1.0520721181564834,0.43283582089552236,0.8778436819242684,1.0,2/7,14.93%,PLPP1;TMF1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.6595476688433727,-1.0512594241170534,0.5,0.8792817611019217,1.0,1/7,1.46%,TSG101
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.6350045771240078,-1.0512223787754018,0.4626865671641791,0.8785396588989899,1.0,2/8,13.07%,PPARG;NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.5540107985832442,-1.0510074413830708,0.42168674698795183,0.8784146377146431,1.0,7/25,13.23%,PPARG;MAGI2;STARD4;KLF4;NFKBIA;CDKN1A;RAB1A
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),-0.7255231159295644,-1.0508414698155593,0.47368421052631576,0.8781565591838827,1.0,1/5,5.02%,SEMA6B
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.5985081062199553,-1.0507884784857613,0.46153846153846156,0.8775199459754974,1.0,2/15,10.15%,PRKN;PRNP
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.5490169523760966,-1.0507288075199455,0.4605263157894737,0.8769458966810568,1.0,9/18,26.72%,LGALS3;ANXA1;RAB30;LCP2;ZBTB46;FTL;HLA-B;CAMK2D;CD74
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.5141993880125963,-1.050609794165218,0.4634146341463415,0.8764444652588024,1.0,10/31,16.65%,SERPINE1;SLC6A6;GABARAPL1;TMBIM6;ARPP19;ACOX1;BCAR1;LPIN2;UPP1;PINK1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.5660369256677522,-1.0501394313686043,0.3783783783783784,0.8770267829264088,1.0,8/28,17.80%,LDHA;MGLL;GLUL;ACSL5;GABARAPL1;ACOX1;HSPH1;XIST
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.4937165334850314,-1.0497832651651637,0.3522727272727273,0.8774243317578492,1.0,12/72,14.58%,LAMC1;PLS3;HES1;CD9;NES;SMARCA1;PECAM1;KLF4;GJA1;MYO1B;NAV2;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.6824746543035308,-1.049226628495736,0.4788732394366197,0.8780556879530519,1.0,3/5,29.91%,PIAS2;NCOR2;SMARCA4
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.6918885529320682,-1.049226005419339,0.49230769230769234,0.8772596265859139,1.0,3/5,26.72%,PLCG2;GPRC5B;CD74
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),-0.5870722943762205,-1.0490222263373343,0.48717948717948717,0.8769841075258751,1.0,4/15,9.72%,SLCO4A1;SLC4A10;SLC52A3;SLC4A7
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.655850655491971,1.048926309712525,0.41935483870967744,1.0,1.0,2/7,14.66%,ARHGAP12;SPRY3
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.5499032631067101,-1.048855627032531,0.4375,0.8766175641323327,1.0,4/27,16.49%,GAPDH;LRRFIP1;RIOK3;TBK1
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.618394378719186,-1.0487086237325085,0.4868421052631579,0.8762110434507167,1.0,5/12,28.18%,HIF1A;RAB21;PAFAH1B1;KIF1B;DYNC1H1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.6281439226375911,-1.047955965435446,0.4696969696969697,0.877815125684621,1.0,3/7,16.65%,PRKN;SREBF2;PINK1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.6714585758614373,-1.0475582221217512,0.4827586206896552,0.8780370427055806,1.0,4/6,16.65%,HIF1A;PRKN;RACK1;PINK1
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.5458158622217184,-1.0475019029619295,0.4266666666666667,0.8773871606886117,1.0,8/31,19.07%,DENND3;MYO9B;EPS8;DLC1;OGT;ARHGAP17;ERBIN;GRB2
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.47463684847819315,-1.0474017182393647,0.4479166666666667,0.8768903008714359,1.0,32/165,14.00%,PSMC6;ST18;CX3CL1;JUNB;PSMB9;FOS;RPS27A;CDKN1B;CANX;JAK1;PIK3R1;LAMA5;PSMA1;IFNGR1;ARF1;IFNGR2;HIF1A;BCL6;UBC;ANXA1;TMSB4X;SOD2;CFL1;S1PR1;LIMS1;PAK2;INPP5D;NFKBIA;TEC;CDKN1A;PELI1;MSN
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.5865337778093781,1.0473937921396181,0.4594594594594595,1.0,1.0,1/6,2.18%,GCH1
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.6610479936537811,1.0470002757435433,0.4864864864864865,1.0,1.0,1/5,2.18%,GCH1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),-0.4827940079738623,-1.0468748781391695,0.43333333333333335,0.8775271375499677,1.0,8/82,6.43%,DOK5;NRCAM;MAP1B;S100A6;SEMA6B;FEZ2;PIK3R1;LAMA5
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.6324046741823887,1.04677759505373,0.5111111111111111,1.0,1.0,1/5,8.71%,CARMIL1
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),-0.6907784709440601,-1.0466187873160762,0.4782608695652174,0.876667094554626,1.0,2/5,17.56%,PRNP;MTMR2
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),-0.6907784709440601,-1.0466187873160762,0.4782608695652174,0.876667094554626,1.0,2/5,17.56%,PRNP;MTMR2
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),-0.5986853137181634,-1.0455077650913698,0.4520547945205479,0.8791584367955562,1.0,1/13,3.80%,MAP1B
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.5983327387018552,-1.0454715431223196,0.4225352112676056,0.8784505780493651,1.0,9/12,36.33%,KLF4;PAK2;XIAP;CSNK2A1;MAP2K5;RPS6KA3;DDX3X;DNAJB6;YWHAE
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),-0.5938427699959763,-1.045409587491613,0.4025974025974026,0.8778648157365807,1.0,4/11,27.04%,GOLPH3;PREPL;ANK3;SPTBN1
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.593783795483777,-1.045257854476002,0.43243243243243246,0.8775718415063821,1.0,3/13,8.84%,RPS27A;PRKN;UBC
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.5669565727118975,-1.0450735414216246,0.42857142857142855,0.8774301560294901,1.0,6/20,17.56%,LGALS3;NDFIP1;PRKN;DYSF;RACK1;MTMR2
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.7090402007870562,-1.0448083226825526,0.5,0.8772686397994752,1.0,2/7,14.61%,NES;CACNA1C
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.539882887088895,1.0446911308646671,0.40540540540540543,1.0,1.0,1/10,0.82%,PSMD14
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.6551685237006186,-1.0446047793441282,0.43661971830985913,0.8771375110766098,1.0,2/9,13.33%,PRKN;FOXK1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.678893049472914,-1.044350899993926,0.45454545454545453,0.8770366885383948,1.0,3/7,12.43%,PRKN;HERPUD1;TMBIM6
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.6821286734022386,-1.043808561275956,0.46551724137931033,0.8776270906727848,1.0,1/6,3.98%,CCDC14
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.6019306876570352,1.0435039892176778,0.375,1.0,1.0,2/6,7.94%,HSPD1;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.4621311329968924,-1.0434401231748522,0.44086021505376344,0.8779762919090031,1.0,21/136,12.99%,PIK3R3;VSIR;RPL23;TAF1D;GAPDH;RIMS1;NFE2L2;PIK3R1;IFNGR1;HIF1A;ANK2;PRKN;KLF4;AFDN;LIMS1;RPS7;GJA1;PLCG2;RIMS2;CLDN5;NPM1
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5677520498328258,-1.0433506840151272,0.4492753623188406,0.8774051180094672,1.0,4/18,13.71%,NEDD9;RREB1;LIMS1;CASS4
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),-0.5312113067109022,-1.0429356857040608,0.43902439024390244,0.8778537801245136,1.0,11/24,29.93%,SEPTIN11;SPIRE1;MYH10;ANK3;CHMP4B;ECT2;RASA1;SNX9;SPTBN1;RHOB;RHOA
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.5456108484613472,-1.0423439341854033,0.4050632911392405,0.878571093621172,1.0,7/27,15.59%,JUN;NES;KDM1A;TMBIM6;NFKBIA;CDKN1A;RACK1
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.5255464976532819,-1.0423145583482574,0.4074074074074074,0.8778712931253173,1.0,4/39,5.47%,PRKAG2;RFC3;RPL23;RPL37
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),-0.6500145852350546,-1.0421999265257984,0.39705882352941174,0.8774118183434424,1.0,2/8,15.22%,RAD21;PPHLN1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.6160835068577066,-1.04216639446102,0.44285714285714284,0.8767142843456118,1.0,7/14,25.07%,DMD;PRKCE;ANK3;STK39;NEDD4;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.5584615327435948,-1.0414168124255039,0.45977011494252873,0.8781261639230029,1.0,7/29,15.59%,PSMC6;SMAD7;RNF19A;PRKN;ARIH2;TRIB2;RACK1
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.6530858880814735,-1.0413384136169077,0.45454545454545453,0.8775385217313225,1.0,4/8,25.66%,RIOK3;RPS28;RPS19;RPS14
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.5472104192315882,-1.0413305701624838,0.45569620253164556,0.8767930910368138,1.0,4/19,11.93%,KDM1A;EPAS1;OGT;GJA1
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.505453187893641,-1.0410532515763764,0.3723404255319149,0.876772983613595,1.0,17/52,22.26%,SEC22B;TSG101;SEC24D;ARF1;LAMP2;AP1G1;RAB2A;TMED10;RAB14;ARFGEF2;USO1;EGFR;CAV2;CD63;SCAMP1;ATP1A1;CLTA
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.503836874063935,1.0408366173093424,0.39285714285714285,1.0,1.0,4/18,7.07%,BMP6;SLCO1A2;HSD17B4;SLC23A2
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.39553737712234993,1.0404923285862444,0.35,1.0,1.0,10/42,14.21%,PSMD14;UIMC1;HERC2;INO80;ATM;RAD51B;SEM1;BABAM2;SPIDR;MCM9
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.625748254350069,-1.040436883381956,0.4647887323943662,0.8778825563364447,1.0,2/9,13.15%,NGLY1;UGGT2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.6584277319585314,-1.040271613820038,0.5142857142857142,0.8775744118964185,1.0,4/7,19.76%,RTN4;PRNP;PICALM;CLU
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.46984060434724767,1.0401038028219562,0.3548387096774194,1.0,1.0,3/14,9.08%,SLCO1A2;NCOA2;ABCG2
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),-0.614225611757821,-1.0399653630195531,0.45454545454545453,0.8776130201004045,1.0,3/9,18.83%,CDKN1A;DCP2;ACVRL1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),-0.6432574389843303,-1.0393214431130449,0.39705882352941174,0.8785014999689577,1.0,3/9,20.16%,ARF1;MTMR2;SLC30A1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.5129037322673904,-1.0392788440273844,0.4358974358974359,0.8778282736231949,1.0,3/42,6.48%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.5767321971239423,1.0389583947302647,0.5625,1.0,1.0,4/10,14.98%,COL8A1;RTF1;ITGA5;LAMA3
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),-0.6956109295468462,-1.038556379349079,0.47619047619047616,0.879277347277646,1.0,1/5,5.34%,NDFIP1
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),-0.6606802350176928,-1.0384224150005454,0.5230769230769231,0.8788806177539507,1.0,3/7,8.15%,DMD;SLC8A1;TPM1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.7219449379824948,-1.037852966694925,0.4745762711864407,0.879548207755889,1.0,3/5,26.37%,SREBF2;KPNB1;ABCG1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.594219881659189,-1.0376912999564485,0.391304347826087,0.8791420961014758,1.0,4/17,14.61%,BCAP31;SLC8A1;CD55;CACNA1C
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.5408903960646044,1.037618585743511,0.4,1.0,1.0,3/10,5.60%,PLPPR4;PLA2G4A;PLAAT3
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.5449305615799338,-1.0375520044728674,0.38235294117647056,0.8787563573315832,1.0,3/20,8.15%,CX3CL1;RAPGEF3;TPM1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.7166458293951051,-1.0369312524347962,0.5,0.8797464492753364,1.0,2/5,18.19%,DMD;ANK3
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.5367117320392041,-1.0365977608717734,0.4155844155844156,0.8798809966996507,1.0,5/25,8.98%,LAMC1;NR4A1;RTN4;HIF1A;RREB1
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,-0.5237992141951489,-1.0365425979451592,0.4470588235294118,0.8792602932799619,1.0,6/33,13.89%,SLC4A10;SCARB2;KIAA1217;SMARCA1;SHC2;BCAR1
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.6322637920255403,-1.0365118049178057,0.5068493150684932,0.8786112816050786,1.0,2/11,11.02%,NRCAM;FGFR1
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.6686178103066862,-1.0364162714884617,0.515625,0.8781983203027804,1.0,3/6,18.73%,PECAM1;MSN;ITGB1
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),-0.6678853187964084,-1.0362388462786232,0.47368421052631576,0.8779034354363343,1.0,2/8,17.66%,MYO1B;MYO1E
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.5469241220368873,-1.036208411758513,0.44871794871794873,0.8772475254145112,1.0,8/29,21.81%,SUN2;SPC25;RPS27;PAFAH1B1;KPNB1;MECP2;DYNC1I2;EML4
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.6058002143927507,-1.0358847737354677,0.4473684210526316,0.8773152028964897,1.0,3/9,17.56%,RIMS1;RIMS2;MTMR2
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.636193668688735,-1.0352884185950872,0.4647887323943662,0.8779777772081817,1.0,3/10,25.58%,DUSP1;CAV2;TOM1L2
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.5905503649429553,-1.034882124060207,0.4520547945205479,0.8784053012570797,1.0,8/15,24.91%,CDC37;ERBB4;PIK3R1;ERBIN;GRB2;EGFR;HSP90AA1;NRG2
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.5908018880542838,1.0343790727110844,0.375,1.0,1.0,3/6,17.50%,NNT;ATP6V1H;SLC25A27
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.6205111066167868,-1.0342130333453827,0.45588235294117646,0.8793773803280324,1.0,4/14,9.11%,RPS27A;PURA;UBC;ANXA1
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.5154424755230494,-1.033916173919161,0.4523809523809524,0.8793456894261734,1.0,3/25,6.48%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.565724570374948,-1.0339028088909665,0.5362318840579711,0.878643333251146,1.0,4/20,11.18%,ENPP2;PIK3R1;RREB1;ARPC2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.6783456014958082,-1.0336582086771868,0.5074626865671642,0.8786123315704457,1.0,2/6,7.81%,PRKAG2;SLC2A1
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.5733035233062431,-1.0335315702844319,0.4583333333333333,0.878280565862146,1.0,4/13,11.02%,KIAA1217;FOXF1;SULF2;FGFR1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.4265323674072719,1.033412185261391,0.36,1.0,1.0,3/29,4.49%,EVI5;TBC1D5;RALGAPA2
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.6694909850789504,-1.0333372935638658,0.5,0.8780366314377621,1.0,2/8,12.72%,JAK1;PAK2
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.5206359196697704,-1.033331241092781,0.3855421686746988,0.8772893903691514,1.0,6/34,4.44%,GRIK1;SYN3;NRG3;GRM7;KCNMB4;RIMS1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.6381230554943911,-1.0333150499117345,0.5072463768115942,0.8765821514103884,1.0,4/8,29.93%,KLF4;DLL4;MAP2K5;RHOA
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),-0.5953311268096587,-1.0330201948930418,0.5540540540540541,0.8765820681167721,1.0,2/10,3.29%,GRIK1;NRG3
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.4873527962181565,1.0327763646148191,0.38461538461538464,1.0,1.0,4/13,13.39%,UIMC1;ATM;BABAM2;STK33
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.7002659574468085,-1.032422666323602,0.5333333333333333,0.8775385302742702,1.0,5/5,30.09%,COMMD1;STK39;NEDD4L;CAMK2D;CAB39
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.4532408311943478,-1.0322749424225746,0.43434343434343436,0.8771804358889935,1.0,43/324,13.73%,LAMC1;B3GNT2;PSMC6;PPP2R3A;MAP3K5;UFL1;PRKAG2;ERO1A;PKN3;GRK5;PSMB9;SSH1;PPM1D;MACROD2;DUSP1;JAK1;MGAT4A;PSMA1;PRKCE;PTPRD;FEM1C;HIF1A;SHISA5;COMMD1;PLOD2;ANXA1;NGLY1;TGM2;SIK2;ZDHHC6;DUSP16;CDK14;EPAS1;FGFR1;MSRA;RAB2A;DCLK1;PAK2;DUSP5;TEC;RAB1A;TRIB2;CST3
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.6338836329554343,-1.031224463354207,0.5138888888888888,0.8790317726815796,1.0,2/10,8.34%,MTFR1;PRKN
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.5361694754144135,-1.031078413832882,0.5131578947368421,0.8785959141552828,1.0,4/23,11.93%,KDM1A;EPAS1;OGT;GJA1
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.6656319373805388,-1.0308492702428922,0.5076923076923077,0.8783244948564813,1.0,2/6,20.29%,CFL1;CAV2
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.5141178473073053,-1.0308101491485566,0.46511627906976744,0.8777264361019683,1.0,14/44,23.35%,CX3CL1;DUSP1;PEBP1;FLT1;FGFR1;PLCG2;PAK2;VRK2;DAG1;EGFR;CAV2;SPRED1;PHLPP1;JCAD
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.47803891028077267,-1.030802024118457,0.4065934065934066,0.8769852133096219,1.0,13/91,13.23%,LAMC1;SEC22B;CX3CL1;SEC24D;HES1;RIMS1;DMD;SPG7;SLC2A1;AFDN;WIPF1;TMED10;RAB1A
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),-0.6194018216869157,-1.030674928211654,0.4461538461538462,0.8764277386289998,1.0,3/7,15.17%,SDCBP;VEGFC;ANKS1A
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.6639072997428307,-1.0303780386165295,0.423728813559322,0.8759196794849701,1.0,2/5,9.93%,PRKN;TGM2
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.6639072997428307,-1.0303780386165295,0.423728813559322,0.8759196794849701,1.0,2/5,9.93%,PRKN;TGM2
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),-0.6031383542183307,-1.0302145513596777,0.4794520547945205,0.8755944518309842,1.0,4/11,12.72%,PIK3R1;DLC1;TMEFF2;PAK2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4304847928486356,1.0298235709174544,0.3793103448275862,1.0,1.0,3/25,7.22%,EVI5;TBC1D5;MYO10
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),-0.6471222098783337,-1.0289992264689924,0.4492753623188406,0.8781699558512565,1.0,1/8,5.74%,ANO2
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.527544028947654,-1.028621093388032,0.4457831325301205,0.8783789168972621,1.0,9/44,10.04%,PSMC6;ST18;CX3CL1;PSMB9;RPS27A;PSMA1;HIF1A;UBC;HYAL2
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.6602479904522445,-1.027956654603784,0.45,0.8793423885163848,1.0,1/7,4.57%,SMAD7
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.4872250999560107,-1.0279499297791486,0.4074074074074074,0.8786048308301763,1.0,9/52,10.15%,MAFF;LRRC32;FES;PECAM1;SCARF1;TNS1;VWF;PLXDC2;PRNP
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.5003946843286791,-1.0276283828594084,0.4318181818181818,0.8786698049187515,1.0,10/42,9.77%,SERPINE1;SYTL4;SRGN;CD9;ACTN1;TIMP3;LAMP2;PECAM1;VWF;TMSB4X
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.49142695114202817,-1.0270272976091888,0.4166666666666667,0.8794876139588959,1.0,14/52,22.36%,PPARG;FES;REL;CALCOCO2;ALPK1;PLCG2;CYLD;MALT1;TBK1;SERINC3;ADAM15;IFITM3;CAPZA2;B2M
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.5871121602570301,-1.0269792270682727,0.3950617283950617,0.8788660828403189,1.0,6/15,16.65%,BCAP31;HERPUD1;CYLD;RACK1;MCL1;PINK1
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.6009006165848308,-1.0269684438689335,0.5076923076923077,0.8781409413507829,1.0,8/15,27.20%,PPARG;LGALS3;DUSP5;LCP2;SELENOP;CPM;CD74;MARCHF1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.6432956242389777,1.0266381437432803,0.5641025641025641,1.0,1.0,1/5,11.00%,BCOR
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.6364498592005677,-1.0265350417804664,0.49230769230769234,0.8785958652354134,1.0,2/7,18.91%,SPG7;MICU2
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),-0.5680781261754217,-1.0262203023058973,0.3902439024390244,0.8785465875851576,1.0,3/20,6.51%,RFC3;POLA1;BAZ1A
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.6985266857238654,-1.0261459549076195,0.4,0.8779279510196617,1.0,3/5,15.46%,CD9;ANXA1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.5101469889951853,-1.0260318757391806,0.4457831325301205,0.8774336335825784,1.0,17/41,24.70%,RTN4;ENPP2;PRKCE;HIF1A;RREB1;PLCG2;BCAR1;MTOR;SCARB1;PIK3CB;ATOH8;SASH1;SPARC;ADAM9;ANXA3;CALR;RAB11A
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.5882800176984495,-1.0259940695530938,0.4864864864864865,0.8767885545647945,1.0,3/15,4.57%,UFL1;SPOPL;SMAD7
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.4999849145069249,-1.0259074310779008,0.46987951807228917,0.8762108294652745,1.0,21/50,23.05%,NDRG1;AKAP12;SEC24D;ACTN1;ELL2;ADAMTS1;NGLY1;SLC26A2;MYL12A;PLPP1;CDK6;SLC38A2;B4GALT1;TSC22D1;FKBP5;SPCS3;GNAI3;UBE2J1;SELENOP;B2M;STK39
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.6951161424026238,-1.0258326845739472,0.5238095238095238,0.8756246182195841,1.0,4/6,28.37%,KIF16B;INPP5F;ECE1;ANXA2
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.4930008509166743,1.0252935853518095,0.5,1.0,1.0,1/13,1.81%,UBE3D
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.5417183810931145,-1.0252812372522786,0.4861111111111111,0.8763341515540582,1.0,7/17,21.01%,MGAT4A;UGGT2;ALG11;B4GALT1;PMM2;TMEM165;UBE2J1
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.6177474750490497,-1.0236367448289245,0.5223880597014925,0.8799131188847097,1.0,2/11,15.38%,RAB1A;PAFAH1B1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.5504408376378518,-1.0230107818178746,0.48,0.8808631679376908,1.0,5/25,4.78%,NRCAM;RTN4;GRM7;MAP1B;S100A6
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.5425039177502847,-1.022174117386918,0.5333333333333333,0.8823112542976314,1.0,7/25,18.99%,PPARG;HIF1A;TMSB4X;FGFR1;GATA2;ACVRL1;MECP2
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.6595152634253877,-1.0212503688321237,0.5606060606060606,0.8842184491469974,1.0,1/5,8.34%,PRKN
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.5044999586785339,-1.0212345971614596,0.46153846153846156,0.8834967201139581,1.0,13/39,20.48%,PPARG;SMAD7;RPS27A;MAGI2;UBC;SNX6;SMAD3;STRAP;SNX25;SMAD5;PPM1A;CD109;SPRED1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.5077600760533071,-1.0211425886743655,0.44,0.8829642658048081,1.0,7/40,11.39%,LAMC1;HES1;RIMS1;SPG7;SLC2A1;WIPF1;TPR
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.6059218807142368,-1.020609563181388,0.4782608695652174,0.8837292778700656,1.0,4/12,9.99%,CX3CL1;SMAD7;JAK1;AFDN
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.43646541312218967,1.0204287142879438,0.4166666666666667,1.0,1.0,4/29,8.42%,IVNS1ABP;NOVA1;CDK12;WBP4
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.4822831604838037,-1.020002694576082,0.45348837209302323,0.8843897478012626,1.0,16/72,19.39%,SERPINE1;RTN4;GAPDH;KDM1A;RREB1;CFL1;EPAS1;OGT;GJA1;SDCBP;SMAD3;WWTR1;RIF1;MTOR;RPS19;LRPAP1
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.47167365519306687,-1.0199175240672889,0.4157303370786517,0.8838016026608487,1.0,16/64,16.41%,BTG2;BNIP3L;CLIC2;RNF19A;GMPS;ELL2;LAMP2;SLC2A1;TNS1;CDR2;RIOK3;SDCBP;NARF;LPIN2;AGPAT4;PICALM
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.45688273477078345,-1.0198537641493988,0.45918367346938777,0.8832706703989797,1.0,14/141,11.16%,TBX3;BHLHE40;PPARG;PHF10;HES1;JUN;KDM1A;CDKN1B;ARID5A;BCL6;KLF4;ZFPM2;SNX6;LIMS1
prerank,GO_Biological_Process_2021__eye development (GO:0001654),-0.5963161706665657,-1.0196538398191928,0.5074626865671642,0.883002819500692,1.0,2/13,14.61%,PBX3;CACNA1C
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.5143354477232002,-1.0187430730629417,0.45121951219512196,0.884597330866987,1.0,3/25,6.48%,PSMC6;PSMB9;PSMA1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.6255431729845239,-1.0185874431217297,0.5205479452054794,0.8843194733542897,1.0,1/8,5.26%,POLA1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.5745001355286335,-1.018471527514876,0.49295774647887325,0.8839299880883394,1.0,1/15,3.80%,MAP1B
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.6791436207966849,-1.0182542102006358,0.5538461538461539,0.8838211412991367,1.0,4/6,31.42%,SYT1;REST;STXBP3;STXBP1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.5141908031839618,-1.0178465925750178,0.5,0.8840108849105556,1.0,4/29,14.53%,PRKN;ARIH2;PELI1;AMFR
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.587988182756926,-1.0176241526304408,0.4852941176470588,0.883902151551499,1.0,3/12,15.46%,SPOCK1;ANXA1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.5303686078000224,-1.0174318699061011,0.5232558139534884,0.8835701619060631,1.0,9/29,15.59%,BCAP31;SMAD7;NFE2L2;RNF19A;PRKN;ARIH2;HERPUD1;TRIB2;RACK1
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.5561073740369368,-1.0174109460742748,0.4166666666666667,0.8828759382351113,1.0,3/11,13.07%,JUN;KDM1A;NFKBIA
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.7124098577433986,-1.0172082277962566,0.5873015873015873,0.8825825244044014,1.0,3/6,9.19%,PKM;JAK1;KLF4
prerank,PanglaoDB_Augmented_2021__Basophils,0.4714378372948518,1.0171921559251946,0.4230769230769231,1.0,1.0,3/18,3.82%,JAZF1;SLC26A3;H2AC6
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.5449999114037427,-1.0170746845568897,0.44,0.8821781543137514,1.0,4/15,16.47%,GPM6B;COMMD1;PICALM;CTNNA1
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),-0.671245157317953,-1.0170381246714626,0.5223880597014925,0.8815517536168282,1.0,1/8,3.35%,SLC4A10
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),-0.6375602630895199,-1.0166932869583931,0.5466666666666666,0.8816773736634441,1.0,4/10,18.14%,RIMS1;RIMS2;SYT1;PREPL
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.6165404675242148,1.0158726886660157,0.5161290322580645,1.0,1.0,1/6,6.08%,SMYD3
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.5458197527522805,-1.0156985685147735,0.4935064935064935,0.8835165899606672,1.0,8/19,23.32%,PRKN;SOD2;SNX6;CPEB4;PINK1;CD34;CHMP4B;RASA1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.6870463266441993,-1.0154334578349604,0.47619047619047616,0.8834460049782324,1.0,3/5,21.30%,SLC8A1;TGM2;RYR3
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.6248026757907243,1.0150106463144521,0.5151515151515151,1.0,1.0,2/6,14.69%,MVB12B;RBPJ
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.6964486557367114,-1.0144992357731752,0.5245901639344263,0.8851235126949258,1.0,3/5,23.77%,GJA1;AGO2;CALR
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.5237785495635128,1.0144314901322529,0.4375,1.0,1.0,2/10,2.82%,RSAD2;IL1R1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.5970275772644691,-1.0140649308262397,0.48717948717948717,0.885550733474893,1.0,1/14,0.50%,B3GNT2
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.5754292451526584,-1.0137590841078346,0.45714285714285713,0.8853770841548189,1.0,4/11,14.50%,LGALS3;PNP;ANXA1;NCK1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.5050249775344192,-1.0135882525166948,0.4772727272727273,0.8850561076007997,1.0,14/46,22.12%,SSH1;FES;RAPGEF3;RAP1A;TGM2;GOLPH3;RIOK3;MSN;CTNNA1;TFPI;EGFR;RYR3;ADCY2;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.5750083225024799,-1.0135821434535293,0.4342105263157895,0.8843484930610929,1.0,3/14,8.34%,SSH1;HIP1R;PRKN
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.5319901321477284,1.0133454318534105,0.4,1.0,1.0,2/9,8.79%,DTWD1;CDKAL1
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.5193495029299958,-1.0131496798330741,0.4567901234567901,0.8847012631867334,1.0,7/34,11.66%,TSG101;PRKAG2;ATG12;RB1CC1;LAMP2;PRKN;GABARAPL1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.6337073200156078,-1.0130970797020173,0.45454545454545453,0.8841699573436899,1.0,2/7,14.82%,RPL10;RPL24
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.5346372953273912,-1.0129376846287668,0.48148148148148145,0.8839061927243038,1.0,7/21,14.71%,TSG101;DUSP1;FLT1;HYAL2;FGFR1;TRIB2;STK38
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.5547934679892126,-1.0126420748962863,0.5185185185185185,0.8839368772205427,1.0,6/23,19.42%,TSG101;HIP1R;ZFYVE28;SH3KBP1;GRB2;EGFR
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.5800252977944469,-1.0125393631353434,0.5,0.8835268452316931,1.0,3/16,8.84%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.6219983736162991,-1.0125132484632668,0.49206349206349204,0.8828881563185587,1.0,1/8,7.60%,ANK2
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.4133085641444179,1.0122696911267646,0.35294117647058826,1.0,1.0,8/21,16.71%,PRKG1;ZNF521;PODN;LDB2;TEK;CNRIP1;FAT4;IGFBP7
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.6555886691601567,-1.0121216416322862,0.48214285714285715,0.8832037288492499,1.0,1/6,7.22%,RAPGEF3
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.5108287337021035,1.0119327079154665,0.41935483870967744,1.0,1.0,1/11,0.77%,ZNRF3
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.6282081666720832,-1.01123944235907,0.48484848484848486,0.8846818660252318,1.0,1/7,6.27%,PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),-0.6343100918117339,-1.010767976244897,0.5352112676056338,0.8850961210116004,1.0,6/8,30.09%,PRKCE;STK39;NEDD4;NEDD4L;CAMK2D;CAB39
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.7066039157017118,-1.0105701606497663,0.5147058823529411,0.8849245371140684,1.0,2/5,18.94%,PRNP;MT1M
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),-0.4961402816649565,-1.0102696972129113,0.5,0.8849359475293629,1.0,2/36,8.29%,UFL1;SIN3B
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.5694102613564034,1.0095987640019863,0.5151515151515151,1.0,1.0,1/5,1.83%,PIGU
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.4980943578608423,-1.009427987261642,0.4875,0.8861796658884393,1.0,15/47,20.35%,RTN4;CX3CL1;ERBB4;PIK3R1;MAGI2;HYAL2;FGFR1;CASS4;RACK1;PINK1;DAG1;ITGB1;GRB2;EGFR;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.48356296191231235,-1.0092983947678544,0.4945054945054945,0.8858069597393943,1.0,14/54,16.65%,CX3CL1;GAPDH;NDFIP1;REL;SHISA5;PRKN;ALPK1;GJA1;SLC20A1;PELI1;TNFRSF10B;MALT1;TBK1;PINK1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.6703468024378509,-1.0087678007103646,0.5147058823529411,0.8861366005365595,1.0,2/6,6.96%,SMAD7;MAGI2
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.36910963103617583,1.0087246981647642,0.4166666666666667,1.0,1.0,3/32,6.69%,RSAD2;IL15;HERC5
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.3882476605965648,1.0077261334828713,0.42857142857142855,1.0,1.0,4/28,7.89%,GBP2;TAF3;IPO8;TNPO3
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.6046759299490619,-1.0069377172131884,0.4583333333333333,0.8903540340711338,1.0,4/8,31.74%,MYO1B;EMP2;DSP;RND3
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.6458493209600975,-1.006735956428948,0.5423728813559322,0.8902427178118765,1.0,3/8,17.56%,RAB21;MSN;MTMR2
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.6562355392428689,1.0065924325512523,0.5,1.0,1.0,2/7,10.20%,EIF2AK2;KLHDC10
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.44529772204288137,1.0060887173833275,0.38461538461538464,1.0,1.0,5/24,13.92%,UIMC1;OTUD4;ERCC6;BABAM2;TOX
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.44683581602638267,-1.0059397185977306,0.5425531914893617,0.8916316655393642,1.0,12/108,9.80%,PSMC6;PSMB9;NPLOC4;HSPA5;SPOPL;RPS27A;NFE2L2;PSMA1;FEM1C;PRKN;UBC;HERPUD1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.5911474068696221,-1.0058401350820794,0.44285714285714284,0.8910925452252512,1.0,7/12,35.86%,OGT;SDCBP;TLK2;USP7;EIF3H;RPL11;FHIT
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),-0.464235104164952,-1.0057786271721307,0.4659090909090909,0.8905361424046195,1.0,7/69,8.34%,PSMC6;PSMB9;SPOPL;NFE2L2;PSMA1;FEM1C;PRKN
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.6082002383173115,-1.0052842798461417,0.4852941176470588,0.8911233826660101,1.0,3/9,19.97%,PTPRD;IL1RAPL1;HMCN1
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.5284386587552747,-1.0049180174084493,0.45,0.8913109437968504,1.0,9/24,19.76%,BNIP3L;PRKN;NPAS2;NCK1;PINK1;CD34;CHMP4B;LRPAP1;CLU
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),-0.6175549507486018,-1.0048139446256719,0.5,0.8908281483450206,1.0,2/8,9.19%,KLF2;KLF4
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.5603953305447454,-1.004406279475145,0.5,0.8911604051132561,1.0,3/15,11.02%,MAP3K5;FLT1;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3900124378966533,1.0043999623211262,0.45454545454545453,1.0,1.0,6/42,3.35%,ANKRD6;ZNRF3;PSMD14;MLLT3;TLE4;NKD1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.33748456695706264,1.0043142070362001,0.45454545454545453,1.0,1.0,3/46,2.31%,STX8;EVI5;TBC1D5
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.48808298719569926,-1.0034948265747115,0.4418604651162791,0.8927848785515491,1.0,12/48,13.31%,MAP2;MAP1B;NFASC;GRIA2;CNTN1;ANK2;LSAMP;PPFIA2;DCLK1;ATRNL1;ADGRL3;LRRC4C
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.5208352093922921,-1.003422164243241,0.4605263157894737,0.8922659307558322,1.0,8/23,23.35%,NR4A1;HIF1A;FGFR1;VEGFC;EGFL7;GATA2;PPP1R16B;JCAD
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.6175504229719624,-1.0032925410419855,0.5373134328358209,0.8918832020551577,1.0,3/9,8.15%,DMD;SLC8A1;TPM1
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.44955501397621583,-1.0026189597164148,0.5204081632653061,0.8928899293754778,1.0,20/168,13.33%,TBX3;BHLHE40;BTG2;PPARG;PHF10;HES1;JUN;GAPDH;KDM1A;CDKN1B;ARID5A;BCL6;KLF4;ZFPM2;SNX6;LIMS1;RPL13A;CBX5;CDKN1A;FOXK1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.579155204816345,-1.0018950178535115,0.547945205479452,0.8942554908732823,1.0,2/9,9.93%,PRKN;TGM2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.6468991303734664,-1.001859331241491,0.4868421052631579,0.8936289799979759,1.0,2/7,21.12%,SRRM1;TRA2B
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.6223533966927467,-1.0007021496239896,0.46153846153846156,0.8961973331164034,1.0,1/7,7.22%,RAPGEF3
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.637410574606411,-1.0005842721859453,0.5614035087719298,0.8957860214282052,1.0,4/6,29.51%,PLPP1;ACER2;ACER3;SPTLC2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.5031784593174953,-1.0000524950849337,0.4657534246575342,0.896345467328398,1.0,5/31,9.69%,EPS8;GPM6B;RAPGEF3;HIP1R;DLC1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.5491822525830105,-0.9997262491561112,0.52,0.8965001340552609,1.0,5/16,14.50%,VAV3;PNP;CD81;ANXA1;NCK1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.4981029535857752,-0.9996616741980804,0.4823529411764706,0.8959371082989793,1.0,12/40,15.86%,MAP2;MAP1B;GRIA2;GPM6B;ANK2;INSYN2A;PPFIA2;DCLK1;ATRNL1;ADGRL3;SYT1;CADM2
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),-0.5893883738834337,-0.9994919091012257,0.5151515151515151,0.8955721207182895,1.0,5/9,21.91%,ATP2B1;ANK2;ANK3;DLG1;AHCYL1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.6003392374816168,-0.9987030216562189,0.5342465753424658,0.8970074242426408,1.0,9/12,30.09%,ANK2;ATP1B3;DLG1;ITGB1;STK39;NEDD4;NEDD4L;ATP1B1;CAB39
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),-0.6145364212769994,-0.9984115711708392,0.5909090909090909,0.8969016185272705,1.0,6/9,36.47%,RAB14;SPAAR;DUSP6;DHX36;TRIP12;MYSM1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.6644663151136203,-0.9981650803567079,0.5294117647058824,0.8968317392867029,1.0,2/6,10.15%,RTN4;PRNP
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.5148371082147448,-0.9978866620196305,0.5294117647058824,0.8967887684197666,1.0,12/42,22.60%,NES;KDM1A;HIP1R;PRKN;TMBIM6;CLDN5;CDKN1A;AMFR;RACK1;LRPAP1;B2M;MAPK8
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.66973645830619,0.9977886712214392,0.5806451612903226,1.0,1.0,2/5,3.61%,PGM5;TTN
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),-0.6638848434921993,-0.9976840761745278,0.5357142857142857,0.896558433861729,1.0,2/5,4.57%,NFKBIZ;SMAD7
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.6030571142046353,-0.9967380899838837,0.53125,0.8979605042064672,1.0,5/12,14.53%,RPS27A;EDEM3;UBC;UGGT2;AMFR
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.4742669607897413,0.9966687922846061,0.46875,1.0,1.0,4/16,2.18%,GBP2;GBP4;GBP1;GCH1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5677755698348639,-0.9965312999113703,0.5135135135135135,0.8977830728081629,1.0,2/8,10.09%,ERBB4;ZFPM2
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.5940124859001269,-0.9965103060449781,0.5,0.8971161963314888,1.0,3/11,16.65%,PRKN;CYLD;PINK1
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.5757392426251753,0.9964710253111922,0.4857142857142857,1.0,1.0,2/7,3.13%,MMRN1;SLC26A3
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),-0.48622039782299975,-0.9959800567081414,0.47126436781609193,0.8976514795163973,1.0,10/47,18.43%,SPOCK1;NRG3;CHPT1;HIP1R;RAP1A;BCAR1;PICALM;PINK1;RUFY2;MTOR
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.6013552983202699,-0.995708405031322,0.5507246376811594,0.897492493768871,1.0,1/12,0.90%,UFL1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.5971076460932137,0.9957076061099961,0.5365853658536586,1.0,1.0,1/7,2.63%,ATR
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.6216188491085477,-0.9955782826183409,0.48484848484848486,0.8971028014469723,1.0,2/5,22.76%,AP1G1;ZBTB1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.5979400007160744,-0.9950088268479557,0.4838709677419355,0.8976279507878688,1.0,3/9,10.84%,HES1;ERBB4;CRLF3
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.5482189577860068,-0.9946914973937186,0.4936708860759494,0.8975846567372714,1.0,5/19,14.58%,PIK3R1;RAPGEF3;HYAL2;TPR;SMAD3
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.6327490014913649,-0.9945561882790542,0.5,0.89646223862659,1.0,1/9,4.17%,EPS8
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.6327490014913649,-0.9945561882790542,0.5,0.89646223862659,1.0,1/9,4.17%,EPS8
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.4787695153873891,-0.9941085618375763,0.5,0.8968800620330517,1.0,12/44,18.43%,ATF3;PRKN;NPAS2;TPR;NPM1;AMFR;MCL1;SLC38A2;PINK1;HSPH1;NUP54;MTOR
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.5436872733637969,-0.9935130146715023,0.45454545454545453,0.8976773937028476,1.0,5/19,15.27%,PRKAG2;CDKN1B;PAK2;TRIB2;WWTR1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),-0.5393262083337951,-0.9931572233187699,0.5063291139240507,0.8977755767724729,1.0,5/19,13.78%,SYTL4;CAVIN2;ANK2;DYSF;PLSCR4
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.5808367861963398,-0.9926683001903481,0.5,0.8983767544762367,1.0,4/14,18.41%,KLF4;CDKN1A;CDK6;DLG1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.477431590375779,-0.9924425627049364,0.4878048780487805,0.8982713688335846,1.0,6/44,14.02%,NEDD9;TPM1;CFL1;FGD4;BRWD3;SH3KBP1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.5194564986005761,-0.9923830659289177,0.5303030303030303,0.8976990421739004,1.0,11/17,34.93%,GAS7;PRKN;SPIRE1;CHMP4B;PREX1;FAM107A;RAC1;MICALL2;UBE2K;GSN;HDGFL3
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),-0.6079953396379583,-0.9912195511238092,0.5454545454545454,0.8998223770809386,1.0,3/11,10.09%,HES1;SMAD7;ZFPM2
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.4862026453116768,-0.9907598508580704,0.46153846153846156,0.9001824817298483,1.0,6/39,12.88%,NRCAM;GPM6A;LIMS1;CTNND2;ADGRL3;CLDN5
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.48531326775556555,0.9901708590224025,0.5357142857142857,1.0,1.0,4/17,7.84%,ATR;RHBDD1;INO80;TAF1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.5016344768930444,-0.9899406207194845,0.45121951219512196,0.9013597382040056,1.0,7/32,18.70%,B3GNT2;MGAT4A;PLOD2;OGT;ALG11;B4GALT1;PMM2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.5787235853991353,-0.9898466856962704,0.5441176470588235,0.9008307156072719,1.0,4/16,16.47%,GLUL;TPR;WWTR1;CTNNA1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.493644640532738,-0.9897746265692302,0.524390243902439,0.9002586251089353,1.0,15/34,27.57%,ADAMTS9;GLUL;BCAR1;SCARB1;ACVRL1;EMP2;PIK3CB;ATOH8;SASH1;SPARC;ANXA3;CALR;DLL4;RHOB;RHOJ
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.6257582315868523,0.989253118292541,0.5428571428571428,1.0,1.0,1/5,2.18%,GCH1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.5328697204777102,-0.9889715880956095,0.5384615384615384,0.9015734178491223,1.0,3/19,11.53%,B3GNT2;CHST11;GOLPH3
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.5612273228060044,0.9885949580095604,0.4722222222222222,1.0,1.0,3/10,17.88%,TNRC6C;HELZ;TNRC6A
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.4744721982190194,-0.9885634542126889,0.5104166666666666,0.9018343349205337,1.0,11/68,14.85%,BTG2;RFC3;RAD21;RPS27A;POLA1;PURA;UBC;NOC3L;NPM1;CNBP;USP45
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.5441406715612598,-0.9879910732221908,0.4675324675324675,0.9025502806295208,1.0,1/16,3.75%,TAF1D
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.6787747537313864,-0.9879583104594191,0.6190476190476191,0.9019611300169106,1.0,2/5,10.04%,GPC5;HYAL2
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),-0.6536397249895166,-0.9866423814956218,0.5714285714285714,0.9038962844697215,1.0,1/5,5.87%,JAK1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),-0.6536397249895166,-0.9866423814956218,0.5714285714285714,0.9038962844697215,1.0,1/5,5.87%,JAK1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.578364904984698,-0.9866028005713363,0.45454545454545453,0.9032725367169412,1.0,4/11,16.65%,NFE2L2;PRKN;SOD2;PINK1
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.6443938701203049,-0.9865875207489722,0.5633802816901409,0.9025974112812505,1.0,1/7,11.39%,TPR
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.5750094107076271,-0.9865192781144497,0.5806451612903226,0.9020889678440112,1.0,2/12,3.19%,GLUD1;GLUL
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),-0.5448817714383648,-0.9862357285179392,0.524390243902439,0.9020168550109025,1.0,8/20,15.70%,SYTL4;ANXA1;IL1RAPL1;RAB21;STXBP5L;RIMS2;SYT1;RAB8B
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),-0.5810327367123503,-0.9859738798854384,0.5714285714285714,0.9019970784882203,1.0,3/9,18.67%,LPGAT1;MTOR;SCARB1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.47898483643990086,-0.9858454296233828,0.5301204819277109,0.9016468328190832,1.0,13/38,29.93%,ENPP2;FES;ERBB4;TMSB4X;CDK6;EGFR;PLXNA2;NRG2;INPP5F;RHOB;CRK;RAC1;RHOA
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.5190815404318819,-0.9856378125777284,0.4939759036144578,0.9014274884408005,1.0,4/27,6.19%,CD9;FES;ACTN1;ERBB4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.5479645122956481,0.98510680496398,0.4444444444444444,1.0,1.0,2/7,2.15%,GBP1;HOMER2
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.6167096019191234,-0.9847442913094033,0.5507246376811594,0.9029365830630766,1.0,1/8,7.73%,HIP1R
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.5419292441385484,-0.9846280051499027,0.5128205128205128,0.90247361950853,1.0,4/17,14.10%,GRIN2B;RIMS1;RIMS2;SYT1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.4800324042815676,-0.9842531961718527,0.5333333333333333,0.9026703298024703,1.0,15/51,24.67%,NEDD9;PRKAG2;RAP1A;PRNP;PAK2;CDKN1A;CASS4;LCP2;EMP2;CLU;ECT2;GPRC5B;CCDC88A;SNX9;HSP90AA1
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.559981384982012,0.9841978321375401,0.5,1.0,1.0,1/5,11.74%,ST3GAL1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.45801843800411146,0.9838702886214307,0.4782608695652174,1.0,1.0,4/19,2.82%,GBP2;GBP1;RC3H1;IL1R1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.6252580656155196,-0.9832224688400555,0.5573770491803278,0.9044088991006887,1.0,1/7,4.73%,RAD21
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.4775268898406271,0.9831509684127027,0.3793103448275862,1.0,1.0,4/18,8.10%,HABP4;RBM20;HSPA1A;HNRNPLL
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.5123352263146882,-0.983106799531806,0.5072463768115942,0.9040237857012018,1.0,8/17,31.55%,S1PR1;GOLPH3;PARVB;ITGB1;CCDC88A;VCL;RAC1;SNX1
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),-0.5993257204312534,-0.9830122887585556,0.5483870967741935,0.9036392652399745,1.0,4/9,19.39%,SDCBP;PICALM;MTMR2;LRPAP1
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.537869472967849,-0.9826657339216186,0.5068493150684932,0.9037998982613735,1.0,4/23,16.60%,RFTN1;TPR;ZFP36;SRRM1
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.48423245413400734,-0.9824847704421393,0.49411764705882355,0.9035025129629849,1.0,10/48,19.60%,PRKAG2;CDKN1B;HIF1A;TPR;OGT;CDKN1A;SDCBP;NUP54;EGFR;EMP2
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.5592779501453904,-0.9824757499123266,0.5362318840579711,0.9028172091833276,1.0,4/13,20.03%,GLUL;ZDHHC6;ZDHHC21;ZDHHC14
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5624654757706876,0.9821029121639855,0.45161290322580644,1.0,1.0,4/7,14.02%,CIRBP;TRA2A;RBMX;NCL
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.5781671794590302,-0.9820359625227436,0.5606060606060606,0.9032713171700845,1.0,2/7,10.09%,ERBB4;ZFPM2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.6485434501186264,-0.981767963093487,0.5535714285714286,0.9032163064949784,1.0,1/5,7.49%,HIF1A
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.5137618851521654,0.9817308222479004,0.4594594594594595,1.0,1.0,4/12,10.49%,PARD3;CLASP1;OPHN1;CYTH3
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.5745348227345782,0.9806273703659353,0.4642857142857143,1.0,1.0,2/7,12.80%,HSD17B4;FAR2
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.4710602512916164,-0.9802144239965522,0.5909090909090909,0.9061665220088987,1.0,26/55,22.92%,SERPINE1;SYTL4;SRGN;CD9;RIMS1;ACTN1;TIMP3;LAMP2;PECAM1;VWF;TMSB4X;RIMS2;TMED10;SYT1;VEGFC;PIP5K1C;PSAP;ARHGAP17;CLU;CD109;PCDH7;SELENOP;SPARC;CD63;DNAJC5;ANXA5
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.5015991872155421,-0.9799445220134207,0.4883720930232558,0.9060921704707094,1.0,11/33,21.83%,PBX3;TIMP3;EMP1;GJA1;CREB3L2;CALD1;BOC;HMCN1;GADD45B;SPARC;GLI3
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.6014970758803834,-0.9797733840456461,0.47058823529411764,0.9058803719803329,1.0,1/9,1.54%,PCK1
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.5256252265338658,-0.9797339263992844,0.5844155844155844,0.9052307577504132,1.0,7/26,19.31%,RPS27A;PRKN;UBC;NGLY1;CHFR;MALT1;CHMP4B
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),-0.5532919693264001,-0.9795162369763426,0.5142857142857142,0.9050027721141257,1.0,8/17,27.30%,MYH10;ANK3;CHMP4B;ECT2;RASA1;SNX9;SPTBN1;RHOB
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.5078581330231897,-0.9789451259593003,0.45714285714285713,0.9056500758975933,1.0,7/25,18.57%,RPL23;IPO7;TPR;PTTG1IP;KPNB1;NUP54;KPNA4
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.5377243519892214,-0.9785961025888719,0.5277777777777778,0.9058592552021361,1.0,3/16,15.38%,ARHGAP21;RAB1A;PAFAH1B1
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.596709750115266,-0.9785292323729295,0.578125,0.9052972854022383,1.0,4/11,19.18%,VSIR;PLCG2;TRIB2;CD34
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.6339882963524532,-0.9785233179700704,0.532258064516129,0.9046334725234456,1.0,3/7,25.98%,HYAL2;SOCS3;INPP5F
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.6093495280633165,-0.9782673009428907,0.5428571428571428,0.9045692921067479,1.0,2/7,26.43%,NOTCH4;DLL4
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.6358287436164661,-0.9780956998885848,0.59375,0.9042830330381548,1.0,1/6,1.04%,ITPR1
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.6276171585682268,-0.9778617579698936,0.5806451612903226,0.9040655189945843,1.0,1/6,12.01%,CSTF3
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.4653220403281343,-0.977626650132035,0.4878048780487805,0.9039165933814464,1.0,10/53,15.51%,PPP2R3A;SSH1;PPM1D;ALPL;DUSP1;PTPRD;DUSP16;DUSP5;PLPP1;PPP3CC
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.6234530929892844,-0.9776006668113939,0.5373134328358209,0.9032648721174213,1.0,4/7,32.03%,RIOK3;RPS19;UBE2K;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.44121677813992566,-0.9772765163719028,0.5520833333333334,0.9034234750900836,1.0,38/199,16.33%,TBX3;BHLHE40;MAFK;ATF3;ZEB2;RPL23;PPARG;HES1;JUN;LRRFIP1;KDM1A;SMAD7;ESR2;RPS27A;ARID5A;KLF2;BCL6;SIN3B;PRKN;PURA;UBC;RREB1;RPL10;KLF4;ZFPM2;CREM;TPR;MEF2A;ZFP36;CBX5;CNBP;SDCBP;SMAD3;MAX;SREBF2;KLF12;THRB;MBD2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),-0.6072139909799353,-0.9770827113288456,0.515625,0.9034115803029527,1.0,5/9,24.44%,ANK2;GJA1;CACNA1C;ATP1A1;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.48490733782173706,-0.9765921219591438,0.5176470588235295,0.9037739863719412,1.0,14/50,19.76%,ZEB2;KLF2;HIF1A;STARD4;KLF4;LPGAT1;NPM1;ARPP19;SMAD3;NOS1AP;MTOR;SCARB1;EGFR;CLU
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.5147575181741665,-0.976464669559289,0.5308641975308642,0.903345344744937,1.0,9/31,21.67%,PSMC6;PSMB9;PSMA1;KLF4;CDKN1A;CDK6;DLG1;PSMA7;CUL1
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.6277078350734165,-0.9758140005425833,0.5428571428571428,0.9040300086473988,1.0,3/9,8.84%,RFC3;RPS27A;UBC
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),-0.44641549031922884,-0.9757195979639909,0.5617977528089888,0.9035169496053552,1.0,16/66,23.64%,DOK5;SEMA6B;FEZ2;PIK3R1;LAMA5;EFNB2;SH3KBP1;ROBO2;DAG1;GRB2;PIK3CB;UNC5C;NRXN3;BSG;NFIB;PLXNA2
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.4972254778342124,-0.9757012088438054,0.47619047619047616,0.9028859345121393,1.0,8/49,10.70%,NFKBIZ;SCARB2;YBX3;ARF1;HIF1A;SLC8A1;AFF4;KIF16B
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.4938374898785058,0.9754752109374207,0.47058823529411764,1.0,1.0,1/10,1.25%,SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.6253387930480007,0.9749610179011896,0.5476190476190477,1.0,1.0,1/5,4.22%,MFF
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.5290999323442409,-0.9747640052745178,0.4868421052631579,0.904171074915212,1.0,4/17,12.46%,LAMC1;ACTN1;DLC1;PLEC
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.6435310827683381,-0.9735826878696109,0.6065573770491803,0.9061063118454684,1.0,1/6,7.49%,HIF1A
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.6090761866534653,0.9732513999897827,0.5675675675675675,1.0,1.0,1/5,8.07%,WWC3
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.5022205336717093,-0.9732209877030954,0.49382716049382713,0.9064055473444503,1.0,12/38,20.05%,BHLHE40;DTNA;DMD;PRNP;ITGB5;MEF2A;CDKN1A;NAV2;WWTR1;ITGB1;CLU;GADD45B
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.484144475767152,-0.9727662849737752,0.49333333333333335,0.9069664444508991,1.0,13/38,21.75%,ZEB2;SMAD7;RPS27A;UBC;SNX6;SDCBP;SMAD3;STRAP;SNX25;PPM1A;CD109;SPRED1;RNF111
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.3089582199953135,0.9726640008215441,0.625,1.0,1.0,11/109,5.63%,PGM5;PACS2;EXOC5;RC3H1;ATP2A2;INO80;OFD1;STARD9;WDPCP;RFX3;UBQLN1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),-0.5929165718928895,-0.9715943432295245,0.5921052631578947,0.9091233337868688,1.0,5/9,29.93%,DUSP1;STK39;LRCH1;FOXC1;RHOA
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.5189166019552504,0.9712428998283198,0.4857142857142857,1.0,1.0,4/10,20.24%,TENT2;CIRBP;PARN;LARP1
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.4653377618064754,-0.9711674686483435,0.5789473684210527,0.9094702832021965,1.0,13/63,15.56%,DOK5;MGLL;CX3CL1;GRK5;GIT2;CD55;SIK2;PRNP;OGT;NCK1;AMFR;WWTR1;SREBF2
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.507310529513028,-0.97061650126826,0.48,0.9100191799940609,1.0,4/23,11.50%,PRKAG2;HIF1A;TPR;OGT
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.6058266748084572,-0.9705329886826864,0.6,0.9094966621134445,1.0,2/9,8.84%,RPS27A;UBC
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.4257334778935456,-0.9704959873222697,0.59,0.9089243864252319,1.0,83/490,16.92%,MAFF;TBX3;ST18;MAP3K5;BHLHE40;MAFK;NR4A1;ATF3;KLF6;ZEB2;ZNF43;PPARG;PHF10;HES1;PBX3;JUN;JUNB;FOS;LRRFIP1;KDM1A;SMAD7;RAD21;ESR2;ELP3;POLA1;NFE2L2;CDKN1B;JUND;NPAS3;ARID5A;ERBB4;BAZ1A;FOXF1;KLF2;SMARCA1;HIF1A;REL;BCL6;FOSL2;NPAS2;PURA;RREB1;KLF4;CCNH;SOD2;ZFPM2;CREM;CDK14;SBNO1;CRLF3;EPAS1;SNX6;LIMS1;OGT;ELP4;MEF2A;ZNF586;PIAS2;ZNF280D;CBX5;NPM1;BRWD3;CDKN1A;FOXK1;ZNF160;CCNL1;CNBP;SMAD3;MAX;NAA16;BTG1;CREB3L2;WWTR1;SREBF2;CHD1;KLF12;RCOR1;MBD2;SMARCC1;PICALM;NSD2;NOTCH4;ZBTB38
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.46873953195499607,-0.9701643620591185,0.5294117647058824,0.9089421736439949,1.0,11/37,13.71%,NEDD9;ENPP2;HES1;ERBB4;PECAM1;CD81;PRNP;PLCG2;PAK2;TEC;CASS4
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.5206359514868338,-0.9700808044463408,0.5342465753424658,0.9084216352244504,1.0,3/27,6.48%,PSMC6;PSMB9;PSMA1
prerank,PanglaoDB_Augmented_2021__Neurons,-0.4556260424244929,-0.9688416023790536,0.5434782608695652,0.91030559998043,1.0,13/61,22.18%,PPP1R9A;GRIA2;RB1CC1;NCALD;PPFIA2;RNPC3;SGIP1;CADM2;MECP2;CSPP1;SCN2A;SCAMP1;NOL4
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.5699902167498618,-0.9688119849260937,0.547945205479452,0.9096924387956857,1.0,2/12,12.22%,YBX3;ZFP36
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.623188631506722,-0.9683944029612298,0.5,0.9100201061467642,1.0,2/6,18.88%,ARID5A;ZNF366
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.49014849345997386,-0.9680850864698171,0.5066666666666667,0.9099699227755211,1.0,4/23,20.13%,HES1;JAG2;NOTCH4;MIB1
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.5890972219518298,-0.9680798205541586,0.5866666666666667,0.9092913471433245,1.0,3/11,11.66%,TSG101;LAMP2;GABARAPL1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5787709991660694,-0.96788093739704,0.5857142857142857,0.9090575686193737,1.0,2/6,10.09%,ERBB4;ZFPM2
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.5175040531063155,-0.9677002665203883,0.5416666666666666,0.9086818978360136,1.0,7/20,20.35%,CX3CL1;SPOCK1;LIMS1;RSU1;TBCD;EMP2;PIK3CB
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),-0.6058528859967707,-0.9676651342047167,0.582089552238806,0.908064321232671,1.0,3/8,33.41%,AGO2;TUT7;PRKRA
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.5480777682423353,-0.9676476289269886,0.5131578947368421,0.90742259903651,1.0,2/17,8.50%,LBR;PNP
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.45140017530038956,-0.9664411193836231,0.5,0.9096703884482052,1.0,14/59,18.11%,RTN4;SLC6A6;ENPP2;RAPGEF3;PRKN;RREB1;CFL1;ZDHHC6;FGFR1;GJA1;SPIRE1;PINK1;DAG1;RIF1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.623353341160242,-0.966145960442772,0.5606060606060606,0.9096874633814089,1.0,2/6,13.23%,SEC24D;RAB1A
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),-0.6688099764721706,-0.9659538780550058,0.5166666666666667,0.9094961117967392,1.0,2/5,18.41%,ANK2;DLG1
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.6463652833748543,-0.9659069669722496,0.6060606060606061,0.9088802206411772,1.0,2/7,18.43%,MAGI2;MTOR
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.5573927843356649,-0.9658658177517249,0.5915492957746479,0.9083235078006185,1.0,3/10,15.46%,S100A6;CDKN1A;CDK6
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.5789939173940756,0.9657400523133717,0.5121951219512195,1.0,1.0,3/5,21.67%,CDH2;TAPT1;FBXL17
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.624153981965561,-0.9652323722650533,0.6119402985074627,0.909214870465183,1.0,4/7,20.03%,GLUL;ZDHHC6;ZDHHC21;ZDHHC14
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.5203315144126084,-0.9651423028769123,0.5119047619047619,0.9087086019492927,1.0,2/29,2.20%,LDHA;GLUD1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.4231499566798699,-0.9649776537043004,0.67,0.9084937652528774,1.0,91/514,16.49%,MAFF;TBX3;SERPINE1;ST18;BHLHE40;MAFK;NR4A1;ATF3;KLF6;ZEB2;RPL23;ZNF43;PPARG;CX3CL1;PHF10;HES1;PBX3;JUN;JUNB;FOS;LRRFIP1;PPM1D;KDM1A;SMAD7;RAD21;ESR2;RPS27A;ELP3;NFE2L2;JUND;NPAS3;ARID5A;PIK3R1;BAZ1A;FOXF1;KLF2;SMARCA1;HIF1A;REL;BCL6;FOSL2;SIN3B;PRKN;NPAS2;PURA;UBC;RREB1;CD81;RPL10;KLF4;CCNH;CEBPZ;SOD2;HYAL2;ZFPM2;CREM;CRLF3;EPAS1;TPR;OGT;ELP4;MEF2A;ZNF586;PIAS2;ZFP36;CBX5;NPM1;NFKBIA;BRWD3;CDKN1A;FOXK1;ZNF160;CCNL1;CNBP;SDCBP;NCK1;SMAD3;MAX;TMF1;CREB3L2;LPIN2;WWTR1;CRTC3;SREBF2;CHD1;KLF12;RCOR1;THRB;MBD2;SMARCC1;TBK1
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3416834804376893,0.9648502317988235,0.5384615384615384,1.0,1.0,7/54,5.87%,BMP6;GCNT2;HIVEP1;SMAD1;PARD3;TGFBR3;SMAD9
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.4978280497505043,-0.9644121220558528,0.5487804878048781,0.90911745577223,1.0,5/30,18.01%,YTHDC1;TPR;ZFP36;SRRM1;NUP54
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.43712794278299427,-0.9642018870879421,0.5684210526315789,0.9088445835604098,1.0,33/146,21.59%,DDIT4;UFL1;PRKAG2;RFC3;AKAP12;MYO9B;ARHGAP21;VAV3;VWF;DLC1;TMSB4X;ARHGAP23;GNA13;PLCG2;FGD4;PAK2;NFKBIA;CYLD;VRK2;RASGRF2;FAM13A;ARHGAP29;PIP5K1C;ARHGAP15;ARHGAP17;DLG1;MTOR;EGFR;ECT2;SPRED1;XIAP;PRKAR1A;PPP1R16B
prerank,PanglaoDB_Augmented_2021__Paneth Cells,-0.6263611832218369,-0.9641644675358466,0.5507246376811594,0.9082489259963104,1.0,3/8,11.29%,TMEM45B;RAP1A;ACSL5
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.5659192465157616,-0.9636849495733661,0.5555555555555556,0.9087720489884044,1.0,4/10,15.94%,CANX;GOLPH3;RAB8B;MIA2
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.5954395549499067,0.9631903436832643,0.5,1.0,1.0,2/5,8.79%,DTWD1;CDKAL1
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.5103717824458428,-0.9630345416926734,0.5507246376811594,0.9096336627167484,1.0,6/20,22.44%,LGALS3;FES;CDK6;KMT2A;CBFB;HSPA9
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.47960885525026875,-0.9629833546889521,0.5529411764705883,0.9090800823070136,1.0,8/46,13.78%,CX3CL1;ARID5A;TIMP3;TNS1;VWF;EPAS1;PARVB;PLSCR4
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.48573198818011454,-0.9628756664020821,0.569620253164557,0.9086099409261833,1.0,11/32,23.27%,PTPRD;PECAM1;IL1RAPL1;ADGRL3;CLDN5;LRRC4C;ROBO2;ITGB1;HMCN1;BSG;CDH5
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.5567556157770216,-0.9625338942618719,0.5942028985507246,0.9086358758081793,1.0,4/12,20.35%,DUSP1;HYAL2;STK38;PIK3CB
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.38192778494243723,0.9622026339735095,0.68,1.0,1.0,6/34,6.61%,PLPPR4;NREP;ZNF385D;PRKG1;NOVA1;PDZRN3
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),-0.6308280455475466,-0.9619390049349297,0.609375,0.9092640489686034,1.0,3/6,22.79%,RIMS1;PIP5K1C;DNAJC5
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.6306679226462883,-0.9618202399400073,0.6031746031746031,0.9088607618741074,1.0,2/5,25.37%,NPM1;ALMS1
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.6320737270257262,-0.9618171121005018,0.6440677966101694,0.9081944416674547,1.0,1/6,6.43%,LAMA5
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.5961187648432255,-0.9617629873192365,0.5967741935483871,0.9076690456379799,1.0,2/7,12.22%,ANXA1;ZFP36
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.46069717515600106,0.9617439717910635,0.5925925925925926,1.0,1.0,5/15,15.43%,UIMC1;ERCC6;WRNIP1;BABAM2;PARG
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.5886714030926716,-0.9610895518100074,0.5507246376811594,0.9084688373682128,1.0,3/7,25.87%,DCP2;TNKS2;TNKS
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.3780510997410509,0.9607729530941163,0.5416666666666666,1.0,1.0,4/28,5.79%,ANKRD6;TPD52L1;EIF2AK2;MFHAS1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.5642896797862749,-0.9598677256947622,0.6197183098591549,0.9105991288029742,1.0,2/16,9.19%,PPARG;KLF4
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.5826313297830652,-0.9596987200035646,0.6301369863013698,0.910278481528748,1.0,3/8,19.07%,PLCG2;CDKN1A;GRB2
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.4097116682759039,0.9593440287738804,0.45161290322580644,1.0,1.0,5/19,22.05%,YEATS2;KAT6B;ZZZ3;MORF4L2;EPC1
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.5531805931811551,0.9591398218021037,0.4523809523809524,1.0,1.0,2/6,16.18%,ENTPD1;APP
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.5011387506182681,-0.9591213004393915,0.5,0.9109268673682833,1.0,9/27,20.19%,CDKN1B;EEF1A1;ERBB4;FLT1;FGFR1;TIE1;EGFR;EMP2;ECT2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.5869334578281965,-0.9591006878043151,0.6086956521739131,0.9103111703491054,1.0,5/10,13.17%,PPARG;CDKN1B;TPM1;SOD2;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.5324989872134201,-0.9582825960012473,0.569620253164557,0.9114257699558896,1.0,5/28,11.79%,BTG2;RTN4;GAPDH;PRNP;RPL13A
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.4682472191715525,-0.9578683374934215,0.5476190476190477,0.9116542002340192,1.0,10/41,18.30%,YTHDC1;KHDRBS3;PIK3R1;PRX;AHNAK;HNRNPH3;TMBIM6;SLC38A2;PTBP2;ZNF326
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),-0.5682844694775813,-0.957492772104798,0.5362318840579711,0.9118086394071249,1.0,1/6,5.02%,SEMA6B
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),-0.5899154351626653,-0.9571602954134327,0.6,0.9119383188612398,1.0,2/13,18.43%,MAGI2;MTOR
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.536226759457986,-0.9569011889640597,0.5675675675675675,0.9118308113171496,1.0,6/15,15.94%,CANX;ANXA1;GOLPH3;RIMS2;RAB8B;MIA2
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),-0.49037016230010955,-0.9567902701069121,0.5454545454545454,0.9114294689682059,1.0,4/31,8.66%,SPNS2;ENPP2;ESYT2;PDXDC1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,-0.49131591079880366,-0.9562290204176634,0.5609756097560976,0.9120814124821734,1.0,11/24,21.94%,SPOCK1;NFASC;GRIA2;LSAMP;PPFIA2;PLP1;LRRC4C;CADM2;PDE10A;SCN2A;NEGR1
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),-0.6192683941585982,-0.9562268504920737,0.5901639344262295,0.910758596800546,1.0,3/5,27.14%,CHST11;CHSY1;CSGALNACT1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.6192683941585982,-0.9562268504920737,0.5901639344262295,0.910758596800546,1.0,3/5,27.14%,CHST11;CHSY1;CSGALNACT1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.5173664965793869,-0.9562079362549056,0.5555555555555556,0.9101230550460147,1.0,6/20,19.42%,PIK3R1;KIF16B;BCAR1;ERBIN;GRB2;EGFR
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.6199386827112602,-0.9552621228523698,0.6212121212121212,0.9118074363620821,1.0,2/6,15.33%,SLC26A2;SULT1C4
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.5718783204044902,-0.9547788046188778,0.5277777777777778,0.9119607589008273,1.0,1/9,8.34%,PRKN
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.5079853775656179,0.9544212520418172,0.5454545454545454,1.0,1.0,4/10,8.45%,THOC1;ERCC6;CDK12;SCAF8
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.5514809344118543,-0.9538753489835393,0.5915492957746479,0.9129751186708992,1.0,10/14,40.05%,KLF4;XIAP;CSNK2A1;MAP2K5;RPS6KA3;DDX3X;DNAJB6;YWHAE;CAST;CARD8
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.39129485736095004,0.9536936526842873,0.5217391304347826,1.0,1.0,3/21,5.79%,ANKRD6;TPD52L1;MFHAS1
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.49734862229133414,0.9536513370113261,0.4166666666666667,1.0,1.0,4/11,10.41%,GBP2;IL1R1;ENTPD1;TNFRSF1B
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.626921805227523,-0.9532391571096291,0.6181818181818182,0.9136388864113105,1.0,3/6,27.97%,UGGT2;DNAJB14;ATXN3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.4951607116305963,0.9526273005362608,0.41379310344827586,1.0,1.0,1/8,1.86%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.4951607116305963,0.9526273005362608,0.41379310344827586,1.0,1.0,1/8,1.86%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.4951607116305963,0.9526273005362608,0.41379310344827586,1.0,1.0,1/8,1.86%,GBP1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.6236702127659575,-0.9525937588156487,0.660377358490566,0.9145937762969102,1.0,5/5,37.74%,DSP;MTM1;VIM;DNAJB6;KLHL24
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.5625260364665998,-0.9525511476584859,0.5882352941176471,0.9140311862001511,1.0,3/10,18.33%,ANXA1;PRNP;ERBIN
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.5540516646957518,-0.9516787446043347,0.5333333333333333,0.9154138039072658,1.0,1/14,2.34%,SLC6A6
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.6422059088579417,-0.9514076078203292,0.6206896551724138,0.9152967035109986,1.0,1/5,23.43%,AGO2
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.6321808510638298,-0.9512512364878777,0.576271186440678,0.9149208921439768,1.0,5/5,36.89%,CD55;CD46;STAT3;BACH2;MSH2
prerank,PanglaoDB_Augmented_2021__Beta Cells,-0.4910861955567536,-0.9508248115956157,0.5,0.9149740823530237,1.0,10/27,17.29%,NFASC;RIMS1;GRIA2;CNTN1;LSAMP;CTNND2;ERO1B;LRRC4C;CADM2;ROBO2
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.4478122537470043,-0.9508154986264127,0.574468085106383,0.9143405359067219,1.0,18/65,20.42%,SUN2;SRGN;NPLOC4;ARHGAP21;SUN1;RAB2A;GOLPH3;DYSF;TMED10;RAB1A;RAB30;TOR1AIP2;ANK3;ATP8B1;ARFGEF2;CAV2;CSNK1D;REEP3
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.48168458740910614,-0.9500883428432157,0.5432098765432098,0.9153547002579091,1.0,10/35,19.42%,PCK1;PPARG;TIMP3;TNS1;EPAS1;CFH;PLSCR4;PIKFYVE;ACVRL1;EGFR
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.5053363488671719,-0.9497449495475914,0.5733333333333334,0.9152783963906268,1.0,2/28,4.09%,SPNS2;ABCA5
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.5120473429588308,-0.9496610377583168,0.5972222222222222,0.9147830315703908,1.0,1/22,0.72%,SPNS2
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),-0.6158815227569097,-0.9494116475563396,0.5915492957746479,0.9140922595856046,1.0,4/6,28.61%,SLC8A1;ATP1A1;CAMK2D;ATP1B1
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),-0.6158815227569097,-0.9494116475563396,0.5915492957746479,0.9140922595856046,1.0,4/6,28.61%,SLC8A1;ATP1A1;CAMK2D;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.5522362918248934,-0.9486512468196714,0.5733333333333334,0.9147088325652531,1.0,7/15,31.47%,KLF4;CDKN1A;CDK6;DLG1;FAM107A;SLFN11;NACC2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.568338540574052,-0.9485884678443919,0.6307692307692307,0.914223330416659,1.0,3/9,16.41%,GPM6B;COMMD1;PICALM
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.5206614156962419,-0.9481269392635286,0.6216216216216216,0.9145899312990154,1.0,3/17,8.45%,TIMP3;TPM1;TNS1
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.5008441433713557,-0.9471049173856647,0.52,0.9161760247237255,1.0,4/28,7.46%,JUN;CD9;IFNGR1;IFNGR2
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.5130533428512194,-0.9470980464840937,0.5671641791044776,0.9155381217679613,1.0,10/24,21.38%,DUSP1;PEBP1;TIMP3;HYAL2;STK38;DAG1;DLG1;PIK3CB;SPRED1;DUSP6
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.46644810428378525,0.9470317366382305,0.5142857142857142,1.0,1.0,2/10,10.81%,IL15;RAB27A
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),-0.5106501868093917,-0.9465968019881269,0.5616438356164384,0.9160312399652869,1.0,5/19,15.72%,PLCL1;PIK3R1;FGFR1;OGT;PIK3C3
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.45003683563634533,-0.9463191864417425,0.5681818181818182,0.9159710162709653,1.0,14/52,18.83%,JUN;FOS;LRRC32;SMAD7;RPS27A;UBC;HYAL2;ITGB5;LIMS1;CLDN5;SMAD3;ITGB1;SMAD5;ACVRL1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),-0.6170406118762535,-0.9446146357658827,0.6451612903225806,0.9189602329910938,1.0,1/7,4.46%,KDM1A
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.5918554829093766,-0.9443997760730705,0.5873015873015873,0.9188340274601672,1.0,7/8,35.43%,ANXA1;ZFP36;ADAM9;FAM107A;REST;ZFP36L1;HNRNPU
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.5005726887575465,-0.9442023201237422,0.5263157894736842,0.9185721345534423,1.0,3/29,9.69%,MYO9B;EPS8;DLC1
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.4526974020670946,-0.9441249113854421,0.5632183908045977,0.9180630327188509,1.0,15/56,15.59%,NR4A1;SMAD7;EEF1A1;MAGI2;FLT1;RAP1A;ANXA1;KLF4;HYAL2;LIMS1;ZFP36;ACAP2;BCAR1;SMAD3;RACK1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.5027914414130251,-0.9434432862494957,0.5185185185185185,0.9187198534791706,1.0,5/26,10.94%,LRRC32;TIMP3;PECAM1;TNS1;CFH
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.5596374319678565,-0.94326608372101,0.6212121212121212,0.9184904998344027,1.0,1/9,3.93%,SCP2
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.5542831857138484,-0.9422677933774238,0.5975609756097561,0.9200546085111472,1.0,9/15,24.75%,PRKN;SNX6;SYT1;ANK3;ATP1A1;B2M;NEDD4;NEDD4L;TF
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),-0.6468549673640495,-0.9418385832362391,0.6417910447761194,0.9202148626288617,1.0,2/5,28.50%,ZDHHC21;ADCY9
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.4824300906441998,-0.9417439082536159,0.5733333333333334,0.9198098568814769,1.0,6/32,13.89%,NEDD9;ANXA1;S1PR1;PARVB;CASS4;BCAR1
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5156725658064001,-0.9416921484598166,0.6052631578947368,0.9192861357298164,1.0,1/20,0.24%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.5534828476322968,-0.9415851168907228,0.6376811594202898,0.9188903065950503,1.0,4/13,17.18%,RPL10;TMED10;PICALM;SAMD8
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.46176583856282416,-0.9412888321453233,0.5568181818181818,0.919011223840821,1.0,17/62,24.41%,DDIT4;CX3CL1;SULF2;TMBIM6;NCK1;RACK1;EGFL7;MTMR2;GATA2;LRPAP1;EGFR;PIK3CB;GLI3;GPC3;CALR;NEDD4;TNS2
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.49390158096359715,-0.9410947117702566,0.5569620253164557,0.9187431195928796,1.0,8/29,16.95%,ERO1A;NFE2L2;SERPINB6;SOD2;MSRA;PINK1;VRK2;TXNRD1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.5900576610916949,-0.9410682238327411,0.6307692307692307,0.918158188622661,1.0,4/12,24.44%,PTPRD;IL1RAPL1;NEDD4;NEDD4L
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.4168755616654636,-0.9407263875278593,0.5913978494623656,0.91820804552964,1.0,14/131,10.73%,PSMC6;TSG101;PSMB9;NPLOC4;SPOPL;NFE2L2;NDFIP1;RNF19A;PSMA1;FEM1C;PRKN;ARIH2;HERPUD1;CHFR
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.6396711938292644,-0.9403853894505279,0.5942028985507246,0.9183528595813513,1.0,2/5,6.37%,SCP2;LSS
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.575714390664335,-0.940270052901191,0.5942028985507246,0.9180384939461962,1.0,3/7,28.47%,HIP1R;PIK3CB;SCYL2
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.5343977047192299,-0.9399580251420915,0.5675675675675675,0.9180566986058559,1.0,2/14,8.34%,HIF1A;PRKN
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),-0.5966041314689303,-0.9397052581164073,0.576271186440678,0.9180353664381142,1.0,2/7,17.29%,SEMA6B;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.5471963030519175,-0.9389863431760141,0.6133333333333333,0.9188274234655878,1.0,4/11,28.34%,GOLPH3;LARS1;WDR59;SIK3
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.5378595593662182,-0.9388662536512693,0.582089552238806,0.9184899341809307,1.0,7/14,32.14%,DMD;SPCS3;CPM;SPPL3;BACE2;NPEPPS;ERAP1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.45628980064677216,-0.9386807527561161,0.6625,0.9182238890402814,1.0,8/48,11.02%,SLC6A6;LGALS3;SMAD7;FES;BCL6;KLF4;PLEKHB2;FGFR1
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.4274678853531712,-0.9386016030403929,0.6170212765957447,0.9177139346029701,1.0,16/88,15.78%,PSMC6;PSMB9;SMAD7;RPS27A;WDR48;PSMA1;HIF1A;PRKN;UBC;OGT;NFKBIA;FOXK1;CYLD;SMAD3;USP45;USP34
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.4200026194912826,-0.9380534533882219,0.6363636363636364,0.9183307564398657,1.0,24/179,16.71%,MAP3K5;PCK1;PRKAG2;PKN3;GRK5;SMAD7;FES;JAK1;ERBB4;PRKCE;FLT1;CCNH;SIK2;CDK14;FGFR1;DCLK1;PAK2;TEC;TRIB2;STK38;CDK6;TBK1;PINK1;VRK2
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.5833343989495107,-0.9379018699076154,0.6056338028169014,0.9179473460579188,1.0,1/9,2.34%,SLC6A6
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.5752447563148535,-0.9375460884809805,0.5645161290322581,0.9181385103615889,1.0,2/8,23.82%,AP1G1;HLA-B
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.4629840570526614,-0.9374101467049829,0.5662650602409639,0.917897215308401,1.0,12/46,20.64%,CD9;CHPT1;FOS;JAK1;KLF4;SLC26A2;ZFP36;AMFR;FKBP5;SCARB1;EMP2;COX6C
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.5561091882492066,-0.9373744673026996,0.5714285714285714,0.9173028929714241,1.0,4/9,23.21%,GPC5;HYAL2;OMD;GPC3
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.501723571587874,0.9373252452806062,0.5,1.0,1.0,1/8,3.48%,DISP1
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.5309096360976706,0.9372843886895085,0.5263157894736842,1.0,1.0,2/7,11.50%,MDM4;ACVR1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.5943209038018338,-0.9372838992662192,0.5806451612903226,0.9168820360432137,1.0,3/7,32.03%,B2M;HLA-B;HLA-E
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,-0.6006484827242419,-0.937203599333613,0.6231884057971014,0.9164382417376896,1.0,4/8,25.05%,TMEM45B;EGFR;VWA2;DSP
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.5650084718500483,-0.9367339202754364,0.6212121212121212,0.916778678097102,1.0,1/13,5.60%,CDC37
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.5337585888731264,-0.93670708068591,0.6027397260273972,0.9161867918761942,1.0,2/13,4.78%,PCK1;S100A6
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.42569583854733273,-0.9364688309720786,0.5760869565217391,0.9159791649679931,1.0,16/88,15.78%,PSMC6;PSMB9;SMAD7;RPS27A;WDR48;PSMA1;HIF1A;PRKN;UBC;OGT;NFKBIA;FOXK1;CYLD;SMAD3;USP45;USP34
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.626456437401175,-0.9362212724679971,0.6176470588235294,0.9158969431561048,1.0,2/6,18.49%,OGT;KMT2A
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),-0.4704536720675277,-0.9358461848270571,0.5647058823529412,0.9158773502582753,1.0,10/38,18.67%,FES;HIP1R;RAB21;STXBP5L;RIMS2;SYT1;RAB8B;PICALM;RUFY2;SCARB1
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.616973438721339,-0.9355783342350761,0.5692307692307692,0.9157875045870992,1.0,3/7,23.21%,RACK1;GLI3;GPC3
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4046037469985485,0.9354131796498765,0.5555555555555556,1.0,1.0,2/22,6.03%,BMP6;ELAPOR2
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.5224412151124418,0.93524359844595,0.5294117647058824,1.0,1.0,1/8,1.25%,SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.5224412151124418,0.93524359844595,0.5294117647058824,1.0,1.0,1/8,1.25%,SLC4A4
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.48983272136936196,0.9344329278736555,0.5925925925925926,1.0,1.0,2/9,11.42%,CLASP1;CLIP1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.43769409152227057,0.9339749778367251,0.5,1.0,1.0,2/17,7.94%,RC3H1;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.5023336940703231,-0.9338157393653181,0.5375,0.9187333321941411,1.0,4/18,12.88%,PTPRD;IL1RAPL1;LIMS1;CLDN5
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.5081398632186296,-0.9334313788167651,0.631578947368421,0.91876639809756,1.0,2/22,2.82%,NRCAM;HES1
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.5144084036125065,-0.9328460150060623,0.625,0.9193916590417025,1.0,1/22,0.72%,SPNS2
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.5747322418398865,-0.9325149246445078,0.609375,0.9195254570555743,1.0,2/7,17.18%,DMD;SAMD8
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.34359613439635506,0.931745669112081,0.6923076923076923,1.0,1.0,7/82,6.56%,BMP6;TPD52L1;HOMER1;CTBP2;LIMS2;WLS;NPTN
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.6242188946108936,-0.9314926960825205,0.6964285714285714,0.9209508569052633,1.0,3/6,34.29%,IFITM3;LY6E;GSN
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.41341983297959,0.9311228067097512,0.4583333333333333,1.0,1.0,4/13,9.61%,CTNNA2;HDAC9;ABL1;CDH2
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.5349742857551538,0.9309478177414098,0.5384615384615384,1.0,1.0,3/6,14.00%,SPG11;RAB27A;NLGN1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.287453933773126,0.9297521979596052,0.8181818181818182,1.0,1.0,13/104,10.92%,SCFD2;STX8;EVI5;HERC2;TBC1D5;XPO4;WLS;VPS45;IPO8;TNPO3;RAB28;TBC1D4;SYNRG
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.49984407044015,-0.9296670927343192,0.6,0.9237662711087832,1.0,3/20,15.27%,RTN4;PRKN;WWTR1
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.47450006757086216,-0.9296173900997645,0.5529411764705883,0.923282850338294,1.0,4/29,18.01%,YTHDC1;TPR;SRRM1;NUP54
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.5022376546342997,-0.9293614262620642,0.6375,0.9230796635333252,1.0,8/28,24.44%,LGALS3;RAPGEF3;RACK1;TMEM30A;CLU;GPC3;CDH5;NEDD4L
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.4387571052126379,0.929316668662263,0.5333333333333333,1.0,1.0,3/12,17.53%,SLC25A29;TRPM7;PKD2
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.49741116125247975,-0.9291733932918179,0.6176470588235294,0.9228224348987061,1.0,3/15,9.08%,PBX3;NES;RPL10
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),-0.620335322108525,-0.929136696423053,0.6271186440677966,0.9222708713896938,1.0,3/5,13.81%,MGLL;GGT5;PON2
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.5812271911615225,-0.9289644414905097,0.6666666666666666,0.9219603077940192,1.0,6/8,34.00%,TINAGL1;ATP8B1;DSP;TM4SF1;S100A10;EFNA1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.6073178892173483,0.9289007193692146,0.631578947368421,1.0,1.0,1/5,2.68%,DCP1A
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.47605449581607906,-0.9285423283268459,0.6190476190476191,0.9214488095747504,1.0,4/28,18.01%,YTHDC1;TPR;SRRM1;NUP54
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.47605449581607906,-0.9285423283268459,0.6190476190476191,0.9214488095747504,1.0,4/28,18.01%,YTHDC1;TPR;SRRM1;NUP54
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.5588496052342529,-0.9284591558330318,0.6176470588235294,0.9210234482329406,1.0,7/13,23.11%,DUSP1;CYLD;RELL1;DLG1;GADD45B;SASH1;PHLPP1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.45284347296991845,0.9284006273251567,0.5333333333333333,1.0,1.0,2/15,4.91%,OFD1;CLASP1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.46537021831924924,-0.9278105247445321,0.5694444444444444,0.9217733781454249,1.0,8/35,14.50%,PIK3R1;FLT1;VAV3;SHC2;PAK2;BCAR1;VEGFC;NCK1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.527570301909688,-0.9277568913910303,0.6231884057971014,0.9212402561632208,1.0,4/13,22.74%,GOLPH3;TMED10;CSNK1D;ARL5B
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.5219150719290004,-0.9272902947812164,0.6029411764705882,0.921549097337276,1.0,4/17,16.97%,RAP1A;MSN;PINK1;TIE1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.6021697406967799,-0.9272618843510513,0.6129032258064516,0.9209397369242422,1.0,2/6,18.49%,KDM1A;KMT2A
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.5728701423856749,-0.9260850426448065,0.5942028985507246,0.9226818862744427,1.0,3/10,17.29%,PTPRD;IL1RAPL1;ROBO2
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.4858955163113207,-0.9260389137773172,0.5903614457831325,0.9221804105891515,1.0,5/24,15.72%,PLCL1;PIK3R1;FGFR1;OGT;PIK3C3
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.4813408221485734,-0.9255416047745401,0.5822784810126582,0.9224800651118564,1.0,5/23,18.80%,SCARB2;SCP2;TMEM30A;SCARB1;ATP8B1
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.3809756849635776,0.9252101025890898,0.5416666666666666,1.0,1.0,2/24,3.59%,UBE3D;RNF213
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.4228801117585749,-0.9243507797483401,0.6288659793814433,0.9242637306666132,1.0,11/72,10.94%,ADAMTS9;ENPP2;LRRC32;DUSP1;SMARCA1;TNS1;CD55;LSAMP;VWF;GPM6A;CFH
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.5313373512970287,-0.924208888942759,0.6666666666666666,0.923862120560461,1.0,1/11,3.80%,MAP1B
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.6041568798101786,-0.9240314712566126,0.6333333333333333,0.9235071442009303,1.0,2/6,9.06%,RTN4;CD81
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.6286192495169555,-0.9239862888565703,0.6964285714285714,0.9229530887188878,1.0,2/5,5.98%,CHPT1;DHRS7B
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),0.5979577957705892,0.9239701530109976,0.575,1.0,1.0,1/5,3.75%,MRPS31
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),-0.5650511135418276,-0.9233583069927889,0.582089552238806,0.9235196536606882,1.0,4/9,17.48%,CANX;SYNJ2;SYT1;PIP5K1C
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.5561931250199599,-0.9230675911100125,0.640625,0.9233955894099232,1.0,3/13,19.42%,ANXA1;ADAMTS1;EGFR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.46160489355679307,-0.9228057466673133,0.6962025316455697,0.923287013988197,1.0,11/38,20.35%,RTN4;CX3CL1;ERBB4;PIK3R1;FGFR1;CASS4;PINK1;ITGB1;GRB2;EGFR;PIK3CB
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.48562758235083325,-0.9223387072030634,0.5844155844155844,0.9234618076735955,1.0,9/22,26.56%,PPP1R9A;TMEM132C;SHC2;NEBL;ANK3;KALRN;VWA2;SPARCL1;MCF2L
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.5097750375310413,0.9217920621239072,0.5625,1.0,1.0,4/9,14.02%,CIRBP;TRA2A;RBMX;NCL
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.4378742655011193,-0.9216405052879114,0.627906976744186,0.9241335754112879,1.0,11/59,15.27%,TAMALIN;PKN3;CLEC1A;TIMP3;TMEM184B;HYAL2;ITGB5;EPAS1;EFNB2;PLSCR4;WWTR1
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,-0.48077133939089245,-0.9214697983400258,0.6547619047619048,0.9238641910857744,1.0,5/28,8.63%,SEC24D;TIMP3;TPM1;TNS1;MSRB3
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.5144196995055748,-0.9212336398134524,0.5584415584415584,0.9236562851446553,1.0,7/21,34.24%,CDC37;RIOK3;XIAP;FGR;HLA-E;ERAP1;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.6252082993233844,-0.9208806716713471,0.6229508196721312,0.9236929441159362,1.0,1/6,12.22%,ZFP36
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.5027578132392356,-0.920867498806126,0.6027397260273972,0.923088747260153,1.0,2/11,6.19%,HES1;ERBB4
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),-0.6080060497558843,-0.9208269907038787,0.6129032258064516,0.9219056661971842,1.0,2/5,27.36%,PTBP1;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.6080060497558843,-0.9208269907038787,0.6129032258064516,0.9219056661971842,1.0,2/5,27.36%,PTBP1;SPPL3
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.5343778480698662,0.919608208868397,0.5555555555555556,1.0,1.0,1/5,11.50%,ACVR1
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.49985074759387726,-0.9195366126020369,0.6162790697674418,0.922376083308771,1.0,2/20,2.63%,SEC22B;SEC24D
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.49985074759387726,-0.9195366126020369,0.6162790697674418,0.922376083308771,1.0,2/20,2.63%,SEC22B;SEC24D
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.49985074759387726,-0.9195366126020369,0.6162790697674418,0.922376083308771,1.0,2/20,2.63%,SEC22B;SEC24D
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.4252711904485249,-0.9191149956433892,0.6631578947368421,0.9225729859702935,1.0,20/104,20.66%,UFL1;BTG2;RFC3;MACROD2;POLA1;WDR48;VAV3;BCL6;CBX5;NPM1;CDKN1A;SMC6;USP45;MCL1;ZBTB38;ATF2;RIF1;GRB2;ACER2;XIAP
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.454766974573254,-0.9179815702264198,0.5733333333333334,0.9242198019006345,1.0,8/31,19.60%,KIAA1217;TINAGL1;LAMA5;SMARCA1;EPAS1;WWTR1;EGFR;EMP2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-0.5872352709939693,-0.9176989764192435,0.6190476190476191,0.9240661717134246,1.0,1/5,12.99%,NPM1
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.524398314870364,-0.9172773632456059,0.6081081081081081,0.9242842823230969,1.0,1/14,2.52%,CX3CL1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.48502024355890105,-0.9168404358105949,0.6285714285714286,0.9245702936107345,1.0,5/24,13.09%,FES;ERBB4;FLT1;FGFR1;TEC
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.5286049724425477,0.9166294233839176,0.6,1.0,1.0,2/6,7.20%,EZH1;BAZ2A
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.4069031074988797,-0.916519595021771,0.6565656565656566,0.924484886688682,1.0,24/126,20.53%,NEDD9;MTFR1;NPLOC4;ARHGAP21;TPM1;PRKN;CFL1;RAB2A;GOLPH3;FGD4;TMED10;BRWD3;RAB1A;SH3KBP1;RAB30;PINK1;RAB14;TOR1AIP2;PIKFYVE;ATP8B1;CHMP4B;CAV2;CSNK1D;PRPF40A
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.5568549096438871,0.9164281321498904,0.5365853658536586,1.0,1.0,1/5,1.65%,PLA2G4A
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.49623583088247564,-0.9163287463446157,0.6,0.9242179868437109,1.0,4/22,18.01%,PPARG;TPR;ZFP36;NUP54
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.4801554826676039,-0.916215853465242,0.68,0.9237699604814532,1.0,8/32,26.43%,JAG2;SREBF2;EGFL7;NOTCH4;GATA2;EGFR;CD46;DLL4
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.5179751108567747,0.9158438970292107,0.6,1.0,1.0,1/6,3.03%,IGFBP3
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.41181583668806937,0.9158023429780427,0.6129032258064516,1.0,1.0,3/18,10.20%,TGFBR3;EIF2AK2;KLHDC10
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.6345594502776749,-0.9154389478071001,0.7,0.9247356621141536,1.0,2/5,21.97%,MTOR;ADAM9
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.4955176756252643,-0.9153166381915427,0.6111111111111112,0.9243483039724919,1.0,3/11,17.29%,SULF2;HYAL2;ROBO2
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.5986947710778586,-0.9148628676756095,0.6885245901639344,0.9246859464579591,1.0,2/7,11.93%,KDM1A;GJA1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.6303310727765851,-0.9147170146877561,0.6842105263157895,0.9243368496526629,1.0,2/6,6.96%,LRRC7;MAGI2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.6223806537002478,-0.9144323742285624,0.6451612903225806,0.924252000270793,1.0,2/5,18.11%,KDM1A;RIF1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.4753279447053904,0.913231063210295,0.4772727272727273,1.0,1.0,1/10,4.91%,CLASP1
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.437859876115783,-0.912588916461126,0.5681818181818182,0.9274133393512001,1.0,12/45,18.83%,JUN;FOS;LRRC32;SMAD7;RPS27A;UBC;ITGB5;CLDN5;SMAD3;ITGB1;SMAD5;ACVRL1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.545854157182786,-0.9125715964221474,0.6515151515151515,0.9268072178805684,1.0,1/12,2.90%,PBX3
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.4327136292724484,0.9122385411549782,0.6896551724137931,1.0,1.0,2/16,2.68%,RC3H1;DCP1A
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.6243277202661565,-0.9119013198783088,0.6379310344827587,0.9266947993799671,1.0,3/5,28.50%,PRKAR1A;ADCY2;ADCY9
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.6243277202661565,-0.9119013198783088,0.6379310344827587,0.9266947993799671,1.0,3/5,28.50%,PRKAR1A;ADCY2;ADCY9
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.49085944468803183,-0.9113004830858712,0.618421052631579,0.9272846796529095,1.0,4/24,7.57%,SLC6A6;KCNMB4;NDFIP1;SLC8A1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.4477332455326541,0.910879363297857,0.45454545454545453,1.0,1.0,2/21,2.31%,EVI5;TBC1D5
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.4981494100338003,-0.9106826966937339,0.625,0.9278587591614937,1.0,3/27,11.50%,B3GNT2;PLOD2;OGT
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.5644391991044928,0.9101350673018773,0.6444444444444445,1.0,1.0,2/5,8.13%,PRKD1;HSPB1
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),-0.5503003357414755,-0.9100590425802857,0.6984126984126984,0.9283495575823898,1.0,1/8,3.51%,SCARB2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.538333554419314,-0.9099682812011856,0.6216216216216216,0.9279026604876244,1.0,2/16,5.50%,KDM1A;WDR48
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.3803602736867487,0.909829284733908,0.5454545454545454,1.0,1.0,2/22,1.20%,DSE;GCNT2
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.4598374787266949,-0.9094049644024058,0.6835443037974683,0.9283553186035782,1.0,9/42,21.81%,SUN2;SPC25;RPS27;PAFAH1B1;SMC3;KPNB1;MECP2;DYNC1I2;EML4
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.5290800596766603,-0.9093802405427135,0.5909090909090909,0.9277742590703616,1.0,8/12,26.06%,MTMR12;SYNJ2;MTMR2;MTMR6;SACM1L;MTM1;INPP5F;SYNJ1
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),-0.5750379775620784,-0.9093463228537279,0.639344262295082,0.9272238986626193,1.0,1/5,7.60%,ANK2
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),-0.5307230609855768,-0.9089624777230088,0.6153846153846154,0.9267081429579561,1.0,5/13,26.37%,ABCA5;CNBP;SCARB1;LIMA1;ABCG1
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),-0.5307230609855768,-0.9089624777230088,0.6153846153846154,0.9267081429579561,1.0,5/13,26.37%,ABCA5;CNBP;SCARB1;LIMA1;ABCG1
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.5902081744793191,-0.9087667582304048,0.6376811594202898,0.9264283798285546,1.0,2/5,20.35%,PIK3C3;PIK3CB
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.45589246000038486,-0.9082088478421054,0.6506024096385542,0.926887674945712,1.0,4/29,8.45%,WNT2B;TIMP3;TPM1;TNS1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.31739158197590256,0.9077524962100509,0.5833333333333334,1.0,1.0,11/52,13.89%,RC3H1;EFNA5;CLASP1;CHN1;PHLDB2;CDH2;ZMYM4;STAT2;MARK2;PDLIM5;SIPA1L1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),-0.5525115143929009,-0.9074097472503572,0.6290322580645161,0.9277788392977812,1.0,1/8,5.02%,SEMA6B
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),-0.46986079414148135,-0.9072117197841559,0.6282051282051282,0.9274840195432802,1.0,12/26,24.44%,ATP2B1;SLC8A1;ANK2;ATP1B3;ATP13A3;SLC30A1;TMEM165;VAPB;ATP1A1;CDH5;CALR;NEDD4L
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.5863782414377208,-0.9071799396249204,0.671875,0.9268991712648529,1.0,3/6,22.42%,MAGI2;MYO1E;PODXL
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.5554130923849727,0.9064240082530161,0.6153846153846154,1.0,1.0,2/6,4.78%,PRKD1;LIMS2
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.520329502104804,-0.9063647297853881,0.6351351351351351,0.9278257660605449,1.0,2/12,5.05%,BCAP31;SPG7
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.4460090634707937,-0.9056571791586899,0.6385542168674698,0.9286916400591592,1.0,6/33,16.57%,SLC6A6;SCARB2;SLC52A3;LRP1B;TMEM30A;SLC38A2
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.48553319816515206,-0.905506878020123,0.6153846153846154,0.9284044284198075,1.0,1/19,2.05%,RFTN1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.4462421267286207,-0.9052989472747344,0.6179775280898876,0.9281547312434593,1.0,15/53,21.57%,SEC22B;BCAP31;SEC24D;ANK2;CD55;RAB2A;TMED10;RAB1A;COPA;MIA2;ANK3;USO1;DYNC1I2;CAPZA2;VAPB
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),-0.6036743623801823,-0.9041861318322398,0.7352941176470589,0.9288949908985874,1.0,3/5,28.61%,ATP1B3;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),-0.6036743623801823,-0.9041861318322398,0.7352941176470589,0.9288949908985874,1.0,3/5,28.61%,ATP1B3;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.5420456374073387,-0.9030876586079544,0.6521739130434783,0.9295814470062114,1.0,3/12,20.19%,PRKCE;CSPP1;ECT2
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.5420456374073387,-0.9030876586079544,0.6521739130434783,0.9295814470062114,1.0,3/12,20.19%,PRKCE;CSPP1;ECT2
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),-0.5666095677819123,-0.9023584792703738,0.6507936507936508,0.9302719141461532,1.0,4/8,17.48%,CANX;SYNJ2;SYT1;PIP5K1C
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.5980943414404258,-0.9021994450111905,0.6825396825396826,0.9299479976010367,1.0,1/5,4.57%,SMAD7
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.4042595487154415,-0.902166421164122,0.6530612244897959,0.9293953317702417,1.0,32/152,19.52%,MAP3K5;KLF6;PPARG;HES1;JUN;FOS;ESR2;NPAS3;ERBB4;FOXF1;KLF2;SMARCA1;HIF1A;NPAS2;RREB1;KLF4;CRLF3;NPM1;FOXK1;CNBP;SMAD3;NAA16;CREB3L2;SMARCC1;PICALM;NOTCH4;KMT2A;SMAD5;ACVRL1;PPM1A;EGFR;RLF
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),-0.4518887927173353,-0.9020907146764405,0.569620253164557,0.9289320474212683,1.0,4/23,14.71%,ERO1A;PLOD2;MSRA;STK38
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.48442045487185204,0.9019941202146025,0.5454545454545454,1.0,1.0,1/8,2.74%,CPEB3
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),-0.47137380735916223,-0.9019725291969528,0.6049382716049383,0.9284619888126685,1.0,7/25,21.57%,RTN4;TRAM1;PRNP;TOR1AIP2;CAV2;REEP3;VAPB
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.5472669088469608,-0.9019385216536197,0.6417910447761194,0.9278744963548449,1.0,1/7,6.24%,GGT5
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.4234099398421346,-0.9018252414032663,0.6162790697674418,0.9275089755114491,1.0,14/52,20.19%,PIK3R1;RAPGEF3;ARIH2;CD81;HYAL2;PRNP;TPR;SMAD3;PPP3CC;SREBF2;TMEM30A;PINK1;ANK3;ECT2
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.5213872175274583,-0.9015574187683311,0.6375,0.926830916831213,1.0,3/12,8.13%,GRM7;SLC52A3;SERPINB6
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.5213872175274583,-0.9015574187683311,0.6375,0.926830916831213,1.0,3/12,8.13%,GRM7;SLC52A3;SERPINB6
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.5023228249122178,-0.9013998381856607,0.6285714285714286,0.926540386204284,1.0,3/14,17.93%,TPM1;ATP1B3;TOR1AIP2
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.45122148140010593,-0.9007188091546048,0.5853658536585366,0.9272650950645452,1.0,13/27,34.21%,RIMS1;RIMS2;SYT1;SDCBP;EGFR;NEDD4L;CSNK2A1;MAP3K13;CDKL5;RPS6KA3;DDX3X;MTPN;MFSD2A
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.38465310748871523,0.9006303405676517,0.5217391304347826,1.0,1.0,4/25,4.17%,BMP6;IL6R;IL15;EFNA5
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.4037022891153112,-0.9005104902984024,0.8247422680412371,0.9270261052001826,1.0,46/272,16.92%,TBX3;BHLHE40;MAFK;ATF3;ZEB2;RPL23;PPARG;PHF10;HES1;JUN;LRRFIP1;KDM1A;SMAD7;ESR2;RPS27A;CDKN1B;ARID5A;KLF2;BCL6;SIN3B;PRKN;PURA;UBC;RREB1;RPL10;KLF4;ZFPM2;CREM;SNX6;LIMS1;TPR;MEF2A;ZFP36;CBX5;FOXK1;CNBP;SDCBP;SMAD3;MAX;SREBF2;KLF12;RCOR1;THRB;MBD2;NOTCH4;ZBTB38
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,-0.4713738375086448,-0.9004217988354107,0.620253164556962,0.9265891278847112,1.0,5/24,13.28%,ADM;DMD;TPM1;ZFPM2;CTNNA3
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.4835358664288728,-0.9002093786757304,0.5949367088607594,0.9263435520994204,1.0,6/24,15.59%,PPARG;HIP1R;DLC1;TNFRSF10B;SMAD3;RACK1
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.5746008892204942,-0.8994193755432481,0.6349206349206349,0.9269271350807858,1.0,2/9,9.19%,CD9;KLF4
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.5393679401691831,0.899334062793142,0.6216216216216216,1.0,1.0,2/5,23.51%,PDGFB;PHIP
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.4833677184249312,-0.8987149329273245,0.7051282051282052,0.9277225286281396,1.0,6/34,15.59%,BTG2;GAPDH;TPR;RPL13A;CPEB4;RACK1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.5845495817432789,-0.8986953590114253,0.5660377358490566,0.9271690321576803,1.0,1/6,10.81%,DGKG
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.533650386625163,-0.8986313373578756,0.6027397260273972,0.926645538918711,1.0,4/11,26.35%,CNOT6L;ZFP36;CNOT8;TUT7
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.5508218035364825,-0.8982937863714603,0.6666666666666666,0.9267226188035064,1.0,4/7,25.95%,TRAM1;PRNP;EGFR;SERP1
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.5422136107638033,0.8970637630546949,0.6176470588235294,1.0,1.0,1/5,8.05%,CDK12
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.5141272073890903,0.896019554335294,0.5882352941176471,1.0,1.0,2/8,7.70%,PDZRN3;ZC4H2
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.40787557428465965,-0.8959394491801432,0.7010309278350515,0.930455093460436,1.0,20/152,16.71%,MAP3K5;PRKAG2;PGK1;PKN3;GRK5;JAK1;PRKCE;SIK2;CDK14;DGKG;FGFR1;DCLK1;PAK2;TEC;TRIB2;STK38;CDK6;TBK1;PINK1;VRK2
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.5453873014517269,-0.8957641596544055,0.65625,0.9301935092754208,1.0,2/11,9.11%,GGT5;ANXA1
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.5353448971225527,0.8956387020778177,0.6578947368421053,1.0,1.0,4/8,18.62%,DTWD1;CDKAL1;PARN;ADARB1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5613914719264905,0.8955414888034184,0.6341463414634146,1.0,1.0,2/5,14.69%,ACVR1;RBPJ
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.5017881334583383,-0.895065351186895,0.5945945945945946,0.9307938407541879,1.0,3/17,16.65%,FES;PRKN;PINK1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.5515834617163187,-0.894579049183917,0.6417910447761194,0.9309045104687694,1.0,3/10,10.20%,ADSS2;GMPS;SLC26A2
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.5254677615045843,0.8943258701378313,0.6,1.0,1.0,2/5,23.13%,PDGFC;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.44744616900009254,-0.8938790748584792,0.5952380952380952,0.9316494416703339,1.0,16/50,20.29%,CX3CL1;RAPGEF3;RAP1A;TGM2;AFDN;LIMS1;RSU1;RGS7;LARS1;RACK1;PICALM;PINK1;PSAP;ITGB1;ECT2;CAV2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.5825799731951169,-0.8935508687919779,0.65625,0.9317302638442272,1.0,2/6,16.65%,SMAD7;PINK1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.5108487022433225,-0.89243050619279,0.691358024691358,0.9331364073870022,1.0,5/15,15.59%,BCAP31;HYAL2;PAK2;CYLD;RACK1
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.5008936418895947,-0.8922864205873445,0.6753246753246753,0.9327576576071669,1.0,3/10,14.50%,PNP;ANXA1;NCK1
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.48869650138172627,-0.8916844497791765,0.6388888888888888,0.9332012622470766,1.0,3/23,14.90%,SRGN;OGT;NAA16
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.48163256724314957,-0.8913698789190875,0.64,0.9331282345256895,1.0,8/17,29.93%,ANXA1;KLF4;GATA2;JCAD;DLL4;RHOJ;MAP2K5;RHOA
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),-0.508257972105027,-0.8904384924210784,0.631578947368421,0.934173915789565,1.0,7/18,19.60%,RFTN1;PTPRD;IL1RAPL1;PICALM;ANK3;CHMP4B;EMP2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.5961064751867191,-0.8900999254145638,0.7,0.9343108662112812,1.0,2/6,27.14%,HS6ST3;CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.49553235420000485,-0.8898401752695884,0.6714285714285714,0.9342735353513826,1.0,4/20,12.30%,CX3CL1;MBP;HYAL2;PLCG2
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),-0.5402104081124356,-0.8882990476768684,0.6567164179104478,0.9364619020136693,1.0,4/11,21.62%,GOLPH3;CTNNA1;ADAM15;ADCY2
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.5083797980098462,0.8879489502500455,0.6285714285714286,1.0,1.0,2/7,11.50%,MDM4;ACVR1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.5096647860034567,-0.8878933602086919,0.6619718309859155,0.9365826223765927,1.0,4/12,18.43%,VAV3;MSN;LARS1;MTOR
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),-0.4840758875681659,-0.8875957722405219,0.5972222222222222,0.9364714966184489,1.0,5/17,24.41%,SIK2;OGT;NCK1;VWA2;TNS2
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.4760343740319204,-0.88711369571769,0.6351351351351351,0.9365992910035993,1.0,2/22,1.75%,LAMC1;NR4A1
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.5941900720064432,-0.8867469231584593,0.6268656716417911,0.9365895316989796,1.0,3/5,38.65%,DNM2;ASAP1;WASL
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.5189945069835327,-0.8859561457341634,0.5942028985507246,0.9376203809762742,1.0,5/11,25.26%,YBX3;SERPINB6;SCN2A;STK39;ARHGEF2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.465830283637511,0.885809713944861,0.5483870967741935,1.0,1.0,2/7,8.98%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.6260360989809433,-0.8852511327297298,0.7407407407407407,0.9382454890954048,1.0,3/5,34.29%,IFITM3;LY6E;GSN
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),-0.5326999277210223,-0.8851001406034131,0.6428571428571429,0.9379099227558547,1.0,8/10,46.16%,TERF2IP;USP7;DHX36;SMG1;SMG6;XRCC5;PPP1R10;YLPM1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),-0.5756716175787787,-0.8850448540060336,0.746031746031746,0.9374233258026001,1.0,2/6,15.19%,CHPT1;LPIN2
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),-0.5043185241018601,-0.8849883421375343,0.6119402985074627,0.9368796905293417,1.0,4/11,18.91%,ATP2B1;SLC8A1;CACNA1C;MICU2
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.5496419369159687,-0.8849853554543379,0.6666666666666666,0.9362863298250595,1.0,3/8,24.67%,PTTG1IP;MSN;HSP90AA1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.5688095606152532,-0.8848112048285781,0.7313432835820896,0.9359456798421908,1.0,2/7,3.93%,MGLL;SCP2
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.46013617575786603,-0.8840372252324634,0.6216216216216216,0.9366198167675717,1.0,5/21,18.03%,SSH1;PRKCE;HIP1R;NCK1;KANK3
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.4892601402584268,-0.8833070741869833,0.6557377049180327,0.937228386706073,1.0,7/15,29.61%,S1PR1;GOLPH3;PARVB;ITGB1;CCDC88A;VCL;RAC1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.5592579032506337,-0.8833036573976915,0.6714285714285714,0.9366435053742265,1.0,4/7,26.43%,EGFL7;GATA2;EGFR;DLL4
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.4815824843299964,-0.882437049117554,0.6493506493506493,0.9375887512158738,1.0,5/15,10.25%,SRGN;ATP2B1;GPM6B;SLC8A1;S1PR1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.5405942873795102,-0.8824345006700516,0.6507936507936508,0.9369900355382136,1.0,3/8,20.16%,PRKN;MT1M;SLC30A1
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.541190542421814,-0.881675904134397,0.6666666666666666,0.9377545782413323,1.0,2/11,20.35%,PIK3R1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.5484723514484421,-0.8814178865042227,0.6363636363636364,0.9375936738564806,1.0,5/10,27.36%,DLC1;PPP1R16B;CDH5;PTBP1;SPPL3
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.45890975366214726,0.8812540580678888,0.5172413793103449,1.0,1.0,6/12,13.28%,ACAT1;HSD17B4;HADHB;AUH;PPARD;DECR1
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),-0.46516192567385556,-0.8811608296985666,0.7164179104477612,0.9373685176437947,1.0,3/23,17.29%,JAG2;NOTCH4;ROBO2
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.5208750748955,-0.8804766565399679,0.6891891891891891,0.9380669424890427,1.0,4/12,13.86%,MGLL;SCP2;ACSL5;ACOX1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5897490684072862,-0.8799703229321021,0.6515151515151515,0.9384497565825086,1.0,5/6,40.77%,CLU;NACC2;CXCL12;TPT1;BCL2L1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.5636960877539173,-0.8798146257341137,0.7101449275362319,0.9381101140570535,1.0,4/8,25.95%,HSPA5;VAPB;DNAJC3;SERP1
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),-0.5418461684473316,-0.8795540179979044,0.6363636363636364,0.9380566501450845,1.0,2/9,7.57%,DMD;SLC8A1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.45846587261565397,0.8795442467149539,0.696969696969697,1.0,1.0,3/11,14.21%,ASCC3;MTERF1;MCM9
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),0.5504093465431216,0.879246035447372,0.5714285714285714,1.0,1.0,1/6,3.75%,MRPS31
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.5221582399490294,0.8787624628730536,0.631578947368421,1.0,1.0,1/5,1.27%,CTBP2
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.36559293359466416,0.8785819669049714,0.75,1.0,1.0,13/42,17.08%,GBP2;GBP1;DCP1A;COG3;UBAC2;BICD1;CEP68;TRAM2;CNTLN;GBF1;APP;MDM2;RIPOR1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.4067994319834895,0.8783102797947702,0.5789473684210527,1.0,1.0,4/18,9.51%,IL15;NOVA1;NOVA2;ID1
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.4743837201631145,-0.8782935810980373,0.6111111111111112,0.9396595325080906,1.0,1/15,1.12%,NDRG1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.4645295653283075,-0.8777575447102725,0.6891891891891891,0.93993334423703,1.0,7/24,19.76%,LAMP2;IPO7;TPR;PTTG1IP;RAB8B;KPNB1;CLU
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.552613154677825,0.8776836628740124,0.71875,1.0,1.0,1/5,12.30%,ROCK1
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.5269657905373126,-0.8776218928504154,0.6891891891891891,0.939607882527657,1.0,3/12,23.21%,RACK1;GLI3;GPC3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5262145749151154,0.8776013236701491,0.65,1.0,1.0,3/5,26.43%,IGF1R;GSPT1;CLEC16A
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.5384263868541422,-0.8770460876827251,0.6363636363636364,0.9399668863483602,1.0,2/7,29.22%,CBR4;ABHD2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.48300932305569977,-0.8770373161906524,0.6582278481012658,0.9393925796875231,1.0,9/15,24.67%,HIF1A;NOSTRIN;NOS1AP;ZDHHC21;SCARB1;EGFR;PIK3CB;DNM2;HSP90AA1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.5333617835523861,-0.8767877767847324,0.6527777777777778,0.9391392440504541,1.0,4/12,18.73%,KLF6;PLCG2;MALT1;ITGB1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.48423884157412256,-0.8765692221013784,0.7105263157894737,0.9390142454542445,1.0,7/29,19.81%,BTG2;GAPDH;RPL13A;CST3;RACK1;PLAT;GIGYF2
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.4381998066364674,-0.8763156024210211,0.7160493827160493,0.9388112222450385,1.0,12/46,14.16%,PGK1;PPA1;ALPL;PTPRD;DUSP16;PLCG2;PAK2;DUSP5;INPP5D;PPA2;SLC20A1;PLPP1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.49352974717954273,-0.8763004145652143,0.6623376623376623,0.9382390981952928,1.0,12/22,25.74%,RFTN1;AFDN;ZDHHC6;SDCBP;ZDHHC21;PIKFYVE;EGFR;ZDHHC14;VPS37A;CHM;RAB11A;ZDHHC20
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.5633609912353634,-0.8762760616671595,0.6935483870967742,0.9377031896903005,1.0,2/5,25.66%,RPS19;RPS14
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.41933648135928714,-0.8761127524303555,0.6506024096385542,0.9374375321368709,1.0,5/49,8.84%,PSMC6;PSMB9;RPS27A;PSMA1;UBC
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.4648800353759497,-0.875293523922328,0.6233766233766234,0.938214378758155,1.0,8/23,25.15%,MAP3K5;CDKN1A;LARS1;ATF2;MTOR;MAPK8;ATP6V1E1;WDR59
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.3978992927022984,-0.8752317405560003,0.6629213483146067,0.9377290953401083,1.0,25/63,30.68%,MYO9B;ARHGAP21;VAV3;DLC1;TGM2;ARHGAP23;GNA13;FGD4;RASGRF2;FAM13A;ARHGAP29;ARHGAP15;ARHGAP17;ECT2;KALRN;ARHGEF2;BCR;PREX1;MCF2L;RHOB;RHOJ;TRIO;RAC1;RHOA;STARD8
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.5626631828279589,-0.8751481017055137,0.7536231884057971,0.9373081493470636,1.0,2/7,10.15%,TRAM1;PRNP
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.49661690659440805,-0.8745688716423013,0.6486486486486487,0.93775810504761,1.0,3/15,12.30%,KLF6;JAG2;PLCG2
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.5640088919193711,-0.8743003863750424,0.6451612903225806,0.9376700423139643,1.0,2/6,9.80%,NPLOC4;HERPUD1
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.4381130508941328,0.8742697709707764,0.5882352941176471,1.0,1.0,4/8,15.91%,TGFBR3;TEK;RBPJ;ADGRG6
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.4633234809379616,-0.8742318623897278,0.6753246753246753,0.9372357931179679,1.0,4/19,11.95%,DMD;TPM1;WIPF1;MEF2A
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.5249371957686689,-0.8742031254161025,0.6567164179104478,0.9367102727744882,1.0,4/10,16.65%,HIF1A;PRKN;EPAS1;PINK1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.35044749961872357,0.8736215976675578,0.6785714285714286,1.0,1.0,2/27,3.61%,BMP6;TTN
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.521242375737311,-0.8735709749608181,0.7272727272727273,0.937251232839236,1.0,5/11,32.67%,NOTCH4;TIE1;DLL4;RASIP1;LRP6
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.5215700518990676,-0.8734225232952599,0.6708860759493671,0.9369732519280748,1.0,2/10,11.95%,DMD;MEF2A
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.4296489937916053,-0.873239254563453,0.6835443037974683,0.9366956198009928,1.0,7/37,15.17%,GRIN2B;VAV3;ANKS1B;EFNB2;ARPC2;SDCBP;ANKS1A
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.4718576854666674,-0.8731070003901638,0.6623376623376623,0.9363549295783701,1.0,5/24,20.19%,RAD21;PRKCE;TPR;CSPP1;ECT2
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.5094768320709215,-0.8729859558400379,0.6621621621621622,0.9359442590687513,1.0,4/17,19.60%,CX3CL1;LIMS1;CDK6;EMP2
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.4253566104042896,-0.8728039017320528,0.7051282051282052,0.9355903933655272,1.0,2/42,4.20%,YTHDC1;KHDRBS3
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.5246175329138698,-0.872637393782442,0.7105263157894737,0.9352299386382463,1.0,6/13,26.72%,VAV3;CD81;SH3KBP1;RIF1;CD320;CD74
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,-0.4671837817758054,-0.872095113527116,0.7692307692307693,0.9354953833381214,1.0,5/25,15.86%,PDE5A;GRIA2;CTNND2;PLP1;CADM2
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.4256712582627156,0.8717395889844637,0.5,1.0,1.0,1/10,0.16%,BMP6
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.4256712582627156,0.8717395889844637,0.5,1.0,1.0,1/10,0.16%,BMP6
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.5209872503879003,0.8715909000144775,0.6470588235294118,1.0,1.0,1/6,4.91%,CLASP1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.5772194243177645,-0.8713206051109558,0.7692307692307693,0.9362802071051417,1.0,2/6,25.52%,MEF2A;MTM1
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),-0.565097111602175,-0.8708623267234029,0.6724137931034483,0.9362919898034969,1.0,2/6,22.60%,CACNA1C;MAPK8
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.46015959495610964,0.8702362532155092,0.5641025641025641,1.0,1.0,3/6,19.58%,WWC3;LATS1;PTEN
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.5309530168533426,-0.8696017927037135,0.6612903225806451,0.9376855851291129,1.0,2/8,17.45%,BCL6;LCP2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.49652456005241447,-0.8689109765940771,0.625,0.9381731547908599,1.0,7/11,25.07%,ANK2;CTNNA3;CACNA1C;NOS1AP;DLG1;DSP;CAMK2D
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.4570759213199427,-0.8686642291242695,0.6623376623376623,0.9380716456155455,1.0,8/24,25.15%,MAP3K5;CDKN1A;LARS1;ATF2;MTOR;MAPK8;ATP6V1E1;WDR59
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.4904124079696348,0.8683128395275631,0.6041666666666666,1.0,1.0,3/6,24.30%,ATM;CREB1;ABL2
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.46160989515617507,-0.8681038030381983,0.6410256410256411,0.9385513659366947,1.0,5/17,18.65%,SLC6A6;SLC16A6;SLC38A2;PSAP;SLC16A14
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.48073745667197365,-0.8680535709545196,0.6056338028169014,0.9380719160685748,1.0,2/13,6.19%,HES1;ERBB4
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.3736088046173785,0.8670020923344534,0.68,1.0,1.0,1/27,0.16%,BMP6
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),0.5579872768385776,0.8667957841562189,0.71875,1.0,1.0,1/6,0.42%,RSAD2
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.538815305039967,-0.8667379063633924,0.7014925373134329,0.9399285671197635,1.0,3/8,19.76%,PRKN;PINK1;CLU
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4465347533548984,-0.8664731248815788,0.6075949367088608,0.939798266064459,1.0,3/28,7.84%,PPARG;SMAD7;SULF2
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.44045686254105243,0.8655906965911955,0.6153846153846154,1.0,1.0,1/11,2.82%,IL1R1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.4331618898247346,0.8653631079949158,0.65625,1.0,1.0,4/13,19.52%,TEAD4;FAT4;STK4;LATS1
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.49894767237727855,0.8644625921238344,0.6086956521739131,1.0,1.0,3/6,23.16%,PARP9;PARP11;PARP4
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.4707042442303132,-0.8635531423359983,0.6438356164383562,0.944074927382604,1.0,4/15,16.65%,PRKN;GOLPH3;SREBF2;PINK1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.3533828136724749,0.86337291883489,0.75,1.0,1.0,6/35,9.08%,ZNRF3;ARNT2;PTPN21;SLC23A2;SLC38A3;ABCG2
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.5318209554863855,-0.8630851905002237,0.6470588235294118,0.9443051467111504,1.0,1/10,0.90%,UFL1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.4901507230619351,-0.8626954636833302,0.65,0.9443955769176368,1.0,3/16,16.49%,REL;RIOK3;TBK1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.5769475002418447,-0.8622859153623158,0.6956521739130435,0.9445974283456939,1.0,1/5,15.46%,CDK6
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.44352433610452124,-0.8622348312012882,0.7297297297297297,0.9441232773483225,1.0,14/35,25.68%,PLS3;NES;TPM1;EFNB2;GJA1;VEGFC;WWTR1;CALD1;PLAT;GLI3;CTTNBP2NL;SERPINH1;CNN3;MID1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.5506347622189627,-0.8621597126989222,0.6557377049180327,0.9436706005006051,1.0,3/8,24.83%,RAB1A;PINK1;ARRDC3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.5632066723750487,-0.8611902402993451,0.7285714285714285,0.9447631357545542,1.0,1/6,5.50%,WDR48
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.5440317523696743,-0.8609643051959583,0.6229508196721312,0.9446583024017273,1.0,2/7,18.54%,AP1G1;PIKFYVE
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.500979466674318,-0.8605988756619164,0.6567164179104478,0.9445674972804428,1.0,6/12,28.02%,KLF4;RACK1;ACVRL1;ACVR2A;STAT5B;MAP2K5
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.4541113727764696,-0.8605343793502297,0.7125,0.9440809400422516,1.0,7/30,19.42%,ANXA1;KLF4;ADAMTS1;CDKN1A;CDK6;DLG1;EGFR
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),-0.4202785302242064,-0.8603792882495065,0.6987951807228916,0.9437754420397321,1.0,6/33,12.72%,PIK3R1;RAPGEF3;TPM1;DLC1;TMEFF2;PAK2
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.47053494786039185,-0.8602909738062036,0.640625,0.9433038472419208,1.0,6/12,30.36%,GAS7;SPIRE1;PREX1;FAM107A;RAC1;MICALL2
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.4906622424659831,0.8596409737355181,0.6428571428571429,1.0,1.0,3/6,17.32%,TAPT1;SEPTIN9;ARHGAP35
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.49977370092480966,0.8595961389587083,0.6842105263157895,1.0,1.0,1/7,0.16%,BMP6
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.559916804358144,-0.8592160753068694,0.7049180327868853,0.9445034789865053,1.0,1/6,5.42%,FES
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.4695259753674483,0.8591790520078196,0.631578947368421,1.0,1.0,2/9,7.33%,STX8;EEA1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),-0.5653319872071868,-0.8589310017534117,0.746031746031746,0.944468472128978,1.0,3/7,10.25%,SMAD7;TPM1;S1PR1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),-0.4720471694170701,-0.8586471254879341,0.6944444444444444,0.9442742657650961,1.0,2/20,4.57%,PPARG;SMAD7
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.5045948326908956,-0.8586224689886613,0.6567164179104478,0.9437412514037526,1.0,3/11,18.01%,TPR;NPM1;NUP54
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.48955298642783096,-0.8583277077207851,0.6764705882352942,0.943644542590234,1.0,3/17,15.46%,S100A6;CDKN1A;CDK6
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.5387981387672535,-0.8574264314749707,0.7333333333333333,0.9445845755940515,1.0,4/8,24.70%,KPNB1;CHMP4B;EML4;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.32165906634997005,0.8572171071277583,0.5,1.0,1.0,3/33,4.28%,ATG10;CPEB3;LARP4B
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.550627250406095,-0.8570317463713675,0.65,0.9439349246392872,1.0,2/5,32.03%,HLA-B;HLA-E
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.550627250406095,-0.8570317463713675,0.65,0.9439349246392872,1.0,2/5,32.03%,HLA-B;HLA-E
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.44433832801954043,0.8568805087864501,0.6538461538461539,1.0,1.0,2/11,2.15%,HOMER1;HOMER2
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.38537513670764945,0.8567321307524639,0.6896551724137931,1.0,1.0,4/20,7.84%,ATR;RHBDD1;INO80;TAF1
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.3569798335214687,0.8564715254402044,0.6818181818181818,1.0,1.0,4/30,5.68%,ALS2;DISP1;RNF213;CLYBL
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.5572593058476178,-0.8563675605015659,0.676056338028169,0.9444660607737638,1.0,2/6,27.14%,CHST11;CSGALNACT1
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5886438801054753,-0.8562616001922341,0.711864406779661,0.9440107232231564,1.0,1/6,27.84%,WTAP
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.43571477109519186,-0.8562409240230917,0.7625,0.9434525995274631,1.0,15/45,24.67%,RTN4;DMD;HIP1R;TPR;NCK1;SMAD3;SGIP1;TBCD;PICALM;CHMP4B;CLU;CLTA;DNAJB14;SNX9;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.48416928298024137,-0.8560031103332416,0.6716417910447762,0.943225659567154,1.0,7/11,25.07%,ANK2;CTNNA3;CACNA1C;DLG1;PDE4B;DSP;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.4990036467688479,-0.8559746847929048,0.6623376623376623,0.94270310615333,1.0,2/13,11.71%,RPL23;RPS7
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.4493315191136754,0.8554416462178396,0.6153846153846154,1.0,1.0,6/12,13.28%,ACAT1;HSD17B4;HADHB;AUH;PPARD;DECR1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.5405947027402331,-0.8551666540572767,0.6363636363636364,0.9433434026350519,1.0,2/5,15.72%,RB1CC1;PIK3C3
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.45163960850454926,-0.8551096725553274,0.7349397590361446,0.9428626530835241,1.0,3/25,8.84%,RPS27A;HMGN1;UBC
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.4730789524409301,0.854556060459697,0.6176470588235294,1.0,1.0,2/6,9.64%,TENT2;ATM
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.4730789524409301,0.854556060459697,0.6176470588235294,1.0,1.0,2/6,9.64%,TENT2;ATM
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.5445976425780018,-0.8542198382418252,0.6666666666666666,0.9436600465534095,1.0,5/7,36.63%,CACNA1C;ATP1A1;CAMK2D;GSN;CACNA2D1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.3602787073553702,0.8538761397096725,0.5333333333333333,1.0,1.0,3/22,4.91%,INO80;OFD1;CLASP1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.49397002468164913,-0.8521130910124518,0.7142857142857143,0.9463647637539634,1.0,3/8,17.56%,LGALS3;PICALM;MTMR2
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.4438960788543218,0.8517436525209756,0.6363636363636364,1.0,1.0,3/12,6.85%,STX8;GBP1;ZDHHC2
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.5745100426253735,-0.8515826245651816,0.7611940298507462,0.9466582516667101,1.0,3/8,21.43%,OGT;KMT2A;SETD3
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),-0.5405418287810656,-0.85128106338003,0.711864406779661,0.9465400211616594,1.0,2/6,11.02%,FLT1;FGFR1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.4926500969622447,-0.851035234585145,0.6825396825396826,0.9463739720700637,1.0,6/14,31.42%,ACTN1;MYL12A;PIK3CB;VCL;STXBP3;STXBP1
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.4996232567762967,-0.8503088643081237,0.6268656716417911,0.9471394056047068,1.0,1/13,2.34%,SLC6A6
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.5328119350028965,-0.8494236649725319,0.7230769230769231,0.9480955242213873,1.0,3/7,38.59%,SPCS3;SRP14;RAB3GAP2
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.33257287207800174,0.8493732024747085,0.7142857142857143,1.0,1.0,4/36,5.79%,ANKRD6;TPD52L1;TGFBR3;MFHAS1
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.4285746166053426,-0.8492306103548889,0.6966292134831461,0.947853599130933,1.0,17/36,25.07%,JUN;FOS;CDKN1B;PRKN;PRNP;MEF2A;PLCG2;SYT1;ANK3;MT1M;EGFR;ECT2;RYR3;B2M;MAPK8;TF;CAMK2D
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.44526293455703814,0.8489297277410084,0.6136363636363636,1.0,1.0,2/11,8.29%,PPP1R13B;YWHAG
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.44526293455703814,0.8489297277410084,0.6136363636363636,1.0,1.0,2/11,8.29%,PPP1R13B;YWHAG
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.3691006433600067,0.8487449037760748,0.7857142857142857,1.0,1.0,7/32,16.47%,PRKD1;TAF1;ACVR1;ROCK1;MARK2;HIPK2;GALNT2
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.4860738014967911,-0.8479136512612968,0.7142857142857143,0.9495941627791732,1.0,7/13,23.37%,ARF1;MAGI2;SDCBP;MTMR2;LRPAP1;CD63;AHI1
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),-0.45747957802616546,-0.8477220710684374,0.7261904761904762,0.9493516207960886,1.0,2/23,2.63%,SEC22B;SEC24D
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.47095693514454917,-0.8475206475766298,0.625,0.9490752392775974,1.0,1/15,2.82%,HES1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.5506133499673835,-0.8470797553274796,0.703125,0.9493723004296343,1.0,1/5,17.24%,DCP2
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.5374357868864877,-0.8465973923471949,0.7301587301587301,0.9495394483732751,1.0,2/6,25.68%,BCAR1;MID1
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5126776417447554,-0.8462549737130003,0.7,0.9497268368746236,1.0,2/13,3.77%,GRIK1;GRM7
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.42185590481918284,-0.8461634814234115,0.6746987951807228,0.9492465890255402,1.0,14/35,30.23%,IL1RAPL1;KLF4;SMAD3;RACK1;TBK1;IL18R1;ROBO2;ACVRL1;MAPK8;ACVR2A;STAT5B;MAP2K5;RHOA;STAT3
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.48046858871045495,0.8456951681076361,0.6774193548387096,1.0,1.0,2/6,8.98%,CLASP1;PHLDB2
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.5042986815678998,-0.8452246035538764,0.7066666666666667,0.9500260649728093,1.0,4/13,18.80%,CX3CL1;SULF2;B4GALT1;ATP8B1
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.3671029220445565,0.8441042414951424,0.8235294117647058,1.0,1.0,6/29,15.33%,PRKD1;TAF1;ACVR1;ROCK1;MARK2;HIPK2
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.41666519654205736,-0.8440392751615842,0.7411764705882353,0.9514984066686931,1.0,14/69,17.61%,PPARG;CX3CL1;KDM1A;ESR2;RPS27A;UBC;PLCG2;NPM1;NFKBIA;SMAD3;CRTC3;MALT1;IL18R1;ATF2
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.41335298364596595,0.8433409351988354,0.75,1.0,1.0,1/12,3.43%,ATP10D
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.513004314726554,-0.8432641607217587,0.703125,0.9521872040536057,1.0,5/10,19.73%,KLF2;CPEB4;LARS1;MTOR;SPAAR
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),-0.5342020732061101,-0.8427658830795195,0.7096774193548387,0.9523248684672089,1.0,1/7,21.51%,PRKAR1A
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.4189875115921452,0.8422811011112644,0.6428571428571429,1.0,1.0,2/9,9.91%,ATM;NEK7
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.46801353544452423,0.8421261778137824,0.6923076923076923,1.0,1.0,1/6,1.73%,RARB
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.545884745634951,-0.8420183447258349,0.7083333333333334,0.9517942323537727,1.0,1/5,23.05%,STK39
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.545884745634951,-0.8420183447258349,0.7083333333333334,0.9517942323537727,1.0,1/5,23.05%,STK39
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.545884745634951,-0.8420183447258349,0.7083333333333334,0.9517942323537727,1.0,1/5,23.05%,STK39
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.48392432935761914,0.8412520622019257,0.6451612903225806,1.0,1.0,1/6,2.52%,MSL2
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),-0.44597565693668173,-0.8409564559036583,0.7567567567567568,0.9529755270802854,1.0,9/23,23.77%,ATP2B1;SLC8A1;ANK2;ATP13A3;SLC30A1;TMEM165;VAPB;CDH5;CALR
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.5172488292885685,-0.8397013144772102,0.7230769230769231,0.9542976381053981,1.0,1/7,5.58%,ARHGAP21
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4076035526696801,0.8392708910945934,0.6428571428571429,1.0,1.0,1/15,1.20%,GCNT2
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.507842058040523,-0.8389892229983535,0.6865671641791045,0.9549006133726478,1.0,3/9,9.11%,PRKCE;SCARF1;ANXA1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.5658824773260813,-0.8389250894656842,0.7777777777777778,0.954440726706821,1.0,1/6,11.63%,CTNND2
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.44656900393948895,-0.8382129738515312,0.7125,0.9550428902778397,1.0,5/20,10.89%,NFASC;GRIA2;CNTN1;PTPRD;SHC2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.5463114698523721,-0.8379181124965772,0.7681159420289855,0.95501592301957,1.0,2/6,9.83%,NFE2L2;SOD2
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.4462542445747763,0.8377114184866409,0.5897435897435898,1.0,1.0,1/9,1.22%,UGCG
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.4140614643886794,-0.8374459322906949,0.7228915662650602,0.955130801171966,1.0,3/42,4.86%,SPNS2;CHPT1;DMD
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.42066101701808917,0.8373998662353129,0.59375,1.0,1.0,3/11,12.88%,UIMC1;ATM;BABAM2
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.5074066292207193,-0.8372956417221857,0.704225352112676,0.9547663663047885,1.0,3/10,18.73%,KLF6;PLCG2;ITGB1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),-0.5397541559252175,-0.8368773450519779,0.7333333333333333,0.954840786983784,1.0,1/6,4.54%,LRRC32
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.4499082740758598,-0.8367315049994011,0.6351351351351351,0.954537630947179,1.0,6/17,19.26%,NFKBIZ;PECAM1;DYSF;LCP2;PSAP;IFITM3
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.5425098315369434,-0.8367239243842753,0.7391304347826086,0.953972102986089,1.0,6/8,43.24%,ADGRG1;RAC1;ARHGEF3;GPR174;LPAR6;PRAG1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.5168472927108297,-0.8365089857910235,0.6956521739130435,0.9537304256329548,1.0,1/10,1.09%,BTG2
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.43608891536791894,-0.8348946459089284,0.6962025316455697,0.9555547601674695,1.0,7/30,20.35%,CX3CL1;GPM6B;CDK6;ADAM15;EMP2;ACER2;PIK3CB
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.4282133484726345,0.8347065690176545,0.7407407407407407,1.0,1.0,2/14,9.64%,ATR;ATM
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.5112671992792942,0.8345851915099357,0.7777777777777778,1.0,1.0,2/7,20.00%,NCOA3;ZNF706
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.3974273574636391,0.834338892959001,0.6578947368421053,1.0,1.0,1/10,7.36%,SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.4409697756760616,-0.8343036088195567,0.7341772151898734,0.9558638512339339,1.0,4/20,28.18%,CNOT6L;SDCBP;CCDC88A;DYNC1H1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.351447555978563,0.8337869684403135,0.76,1.0,1.0,4/26,8.71%,BMP6;PRKD1;HSPA1A;CARMIL1
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.39142783039500817,0.8336797805536341,0.7777777777777778,1.0,1.0,3/17,8.98%,WDPCP;CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.45496206635121417,-0.8336188622187927,0.7297297297297297,0.9563876346192006,1.0,3/19,9.08%,YTHDC1;ZC3H7A;RPL10
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.4516787190734672,0.8335827802351466,0.7333333333333333,1.0,1.0,2/10,9.48%,PLA2G4A;GPD1L
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.4516787190734672,0.8335827802351466,0.7333333333333333,1.0,1.0,2/10,9.48%,PLA2G4A;GPD1L
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.5421796509270629,-0.8335491102434153,0.6984126984126984,0.9559435911108403,1.0,2/5,9.72%,SLC4A10;SLC4A7
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.36888604452807827,0.8329689087440719,0.6086956521739131,1.0,1.0,1/14,1.65%,PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.41921803402498614,0.8327849217579618,0.75,1.0,1.0,4/12,11.42%,OCLN;CLASP1;HSPA1A;CLIP1
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.4430577146850823,-0.83217203334106,0.7283950617283951,0.9572185189288727,1.0,10/31,21.30%,SSH1;RAPGEF3;RAP1A;GOLPH3;CPEB4;LARS1;CTNNA1;MTOR;SPAAR;RYR3
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.3933482322780435,-0.8319900309537677,0.7528089887640449,0.9569086826083864,1.0,19/71,26.75%,PCK1;PKN3;PRKCE;PAK2;STK38;TBK1;PINK1;VRK2;MTOR;PIKFYVE;CSNK1D;MAPK8;PRKCH;STK39;RPS6KA2;CAMK2D;TNKS;TLK2;CSNK2A1
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.4537310484964451,-0.8317579784300669,0.7066666666666667,0.9567131950552479,1.0,2/20,9.19%,RFC3;KLF4
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.5160638189320081,-0.8312141658274078,0.704225352112676,0.9569199797060756,1.0,1/6,3.88%,LGALS3
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.44531657016097165,-0.8308795018764319,0.7948717948717948,0.9569524047875482,1.0,6/27,12.22%,CX3CL1;NFE2L2;GGT5;YBX3;HYAL2;ZFP36
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),-0.45905268469221383,-0.830826015967854,0.7323943661971831,0.9564426850268896,1.0,3/14,11.85%,SLC6A6;SLC8A1;ATP1B3
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.34816910856938676,0.8306326487438268,0.8333333333333334,1.0,1.0,6/29,10.41%,RC3H1;RBM20;NOVA1;NOVA2;HNRNPLL;TNFRSF1B
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5648519143862902,-0.8301941963042409,0.7285714285714285,0.9568499220060199,1.0,1/5,4.57%,SMAD7
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),-0.47076170624545516,-0.8295909930381398,0.6891891891891891,0.9572232509344638,1.0,3/12,11.85%,SLC6A6;SLC8A1;ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.43495253266607936,-0.8294679459165988,0.6904761904761905,0.9569414241797527,1.0,8/29,20.37%,SMAD7;RNF19A;PRKN;ARIH2;TRIB2;RACK1;CLU;CSNK1D
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.5401350989454468,-0.8283087884174984,0.7352941176470589,0.9570782701606468,1.0,2/9,4.41%,FOS;PPM1D
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.5401350989454468,-0.8283087884174984,0.7352941176470589,0.9570782701606468,1.0,2/9,4.41%,FOS;PPM1D
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.5401350989454468,-0.8283087884174984,0.7352941176470589,0.9570782701606468,1.0,2/9,4.41%,FOS;PPM1D
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.5408558535988658,-0.8280908468176015,0.7678571428571429,0.9568905063796486,1.0,2/7,8.92%,LGALS3;CD55
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.5109349781334045,-0.8272695257618539,0.7611940298507462,0.9575888691211694,1.0,4/9,38.83%,CD34;NFKB1;FYN;ATP2B4
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.45091774520658046,0.8266943816932207,0.6511627906976745,1.0,1.0,2/10,5.26%,NREP;TGFBR3
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.46892653637654746,0.8266437970004286,0.7073170731707317,1.0,1.0,2/8,11.08%,PPIP5K2;TPK1
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.41336176570388233,-0.8264831562045035,0.6712328767123288,0.9576658109674039,1.0,3/29,7.81%,SLC6A6;SLC2A3;SLC2A1
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.41336176570388233,-0.8264831562045035,0.6712328767123288,0.9576658109674039,1.0,3/29,7.81%,SLC6A6;SLC2A3;SLC2A1
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,-0.42259894023370537,-0.8264355562541793,0.6794871794871795,0.9571722849907012,1.0,3/28,7.25%,MAP1B;NES;SMARCA1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.4239973246207395,0.8261664776381465,0.6333333333333333,1.0,1.0,1/12,0.16%,BMP6
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),-0.4682757199193251,-0.8258506045156289,0.72,0.9575897317728853,1.0,8/17,28.21%,CANX;SGIP1;PICALM;PIP5K1C;CLTA;INPP5F;FCHO2;DNAJC6
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.48703763532499617,0.8256889119472672,0.7352941176470589,1.0,1.0,1/6,4.99%,HSPD1
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.5176224136902989,-0.8250564773842384,0.6724137931034483,0.9582789762928045,1.0,2/6,12.40%,RIMS1;RIMS2
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),-0.531823222103286,-0.824995312670825,0.7258064516129032,0.9578191492953398,1.0,4/5,38.54%,AHCYL1;ZFP36L1;DHX36;PAPOLA
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.45771487117202814,-0.8248590044603967,0.7066666666666667,0.957472633109817,1.0,5/18,19.44%,GRIA2;CDK14;DPP10;NARF;MTUS2
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.43645289287826344,-0.823850169189476,0.7236842105263158,0.9584789425110689,1.0,5/28,14.05%,PKM;RPS9;YBX3;NPM1;CNBP
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4221232990465853,-0.8232396752688746,0.7341772151898734,0.958854634669122,1.0,9/23,24.25%,TMSB4X;LIMS1;NFKBIA;CYLD;DLG1;PPM1A;EGFR;SASH1;TERF2IP
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.39260818563584504,-0.8231935693522026,0.7037037037037037,0.9583425788648343,1.0,4/47,4.91%,NR4A1;PPARG;TAF1D;ESR2
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.49814380229155464,0.8230783739840987,0.7419354838709677,1.0,1.0,1/7,3.80%,RALA
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.5018193510843496,-0.8230198558267856,0.6764705882352942,0.9580627485177469,1.0,4/8,21.17%,OGT;RIF1;KMT2A;MTF2
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),-0.5510247563795129,-0.8228865306045277,0.8103448275862069,0.957770019805148,1.0,2/5,15.38%,DHRS7B;PAFAH1B1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.4166952094195316,0.8228704809205502,0.6206896551724138,1.0,1.0,3/10,12.27%,COG3;COG6;COG5
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),-0.47487482860329416,-0.8228679376592736,0.7222222222222222,0.9572330656566723,1.0,2/11,3.32%,ENPP2;CHPT1
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.4873649845898558,-0.8227851879221615,0.7846153846153846,0.9568024405957227,1.0,5/11,30.07%,ROBO2;PLXNA2;MAP3K13;RHOA;CDKL5
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.5259271471523785,-0.822780221520738,0.75,0.9562468792274815,1.0,3/6,19.18%,DLG1;ACVRL1;CD34
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.5033555721452818,-0.822773092894023,0.7313432835820896,0.9556985686605237,1.0,2/9,15.83%,NPM1;MALT1
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.4402697599226516,-0.8220172338722225,0.7402597402597403,0.9562258016924706,1.0,2/22,7.49%,NDRG1;HIF1A
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.49984287718429804,-0.8219072013303534,0.6923076923076923,0.9558165494994127,1.0,4/9,35.35%,LCP2;FGR;MAP3K8;MAP3K2
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5417710166478832,-0.8204694310706097,0.7096774193548387,0.9574760159142077,1.0,3/7,26.80%,GOLPH3;ITGB1;GCNT1
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.441587839660451,-0.8188717088340013,0.6714285714285714,0.9591401209107366,1.0,2/14,13.17%,PPARG;CDKN1A
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),-0.4822678866813829,-0.8186825851555714,0.7681159420289855,0.9588614619696358,1.0,2/11,11.85%,SLC8A1;ATP1B3
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.43715457842347166,0.8168763341689044,0.59375,1.0,1.0,1/10,1.22%,UGCG
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.5507860236223947,-0.8166997948453054,0.7647058823529411,0.9614236092290526,1.0,1/5,18.43%,MTOR
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5230805214288381,-0.8166149435982096,0.7391304347826086,0.9609993713457787,1.0,2/7,9.54%,TPM1;ADAMTS1
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.5059661385848112,0.8160512383590701,0.7222222222222222,1.0,1.0,2/5,10.81%,SPG11;RAB27A
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.42387450808826427,-0.816022362528976,0.7682926829268293,0.9613440268126561,1.0,3/28,8.26%,CX3CL1;ERBB4;RAP1A
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.5119280616620479,-0.8159351029834013,0.6417910447761194,0.9603462537779259,1.0,3/7,16.25%,DMD;TPM1;MYL6
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.5119280616620479,-0.8159351029834013,0.6417910447761194,0.9603462537779259,1.0,3/7,16.25%,DMD;TPM1;MYL6
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),-0.4263770514837485,-0.8157514578726812,0.7763157894736842,0.9601072026383851,1.0,9/20,28.37%,HIP1R;ANXA1;GATA2;KMT2A;GPC3;CALR;NEDD4L;DYNC1H1;ANXA2
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.5677506028111964,-0.8155787983907216,0.7647058823529411,0.959757043184468,1.0,1/6,4.17%,EPS8
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.48715151922953526,0.8154114707194222,0.75,1.0,1.0,1/5,4.99%,HSPD1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.5126807400052377,-0.8153098048094155,0.7878787878787878,0.9596561296566423,1.0,4/9,25.07%,COMMD1;DLG1;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),-0.4613543138990961,-0.8152998300330729,0.7733333333333333,0.9591037597452808,1.0,7/15,30.23%,HIF1A;ZFP36;CDK6;HSPA9;ACVR2A;STAT5B;STAT3
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.5039000607602483,-0.8147268514072201,0.75,0.9593172994882647,1.0,4/10,18.73%,GJA1;PAFAH1B1;KPNB1;ITGB1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.48296118326181503,-0.813866476391614,0.7384615384615385,0.96000778706458,1.0,2/8,9.11%,PCK1;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.41157602542275584,0.8136408112631084,0.6764705882352942,1.0,1.0,1/8,5.79%,MFHAS1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.3804704579591422,-0.8133107655674451,0.8021978021978022,0.9602989505258102,1.0,19/71,19.18%,NRCAM;SLC6A6;PPARG;FES;RAP1A;AAMDC;FGFR1;GJA1;MEF2A;ZFP36;SDCBP;SMAD3;BTG1;WWTR1;CTNNA1;MTOR;ACVRL1;BOC;CD34
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.4608030292589811,-0.8127913146308301,0.6923076923076923,0.9605440702509181,1.0,2/13,11.16%,PIK3R1;LIMS1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.5276596958922962,-0.812655920700389,0.7352941176470589,0.960188554964664,1.0,4/5,26.19%,NPM1;MECP2;RAB11A;BRD4
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.48656053065944793,-0.8124068736004728,0.7162162162162162,0.9600486704164206,1.0,5/10,19.76%,PRKN;HERPUD1;TMBIM6;RACK1;CLU
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),-0.5291768960150726,-0.8121285669968541,0.7272727272727273,0.959752516706181,1.0,6/8,46.16%,TERF2IP;WAPL;SMG1;SMG6;XRCC5;YLPM1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.46277957809884684,-0.8120821085884606,0.7391304347826086,0.9592417378228403,1.0,1/8,10.25%,S1PR1
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.518260934305198,-0.8118125600042836,0.75,0.9590245198844447,1.0,1/9,1.09%,BTG2
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.4078433785609597,0.8117938070111471,0.7027027027027027,1.0,1.0,1/7,1.22%,UGCG
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.46042453215745816,-0.8116116678335503,0.7536231884057971,0.9588140601555024,1.0,4/16,14.37%,NR4A1;FLT1;ANXA1;VEGFC
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.4760080299348567,-0.8113938295792567,0.6756756756756757,0.9586623700134235,1.0,1/11,7.49%,HIF1A
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),-0.41532497946023456,-0.8113266936924333,0.7272727272727273,0.9582053963336797,1.0,10/28,23.77%,ATP2B1;SLC8A1;ANK2;MT1M;ATP13A3;SLC30A1;TMEM165;VAPB;CDH5;CALR
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.4218592444180881,0.8107698138254065,0.7307692307692307,1.0,1.0,4/14,9.19%,TBL1X;HDAC9;BAZ2A;TBL1XR1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),-0.5184423853405006,-0.810653309175343,0.7213114754098361,0.9584569463874092,1.0,1/5,15.41%,UPP1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.4085875931491881,-0.810598499129551,0.782051282051282,0.9579876361318637,1.0,11/33,25.29%,PAK2;TNFRSF10B;MALT1;PINK1;MTOR;EMP2;ECT2;PRKAR1A;ADCY2;CCDC88A;MAPKAP1
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.507496840691363,-0.8105552995984255,0.7536231884057971,0.9574864284521065,1.0,1/7,13.07%,NFKBIA
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.38889245422890534,-0.8105499934307169,0.8,0.9569404103121164,1.0,10/53,13.78%,AKAP12;ACTN1;TIMP3;TPM1;TNS1;DLC1;OGT;GJA1;NOSTRIN;PLSCR4
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.3962273126943218,-0.810539405794547,0.6666666666666666,0.9564144631132029,1.0,7/44,13.23%,SEC22B;NPLOC4;ARHGAP21;RAB2A;GOLPH3;TMED10;RAB1A
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.46437060820176235,-0.810362187269819,0.7424242424242424,0.9561093283738092,1.0,7/17,27.36%,DLC1;ENSA;ARPP19;PPP1R16B;CDH5;PTBP1;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.4279474093601497,0.8097568318624515,0.6756756756756757,1.0,1.0,6/14,29.51%,ABL1;MSH3;BCAS3;ABL2;WRN;PSEN1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.4111136806409356,-0.8097219329480446,0.7468354430379747,0.9564194727214784,1.0,2/25,4.41%,JUN;PPM1D
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.4906045396148011,-0.8073389621847114,0.676923076923077,0.9590387626082532,1.0,2/8,11.39%,RAPGEF3;TPR
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.48931032397189755,-0.8071521156305882,0.7183098591549296,0.9587843683979248,1.0,6/13,24.52%,NFASC;MBP;PLP1;CMTM8;SCN2A;ACER3
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.5676388810913927,-0.8066106559706305,0.828125,0.9589825896090205,1.0,4/5,41.27%,NEDD4;DAB2IP;PTPN1;MMRN2
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.46303823994797016,0.8062352502959393,0.6578947368421053,1.0,1.0,2/7,9.22%,ARNT2;CHD7
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),-0.44523670437400115,-0.8058006960389928,0.7605633802816901,0.9596261878288314,1.0,4/19,17.29%,RTN4;PAK2;LRRC4C;ROBO2
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,-0.38645423208167534,-0.8056204351461723,0.7333333333333333,0.9593460772428649,1.0,9/50,14.13%,MAP1B;NES;NFASC;ANK2;GJA1;DCLK1;ADGRL3;PLP1;NAV2
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.5515910487909942,-0.8055417074244775,0.7377049180327869,0.9583742170492308,1.0,2/5,25.98%,SOCS3;INPP5F
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.5515910487909942,-0.8055417074244775,0.7377049180327869,0.9583742170492308,1.0,2/5,25.98%,SOCS3;INPP5F
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.42129653710126214,0.805045535473876,0.6551724137931034,1.0,1.0,2/11,9.91%,ATM;NEK7
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.3829064949877017,0.805025243737463,0.7241379310344828,1.0,1.0,2/16,4.91%,EFNA5;CLASP1
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.4062252426900902,-0.8047340380806715,0.7466666666666667,0.9589200395247436,1.0,11/25,29.93%,GPM6B;HIP1R;DLC1;ARHGAP17;MTOR;CCDC88A;RHOB;FAM107A;CRK;RAC1;RHOA
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.4375919878098461,-0.8042956401147043,0.7714285714285715,0.9590273479081712,1.0,4/19,16.81%,HIF1A;FGFR1;LIMS1;NOTCH4
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.38092031709457724,-0.8028612503828325,0.797752808988764,0.9605954710298432,1.0,18/70,26.75%,PCK1;PKN3;PRKCE;PAK2;STK38;TBK1;PINK1;VRK2;MTOR;CSNK1D;MAPK8;PRKCH;STK39;RPS6KA2;CAMK2D;TNKS;TLK2;CSNK2A1
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),-0.49623141595660514,-0.8026069367750487,0.7571428571428571,0.96040581795172,1.0,3/10,19.42%,TIMP3;CST3;EGFR
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.5009221042926144,-0.8024292164641357,0.684931506849315,0.9601649539876491,1.0,4/9,29.30%,CLDN5;ZDHHC21;CDH5;VCL
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.4657817799649422,-0.8023772970771579,0.7384615384615385,0.9597123467399353,1.0,6/12,26.37%,ABCA5;STARD4;SCARB1;CLU;LIMA1;ABCG1
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.45251768039308904,-0.8018736362538537,0.7808219178082192,0.9597932112282038,1.0,9/16,28.21%,CANX;SYNJ2;SYT1;PICALM;PIP5K1C;DNM2;SYNJ1;FCHO2;DNAJC6
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.5386283089538044,-0.8011729690627774,0.8620689655172413,0.9602012743774242,1.0,1/5,5.50%,WDR48
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.5088462546538484,-0.8010172263142756,0.7164179104477612,0.9592724433673393,1.0,3/7,22.31%,LARS1;MTOR;UBR1
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.5088462546538484,-0.8010172263142756,0.7164179104477612,0.9592724433673393,1.0,3/7,22.31%,LARS1;MTOR;UBR1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.40683080339858513,-0.800244950887519,0.825,0.9597954223841174,1.0,8/33,24.67%,HSPA5;LGALS3;RIOK3;RACK1;PINK1;CLU;CDH5;HSP90AA1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.45995303208949423,-0.7998129553062412,0.7049180327868853,0.9598375920865283,1.0,2/15,10.86%,ACTN1;MYL12A
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.5456481778801503,-0.7994573272621072,0.7818181818181819,0.9598413185711151,1.0,1/5,11.82%,TMEFF2
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.5186493258626201,-0.7991244835818925,0.7619047619047619,0.9598450408138299,1.0,1/5,14.90%,NAA16
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.5683779191711731,-0.7983117343064204,0.8153846153846154,0.9603601122621424,1.0,1/5,15.96%,MCL1
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),-0.4357497042437189,-0.7978451335049274,0.75,0.960510465871743,1.0,6/20,18.43%,TIMP3;FOXK1;CST3;MCL1;MTMR2;MTOR
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.4230852645987082,-0.7977104468543434,0.8313253012048193,0.9602009535038704,1.0,5/32,7.46%,CX3CL1;GAPDH;JAK1;IFNGR1;IFNGR2
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.42249982722261803,0.7972772256628057,0.7428571428571429,1.0,1.0,2/12,5.26%,NREP;TGFBR3
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.46986951950743805,0.7972383196107794,0.8,1.0,1.0,1/5,1.73%,RARB
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.5222407191749409,-0.7969724926475695,0.7424242424242424,0.9607404694952615,1.0,2/6,21.97%,MTOR;ADAM9
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),-0.4978748349359374,-0.7969698444824883,0.78125,0.9601952138372053,1.0,2/8,18.83%,FOXF1;ACVRL1
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.39674209899884727,0.7967868281748031,0.7419354838709677,1.0,1.0,2/15,5.74%,PLPPR4;MTMR3
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.5077341685642096,-0.7966686013126615,0.7647058823529411,0.9600712468764577,1.0,3/7,28.50%,PRKAR1A;ADCY2;ADCY9
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),-0.3968118276011775,-0.7955300667947636,0.8169014084507042,0.9609539083998802,1.0,5/30,14.56%,TSG101;TBC1D15;NPM1;MSN;CYLD
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),-0.4856388382871275,-0.7950952069362107,0.7966101694915254,0.9609442502734908,1.0,1/8,14.90%,NAA16
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.3591824672614058,-0.7947858277683006,0.8111111111111111,0.9608455216093698,1.0,12/88,15.70%,EHD4;RAB11FIP3;EMP1;RAP1A;S1PR1;NUDCD3;GOLPH3;FGD4;RAB1A;PARVB;SDCBP;RAB8B
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.5040775629377184,-0.7947206548125472,0.6825396825396826,0.9604098585306062,1.0,2/6,32.03%,HLA-B;HLA-E
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.5421501960996367,-0.7943952664720756,0.7627118644067796,0.9603751014544728,1.0,3/6,26.80%,GOLPH3;ITGB1;GCNT1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.3975946631088245,0.7937261816071322,0.7857142857142857,1.0,1.0,7/15,15.11%,ACAT1;HSD17B4;HADHB;AUH;PPARD;DECR1;AIG1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.4636036194542007,-0.7935096466440159,0.7611940298507462,0.9611788703468133,1.0,2/11,11.39%,RAPGEF3;TPR
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.40721178969,-0.7932677285765977,0.8493150684931506,0.9609596091682575,1.0,6/23,17.34%,LAMP2;IPO7;TPR;PTTG1IP;PINK1;KPNB1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.4253174916635537,-0.7920548766845981,0.7702702702702703,0.9621428402093537,1.0,3/22,18.43%,LAMP2;SREBF2;MTOR
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.45622906985449435,-0.7917266291918303,0.7323943661971831,0.961999379513125,1.0,2/12,10.78%,PIK3R1;GPM6A
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.5211331163330362,-0.791614713944499,0.8461538461538461,0.9615708778062837,1.0,2/5,11.21%,LAMA5;RPL8
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.4595360228287292,-0.7914728523728798,0.75,0.9606393544534754,1.0,1/14,6.80%,ELL2
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.4595360228287292,-0.7914728523728798,0.75,0.9606393544534754,1.0,1/14,6.80%,ELL2
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.4167592782858688,-0.7913788945730112,0.7439024390243902,0.9602186694820107,1.0,8/24,24.44%,LGALS3;HIP1R;PICALM;RUFY2;MTMR2;LRPAP1;GPC3;NEDD4L
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.40273342455396177,-0.7908515124950533,0.8352941176470589,0.9603928739893063,1.0,9/30,19.42%,LGALS3;PIK3R1;PRKCE;DPP10;TMEM59;PICALM;DLG1;ITGB1;EGFR
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.3782563124164,-0.7906783704081269,0.8,0.9601497613587762,1.0,8/76,8.84%,BTG2;RFC3;RAD21;RPS27A;POLA1;WDR48;COMMD1;UBC
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.39891132453133027,-0.7901776655672397,0.8333333333333334,0.9602227453093114,1.0,4/31,11.18%,EPS8;PIK3R1;GPM6A;ARPC2
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,-0.40016448148110945,-0.7901745074349128,0.7790697674418605,0.9596832943288005,1.0,6/32,9.48%,ST18;ENPP2;GRIA2;GPM6B;MBP;ARSG
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.417767721435438,-0.7901150507793409,0.8055555555555556,0.959232780343151,1.0,12/33,21.97%,ADAMTS9;ACTN1;ITGA10;DLC1;ITGB5;PPFIA2;ITGB1;ADAM15;CD34;EMP2;CD63;ADAM9
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.46393286401485584,-0.7899841096592527,0.7536231884057971,0.9588584419636521,1.0,3/10,26.43%,TIE1;ROBO2;DLL4
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.4959237240317803,0.7899335639514788,0.7307692307692307,1.0,1.0,2/6,18.86%,HDAC9;HDAC4
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.3158343281179057,0.7898281302195966,0.8333333333333334,1.0,1.0,2/23,3.88%,TTN;INO80
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.40265805389908066,0.7896436727510123,0.6818181818181818,1.0,1.0,1/14,2.84%,RHBDD1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),0.41684857226130667,0.7894713837100173,0.6756756756756757,1.0,1.0,3/8,22.12%,ATP6V1H;DMXL1;CLCN3
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.450307813512796,0.7889143605056865,0.75,1.0,1.0,1/8,4.99%,HSPD1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.450307813512796,0.7889143605056865,0.75,1.0,1.0,1/8,4.99%,HSPD1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.45674665274088444,-0.7880042350265218,0.7466666666666667,0.9610243483356607,1.0,2/14,10.15%,VSIR;PRNP
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.5132760569488327,-0.7878645771705178,0.7428571428571429,0.9601364273601992,1.0,1/5,14.56%,CYLD
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.5132760569488327,-0.7878645771705178,0.7428571428571429,0.9601364273601992,1.0,1/5,14.56%,CYLD
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.42857586953976395,-0.7878479635792746,0.8390804597701149,0.9596240038103874,1.0,16/39,27.22%,SRGN;RPS9;IFNGR1;IFNGR2;HIF1A;NPM1;NCK1;LCP2;RPS19;EGFR;B2M;ABI1;EIF3A;CD74;GCNT1;ACVR2A
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.4881771650982494,0.786661198218767,0.6976744186046512,1.0,1.0,1/5,5.60%,PLAAT3
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.44263454202127933,-0.7859358665275074,0.7285714285714285,0.9617280399451401,1.0,3/13,12.43%,HSPA5;PRKN;TMBIM6
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.4561197353090267,-0.7858352478932191,0.8064516129032258,0.9613158541492992,1.0,4/16,19.42%,ANXA1;ADAMTS1;PLCG2;EGFR
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.3978772356313506,-0.7853693058530589,0.7692307692307693,0.9613814971696247,1.0,4/23,11.37%,B3GNT2;GGT5;SLC26A2;CHST11
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.47838922925243743,-0.7853428137915319,0.7808219178082192,0.9608569678324899,1.0,1/8,11.29%,ACSL5
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.45054110891550986,-0.7843996294663108,0.7464788732394366,0.9615815788843227,1.0,6/18,25.07%,MEF2A;PLCG2;SYT1;ECT2;RYR3;CAMK2D
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),-0.50673216911276,-0.7838370201063283,0.7936507936507936,0.9612547740166549,1.0,3/9,21.41%,ITGB5;ITGB1;FAM171A1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),-0.50673216911276,-0.7838370201063283,0.7936507936507936,0.9612547740166549,1.0,3/9,21.41%,ITGB5;ITGB1;FAM171A1
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.36906425979057267,-0.7833744279277386,0.8170731707317073,0.9613829046532133,1.0,7/57,12.99%,PSMC6;PSMB9;RPS27A;PSMA1;UBC;ZFP36;NPM1
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.4918374036092322,0.7833245145462182,0.75,1.0,1.0,2/6,5.66%,IL6R;EIF2AK2
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.3582367882430339,0.7826186180664618,0.8571428571428571,1.0,1.0,7/20,12.24%,SLCO1A2;SLC23A2;SLC25A29;NCOA2;SLC38A3;ABCG2;PPARD
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.4179793190137713,-0.7817782710032914,0.75,0.9630446323603855,1.0,5/16,16.65%,HIP1R;PRKN;ZDHHC6;SPIRE1;PINK1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.36245518941861254,0.7815673763000384,0.8064516129032258,1.0,1.0,3/11,9.61%,CTNNA2;ABL1;CDH2
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.3921936358020252,0.781161928003005,0.6666666666666666,1.0,1.0,3/12,12.83%,HOMER1;GPD1L;WWP2
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.5631800204182654,-0.7810661094508696,0.8253968253968254,0.9634969709348812,1.0,4/5,43.69%,LRP6;CTNNB1;APC;GSK3B
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.40047424968520345,-0.780894633648598,0.7692307692307693,0.9631483970809788,1.0,9/29,24.94%,PIK3R1;FLT1;FGFR1;PIP5K1C;EGFR;PIK3CB;PPP1R16B;NEDD4;DIPK2A
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.4423511510986685,-0.7808463619111123,0.7432432432432432,0.9626564674624375,1.0,2/11,8.66%,ENPP2;PDXDC1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.40608739880485584,-0.780746763146227,0.7532467532467533,0.9622337934134217,1.0,13/29,26.88%,BCAP31;CDC37;LAMP2;ZDHHC6;SDCBP;ZDHHC21;PIKFYVE;SPCS3;ZDHHC14;VPS37A;CHM;ZDHHC20;AP4S1
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.4494337826891923,-0.7801809827982038,0.7837837837837838,0.9624358663271874,1.0,3/12,19.76%,KDM1A;PTTG1IP;CLU
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.46027156267275193,0.7800741505863064,0.7647058823529411,1.0,1.0,1/6,9.11%,RCSD1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.4546661029204527,-0.7797364215321412,0.7763157894736842,0.9625690824635141,1.0,3/12,24.67%,RIOK3;TBK1;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.3917734372511758,0.7794131747027205,0.8148148148148148,1.0,1.0,1/10,4.99%,HSPD1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.40395678841600474,-0.7789672475020488,0.8,0.9630513580400605,1.0,3/25,7.01%,CX3CL1;FES;PRKCE
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.4774645680110636,0.7788049005255286,0.7435897435897436,1.0,1.0,1/5,4.46%,GAB1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.4598278448215205,-0.7781717542134687,0.726027397260274,0.9636390492074449,1.0,9/13,39.36%,NEDD4;NEDD4L;CDKL5;DAB2IP;MFSD2A;CSMD3;ADGRB3;LRP8;CAMSAP2
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.4401061804073235,-0.777402035938136,0.8260869565217391,0.9641388837959924,1.0,4/16,21.70%,TIMP3;GJA1;CALD1;SPARC
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.3482769261784201,-0.7771121332249742,0.9010989010989011,0.9639595872040819,1.0,10/79,10.73%,NPLOC4;RPS27A;NDFIP1;RNF19A;FEM1C;PRKN;UBC;ARIH2;HERPUD1;CHFR
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),-0.4801182900950388,-0.7758888831741786,0.8142857142857143,0.9648693449680812,1.0,2/11,19.42%,SDCBP;EGFR
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.38894255911020525,-0.7757051250470501,0.8148148148148148,0.9646027823253265,1.0,7/32,12.75%,NFASC;GRIA2;GPM6B;TMEM132C;S1PR1;GJA1;PLP1
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.32522048498508127,0.7750245967936854,0.875,1.0,1.0,5/21,11.42%,OCLN;EVL;CLASP1;CARMIL1;CLIP1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.5289651501998243,-0.774443809326339,0.7846153846153846,0.9655608991734758,1.0,3/6,39.73%,RPS19;ETS1;ACTN4
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.42975198886364996,-0.7743391847468286,0.8194444444444444,0.9646057301430538,1.0,4/17,19.76%,IFNGR1;PLCG2;ARFGEF2;CLU
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.42975198886364996,-0.7743391847468286,0.8194444444444444,0.9646057301430538,1.0,4/17,19.76%,IFNGR1;PLCG2;ARFGEF2;CLU
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.3810730245277003,-0.7740793091807694,0.7469879518072289,0.9644764086301036,1.0,10/36,14.61%,ITPR1;SYTL4;RAPGEF3;SLC2A1;RAP1A;ENSA;GOLPH3;STXBP5L;TMED10;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.2990812803768057,0.7738255479817513,0.8823529411764706,1.0,1.0,5/36,11.47%,CPEB3;LARP4B;SLC25A37;CIRBP;SAMD4A
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.43738893325535655,-0.7734359735260258,0.7945205479452054,0.96477512855237,1.0,4/16,14.50%,PNP;CD81;ANXA1;NCK1
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.4397773517313648,0.7719015813604718,0.7631578947368421,1.0,1.0,1/7,4.04%,RAB11FIP2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.49198354356948043,0.7715045991564824,0.6785714285714286,1.0,1.0,2/7,5.79%,RSAD2;MFHAS1
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),-0.5130641872100409,-0.7713050551110748,0.7903225806451613,0.966833753739553,1.0,1/6,11.02%,FGFR1
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.36721912849462096,-0.7713039568761535,0.8271604938271605,0.9663007693108102,1.0,8/47,14.61%,CDKN1B;ERBB4;FOXF1;DLC1;ZFPM2;MEF2A;CDKN1A;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.4190448888846744,0.7711357694271751,0.723404255319149,1.0,1.0,2/9,4.22%,RALA;MFF
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),-0.3695977532862497,-0.7711301660785698,0.8409090909090909,0.9660407841163468,1.0,13/56,19.42%,GRK5;FES;ERBB4;FLT1;SIK2;FGFR1;PAK2;TEC;PINK1;VRK2;MTOR;PIKFYVE;EGFR
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.48573133870861407,0.7707126678001873,0.7083333333333334,1.0,1.0,3/6,20.77%,MBOAT2;SOX5;TRPS1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.4501607228302418,0.7703944753551919,0.7297297297297297,1.0,1.0,1/6,1.97%,ACAT1
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.48031562957843343,-0.7695187977360537,0.76,0.967495097772425,1.0,4/9,26.93%,TMBIM6;PTBP2;PTBP1;SRSF7
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),-0.36392206717220804,-0.7691692837845592,0.8539325842696629,0.9674202724004161,1.0,17/68,20.29%,CX3CL1;RAPGEF3;RAP1A;TBC1D15;TGM2;AFDN;LIMS1;RSU1;RGS7;LARS1;RACK1;PICALM;ARHGAP29;ITGB1;TBC1D9;ECT2;CAV2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.5027116877414892,-0.7691641494352849,0.8656716417910447,0.9668943190007728,1.0,1/5,8.34%,PRKN
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.44883469880183036,-0.7691133255994652,0.7297297297297297,0.9664616073738264,1.0,5/12,29.91%,PIAS2;ZNF366;CALR;NCOR2;SMARCA4
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.4960628912268783,-0.7687823581605676,0.8064516129032258,0.9664245182202839,1.0,1/8,1.27%,ADAMTS9
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),-0.44723844960597986,-0.7686401763935526,0.7948717948717948,0.9660727599805271,1.0,4/18,16.39%,PBRM1;SMARCA1;MBD2;SMARCC1
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.48930157414912223,-0.7682465532061666,0.8253968253968254,0.9660914315033523,1.0,1/8,6.75%,ARF1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.42776417761644175,-0.767892805566615,0.7777777777777778,0.9660546064437929,1.0,5/13,23.82%,CD55;MALT1;B2M;ZBTB1;HLA-B
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.37545632261617234,-0.7675460840345314,0.7804878048780488,0.9659438941846337,1.0,12/36,23.77%,HIF1A;TMSB4X;FGFR1;BCAR1;GATA2;SCARB1;PIK3CB;ATOH8;SASH1;SPARC;ANXA3;CALR
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.4645926543848018,-0.7669612838861474,0.821917808219178,0.965974920137555,1.0,5/11,32.14%,DAG1;ADAM9;SPPL3;BACE2;ERAP1
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.4632339361941922,0.766350897389106,0.75,1.0,1.0,2/7,15.80%,SEMA6A;ZNF609
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.49337003717565564,-0.7662148298540391,0.8461538461538461,0.9663751451370477,1.0,3/8,23.59%,RAB14;PIKFYVE;ATP6V1E1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.4616457953370958,-0.7651633683162227,0.8305084745762712,0.9671931670690737,1.0,2/11,9.99%,SMAD7;AFDN
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.4574901805330499,0.7643699923435098,0.8378378378378378,1.0,1.0,2/5,29.14%,NRP2;NF1
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.4197733464375888,0.7640735294147739,0.84375,1.0,1.0,7/10,25.58%,ZSWIM5;ZSWIM6;STX3;PPM1F;PDGFB;USP14;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.41158244345151773,0.7634952367462498,0.7941176470588235,1.0,1.0,3/10,11.42%,OCLN;CLASP1;CLIP1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.38100672488673604,0.7634129548935993,0.7727272727272727,1.0,1.0,2/12,4.22%,RALA;MFF
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.46577448469497446,-0.7631464279973096,0.7692307692307693,0.9692397241903513,1.0,5/10,19.73%,TMBIM6;CPEB4;LARS1;MTOR;SPAAR
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.3368488321982002,-0.7625896273417736,0.782608695652174,0.9694040436844767,1.0,13/87,13.89%,PPP1R9A;RPS27A;ACTN1;COL18A1;HIP1R;TPM1;PRKN;UBC;PLOD2;MYO1B;PLEC;CST3;BCAR1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.2887288546319062,0.7619043730688758,0.9166666666666666,1.0,1.0,7/58,10.23%,EXOC5;RTTN;OFD1;WDPCP;RFX3;TTC17;PARVA
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.3911959793134486,-0.761666010012187,0.7875,0.9701453842686708,1.0,4/24,13.71%,NEDD9;RREB1;LIMS1;CASS4
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.39638609359582033,-0.7615608453600823,0.7901234567901234,0.9697198700563091,1.0,7/23,21.70%,MSRB3;ADAMTS1;DLC1;GJA1;CALD1;HMCN1;SPARC
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.3993184576546995,-0.761438107394401,0.8372093023255814,0.9693622914000415,1.0,4/28,14.53%,HIP1R;PRKN;CLDN5;AMFR
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.3339027518960285,0.7614106959048118,0.75,1.0,1.0,4/23,10.94%,THOC1;TENT2;SCAF8;RPRD1A
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.38559881327136214,-0.76018927260454,0.8888888888888888,0.9703721782864131,1.0,7/46,16.39%,BAZ1A;PBRM1;HMGN1;SMARCA1;NPM1;CHD1;SMARCC1
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.4990255092859893,-0.7599055103798605,0.7796610169491526,0.9696023658942245,1.0,4/5,25.74%,ZDHHC6;ZDHHC21;ZDHHC14;ZDHHC20
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.4990255092859893,-0.7599055103798605,0.7796610169491526,0.9696023658942245,1.0,4/5,25.74%,ZDHHC6;ZDHHC21;ZDHHC14;ZDHHC20
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.45848910910903506,-0.7598784547782385,0.7910447761194029,0.9690803803963786,1.0,4/9,25.29%,PINK1;MTOR;CCDC88A;MAPKAP1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.41145716112631076,-0.759508545683327,0.8412698412698413,0.9690177407666201,1.0,8/21,30.36%,ARIH2;PPP3CC;SREBF2;PINK1;MAPK8;UBE2D3;NPEPPS;MICALL2
prerank,PanglaoDB_Augmented_2021__Glomus Cells,-0.3706760350361644,-0.7593612732141252,0.8674698795180723,0.9686861662282109,1.0,10/42,13.89%,MAP1B;NES;NFASC;SMARCA1;ANK2;SHC2;EPAS1;GJA1;DCLK1;BCAR1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.4175722577227336,-0.7579020638736073,0.8289473684210527,0.9700780799173805,1.0,3/19,11.02%,PIK3R1;FLT1;FGFR1
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.43004085587563,0.7573271913497529,0.7027027027027027,1.0,1.0,1/6,1.20%,GCNT2
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.38766380492939534,0.7571476468228994,0.8055555555555556,1.0,1.0,1/8,1.22%,UGCG
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.5119345868550229,-0.757144793025215,0.8548387096774194,0.9707295263015953,1.0,3/6,35.17%,AGO2;DDX3X;DHX36
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.3358074933719496,0.7567023157872373,0.6666666666666666,1.0,1.0,7/17,16.84%,MGMT;ERCC6;SLF2;KMT5B;SPIDR;SHLD2;PARP9
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.32631376892916586,0.7565753005447357,0.8260869565217391,1.0,1.0,2/23,2.44%,TLE4;STRBP
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.48961202911544843,-0.756259621488982,0.8208955223880597,0.9708407132671603,1.0,2/6,20.64%,NDUFA12;COX6C
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.48961202911544843,-0.756259621488982,0.8208955223880597,0.9708407132671603,1.0,2/6,20.64%,NDUFA12;COX6C
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.4699573247869214,-0.756236344270582,0.7540983606557377,0.970320038431882,1.0,2/5,12.99%,PLCG2;NPM1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3882772562400076,-0.7561309364907361,0.8780487804878049,0.9699400860272974,1.0,10/28,22.50%,SEC24D;CANX;ARF1;AP1G1;PIKFYVE;DYNC1I2;CAPZA2;KLC1;CLTA;DNM2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",0.37323489214714234,0.7546169282270586,0.8148148148148148,1.0,1.0,3/17,10.36%,MLLT3;CDK12;RTF1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),0.37323489214714234,0.7546169282270586,0.8148148148148148,1.0,1.0,3/17,10.36%,MLLT3;CDK12;RTF1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.34904121519291037,0.7541380874448084,0.8214285714285714,1.0,1.0,3/20,5.47%,BMP6;TTN;WLS
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.4833385317628774,-0.7541180612242433,0.8787878787878788,0.9719175730538256,1.0,3/7,24.04%,TIMP3;ADAM9;SNX9
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.3695788420833911,0.7540883843603876,0.8181818181818182,1.0,1.0,2/10,5.47%,HOMER1;WLS
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.5171418673698778,-0.753805201209369,0.8823529411764706,0.9718719635105013,1.0,2/6,6.37%,SCP2;LSS
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.4196131822885299,-0.7537875884870119,0.8382352941176471,0.9713761936110618,1.0,5/16,15.72%,ATG12;RB1CC1;GABARAPL1;RAB1A;PIK3C3
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.32567760182362415,0.7531240858707082,0.8620689655172413,1.0,1.0,4/26,9.80%,OCLN;LIMS2;OPHN1;SDK1
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.3999988604995966,0.7527848226621733,0.6451612903225806,1.0,1.0,2/6,13.47%,SFSWAP;RBMX
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3999988604995966,0.7527848226621733,0.6451612903225806,1.0,1.0,2/6,13.47%,SFSWAP;RBMX
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.5211859593760579,-0.7524057892169876,0.8709677419354839,0.9724740835624107,1.0,1/5,2.79%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.3619658696448027,0.7523776389396605,0.7333333333333333,1.0,1.0,3/10,12.30%,ABL1;TEK;ROCK1
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.38109429857249477,-0.7522128676444625,0.8375,0.9721608443147933,1.0,6/30,13.78%,PPARG;TIMP3;FOXF1;SLC8A1;GJA1;PLSCR4
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.3607752495623213,-0.7501881966599487,0.8295454545454546,0.9741743047194424,1.0,9/45,18.83%,CDKN1B;ERBB4;FOXF1;ZFPM2;MEF2A;CDKN1A;CACNA1C;NOTCH4;ACVRL1
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.34555697128538776,0.7492623637347703,0.7777777777777778,1.0,1.0,1/15,2.52%,MSL2
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.39896550556889515,-0.7488010744127802,0.8194444444444444,0.975268903595177,1.0,2/28,4.41%,TAF1D;PPM1D
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.36134635310041757,-0.747947795751688,0.7887323943661971,0.9757616388689623,1.0,6/24,16.81%,RAPGEF3;PRKN;CST3;CDK6;PINK1;NOTCH4
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.4631178522043408,-0.7477709044032617,0.7878787878787878,0.9754412374032309,1.0,2/8,18.83%,TMEFF2;ACVRL1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.5086963198575145,-0.7477327886526323,0.8472222222222222,0.9749575360577833,1.0,1/5,3.93%,SCP2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.3036755064347275,0.7475021590418315,0.9310344827586207,1.0,1.0,4/21,15.64%,THOC1;TENT2;RPRD1A;PNPT1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.4391883276214509,-0.7463964497139081,0.855072463768116,0.9761038714832758,1.0,1/12,4.46%,KDM1A
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.3716527173304577,-0.7463075470380535,0.8076923076923077,0.975705096137019,1.0,8/30,31.98%,CSTF3;ZFP36;DCP2;USP39;PTBP1;SRSF7;SFPQ;HIPK3
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.395413724470247,-0.7455636673531933,0.8260869565217391,0.9761539117490624,1.0,4/24,11.02%,HIF1A;ANXA1;TMSB4X;FGFR1
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),-0.4145444460554317,-0.7452658207481131,0.8888888888888888,0.9759369756201894,1.0,4/18,13.39%,SLC20A2;SLC8A1;SLC26A2;SLC20A1
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.5061470895542761,-0.7451128322868183,0.8,0.9755993800159405,1.0,1/6,23.43%,AGO2
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.47891897151923185,-0.745055136497074,0.873015873015873,0.9751231953679709,1.0,2/10,8.26%,RAPGEF3;RAP1A
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.4441289174531691,-0.7450516592581778,0.7910447761194029,0.974599217294157,1.0,2/9,9.11%,JAG2;ANXA1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.4260314835950379,0.744457680086569,0.7948717948717948,1.0,1.0,1/9,1.22%,UGCG
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.4656356731337207,-0.7440133915562864,0.8285714285714286,0.9753069225143063,1.0,3/9,9.93%,BCAP31;HERPUD1;TGM2
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.49388465370845985,-0.7439680182313453,0.8870967741935484,0.9748497566462577,1.0,1/6,4.46%,KDM1A
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.436577179530731,-0.7439210914316604,0.8571428571428571,0.974362939154009,1.0,1/12,4.46%,KDM1A
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",0.42027954589127176,0.7434252766770735,0.8571428571428571,1.0,1.0,3/9,8.45%,THOC1;ERCC6;SCAF8
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.3132219351261421,0.7428643500926884,0.8947368421052632,1.0,1.0,4/42,3.03%,GBP2;PKHD1L1;PTPN21;IGFBP3
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.46215780948187496,-0.7413626670525638,0.819672131147541,0.9769976956096463,1.0,1/6,5.05%,SPG7
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),-0.4078303025324951,-0.7411952376178016,0.8311688311688312,0.9766909078341681,1.0,8/19,23.27%,PECAM1;AFDN;PAK2;CLDN5;TBCD;DLG1;ECT2;CDH5
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.3834542883085789,0.7410045335133334,0.775,1.0,1.0,2/6,10.60%,MFF;CEMIP
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.3834542883085789,0.7410045335133334,0.775,1.0,1.0,2/6,10.60%,MFF;CEMIP
prerank,PanglaoDB_Augmented_2021__Microglia,-0.4605486443366975,-0.7407092613932794,0.8571428571428571,0.9767877044343936,1.0,3/14,10.49%,FOS;PECAM1;ITGB5
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.48662809055405537,-0.7393326777417498,0.8153846153846154,0.9781837497745551,1.0,2/7,20.27%,CACNA1C;GNAI3
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.4226588727056221,-0.7392610176049654,0.8115942028985508,0.9777806230154364,1.0,7/15,40.05%,RIOK3;PPM1A;DAB2IP;OTUD7B;TANK;TNIP1;CARD8
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2874241949883376,0.7391974568297537,0.95,1.0,1.0,1/28,0.80%,TPD52L1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.430272398904837,0.7390540594801187,0.7941176470588235,1.0,1.0,1/8,1.83%,PIGU
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.424161788185205,0.7385855780305816,0.7142857142857143,1.0,1.0,7/7,57.66%,CDC73;HUWE1;UBE2E1;WAC;USP22;UBR2;UBE2B
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),-0.39734370433624855,-0.7376026277240737,0.8285714285714286,0.9792287260654272,1.0,5/17,18.67%,TGM2;DYSF;RACK1;GATA2;SCARB1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.4607787968207427,-0.7375999606657825,0.8208955223880597,0.9787113600931041,1.0,2/8,18.73%,MCL1;ITGB1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.43997535667245957,0.7375280977766648,0.75,1.0,1.0,2/5,20.90%,ARHGAP35;PIK3CA
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.4134981516135933,-0.7375166835041386,0.8055555555555556,0.9782965921941674,1.0,9/21,23.27%,PECAM1;AFDN;PAK2;CLDN5;TBCD;CTNNA1;DLG1;ECT2;CDH5
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.42081375466455023,-0.7373265862372552,0.8472222222222222,0.9779422618041942,1.0,8/17,23.27%,PECAM1;AFDN;PAK2;CLDN5;TBCD;DLG1;ECT2;CDH5
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.3841192485617525,-0.7372203313338674,0.8395061728395061,0.9775223507047438,1.0,6/28,15.27%,DMD;PRKN;PRNP;ENSA;ARPP19;WWTR1
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.3593132148000942,0.735763945900862,0.8947368421052632,1.0,1.0,1/19,2.05%,ALS2
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.4295697989571743,0.733725501017086,0.8214285714285714,1.0,1.0,4/8,8.37%,RALA;MFF;HSPD1;FBXO7
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),0.4180729821370961,0.7336005267411237,0.7631578947368421,1.0,1.0,1/6,10.73%,ATP6V1H
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.38621676705284447,-0.7333242466528235,0.8356164383561644,0.981747510808086,1.0,4/19,17.34%,IPO7;TPR;PTTG1IP;KPNB1
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.43997203496178305,-0.7330494718134697,0.8484848484848485,0.9815656136996582,1.0,3/10,17.88%,EEF1A1;RACK1;MRPL33
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.45953838756576093,-0.7326022292125148,0.8507462686567164,0.9815994307631983,1.0,1/6,4.09%,ABCA5
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.3880779475464816,-0.7322290087800302,0.7894736842105263,0.9815793604141885,1.0,7/16,19.18%,PNP;ANXA1;PRNP;ZFP36;PLCG2;MALT1;CD34
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.42173247105050793,-0.7321461754216355,0.835820895522388,0.9811287295157184,1.0,5/14,22.36%,GRIN2B;SOD2;CBR4;RYR3;B2M
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),-0.46130766193070194,-0.7319117045175139,0.8169014084507042,0.9808877773281603,1.0,5/8,36.41%,ACER2;PDE4B;REST;TFRC;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.3783050624121783,0.7312628012608126,0.95,1.0,1.0,3/15,10.28%,USP25;OPHN1;PSMF1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3778425416839646,0.7307667803893363,0.7941176470588235,1.0,1.0,1/10,2.15%,HOMER2
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.4726024136623231,-0.7306951170580763,0.7878787878787878,0.9818657662578738,1.0,2/7,33.41%,AGO2;PRKRA
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4299161523412934,0.7306742176896891,0.7631578947368421,1.0,1.0,2/7,10.44%,PRKD1;TEK
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.43203442030778644,-0.7300120527481533,0.863013698630137,0.9820366617351508,1.0,5/16,23.93%,ZC3H7A;ZFP36;NOTCH4;AGO2;CNOT8
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.46665618646898127,-0.7296546969584136,0.8666666666666667,0.9820283476816648,1.0,2/8,12.14%,KLF6;DCLK1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.37564593385136924,0.7293357204713635,0.84,1.0,1.0,4/17,9.19%,TBL1X;HDAC9;BAZ2A;TBL1XR1
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.39672569158879756,0.7293078698629826,0.7317073170731707,1.0,1.0,1/7,3.19%,TNRC6C
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.39672569158879756,0.7293078698629826,0.7317073170731707,1.0,1.0,1/7,3.19%,TNRC6C
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.4314476135751908,0.7290818383794851,0.7906976744186046,1.0,1.0,1/5,6.06%,ATF7IP
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.4314476135751908,0.7290818383794851,0.7906976744186046,1.0,1.0,1/5,6.06%,ATF7IP
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.4473228634077645,-0.7286778941317282,0.7866666666666666,0.9826284146243108,1.0,4/11,14.56%,CX3CL1;BCL2L14;TMBIM6;CYLD
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.4600731377932143,-0.7268034898271415,0.890625,0.984294912021652,1.0,2/5,19.31%,TPR;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.357289158187477,0.726310670314939,0.8928571428571429,1.0,1.0,2/13,5.47%,HOMER1;WLS
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.4431634112516516,-0.7259569562963016,0.8507462686567164,0.984666732734982,1.0,1/10,2.60%,BCAP31
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.4027995643527256,-0.725897691534274,0.8148148148148148,0.9842223311246496,1.0,12/20,25.74%,TRAM1;ZDHHC6;SDCBP;RAB8B;ZDHHC21;PIKFYVE;CHMP4B;ZDHHC14;VPS37A;SEC62;CHM;ZDHHC20
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.4001715744024341,-0.7255152922370773,0.8571428571428571,0.9840700383087168,1.0,5/19,15.72%,ATG12;RB1CC1;GABARAPL1;RAB1A;PIK3C3
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.4464958376199049,0.7250986027144829,0.8235294117647058,1.0,1.0,1/5,2.05%,ALS2
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.3498778722256174,-0.7248057810116078,0.9431818181818182,0.9843581065210862,1.0,13/54,22.60%,TIMP3;GGT5;REL;CALCOCO2;ANXA1;IL1RAPL1;SMAD3;MCL1;TBK1;IL18R1;IFITM3;ADAM9;MAPK8
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.44058828460990707,-0.7246197845507002,0.8529411764705882,0.9840513200660841,1.0,2/9,18.73%,MCL1;ITGB1
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.3735975976288632,-0.723379284342157,0.85,0.9848917324475611,1.0,5/26,15.27%,CDKN1B;PRKN;PRNP;CDKN1A;WWTR1
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.49118409855118567,-0.7228998530734088,0.819672131147541,0.98446852256241,1.0,2/6,22.68%,GNAI3;MFN1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.49118409855118567,-0.7228998530734088,0.819672131147541,0.98446852256241,1.0,2/6,22.68%,GNAI3;MFN1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),-0.4473395768562789,-0.7223545633507398,0.819672131147541,0.9845657657671313,1.0,5/6,39.42%,MAP2K1;USP7;DNAJC13;MAPK1;ATP9A
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.4750361236682756,-0.7221061273845546,0.863013698630137,0.9842893282473663,1.0,2/5,25.87%,TNKS2;TNKS
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),-0.44219946510446523,-0.7215431895394557,0.8082191780821918,0.9838913400888031,1.0,4/9,27.89%,DLC1;ACVRL1;DUSP22;FAM107A
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),-0.44219946510446523,-0.7215431895394557,0.8082191780821918,0.9838913400888031,1.0,4/9,27.89%,DLC1;ACVRL1;DUSP22;FAM107A
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),0.35485883492581577,0.7207390183115907,0.8666666666666667,1.0,1.0,3/26,6.96%,GBP2;GBP1;TRIM22
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.4460746534955452,-0.7202783243107805,0.8421052631578947,0.9847346576784762,1.0,2/6,15.22%,TPR;PPHLN1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.41477661939216953,0.7202072728178704,0.8666666666666667,1.0,1.0,1/9,8.05%,CDK12
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),-0.3780660501242658,-0.7189687310848432,0.8309859154929577,0.9855001619299623,1.0,2/28,4.57%,PPARG;SMAD7
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),-0.4729941938915185,-0.7188795455942764,0.8253968253968254,0.9850465339028096,1.0,3/6,22.97%,CD81;CBFB;PRKCH
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),-0.4261829891196299,-0.7181931333117607,0.927536231884058,0.9852731590680285,1.0,5/10,34.29%,PARVB;ITGB1;RHOJ;RAC1;GSN
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.4113644492733296,-0.7176060954414505,0.8888888888888888,0.9854168341090531,1.0,6/23,26.19%,ANXA1;ADAMTS1;MECP2;EGFR;RAB11A;BRD4
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),-0.4520242492823066,-0.7164505568241957,0.8695652173913043,0.9863220880247228,1.0,4/9,32.11%,ATP1B3;ATP1A1;ATP1B1;KCNQ5
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.4720887293011843,-0.7161217749545387,0.8805970149253731,0.9861463650411206,1.0,3/8,28.02%,KLF4;CBFB;MAP2K5
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.46718032329617926,0.7159136106547033,0.8048780487804879,1.0,1.0,2/5,19.39%,GIMAP8;GIMAP4
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.37792597879647905,0.7150400173913097,0.7142857142857143,1.0,1.0,1/12,4.91%,CLASP1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.4194512920579607,-0.7149483841296671,0.821917808219178,0.986832034317851,1.0,2/12,8.26%,RAPGEF3;RAP1A
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.3743696630606528,0.7144192847365497,0.8333333333333334,1.0,1.0,2/9,10.81%,SPG11;RAB27A
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.4483333205857566,-0.7130877875518573,0.8,0.9882421415058528,1.0,1/7,3.85%,HSPA5
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.48510783816725794,-0.7109426873528819,0.9047619047619048,0.9899689646589694,1.0,2/6,9.72%,SLC4A10;SLC4A7
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.42433284014441974,0.710866096156588,0.8275862068965517,1.0,1.0,4/6,26.59%,RNF216;PARP9;TRIM44;DHX9
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.4505505734270321,-0.710452831813643,0.8032786885245902,0.9900272750554846,1.0,2/5,15.19%,LPGAT1;LPIN2
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.34061138361586824,-0.7089351068869969,0.9302325581395349,0.9912098121792816,1.0,18/71,20.29%,CX3CL1;RAPGEF3;VAV3;RAP1A;TBC1D15;TGM2;AFDN;LIMS1;FGD4;RSU1;RGS7;LARS1;RACK1;PICALM;ARHGAP15;ITGB1;ECT2;CAV2
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.43795655442501286,-0.7072805256830588,0.8769230769230769,0.9924675931877858,1.0,1/8,9.11%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.4092944695088402,-0.7072092496104933,0.8125,0.9920129303500841,1.0,2/9,19.42%,CST3;EGFR
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.4401503680579303,-0.7071861767925546,0.8225806451612904,0.9915117263988273,1.0,2/8,9.06%,FLT1;CD81
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.35698802754938086,-0.7071420284895168,0.9529411764705882,0.991040416523445,1.0,7/45,17.26%,CX3CL1;RPS27A;UBC;NPM1;NFKBIA;MALT1;IL18R1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.4920003183184379,-0.7064682770258067,0.9032258064516129,0.9906508542625322,1.0,2/5,37.40%,DNM2;MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.4920003183184379,-0.7064682770258067,0.9032258064516129,0.9906508542625322,1.0,2/5,37.40%,DNM2;MX1
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.40098364277037374,0.7061707335669487,0.8292682926829268,1.0,1.0,1/9,0.61%,ARID5B
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.39521877635462155,-0.706065591668909,0.8181818181818182,0.9906147282068757,1.0,2/10,15.83%,TMED10;MALT1
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.5027089922461072,-0.7046585187682927,0.96,0.9916513417237246,1.0,1/5,23.43%,AGO2
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),-0.4229991936750949,-0.7041015895858377,0.8450704225352113,0.9917611992764501,1.0,4/13,21.04%,DLC1;ROBO2;ACVRL1;DUSP22
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.34564642444637245,0.7040778808809712,0.8055555555555556,1.0,1.0,2/10,14.69%,ELAPOR2;RBPJ
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.4150616980715511,0.7038813580917799,0.875,1.0,1.0,2/8,12.30%,OCLN;ROCK1
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.4545790622563971,-0.702921005457508,0.8596491228070176,0.9925853316027465,1.0,3/5,27.94%,ERBIN;ARHGEF2;VIM
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.4163542958973518,-0.7028587056960975,0.8805970149253731,0.9921151808752413,1.0,3/12,12.43%,HSPA5;PRKN;TMBIM6
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.4137424300364542,0.7026783985350988,0.8181818181818182,1.0,1.0,1/6,0.42%,RSAD2
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.39689839396449167,0.7026217918570832,0.7567567567567568,1.0,1.0,1/7,1.97%,ACAT1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.31838776540141794,-0.7024145195833991,0.9680851063829787,0.9920959352356249,1.0,13/132,12.16%,UFL1;RPS27A;NFE2L2;HIF1A;COMMD1;PRKN;UBC;ARIH2;KLHL7;CHFR;EPAS1;TPR;PIAS2
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.32547685739866256,0.7021883185350873,0.8666666666666667,1.0,1.0,2/16,10.33%,EFNA5;ZMYM4
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.45574227173594806,-0.7020083162169736,0.9206349206349206,0.9920065515050042,1.0,1/6,4.17%,EPS8
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),-0.38013755651780723,-0.7016780360874323,0.8405797101449275,0.9917770174691747,1.0,2/17,11.18%,PIK3R1;ARPC2
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.3453236156902873,0.7015741018889105,0.8205128205128205,1.0,1.0,2/10,15.64%,XAF1;PNPT1
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.376878698581706,-0.7008408001810257,0.881578947368421,0.9921200844049052,1.0,9/35,20.48%,PRKAG2;RAP1A;PAK2;CDKN1A;TRIB2;WWTR1;LCP2;ECT2;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),-0.3818144439144875,-0.7005121249572551,0.8260869565217391,0.9919782908433137,1.0,2/15,11.18%,PIK3R1;ARPC2
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.4548174313554316,-0.7004207001655016,0.921875,0.9915740979846891,1.0,3/8,10.15%,LGALS3;CD81;PRNP
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.4186170212765956,0.7002394300784166,0.7777777777777778,1.0,1.0,5/5,58.19%,UBN1;ATRX;RBBP4;CABIN1;NASP
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.4417507797274779,-0.7001779096394026,0.8787878787878788,0.9913919155443223,1.0,3/9,19.76%,PRKN;PINK1;CLU
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.42348311223654134,-0.7001118625722337,0.8378378378378378,0.9909359912719916,1.0,2/7,23.24%,EGFR;CCNY
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.4541759650511905,-0.6990747658224397,0.9041095890410958,0.9915756949499831,1.0,1/7,3.93%,SCP2
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.3923778227147588,-0.6981136798327773,0.8285714285714286,0.992104112486789,1.0,3/12,13.17%,CDKN1B;PLCG2;CDKN1A
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.4143472210518185,-0.6977801288785397,0.8285714285714286,0.9918580210898811,1.0,3/10,12.93%,DUSP1;ITGB5;DUSP5
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.39813454975280627,-0.697338599785477,0.9076923076923077,0.9917517744068303,1.0,1/12,4.46%,KDM1A
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.39288338944727,-0.6971754660212087,0.8904109589041096,0.9913724153991333,1.0,2/17,3.13%,CX3CL1;SPOCK1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.3798495617914843,-0.6968995108555445,0.8947368421052632,0.9910864124346634,1.0,1/24,1.09%,BTG2
prerank,GO_Biological_Process_2021__morphogenesis of an endothelium (GO:0003159),0.4343620028458374,0.6968850499081067,0.7608695652173914,1.0,1.0,1/5,6.14%,CCM2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.34770755114323654,-0.6960463953373318,0.9178082191780822,0.9913930426353278,1.0,7/42,16.81%,NR4A1;PPARG;ESR2;CCNH;WWTR1;THRB;NOTCH4
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.3858396607248491,0.6959779984637375,0.8529411764705882,1.0,1.0,1/8,2.84%,RHBDD1
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.34133059434080754,-0.6955495392386026,0.9186046511627907,0.9913104725703467,1.0,6/59,15.59%,BTG2;GAPDH;RPL10;RPL13A;NPM1;RACK1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.47085316386443005,-0.6953843819365619,0.896551724137931,0.9910249445422329,1.0,2/6,15.96%,FGFR1;MCL1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.39203888888334193,-0.6950536103245065,0.8260869565217391,0.9908498777634427,1.0,5/14,22.90%,PECAM1;ROBO2;ITGB1;HMCN1;BSG
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.4007450771687069,0.6943728597128562,0.8181818181818182,1.0,1.0,7/7,60.00%,MAPKBP1;ITCH;IFI16;ILRUN;PCBP2;IRAK3;CARD8
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),-0.4567005254342148,-0.6936297098864496,0.8615384615384616,0.9917934750178808,1.0,3/8,21.59%,ENSA;ARPP19;PPP1R16B
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.4282037456281902,-0.6933793397877891,0.8285714285714286,0.9914618014469032,1.0,4/6,41.04%,ZBTB1;PPP2R3C;PRKDC;ZMIZ1
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.3916606570922733,-0.6932928774101564,0.8548387096774194,0.9910146840377806,1.0,3/12,33.28%,SLC30A1;TF;TFRC
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.3106435277131244,-0.6920816540345949,1.0,0.9917426457121706,1.0,24/118,24.89%,BHLHE40;ESR2;HIF1A;RREB1;RPL10;CREM;SBNO1;ZNF280D;CNBP;BTG1;WWTR1;SMC3;NSD2;ZBTB38;ATF2;ACVRL1;MTF2;ZNF141;DNM2;CALR;CCDC88A;FOXN3;TERF2IP;NR2C2
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.3947502156201065,-0.6917397101207721,0.8289473684210527,0.9916023599852684,1.0,3/14,18.33%,GGT5;PELI1;ERBIN
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.34177356984426616,0.6892858892262733,0.875,1.0,1.0,1/15,1.91%,SMAD1
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),-0.4627929955501267,-0.6887875091984422,0.855072463768116,0.9940922758338729,1.0,4/5,41.49%,NEDD4L;YWHAE;CACNA2D1;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.4244538246113472,0.6882454280411672,0.8048780487804879,1.0,1.0,2/5,8.13%,PRKD1;HSPB1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.4554778110701193,-0.6881954703207175,0.875,0.9941184701609324,1.0,3/6,21.59%,ENSA;ARPP19;PPP1R16B
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.38456984774369596,-0.6881478655939985,0.8529411764705882,0.9936538131540626,1.0,3/11,14.63%,PRKCE;NCK1;SPIRE1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.43495878942355537,-0.6880319899518628,0.8620689655172413,0.9932358049652753,1.0,4/8,30.60%,TPM1;LIMA1;RAC1;AIF1L
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.37643452702955943,-0.6879011465161287,0.855072463768116,0.9928701422297833,1.0,4/24,14.50%,ATF3;TPR;NPM1;NCK1
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.40101666246759515,-0.6878519696896519,0.8421052631578947,0.9923895443934653,1.0,3/9,16.18%,MEF2A;PTMA;THRB
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.43042206728726506,-0.6871551308199134,0.8676470588235294,0.9926643348278659,1.0,1/8,6.29%,MGAT4A
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.4748953843723446,-0.6870115876631333,0.8888888888888888,0.9922419312106995,1.0,1/5,15.30%,MYEF2
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.4258700846809617,-0.6869991740630262,0.8484848484848485,0.9917336105492185,1.0,1/6,13.68%,RIOK3
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.41241409293004977,0.6868476480976223,0.8611111111111112,1.0,1.0,1/5,13.09%,PDCD4
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.41852476737849653,-0.6868001999123761,0.8857142857142857,0.9913984216833317,1.0,2/8,23.24%,EGFR;CCNY
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.3552149001784927,-0.6867520983462637,0.8831168831168831,0.9909428098639655,1.0,6/25,17.64%,TIMP3;TPM1;TNS1;GJA1;PLSCR4;CALD1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.4075044676803254,-0.6863348828057259,0.8732394366197183,0.9908037943491201,1.0,5/15,23.90%,SRGN;CD34;ARFGEF2;CAV2;WASHC4
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.3606366436701819,0.6854376224404248,0.8620689655172413,1.0,1.0,2/7,8.98%,CLASP1;PHLDB2
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.3550460924840921,-0.6843512551127221,0.9264705882352942,0.9923998757511723,1.0,10/20,31.85%,GAS7;CFL1;SPIRE1;DSTN;ABI1;PREX1;FAM107A;RAC1;MICALL2;ABI2
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.30237422249454876,0.6826579947017852,0.92,1.0,1.0,5/16,16.18%,EIF2AK2;NFAT5;NOD1;PDCD4;APP
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.4309186165984913,-0.6822027194134872,0.828125,0.9939139387328406,1.0,4/6,48.92%,DIP2A;BRD7;GLYR1;DIP2B
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.35438508749409126,-0.6811481728949905,0.9402985074626866,0.9945196907655212,1.0,2/19,8.15%,RAPGEF3;TPM1
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.43268434777551074,-0.6807896633437837,0.8823529411764706,0.9943963414868703,1.0,3/8,25.52%,MEF2A;MFN1;MTM1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.39846679731502477,-0.680770288330647,0.8235294117647058,0.9939119290511099,1.0,8/11,31.31%,PLPP1;SAMD8;ACER2;NSMAF;ACER3;SPTLC2;ST6GALNAC3;CERK
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.4223194461169343,0.6802934031542839,0.84375,1.0,1.0,2/6,3.13%,SLC4A4;SLC26A3
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.4443698341300054,-0.6800723823224215,0.8701298701298701,0.9941041784527094,1.0,1/6,15.30%,MYEF2
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.3363870320533924,0.6790468080556408,0.8787878787878788,1.0,1.0,2/14,7.14%,PLCB4;PPIP5K2
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.3363870320533924,0.6790468080556408,0.8787878787878788,1.0,1.0,2/14,7.14%,PLCB4;PPIP5K2
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.41346354376334593,-0.6777512089308666,0.864406779661017,0.9958483342214329,1.0,2/7,17.18%,AGPAT4;SAMD8
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.42116852854581327,-0.6771981733572767,0.8970588235294118,0.9958504961879876,1.0,2/6,24.14%,TPR;NEDD4
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.4585284643353125,-0.6761528232451888,0.8870967741935484,0.9963847538358207,1.0,1/6,11.61%,ELP4
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.4043169664653167,-0.6759810513877686,0.8571428571428571,0.9960549635017169,1.0,3/10,9.16%,GRM7;ANXA1;IL1RAPL1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.34158492035855303,-0.6758280634052157,0.9024390243902439,0.995714077336977,1.0,12/35,27.17%,KIAA1217;TIMP3;EPAS1;GJA1;PLSCR4;CALD1;EGFR;SASH1;CDH5;TNS2;SPARCL1;FZD4
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),-0.4018858774978568,-0.6756198294398078,0.9014084507042254,0.9953906760466027,1.0,2/15,12.35%,NDFIP1;STXBP5L
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.4028943827634376,-0.6756084403089508,0.8805970149253731,0.9938805567388408,1.0,2/10,18.01%,TPR;NUP54
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.4028943827634376,-0.6756084403089508,0.8805970149253731,0.9938805567388408,1.0,2/10,18.01%,TPR;NUP54
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.4028943827634376,-0.6756084403089508,0.8805970149253731,0.9938805567388408,1.0,2/10,18.01%,TPR;NUP54
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.4470695948889035,-0.6755617561281755,0.8852459016393442,0.9934333164353157,1.0,3/5,34.00%,SMAD5;DSP;EFNA1
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.4161639048504249,0.6750940038517453,0.7647058823529411,1.0,1.0,3/6,29.14%,SKI;CDC73;NF1
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.4260824972020416,-0.674880345792396,0.8823529411764706,0.9935563568952364,1.0,2/10,18.73%,HIF1A;ITGB1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.394474859668375,-0.6747729514650981,0.8888888888888888,0.9932065557918556,1.0,3/13,25.87%,KLF4;HSP90AA1;TNKS
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.41098806107549773,-0.6740496725270559,0.9230769230769231,0.9933125089691909,1.0,4/9,27.57%,ANXA1;GATA2;JCAD;RHOJ
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.37436565170330593,-0.6739686222562846,0.9090909090909091,0.9928721517040621,1.0,8/17,20.03%,ATG12;GLUL;ZDHHC6;PIGN;PIK3C3;ZDHHC21;PIGC;ZDHHC14
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.3961053994392154,0.6736477395106529,0.9318181818181818,1.0,1.0,2/6,15.46%,SMYD3;KDM6A
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),-0.3464813678942523,-0.6736111539519388,0.9230769230769231,0.9927848178241425,1.0,13/34,25.07%,ATP2B1;SLC8A1;ANK2;HERPUD1;MICU2;ATP13A3;SLC30A1;CAV2;TMEM165;VAPB;CDH5;CALR;CAMK2D
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.4633855955419036,-0.6735564508651767,0.8615384615384616,0.9923338052337618,1.0,3/5,29.22%,TFPI;ATP1A1;ABHD2
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.47820106598075635,-0.6734737355856854,0.9272727272727272,0.9919173345929643,1.0,2/5,12.99%,DDX18;NPM1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.4013144906129522,-0.6728543275774356,0.890625,0.9920236715274052,1.0,1/10,4.46%,KDM1A
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.3908564399034356,-0.6727077944169461,0.8961038961038961,0.9916985821717457,1.0,5/19,20.53%,RAB11FIP3;RACK1;PIK3C3;CSPP1;PRPF40A
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.3602403333344154,-0.672348480226531,0.863013698630137,0.9914702515440748,1.0,4/24,10.89%,NFASC;PTPRD;SMARCA1;SHC2
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.3763767650001273,-0.6720338811956418,0.8961038961038961,0.9912648294071466,1.0,2/15,11.24%,CFL1;PPFIA2
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.3093031251205568,0.670765276690677,0.9166666666666666,1.0,1.0,3/12,12.56%,HSPB1;DLG2;DTNBP1
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.33097168778899433,-0.6703696609153462,0.9,0.9923742801664666,1.0,15/44,26.88%,ARF1;COMMD1;AP1G1;KIF16B;MYO1B;ACBD3;RAB14;ARFGEF2;SCAMP1;FTL;CLTA;DNM2;KLHL20;CLINT1;AP4S1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.3890785302130119,0.6701419756334626,0.9210526315789473,1.0,1.0,1/5,4.22%,MFF
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.30329986122477803,0.6700267346637068,1.0,1.0,1.0,6/24,16.49%,ATR;INO80;ATM;SPIDR;CLOCK;MDM2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.39904093436709365,-0.6689010573921035,0.7692307692307693,0.9931371203389354,1.0,4/8,36.39%,TNFRSF10B;DAB2IP;DDX3X;TNFRSF10A
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),-0.3245022347929186,-0.6688900869914924,0.9310344827586207,0.9926367993715103,1.0,12/49,24.67%,UFL1;HIF1A;PTTG1IP;MSN;DHRSX;TMEM59;PIK3CB;ZC3H18;ADAM9;CNOT8;SNX9;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.3835732901141688,0.6684340538250194,0.8918918918918919,1.0,1.0,2/7,25.84%,APP;AKAP9
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.3929684079832706,-0.6682834086592115,0.8732394366197183,0.9926518695925045,1.0,3/12,19.76%,PRNP;EGFR;CLU
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),-0.40968494383173826,-0.6682460668581436,0.8507462686567164,0.9921692621974139,1.0,1/7,3.85%,HSPA5
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.42059125082708804,0.6682089162057873,0.8181818181818182,1.0,1.0,3/5,16.04%,EYS;CFLAR;PPP3CA
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.4132144867097192,0.6679059514977252,0.84375,1.0,1.0,2/5,11.50%,TTN;ACVR1
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.28592759788688477,0.6673055119801631,0.9259259259259259,1.0,1.0,5/26,14.37%,THOC1;XPO4;XPO7;NUP214;RANBP17
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.41726855739365026,-0.6667593377276755,0.8620689655172413,0.9930380664053012,1.0,2/9,7.49%,NFE2L2;HIF1A
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.3443114293368805,0.6666822940029989,0.9354838709677419,1.0,1.0,4/11,16.18%,TENT2;SCAF8;PNPT1;APP
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.3443114293368805,0.6666822940029989,0.9354838709677419,1.0,1.0,4/11,16.18%,TENT2;SCAF8;PNPT1;APP
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.3927185964943596,-0.6666041119207194,0.873015873015873,0.9926517927856814,1.0,4/12,24.25%,CDKN1A;KMT2A;ACVRL1;TERF2IP
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),-0.3037278778198211,-0.6661386880910657,0.9789473684210527,0.9926385915325333,1.0,21/105,24.89%,BHLHE40;ESR2;HIF1A;RREB1;CREM;SBNO1;ZNF280D;CNBP;BTG1;WWTR1;NSD2;ZBTB38;ATF2;ACVRL1;MTF2;ZNF141;DNM2;CALR;FOXN3;TERF2IP;NR2C2
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.4125196261574792,0.6660536206397396,0.7380952380952381,1.0,1.0,1/5,5.31%,MIA3
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.42947037800493604,-0.6654909281421262,0.8333333333333334,0.9928003642371087,1.0,3/7,29.22%,TFPI;ATP1A1;ABHD2
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.39861887094954773,-0.6651230152800136,0.8805970149253731,0.9926460751500389,1.0,3/11,17.85%,IL18R1;LCP2;CHSY1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.2928807037146318,0.6650456148655887,0.8888888888888888,1.0,1.0,1/16,3.43%,ATP10D
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),-0.44410280358004117,-0.6635300760684599,0.864406779661017,0.9935237369342964,1.0,2/5,16.65%,PRKN;PINK1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.40772051585720803,-0.6629097674425467,0.9,0.9935552080962218,1.0,3/8,18.57%,KPNB1;NUP54;KPNA4
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.28468380969721396,0.6625956159092442,0.9444444444444444,1.0,1.0,5/32,13.33%,ATR;HSPA1A;ATM;NUP58;NUP214
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),-0.33369873158040014,-0.662555729141786,0.9540229885057471,0.9933726097681277,1.0,6/38,16.39%,BAZ1A;PBRM1;SMARCA1;NPM1;MBD2;SMARCC1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.30446119840222763,0.6623799494013091,0.8888888888888888,1.0,1.0,1/16,3.88%,INO80
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.38617203330101957,-0.6618634212071061,0.8243243243243243,0.9933478275564817,1.0,3/12,23.08%,PPA2;PINK1;SLC25A36
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.345844509483502,-0.661592375085733,0.972972972972973,0.9931486351380764,1.0,4/25,9.83%,MGLL;GAS7;SLC8A1;SOD2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3304877335225647,0.6614287552910624,0.9655172413793104,1.0,1.0,4/11,16.84%,ERCC6;KMT5B;SHLD2;PARP9
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2976000014531686,0.6605258509986697,1.0,1.0,1.0,5/26,11.79%,TNRC6C;ATF7IP;MED27;MED23;MED15
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.3962510484102125,-0.6600798494260699,0.8873239436619719,0.9940294731600416,1.0,1/6,14.56%,CYLD
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.3419392493449811,0.6600316196133528,0.8666666666666667,1.0,1.0,2/11,13.84%,EZH1;KAT6B
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),-0.3636812130839461,-0.6598455750562704,0.9090909090909091,0.993745819441735,1.0,5/16,24.04%,WDR48;OGT;PINK1;ADAM9;SNX9
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.40554101493470973,-0.659713483644794,0.8767123287671232,0.9933163684831087,1.0,2/10,7.49%,MBP;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.39251589747290005,-0.659478741348746,0.84375,0.9930221232747546,1.0,2/7,30.07%,MAP3K13;CDKL5
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.3010257021235537,-0.6589235813432133,0.9896907216494846,0.9929807517545253,1.0,22/78,23.24%,PSMC6;ZEB2;PSMB9;GPC5;PSMA1;PRKN;CDK14;CTNND2;AMFR;CYLD;WWTR1;USP34;PPM1A;EGFR;PSMA7;CSNK1D;XIAP;GLI3;GPRC5B;TNKS2;GPC3;CCNY
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.37461695155645736,-0.6575806020527124,0.9014084507042254,0.9937023925331053,1.0,4/15,13.89%,ANK2;FGFR1;CTNND2;BCAR1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.3554539969709314,0.6569531455512637,0.8611111111111112,1.0,1.0,1/6,11.98%,ACBD6
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.42462827282936183,-0.6567584004883893,0.8688524590163934,0.993417333275209,1.0,4/5,20.35%,HIF1A;NOS1AP;SCARB1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.42462827282936183,-0.6567584004883893,0.8688524590163934,0.993417333275209,1.0,4/5,20.35%,HIF1A;NOS1AP;SCARB1;PIK3CB
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.4275659494389967,-0.6565874140274761,0.859375,0.9931069660756798,1.0,1/6,12.01%,CSTF3
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.44084021893117686,-0.6558160960195418,0.9315068493150684,0.9932616168422057,1.0,2/7,22.36%,CDK6;B2M
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.3951253656661854,-0.6555461512546108,0.9324324324324325,0.9929292518754632,1.0,3/10,25.18%,KIF16B;RAB14;KLHL20
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.3818692261915926,0.6552283564779724,0.8666666666666667,1.0,1.0,1/6,2.31%,TBC1D5
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.29820537104095163,-0.6544983274264882,0.956989247311828,0.9931621437064763,1.0,9/119,10.73%,PSMC6;PSMB9;RPS27A;RNF19A;PSMA1;PRKN;UBC;ARIH2;CHFR
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.415092120379162,-0.6538719784566059,0.8450704225352113,0.9932326780512775,1.0,2/8,9.83%,ERBB4;SOD2
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.4114901438466807,-0.6536519946336808,0.8714285714285714,0.9929622886907165,1.0,3/9,18.73%,GJA1;PAFAH1B1;ITGB1
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.432136317306903,-0.6534793761470076,0.8923076923076924,0.9926642431768133,1.0,1/5,17.29%,ROBO2
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.3351455635909197,0.6530264976554937,0.9310344827586207,1.0,1.0,3/12,14.56%,INO80;SPIDR;CLOCK
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.42648991010993675,-0.6526848632517313,0.8088235294117647,0.9928744750346411,1.0,2/5,25.87%,TNKS2;TNKS
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.3982360735214005,-0.6526824203350166,0.9295774647887324,0.9923814887014561,1.0,3/11,13.68%,PCK1;CD81;RIOK3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.3554514872872775,0.652121041247117,0.8888888888888888,1.0,1.0,3/7,16.84%,KMT5B;SHLD2;PARP9
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.39730580262535387,-0.6520985073102062,0.9264705882352942,0.9924801187993723,1.0,5/11,24.14%,ANK3;DLG1;AHCYL1;ATP1A1;NEDD4
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),-0.3799691580589354,-0.6512736026038278,0.88,0.992567503240595,1.0,1/11,7.49%,HIF1A
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.3227931927315733,-0.6511468602999683,0.9873417721518988,0.992209109735953,1.0,4/47,8.26%,CX3CL1;TIMP3;ERBB4;RAP1A
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.4010284318641706,-0.6507702678409232,0.8933333333333333,0.9920571015065467,1.0,6/10,37.10%,PLCG2;MTOR;VIM;MTPN;SORBS1;ZBTB20
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.41297474999724687,-0.6500681824309631,0.8857142857142857,0.9922224843379904,1.0,1/7,19.60%,EMP2
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.36325470526046444,-0.6495046464876784,0.9710144927536232,0.9922653203445121,1.0,3/14,12.46%,COL18A1;PLOD2;PLEC
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),-0.3490081898531848,-0.6489672644566501,0.961038961038961,0.9922580729276518,1.0,5/21,16.79%,HSPA5;PRKN;HERPUD1;TMBIM6;HSPH1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.4058188118093272,-0.6489084286798961,0.9130434782608695,0.9918340303110649,1.0,2/9,13.04%,PIK3R1;ARPP19
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.4045212575732132,-0.6486673087501598,0.9,0.991532608508078,1.0,1/6,12.54%,FGD4
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.360269094258715,0.647607534531463,0.8857142857142857,1.0,1.0,2/8,12.54%,ELAPOR2;PCM1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.29210716560736866,-0.6470565602986045,0.9777777777777777,0.9922752367600481,1.0,13/93,17.32%,NR4A1;PPARG;ESR2;ELL2;RREB1;AFF4;CCNH;ELP4;CSTF3;WWTR1;THRB;NOTCH4;TSC22D1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.36931083560262024,-0.6467943091612496,0.927536231884058,0.9919572473825478,1.0,4/15,18.41%,LRRC7;MSN;ERBIN;DLG1
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.32692121809651414,-0.6467889560122441,0.9493670886075949,0.9914676337362581,1.0,6/28,17.82%,SCARB2;VAV3;TBC1D15;FGD4;PAFAH1B1;ARHGAP15
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.3502689714361396,-0.6462487033347765,0.9324324324324325,0.9913942774239467,1.0,2/20,8.34%,BTG2;PRKN
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.34469626388879554,0.6452539438401642,0.8611111111111112,1.0,1.0,5/8,19.39%,IL6R;TNFRSF1B;GIMAP8;GIMAP7;GIMAP4
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),-0.39692136193432404,-0.6448862882782016,0.9402985074626866,0.9918529220633792,1.0,4/9,27.41%,AHCYL1;NEDD4;NEDD4L;ANO6
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.36717407605249713,-0.6446304346395022,0.9230769230769231,0.9916133024040125,1.0,3/11,16.65%,HIF1A;TMSB4X;PINK1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.45630445426844807,-0.644193471225608,0.8955223880597015,0.9915178408862196,1.0,1/5,15.70%,RAB8B
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.38590425531914896,0.6433046665298641,0.7777777777777778,1.0,1.0,5/5,61.46%,PIP4K2A;RALB;RAB3GAP1;SH3GLB1;RAB3GAP2
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.4077457285725681,-0.6411711478159582,0.8591549295774648,0.993403193748046,1.0,1/6,6.85%,PRX
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.2638067362763335,0.6410394020263863,1.0,1.0,1.0,6/33,12.30%,EFNA5;CLASP1;ABL1;PHLDB2;TEK;ROCK1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.37752028116330194,-0.6402346804387311,0.9193548387096774,0.9936166262141312,1.0,3/13,22.60%,HIP1R;PPP3CC;MAPK8
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),-0.3998095511453359,-0.6397517795058885,0.9,0.9934097742505742,1.0,3/7,18.91%,SLC8A1;CACNA1C;MICU2
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.363416167182211,0.6392522692050748,0.9487179487179487,1.0,1.0,1/6,5.74%,MTMR3
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.3088469534206789,-0.6389583941635293,0.967391304347826,0.9935732724137704,1.0,6/52,12.30%,CX3CL1;ERBB4;FLT1;RAP1A;FGFR1;PLCG2
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.3492296831068684,0.6387053922871947,0.8,1.0,1.0,3/11,12.30%,KANK1;TEK;ROCK1
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.431138172884587,-0.6383448114982972,0.8596491228070176,0.9936482600777469,1.0,1/5,18.43%,MTOR
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.42970697914774814,-0.6377939024842436,0.9491525423728814,0.9936017527535076,1.0,2/5,22.97%,CD81;PRKCH
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.3387152057290298,-0.6376473045570439,0.975609756097561,0.9932408539119638,1.0,7/26,20.48%,SMAD7;SDCBP;SMAD3;WWTR1;DAG1;MTOR;SPRED1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.39339332996266285,-0.6366881941431125,0.873015873015873,0.9935309299653535,1.0,3/7,28.18%,TPR;CHMP4B;DYNC1H1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.3968353719167078,-0.6363414150647277,0.8484848484848485,0.993258596346986,1.0,1/8,10.92%,EPAS1
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.3984967280560249,0.6363258299394491,0.8837209302325582,1.0,1.0,2/5,9.22%,DISP1;CHD7
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),-0.4009402958854338,-0.6358009079251227,0.9166666666666666,0.9931738129198467,1.0,2/10,17.29%,ZFPM2;ROBO2
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.3624257236908916,-0.6356409399682591,0.9090909090909091,0.9927642803735298,1.0,5/20,22.12%,ARID5A;THRB;ROBO2;TFPI;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.37995767150989024,-0.6353183376643964,0.9166666666666666,0.9925532545714145,1.0,1/8,9.69%,DLC1
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.37989799599499163,-0.635273136077018,0.8933333333333333,0.9921004247606084,1.0,2/11,13.04%,PIK3R1;ARPP19
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.32775713460843453,-0.6350634963627114,0.9367088607594937,0.9918019694270017,1.0,3/21,12.14%,GAS7;GPM6A;DCLK1
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.4228078187478552,-0.6343004551948361,0.9078947368421053,0.9917675593351669,1.0,2/6,20.29%,MYL6;CAV2
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.283124567051317,-0.633607858334478,0.9891304347826086,0.9918979481561648,1.0,30/109,25.26%,PPARG;CANX;ARF1;LAMP2;TBC1D15;RAB21;SNX6;GOLPH3;TMED10;NPM1;RAB1A;COPA;LRP1B;RAB8B;MIA2;RAB14;ARL4A;PREPL;ANK3;TBC1D9;USO1;CLU;SCAMP1;DNM2;ARL5B;ATP6V1E1;SNX9;TF;ARRDC3;ARHGEF2
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.3865834620031109,-0.63316706726741,0.9285714285714286,0.9917647139256739,1.0,1/7,5.05%,SPG7
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.3882816966085172,0.6323195134824399,0.8787878787878788,1.0,1.0,1/5,6.91%,CTNNA2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.41123562067299146,-0.6311656854104464,0.9076923076923077,0.992805787665966,1.0,3/7,32.14%,B2M;HLA-E;ERAP1
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.34673026959694686,-0.630411561407599,0.9295774647887324,0.9929299947462891,1.0,2/18,10.78%,PIK3R1;GPM6A
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.2798934896586849,-0.6295688544697118,0.9896907216494846,0.9930047475140257,1.0,14/174,10.92%,PSMC6;PSMB9;RPS27A;NFE2L2;RNF19A;PSMA1;HIF1A;COMMD1;PRKN;UBC;ARIH2;KLHL7;CHFR;EPAS1
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.31517032369510656,-0.6283693376460464,0.9629629629629629,0.9932328334198599,1.0,9/34,22.12%,SLC6A6;SLC8A1;ATP1B3;CACNA1C;SLC30A1;TMEM165;SCN2A;RYR3;ATP1A1
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.3952764728878824,-0.6281169311834985,0.9264705882352942,0.9929295136818481,1.0,2/9,10.04%,GPC5;HYAL2
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),-0.3160865917800846,-0.6273364919215623,0.9726027397260274,0.9930315246970308,1.0,10/44,24.62%,FES;DUSP1;TPM1;TGM2;RSU1;ACVRL1;PODXL;RASA1;PLXNA2;ADGRG1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.41547466348707407,-0.626294268294285,0.9838709677419355,0.9927868628355633,1.0,1/6,10.46%,NDUFA12
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.41547466348707407,-0.626294268294285,0.9838709677419355,0.9927868628355633,1.0,1/6,10.46%,NDUFA12
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.3518482728994544,0.6256026775857091,0.9166666666666666,1.0,1.0,2/8,20.24%,CIRBP;LARP1
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.330877122866731,-0.6254989901351302,0.922077922077922,0.9929379835513501,1.0,7/24,16.47%,AFDN;LIMS1;CTNND2;CLDN5;SMAD3;CADM2;CTNNA1
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.31294805285029936,0.6238432459511691,0.9,1.0,1.0,2/14,7.36%,SLC23A2;SLC25A29
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.3798160800918995,-0.6209495058379739,0.9090909090909091,0.9957329554161515,1.0,2/12,17.24%,ZFP36;DCP2
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.3539829371878551,-0.6204595361583803,0.8955223880597015,0.9955658089495969,1.0,3/9,25.18%,TPR;IFITM3;KLHL20
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.28102100428769344,0.6199562723607993,0.9743589743589743,1.0,1.0,2/15,9.16%,GBP1;SEMA6A
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.3500932751724407,-0.6192629598335608,0.9102564102564102,0.9959336598089981,1.0,6/19,23.56%,CDK6;CAV2;ATOH8;SPARC;B2M;NFIB
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.3975493049725596,-0.6187649234193093,0.9538461538461539,0.9958429460970196,1.0,4/10,21.78%,KCNIP4;DPP10;DLG1;CD63
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.3360880493393973,0.6186628780087841,1.0,1.0,1.0,2/7,21.20%,TMCC1;SLC25A46
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.3646626010705359,0.6175976451857776,0.9393939393939394,1.0,1.0,3/8,21.33%,TMEM106B;GNPTAB;LRRK2
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.29963538856830885,-0.616122429922587,0.9487179487179487,0.9972407720270708,1.0,7/42,18.43%,GPM6B;HIP1R;DLC1;PAK2;CYLD;ARHGAP17;MTOR
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.3587332326438938,-0.6157541518868214,0.9041095890410958,0.9969696769301198,1.0,2/13,7.49%,FES;HIF1A
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.3776878391223524,-0.6156271680878905,0.890625,0.9965681186173744,1.0,2/9,9.06%,VAV3;CD81
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.36606475957068035,-0.614859873489972,0.9538461538461539,0.9965970474522563,1.0,4/8,34.29%,PARVB;RHOJ;RAC1;GSN
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.3325070805817578,0.6146360694041121,0.9487179487179487,1.0,1.0,1/7,7.62%,SGMS1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.3631919206536429,0.6134350008567434,0.8378378378378378,1.0,1.0,2/8,14.69%,CCM2;RBPJ
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.3221781788300625,-0.6097874472539159,0.9166666666666666,0.9993467695398598,1.0,4/25,18.01%,PLOD2;TPR;PIAS2;NUP54
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.40948161017690365,-0.6091516724042447,0.8846153846153846,0.999363447410419,1.0,1/5,12.99%,NPM1
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.33045657297903397,0.6086640837208278,0.875,1.0,1.0,3/9,17.16%,NFAT5;PPP3CA;PLCE1
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.3124610345254359,-0.6084975724775864,0.9342105263157895,0.9993474908799935,1.0,8/36,23.24%,SULF2;PRKN;CDK14;CTNND2;RACK1;CBFB;GPC3;CCNY
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.3148771534808048,0.6083695857869019,0.96875,1.0,1.0,1/10,6.96%,TRIM22
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.4020086835045253,-0.6081315297845282,0.961038961038961,0.9990978985969328,1.0,2/7,27.49%,GLI3;KIAA0586
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.36887609055056725,-0.6080695408117704,0.9692307692307692,0.9986638894273072,1.0,3/13,12.30%,MBP;HYAL2;PLCG2
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.3749071293985168,-0.6076720270864463,0.95,0.9984745820217146,1.0,3/7,28.18%,TPR;CHMP4B;DYNC1H1
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.37300994926669023,-0.6073553067026627,0.8852459016393442,0.9982583280471047,1.0,3/8,25.05%,CTNNA3;ITGB1;DSP
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.4070681205786576,-0.6071165363491122,0.921875,0.9979500874154075,1.0,2/5,23.27%,AFDN;CDH5
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),-0.39527361749355183,-0.6068996109945184,0.96875,0.9971123586968433,1.0,1/6,5.87%,JAK1
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),-0.39527361749355183,-0.6068996109945184,0.96875,0.9971123586968433,1.0,1/6,5.87%,JAK1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),-0.41513398629642084,-0.6067850998292802,0.8888888888888888,0.9966643151269147,1.0,2/5,19.42%,TEC;EGFR
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),-0.36104649226666463,-0.6046224507192622,0.9428571428571428,0.9976456848206163,1.0,2/13,17.85%,S1PR1;CHSY1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.27532681604104714,0.6039661703395346,1.0,1.0,1.0,2/19,10.41%,IL6R;TNFRSF1B
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),-0.37401445419954205,-0.602385119827196,0.8888888888888888,0.9985990585111244,1.0,2/6,18.54%,PINK1;PIKFYVE
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.3649397432804853,0.6018175362324625,0.9032258064516129,1.0,1.0,2/5,14.82%,KMT5B;SHLD2
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.3649397432804853,0.6018175362324625,0.9032258064516129,1.0,1.0,2/5,14.82%,KMT5B;SHLD2
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.3629737507746412,-0.601391498718213,0.9253731343283582,0.9987241518838799,1.0,3/10,22.63%,NPAS2;MCL1;BCLAF1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.3075555859298381,0.598089204649748,0.9666666666666667,1.0,1.0,3/10,14.82%,ERCC6;RNF169;SHLD2
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.3542989626447326,0.5976584298647639,0.7419354838709677,1.0,1.0,1/5,10.76%,EIF4A2
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),-0.37451920449052206,-0.5976567460704587,0.9117647058823529,1.0,1.0,2/9,21.89%,GIGYF2;ZC3H18
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.32113845445204003,0.5971794749739452,1.0,1.0,1.0,3/10,13.01%,CTNNA2;ABL1;PDLIM5
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.3207697049512494,-0.5970084697671717,0.9487179487179487,1.0,1.0,9/19,33.97%,FOXK1;MCL1;PINK1;MTOR;TLK2;RASIP1;STAT3;MTMR9;FOXK2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.3200786646328604,0.596139948599431,0.9230769230769231,1.0,1.0,1/8,8.13%,HSPB1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.3204575849857601,0.5941712540607571,0.9629629629629629,1.0,1.0,2/12,6.99%,ATR;SLF2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.40352976478202895,-0.5931295907424308,0.9565217391304348,1.0,1.0,2/5,28.66%,RIF1;SMCHD1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.38123912929568,-0.5913611537860054,0.9193548387096774,1.0,1.0,3/5,25.87%,TNKS2;TERF2IP;TNKS
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.35690078716532603,0.5901001330108303,0.9024390243902439,1.0,1.0,3/6,31.18%,PARN;XRN1;DIS3L2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.3453012938016371,-0.5897340681817967,0.927536231884058,1.0,1.0,2/12,25.07%,MEF2A;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.3652589036949846,-0.5897034649571044,0.974025974025974,1.0,1.0,1/11,5.50%,WDR48
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.3445520739343444,-0.5894674690982031,0.9859154929577465,1.0,1.0,3/12,11.24%,IL1RAPL1;CFL1;PPFIA2
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.3644062859739546,-0.5885369073567928,0.9193548387096774,1.0,1.0,2/6,22.71%,CHMP4B;TMEM50B
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.339630788963016,-0.5875009120296776,1.0,1.0,1.0,2/14,13.92%,KDM1A;PTTG1IP
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.3134601790052943,-0.5867306416470984,0.9859154929577465,1.0,1.0,7/25,24.67%,RAPGEF3;SH2D3C;TBK1;PINK1;EGFR;TERF2IP;HSP90AA1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.362611264852555,0.5865071028985439,0.9444444444444444,1.0,1.0,2/7,15.64%,ENTPD1;PNPT1
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.36067743392832924,0.5861550188347185,0.9473684210526315,1.0,1.0,1/5,4.91%,CLASP1
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.3256076018883629,0.5848342702730414,0.9487179487179487,1.0,1.0,1/7,9.16%,SEMA6A
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.36360610717769437,0.5847033434251107,1.0,1.0,1.0,1/5,6.93%,HDAC9
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.3569229568787756,-0.5842357224024819,0.9545454545454546,1.0,1.0,5/9,33.73%,ZFP36;CBFB;PRKCH;FOXC1;ZFP36L1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.3639553148942386,-0.5839575493675568,0.9193548387096774,1.0,1.0,2/7,32.03%,HLA-B;HLA-E
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.35048210112855704,-0.5825346166003736,0.9264705882352942,1.0,1.0,1/12,12.99%,NPM1
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.40785604974765444,-0.5817033410991636,0.9523809523809523,1.0,1.0,1/5,30.65%,POLR2B
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),-0.3739237203104522,-0.5813802858294612,0.9523809523809523,1.0,1.0,3/5,48.92%,DIP2A;SIRT1;DIP2B
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.36204052803262,-0.5813534353447933,1.0,1.0,1.0,2/9,25.07%,MEF2A;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.3089356845314253,0.5810999423068979,0.9444444444444444,1.0,1.0,2/8,16.18%,HSPB1;APP
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.27576355027070854,0.5805817374924135,0.9411764705882353,1.0,1.0,1/17,2.63%,ATR
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),-0.33716941185414784,-0.5796484922801554,1.0,1.0,1.0,1/11,14.90%,NAA16
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.2545159276150577,0.5775438196653018,0.9583333333333334,1.0,1.0,3/18,12.54%,CLASP1;CLIP1;PCM1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.3888246882690386,-0.5770095449945072,1.0,1.0,1.0,3/5,23.35%,PIK3CB;CD63;JCAD
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,0.2837081935729439,0.5761834746206486,0.9722222222222222,1.0,1.0,3/12,14.69%,NKD1;PPARD;RBPJ
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3365920167176034,-0.5740051869172329,0.9594594594594594,1.0,1.0,3/11,18.41%,LRRC7;ERBIN;DLG1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.31681169896209643,-0.5734498953258774,0.9577464788732394,1.0,1.0,3/13,24.75%,DNM2;ATP6V1E1;TF
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),0.30638630839160225,0.5718308732683172,0.96,1.0,1.0,6/13,29.93%,STAT2;OAS3;ISG15;PTPN2;A2M;YTHDF2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.3469794794909016,-0.5706805426935238,0.9552238805970149,1.0,1.0,2/10,25.07%,MEF2A;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.32443678453632896,0.5674189122716963,0.9722222222222222,1.0,1.0,1/6,13.09%,PDCD4
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.3627659574468085,0.5672053705107877,0.9375,1.0,1.0,5/5,63.77%,PKD2;STAT1;COL4A1;MEF2C;MTSS1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3284647913800082,0.5663669252228863,0.9705882352941176,1.0,1.0,3/6,22.10%,KMT5B;SHLD2;NECTIN2
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.32099037747953013,0.5656634872067464,0.8936170212765957,1.0,1.0,3/5,21.62%,ST3GAL1;PARN;ST6GAL1
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.3794989092795803,-0.5650072570696002,0.9841269841269841,1.0,1.0,1/5,20.69%,UNC5C
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.3183891342555423,-0.5644245247029366,0.9565217391304348,1.0,1.0,3/16,18.01%,TPR;PIAS2;NUP54
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.29587459024305707,-0.5638265093322976,0.9746835443037974,1.0,1.0,11/27,27.94%,IFNGR1;NPM1;RACK1;PICALM;SLC2A13;MTOR;CLU;NSMAF;ABCG1;LARP4;VIM
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.375707293238244,-0.563430948551183,0.9852941176470589,1.0,1.0,2/5,29.91%,MTOR;SMARCA4
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.35000000000000003,0.5617026401050793,0.8571428571428571,1.0,1.0,5/5,65.05%,HDAC4;LYPLAL1;SIRT1;HDAC7;LYPLA1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.31391327480712944,0.5598123127024982,0.9736842105263158,1.0,1.0,6/6,68.66%,PNPT1;IRF1;STAT1;IFI16;UBE2G2;UBE2K
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.3332080532934205,0.5592695933027646,0.8863636363636364,1.0,1.0,1/5,11.29%,NCOA3
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),0.373936170212766,0.5564018943244895,0.9428571428571428,1.0,1.0,5/5,62.66%,ISG15;SP100;SETD2;TRIM56;MX1
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),-0.3820959318828875,-0.5538641635104606,0.95,1.0,1.0,2/5,20.88%,TGM2;SPEN
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.3505011237809777,-0.5537909370740549,0.9571428571428572,1.0,1.0,2/6,28.18%,PAFAH1B1;DYNC1H1
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.30848550172331324,-0.5531136510733746,0.987012987012987,1.0,1.0,7/14,34.69%,DLG1;RHOB;RAC1;RHOA;RND3;PPP2R3C;FMNL3
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.33264730726426095,-0.5525188307512674,0.9705882352941176,1.0,1.0,3/10,24.75%,DNM2;ATP6V1E1;TF
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.32850709004784595,-0.5522926845154753,0.9859154929577465,1.0,1.0,5/15,23.29%,ADSS2;SULT1C4;GNAI3;MFN1;ACOT9
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.29594992828878963,0.5514134508435067,0.9696969696969697,1.0,1.0,1/10,2.79%,ARHGAP12
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.326416600159617,0.5513468718578031,0.9411764705882353,1.0,1.0,6/6,67.41%,URI1;PPP6R3;PPP6R2;HTT;HSP90B1;MTMR9
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.33846221880218536,-0.5504661326564749,0.9830508474576272,1.0,1.0,1/10,10.46%,NDUFA12
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),-0.36717677693966216,-0.5492687261484094,0.9206349206349206,1.0,1.0,2/6,31.24%,B4GALT1;ST6GALNAC3
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.31343384212879166,-0.5443924059820786,0.9420289855072463,1.0,1.0,3/12,14.50%,JAG2;MSN;NCK1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.35944447774203925,-0.5428741368047657,0.9565217391304348,1.0,1.0,2/6,17.34%,CFL1;KPNB1
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.3486012734608471,-0.5415752360795886,0.9701492537313433,1.0,1.0,3/6,24.44%,CENATAC;ITGB1;NEDD4L
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.33316455335267325,-0.5396906897580721,0.9848484848484849,1.0,1.0,4/9,32.32%,UGGT2;UBE2J1;MCFD2;MGAT1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.33316455335267325,-0.5396906897580721,0.9848484848484849,1.0,1.0,4/9,32.32%,UGGT2;UBE2J1;MCFD2;MGAT1
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.31849342829998717,-0.5392987502282112,0.9523809523809523,1.0,1.0,5/14,22.31%,CPEB4;LARS1;MTOR;SPAAR;UBR1
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.3133414928353391,-0.5377012782617938,0.9692307692307692,1.0,1.0,3/12,28.18%,TPR;NEDD4;DYNC1H1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.34194061687377747,-0.53706854939597,0.9701492537313433,1.0,1.0,6/10,31.16%,DYNC1I2;KIF1B;CCDC88A;TUBA1B;CCDC88C;HOOK3
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.32349893199703283,-0.5350683572100019,0.984375,1.0,1.0,3/13,25.87%,CDKN1A;ACVRL1;TNKS
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.3160066020152738,0.5349700172671173,0.9318181818181818,1.0,1.0,3/8,26.37%,PCM1;DYNC2H1;TRIP11
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.25364515207379684,-0.5337486669730526,1.0,1.0,1.0,11/77,21.12%,YTHDC1;HNRNPH3;CSTF3;RNPC3;STRAP;SRRM1;RBM17;USP39;PRPF40A;SPEN;TRA2B
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.33243458884378574,0.5335601630234401,0.926829268292683,1.0,1.0,1/5,13.07%,ST3GAL6
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.31249882219387737,-0.5323616017842094,1.0,1.0,1.0,4/16,19.76%,KLF4;CDK6;CD34;CLU
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.3156999140939014,0.5323603852000602,0.9655172413793104,1.0,1.0,2/6,14.82%,KMT5B;SHLD2
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),-0.32475415977131383,-0.5306428795158186,0.9714285714285714,1.0,1.0,2/11,11.39%,DUSP16;TPR
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.3301375285041248,0.5299589712002328,0.9523809523809523,1.0,1.0,1/5,7.94%,HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.3301375285041248,0.5299589712002328,0.9523809523809523,1.0,1.0,1/5,7.94%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.3420708455150143,-0.5296282484545395,0.9846153846153847,1.0,1.0,3/7,21.33%,RELL1;GADD45B;SASH1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.378596414528059,-0.5293599595810693,0.9482758620689655,1.0,1.0,2/5,32.14%,B2M;ERAP1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.278012408821648,-0.5289899889135242,1.0,1.0,1.0,5/23,19.23%,COMMD1;GOLPH3;PREPL;ANK3;ARFGEF2
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.3362682742036217,-0.5288137378925003,0.9830508474576272,1.0,1.0,2/7,20.16%,MT1M;SLC30A1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.30472535962823283,-0.5279920861599503,0.9722222222222222,1.0,1.0,2/15,14.63%,KDM1A;SPIRE1
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.31860341402004805,-0.5272209052846375,0.987012987012987,1.0,1.0,2/11,14.69%,CBX5;MAX
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.31860341402004805,-0.5272209052846375,0.987012987012987,1.0,1.0,2/11,14.69%,CBX5;MAX
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.3213086383230379,-0.5269520281483837,0.9433962264150944,1.0,1.0,3/7,34.21%,FZD4;MAP3K13;MFSD2A
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.30047008126351005,-0.5268779220776353,0.9545454545454546,1.0,1.0,3/9,27.97%,TPR;HSP90AA1;ATXN3
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.34229295923420744,-0.5265076348118819,0.9692307692307692,1.0,1.0,2/6,38.59%,ANXA2;RAB3GAP2
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.3133000451290441,-0.526024290731674,0.9838709677419355,1.0,1.0,1/11,16.81%,NOTCH4
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.3142071922962254,-0.5250036010439806,0.958904109589041,1.0,1.0,3/8,31.16%,B2M;REST;HOOK3
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.3195770283394803,-0.5241979269481,0.9714285714285714,1.0,1.0,3/13,21.17%,PPM1D;PPHLN1;MTF2
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.29981558260314917,0.5234109210706925,0.9705882352941176,1.0,1.0,1/6,9.91%,NEK7
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.30359503330471466,-0.5231034935786246,0.984375,1.0,1.0,1/14,11.39%,TPR
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.3271536012597589,0.5229690837220619,0.9393939393939394,1.0,1.0,1/7,3.08%,OCLN
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.3255163346691933,0.521430587887721,0.9743589743589743,1.0,1.0,2/6,19.58%,ARHGAP35;PTEN
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.3103941131340813,0.5196608444543209,0.96,1.0,1.0,3/6,24.46%,CD99;MCU;CAMK1D
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),-0.3349560916544173,-0.5194652767529983,0.95,1.0,1.0,1/7,14.00%,MSN
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.318435754189944,0.5169202141484835,0.975609756097561,1.0,1.0,6/6,68.21%,FCHSD2;WASF2;CYFIP1;NCKAP1;GSN;ABI2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2844854082331202,0.5166264402356463,0.9,1.0,1.0,1/7,9.64%,ATM
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),-0.3397933839108107,-0.5161518509885673,0.9482758620689655,1.0,1.0,1/6,14.00%,MSN
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.30798783849192346,-0.5157703985030188,0.9242424242424242,1.0,1.0,2/8,31.50%,RBM17;SFPQ
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.24536319604418125,-0.5157546192566255,1.0,1.0,1.0,10/71,21.12%,YTHDC1;HNRNPH3;CSTF3;RNPC3;SRRM1;RBM17;USP39;PRPF40A;SPEN;TRA2B
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.3354478281801476,-0.5152977235086539,0.9701492537313433,1.0,1.0,2/6,29.30%,ZDHHC21;VCL
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.30136444666416407,-0.5146221037115779,0.9696969696969697,1.0,1.0,3/12,26.43%,TIE1;ROBO2;DLL4
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.2641740825679574,-0.5103406514943954,0.9873417721518988,1.0,1.0,10/34,25.07%,KCNMB4;MEF2A;PLCG2;SYT1;ECT2;RYR3;AHCYL1;ADAM9;NEDD4;CAMK2D
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.3127908135895852,-0.5070770943802044,1.0,1.0,1.0,3/10,34.82%,ACVRL1;DLL4;CXCL12
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.3137624150075604,-0.5058459859566656,0.9402985074626866,1.0,1.0,1/9,12.99%,NPM1
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.2348282586692344,-0.5049928048792677,1.0,1.0,1.0,22/85,31.50%,YTHDC1;CCNH;HNRNPH3;CSTF3;RNPC3;SRRM1;RBM17;USP39;PRPF40A;SPEN;TRA2B;PTBP1;CWF19L2;PABPC1;SRSF7;RPRD1B;CWC22;THOC2;GCFC2;POLR2B;HNRNPA3;SFPQ
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.3135450329657647,0.5046960475221277,0.9459459459459459,1.0,1.0,2/5,22.05%,MORF4L2;EPC1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.29477136718576036,-0.5043700284128498,0.9859154929577465,1.0,1.0,3/11,27.73%,SLC38A2;SLC3A2;SLC1A2
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.2871986382903842,-0.5038971953980088,1.0,1.0,1.0,4/13,30.65%,RIF1;TERF2IP;SMCHD1;POLR2B
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.29398936142331733,0.5025996988010774,0.9722222222222222,1.0,1.0,3/8,19.52%,ARHGAP35;FCHSD2;LATS1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.3221508959231179,0.5024156497452404,1.0,1.0,1.0,2/5,16.12%,TAPT1;SOX5
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.3022138980630865,-0.5002455947233581,0.9838709677419355,1.0,1.0,2/9,19.63%,BCAR1;PLAT
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.3015114498684755,0.4995185254166263,1.0,1.0,1.0,4/5,27.36%,GAS6;TRIM44;DHX9;IFIH1
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.3176273898146232,0.498131712523261,0.9666666666666667,1.0,1.0,1/5,8.90%,ABL1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.27442108064945425,0.4981237512977022,1.0,1.0,1.0,8/8,72.62%,USP6NL;AKAP9;STX18;ARMH3;PDCD10;CAMSAP2;MAPK1;MAP2K1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.3169050881159842,-0.49688827756843,0.9705882352941176,1.0,1.0,4/8,30.23%,PLCG2;CD34;CD46;STAT3
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.3183510638297873,0.4964198108001019,0.9523809523809523,1.0,1.0,5/5,68.21%,FCHSD2;WASF2;CYFIP1;NCKAP1;ABI2
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),-0.3279772604359342,-0.4949685346070577,0.9821428571428571,1.0,1.0,1/6,17.29%,ROBO2
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),-0.31433560256378296,-0.4948284762220777,0.9863013698630136,1.0,1.0,3/8,34.82%,STK39;RHOA;CXCL12
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.3158524063671862,-0.49438551584148405,1.0,1.0,1.0,4/8,31.00%,LARS1;SPAAR;SIK3;SESN3
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.290894582252475,-0.4938437364265573,1.0,1.0,1.0,4/15,22.97%,RAP1A;CLDN5;CBFB;PRKCH
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.3161315286147363,-0.48922734004825325,0.9696969696969697,1.0,1.0,1/8,12.99%,NPM1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.3161315286147363,-0.48922734004825325,0.9696969696969697,1.0,1.0,1/8,12.99%,NPM1
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.3161315286147363,-0.48922734004825325,0.9696969696969697,1.0,1.0,1/8,12.99%,NPM1
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.3161315286147363,-0.48922734004825325,0.9696969696969697,1.0,1.0,1/8,12.99%,NPM1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.2678614368877227,-0.48883240307241327,1.0,1.0,1.0,4/16,33.68%,VAPB;PABPC1;POLR2B;DDX3X
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.2928053000481925,0.48881801776503414,1.0,1.0,1.0,1/7,10.07%,INVS
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.3109259508974521,0.4859912939110458,0.9714285714285714,1.0,1.0,2/5,12.24%,TNFRSF1B;PPARD
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.2685393892399738,-0.4852914102387371,1.0,1.0,1.0,7/21,34.98%,KPNB1;PTBP1;EIF3A;NUP98;POLR2B;TFRC;ILF3
prerank,PanglaoDB_Augmented_2021__B Cells,-0.27765469349241834,-0.48509213752988706,1.0,1.0,1.0,3/15,19.84%,CD55;LCP2;SPCS3
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.26501952148556107,0.48478713008831015,1.0,1.0,1.0,1/8,9.64%,ATM
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.2615087350777247,-0.48272061367901575,1.0,1.0,1.0,6/24,31.26%,DDX24;PTBP1;WTAP;MMS19;POLR2B;HNRNPA3
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.2872121228214597,-0.472992952923185,0.9846153846153847,1.0,1.0,2/10,24.67%,TERF2IP;HSP90AA1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.2872121228214597,-0.472992952923185,0.9846153846153847,1.0,1.0,2/10,24.67%,TERF2IP;HSP90AA1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.2872121228214597,-0.472992952923185,0.9846153846153847,1.0,1.0,2/10,24.67%,TERF2IP;HSP90AA1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.28991353700399325,-0.4727201480352869,0.9848484848484849,1.0,1.0,1/11,12.99%,NPM1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.3025860262346266,-0.47156839309522053,0.9850746268656716,1.0,1.0,2/5,24.04%,ADAM9;SNX9
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.3028710837931463,-0.4700849071170132,0.971830985915493,1.0,1.0,1/7,18.41%,DLG1
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.2466702184336709,0.469647348340135,1.0,1.0,1.0,11/11,75.41%,KAT6B;MORF4L2;TRRAP;EP300;NAA50;MORF4L1;CREBBP;KAT6A;PHF20;KAT2B;PHF20L1
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.30518079032915213,-0.4693404353882845,1.0,1.0,1.0,1/6,15.51%,PPP3CC
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.30518079032915213,-0.4693404353882845,1.0,1.0,1.0,1/6,15.51%,PPP3CC
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.27247240374892867,-0.46648722034534396,0.9841269841269841,1.0,1.0,1/11,9.69%,DLC1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.25024009096888034,0.4657073222464718,0.9767441860465116,1.0,1.0,1/5,13.49%,SERPINB9
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.2667499490049115,0.4640425690664485,1.0,1.0,1.0,4/11,21.25%,TOP2B;ADARB1;LARP1;STAU1
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.2960415113750178,-0.46233312884902633,0.9838709677419355,1.0,1.0,1/8,14.00%,MSN
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.30057513693494486,0.4604529947933841,1.0,1.0,1.0,3/5,27.07%,MAP4;ODF2L;YAP1
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.27155172995214366,-0.4578019364059943,1.0,1.0,1.0,3/16,25.87%,KLF4;HSP90AA1;TNKS
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.2624888113650985,-0.45758880645659455,1.0,1.0,1.0,2/14,14.69%,CBX5;MAX
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.274807129555733,0.4564433999735082,0.9696969696969697,1.0,1.0,6/6,72.56%,SPIDR;GAPVD1;SCFD1;CEP290;DNAJA1;KIAA0586
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.26713416108250726,-0.4524887323808208,1.0,1.0,1.0,2/10,24.41%,NCK1;TNS2
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.27450900449897053,-0.4450297577695446,1.0,1.0,1.0,2/9,24.41%,NCK1;TNS2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.2981976286006828,-0.44487093304544556,0.9814814814814815,1.0,1.0,2/5,29.61%,CD74;RAC1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.2981976286006828,-0.44487093304544556,0.9814814814814815,1.0,1.0,2/5,29.61%,CD74;RAC1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.2981976286006828,-0.44487093304544556,0.9814814814814815,1.0,1.0,2/5,29.61%,CD74;RAC1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.28810365951686673,-0.4421019387306861,1.0,1.0,1.0,4/6,34.29%,EMP2;CAMK2D;CCDC88C;GSN
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.2470149379180574,0.4409128254101806,1.0,1.0,1.0,2/7,16.68%,DDX17;PARN
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.2535923363491219,0.4401787798379014,1.0,1.0,1.0,7/7,74.69%,ROCK1;ACTG1;ROCK2;CDC42;AKAP13;RAC1;ALMS1
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.30306105392841487,-0.43537622328835157,0.9824561403508771,1.0,1.0,2/5,35.88%,TUBB4B;TUBB
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.30306105392841487,-0.43537622328835157,0.9824561403508771,1.0,1.0,2/5,35.88%,TUBB4B;TUBB
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.26015749768339513,0.43501314166767757,0.9411764705882353,0.9996087238014696,1.0,2/8,20.66%,PCM1;TBC1D32
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.24251368603493945,-0.433887689140982,1.0,0.9995571797181476,1.0,5/17,30.65%,TPR;NUP54;AGO2;NUP98;POLR2B
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.24251368603493945,-0.433887689140982,1.0,0.9995571797181476,1.0,5/17,30.65%,TPR;NUP54;AGO2;NUP98;POLR2B
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.2835106382978723,0.4309406345619854,1.0,0.9982698636428137,1.0,5/5,71.69%,RIC1;EPHA4;EFNA1;DAB2IP;ANXA2
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.2512693055437565,0.4276485444926986,1.0,0.9968479216375737,1.0,3/9,21.33%,TMEM106B;GNPTAB;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.26993731826123335,-0.4226031393857683,1.0,1.0,1.0,4/9,38.86%,LRCH1;ARFGEF1;DAB2IP;RDX
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.2729784844340528,-0.41356611279076344,0.9850746268656716,1.0,1.0,1/5,23.64%,PLXNA2
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.27342087446643837,-0.4111665004503977,0.9852941176470589,1.0,1.0,1/5,26.37%,ABCG1
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.2407745320080543,-0.40801598513673937,1.0,0.9997687231574583,1.0,4/10,32.38%,LCP2;CD74;FGR;BACH2
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.2636375540179141,-0.4058321770151133,1.0,0.9994557341435784,1.0,2/7,30.12%,CDH5;CDH18
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.23834333664311638,-0.39310083137728213,1.0,0.999640742475538,1.0,2/11,25.87%,TNKS2;TNKS
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.22818575475476305,-0.38853106954022054,1.0,0.9994152855566576,1.0,5/11,34.29%,RACK1;CDH5;RAP1B;ARFGEF1;GSN
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.23834027621056544,-0.37600549433428804,1.0,0.999364330753063,1.0,4/9,35.59%,AGO2;TUT7;PRKRA;SND1
